Poster P0001
Abstract 12
Decreased risk of nosocomial transmission of hepatitis B virus and hepatitis C virus among hemodialysis patients from southern Bulgaria
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Radka KOMITOVA
Poster P0002
Abstract 102
Re-engagement of formerly incarcerated people living with HIV lost to care
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Max BRITO
Poster P0003
Abstract 798
Metabolic co-morbidities among people living with HIV (PLWH) in an urban specialist HIV clinic in the United Kingdom
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Irfaan MAAN
Poster P0004
Abstract 1220
Impact of CRISPR-Cas gene cassettes on the packaging efficiency and transduction titer of lentiviral vectors
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Pascal Zion KROON
Poster P0005
Abstract 1306
High levels of HIV-1 recombinants circulating in Portugal
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Vitor DUQUE
Poster P0006
Abstract 1781
CRISPR-Cas therapy towards a cure for HIV/AIDS
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Elena HERRERA CARRILLO
Poster P0007
Abstract 2139
We need to talk about ART: a survey of clinicians and people living with HIV
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Amy BELFIELD
Poster P0008
Abstract 2261
Economic evaluation of post-exposure prophylaxis-in-pocket (PIP) compared to pre-exposure prophylaxis (PrEP) for individuals with a low frequency of high-risk HIV exposures: a matched control study
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Mia SAPIN
Poster P0009
Abstract 2991
The influence of concurrent low-dose oral calcium carbonate supplementation on steady state pharmacokinetics of once daily oral raltegravir
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Luana Leticia TEIXEIRA NUNES PORTO
Poster P0010
Abstract 3067
Perceived knowledge, attitudes, and practices of major non-communicable diseases and their risk factors among people living with HIV in Rwanda
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Vivianne UMUHIRE NIYONKURU
Poster P0011
Abstract 3192
Whole genome sequencing approach to identify HIV-1 drug resistance in clinical samples
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Sofiane MOHAMED
Poster P0012
Abstract 3558
Immune responses after mpox infection or vaccination in a cohort of HIV-PrEP users
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Aleksandra PETTKE
Poster P0013
Abstract 4176
Extinction of all infectious HIV in cell culture by the CRISPR-cjCas9 system
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Yuanling BAO
Poster P0014
Abstract 4307
Clinical impact of APOBEC mutations and prevalence in HIV antiretroviral resistance reports
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Lucia CHAVES BLANCO
Poster P0015
Abstract 4309
Ten years of HIV admissions at a tertiary infectious diseases centre: increased mortality and length of stay
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Bethan ENGLAND
Poster P0016
Abstract 4507
Update on transmitted resistances in treatment-naive patients in Spain (2022)
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Lucia CHAVES BLANCO
Poster P0017
Abstract 4515
Effect of HIV treatment milestones on the HIV care continuum and AIDS diagnoses in CoRIS (2005-2022).
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Alejandro G GARCIA-RUIZ DE MORALES
Poster P0018
Abstract 4528
Cabotegravir/rilpivirine long-acting for HIV treatment in a real-life setting: data from an Italian monocentric cohort
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Maddalena MATONE
Poster P0019
Abstract 4545
Prevalence and risk factors of sarcopenia among people living with HIV
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Jasmin JÄGER
Poster P0020
Abstract 4739
Quantification of HIV RNA in cerebrospinal fluid
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Sandro GRELLI
Poster P0021
Abstract 5143
Altered gut microbiota composition in virologically suppressed HIV-infected individuals on antiretroviral therapy: implications for chronic inflammation and metabolic health
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Joo EUN-JEONG
Poster P0022
Abstract 5411
NeuMoDx HIV viral load failure in a large group of Mayotte patients: viral diversity is still a challenge
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Benoit VISSEAUX
Poster P0023
Abstract 5552
Familiarity of primary care physicians and infectious diseases specialists with PrEP and their willingness to prescribe it in the MENA region
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Jihane NAOUS
Poster P0024
Abstract 6097
Gut innate immunity dysregulation and T cells activation go in parallel during HIV immunopathogenesis
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Luca MADDALONI
Poster P0025
Abstract 6287
HIV-DNA minority mutations profile in long-term infected paediatric population
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Luna COLAGROSSI
Poster P0026
Abstract 6543
Elimination of infectious HIV DNA by CRISPR–saCas9
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Zhenghao YU
Poster P0028
Abstract 6743
Provision of care among migrants and refugees in a tertiary care center in Romania
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Irina IANACHE
Poster P0030
Abstract 6879
Intersection of HIV, biological considerations and comorbidities in women living with HIV: impact of online independent medical education on physician knowledge and confidence
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Julia DUFFEY
Poster P0032
Abstract 7493
A retrospective review of equivocal HIV serology results at a London (UK) teaching hospital
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Merennage Anusha Yasanthi FERNANDO
Poster P0033
Abstract 7509
Endoscopic features of gastric cryptosporidiosis in patients with HIV
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Takashi SHINHA
Poster P0034
Abstract 8141
High level of archived and circulating HIV-1 drug resistance mutations in adolescents with suppressed and unsuppressed viral loads in Cameroon
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Armando Blondel DJIYOU DJEUDA
Poster P0035
Abstract 8307
The newly developed NeuMoDx HIV-1 quant assay compared to the established alinity m HIV-1 assay for routine viral load measurement
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Robert EHRET
Poster P0036
Abstract 8510
HIV prevalence rates amongst migrant sex workers in Europe
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Denis ONYANGO
Poster P0037
Abstract 8712
A framework to evaluate the effectiveness of models of care for people with HIV (PWH)
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Giovanni GUARALDI
Poster P0038
Abstract 8914
Delayed HIV diagnoses in the West of Ireland
27/04 12:00
01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)
Ellen WALSH
Poster P0039
Abstract 387
Comparison of non-invasive methods and liver biopsy for detection of liver fibrosis associated with chronic hepatitis B
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Mine FILIZ
Poster P0040
Abstract 389
Investigation of stanniocalcin-1 as a new biomarker in the detection of chronic hepatitis B associated liver fibrosis: a pilot study
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Mine FILIZ
Poster P0041
Abstract 440
Distribution and relevance of hepatitis B genotypes in the general population of Slovakia
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Ivana HOCKICKOVA
Poster P0042
Abstract 748
The characteristic of maternal HBV quasispecies is related to occult HBV infection of infants born to highly viremic mothers
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Yi LI
Poster P0043
Abstract 1145
Repressed expression of human endogenous retroviruses HERV-K (HML-2) and HERV-9 in chronic hepatitis C patients with endogenous activation of the interferon system in the liver
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Konstantina KITSOU
Poster P0044
Abstract 1248
New molecular assay for the detection and quantification of hepatitis B virus load in EDTA-plasma
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Irene CORTÉS PORTERO
Poster P0045
Abstract 1853
Is HBV RNA a promising biomarker in chronic hepatitis B?
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Aikaterini SKEVA
Poster P0046
Abstract 2301
In silico 3-D structural prediction and characterisation of hepatitis E virus RNA-dependant RNA-polymerase (RdRp) region for antiviral research
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Vikram THAKUR
Poster P0047
Abstract 2542
On the road to Hepatitis C elimination, the need for screening beyond risk factors
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Manuel RODRÍGUEZ MARESCA
Poster P0048
Abstract 2736
Hepatitis Delta virus variability in Italy
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Anna Rosa GARBUGLIA
Poster P0049
Abstract 2783
Hepatitis B associated with severe COVID-19: a nationwide cohort study in Sweden
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Frida JAKOBSSON
Poster P0050
Abstract 3070
Diagnostic performance of two chemiluminescence immunoassays for the detection and quantification of hepatitis B virus surface antigen (HBsAg): a comparative study
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Felipe PÉREZ-GARCÍA
Poster P0051
Abstract 3208
Surveillance of the zoonotic rat hepatitis E virus in rodents in Spain
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Javier CABALLERO GÓMEZ
Poster P0052
Abstract 3591
Evaluation of RT-qPCR for the diagnosis of active hepatitis D virus (HDV) through a single-step approach
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Helena GARCIA LOPEZ
Poster P0053
Abstract 4512
Detection and quantification of hepatitis delta virus RNA by three different assays
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Marta ILLESCAS LÓPEZ
Poster P0054
Abstract 4656
An innovative strategy to relink into care patients with active HCV infection.
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Federico GARCIA
Poster P0055
Abstract 4899
Outbreak of acute hepatitis HCV in HIV-infected individuals
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Goretti REDONDO
Poster P0056
Abstract 4989
Antibody coated liposomes for transmucosal vaccination
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Saurabh BHARGAVA
Poster P0057
Abstract 5198
Limited uptake of hepatitis D virus testing in people living with hepatitis B virus infection in Australia
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Krispin HAJKOWICZ
Poster P0058
Abstract 5405
Hepatitis B infection and immunity in Timor-Leste: a population-representative serological survey
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Joshua FRANCIS
Poster P0059
Abstract 2418
Hepatitis C virus (HCV) screening in an emergency department (ED), an effective strategy to hepatitis C elimination
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Manuel RODRÍGUEZ MARESCA
Poster P0060
Abstract 5784
Analytic validation of a lab-developed qPCR assay for fully-automated high-throughput detection of Rocahepevirus ratti (ratHEV)
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Marc LUETGEHETMANN
Poster P0061
Abstract 5914
Predictive factors for progression of fibrosis in chronic HBV infection on the indeterminate phase
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Sana ROUIS
Poster P0062
Abstract 6072
The newly developed NeuMoDx HBV Quant Assay compared to the established Alinity m HBV Assay in routine viral load measurement
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Robert EHRET
Poster P0063
Abstract 6459
The newly developed NeuMoDx HCV Quant Assay compared to the established Alinity m HCV Assay in routine viral load measurement
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Robert EHRET
Poster P0064
Abstract 6836
Prevalence of HDV infection in HBV positive patients from University Hospital in North Sardinia: updated data
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Lucia DENTI
Poster P0065
Abstract 7288
Performance of a new fully automated platform for HIV, HBV and HCV viral load assessment
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Susana BANDARRA
Poster P0066
Abstract 7438
Evaluation and usefulness of rapid molecular assay for hepatitis C virus RNA detection
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Livia MELO VILLAR
Poster P0067
Abstract 7523
A large outbreak of hepatitis A in a northern community in Canada 2021-2022: public health interventions and immunisation in a remote context
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Yassen TCHOLAKOV
Poster P0068
Abstract 7968
Evaluation of the virological profile of pregnant women infected with the hepatitis B virus treated at a referral center in Rio de Janeiro, Brazil
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Livia MELO VILLAR
Poster P0069
Abstract 8207
Hepatitis E virus molecular surveillance in Hungary between 2018-2023 reveals infections with rare subtypes
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Agnes DENCS
Poster P0070
Abstract 8330
Profile of patients diagnosed with active HCV infection in an emergency department in Almeria, Spain
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Manuel RODRÍGUEZ MARESCA
Poster P0071
Abstract 8358
Opportunistic rescue of patients with HCV infection and lost in the healthcare system: results of the relink-C study in Almeria, Spain
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Manuel RODRÍGUEZ MARESCA
Poster P0072
Abstract 8594
3Hdtect-Q real-time PCR kit for simultaneous detection and differentiation of HIV, HCV and HBV in human plasma, serum and whole blood samples
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
Bahadur Singh GURJAR
Poster P0073
Abstract 8911
Is it cost-effective to implement double reflex testing strategy to diagnose hepatitis D-superinfection? Reflections from Sweden representing a country with low prevalence of hepatitis B and D viruses
27/04 12:00
1b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)
John WALLES
Poster P0074
Abstract 77
Underdiagnosis of viral aetiologies in moderate-to-severe community-acquired pneumonia: an important clinical gap
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ng DOROTHY HUI LIN
Poster P0075
Abstract 137
Phylogenetic lineage dynamics of global parainfluenza virus type 3 post-COVID-19 pandemic
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Kuenyoul PARK
Poster P0076
Abstract 287
Nanobody-based PROTAC strategy provides broad-spectrum antiviral activity against porcine arterivirus
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Fandan MENG
Poster P0077
Abstract 400
Frequency of respiratory virus detection in the upper respiratory tract of hospitalised patients
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Charalampos ZARRAS
Poster P0078
Abstract 429
Beyond influenza and SARS-CoV-2: advancing respiratory sentinel surveillance in Sweden
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Carmen ESPINOSA-GONGORA
Poster P0079
Abstract 454
Prophylactic efficacy of CD388, a novel drug-Fc conjugate (DFC), in an influenza A/H3N2 human challenge model
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Roxana E. ROJAS
Poster P0080
Abstract 504
Clinical performance evaluation of two commercial antigen test kits for diagnosis of SARS-CoV-2, influenza A and influenza B infection
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Jeonghyun CHANG
Poster P0081
Abstract 670
Respiratory syncytial virus infections in recipients of bone marrow transplantations: a systematic review and meta-analysis
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Matteo RICCÒ
Poster P0082
Abstract 673
Influenza virus, SARS-CoV-2, respiratory syncytial virus, rhinovirus, adenovirus, bocavirus, and other respiratory virus circulation during 2022–2023 season in Latvia: focus on codetections
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Oksana SAVICKA
Poster P0083
Abstract 739
The resurgence of influenza activity and out-of-season epidemics of RSV during the Omicron waves in Beijing, China
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Yi LI
Poster P0084
Abstract 802
Determination of RSV reinfection in a German population cohort between 2020 and 2023 using a newly established RSV antigen-derived 9-plex immunoassay (RSV MIA)
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Patrick MARSALL
Poster P0085
Abstract 917
Risk of cardiovascular events after influenza: a population-based self-controlled case series study, Spain 2011-2018
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Cintia MUÑOZ-QUILES
Poster P0086
Abstract 1082
Evaluation and comparison of three case definitions for influenza detection in the same setting and population in the Valencia region of Spain
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ainara MIRA-IGLESIAS
Poster P0087
Abstract 1115
Rapid intra-season waning of vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Alexander DOMNICH
Poster P0088
Abstract 1246
Consumer preferences for features of influenza vaccines in the United Kingdom: results from a discrete-choice experiment study
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Darshan METHA
Poster P0089
Abstract 1281
General population and healthcare professionals' level of knowledge of the burden and prevention of respiratory syncytial virus and other respiratory infections in France
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Joshua PUEL
Poster P0090
Abstract 1338
A generic, saliva-based PCR test for the detection of RSV offers a low-burden approach for sustainable surveillance of RSV
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Anne WYLLIE
Poster P0091
Abstract 1426
A nationwide retrospective cohort study to assess the relative vaccine effectiveness of high-dose compared to standard dose influenza vaccines in France during the 2021-2022 season: results of a complementary analysis of DRIVEN study
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Hélène BRICOUT
Poster P0092
Abstract 1446
Comparison of efficacy and safety between baloxavir marboxil and oseltamivir in outpatients with uncomplicated influenza: a real-world study of more than 1,500 patients
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Yu LUO
Poster P0093
Abstract 1458
Clinical characteristics, complications, and predictors of serious outcomes among adult outpatients with respiratory syncytial virus infection
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Suwei WANG
Poster P0094
Abstract 1550
The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: a meta-analysis of evidence from randomized trials
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Kristoffer Grundtvig SKAARUP
Poster P0095
Abstract 1581
Clinical assessment of a fully automated RT-PCR assay for the qualitative detection of parainfluenza virus 1,3 and 2/4 in human nasal/throat swabs under IVDR
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Jasmin KÖFFER
Poster P0096
Abstract 1587
Evaluation of the clinical performance of a fully automated RT-PCR assay for the qualitative detection of RSV and hMPV in human nasal/throat swabs and bronchoalveolar lavage under IVDR
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ulrich EIGNER
Poster P0097
Abstract 1748
Higher waist circumference was associated with reduced cellular immune response to influenza vaccine: findings from the DYNAMIC cohort study of older adults in Singapore
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Sapna P. SADARANGANI
Poster P0098
Abstract 1873
Relative effectiveness of an adjuvanted influenza vaccine vs non-adjuvanted influenza vaccines in high-risk older adults during the 2019-2020 U.S. influenza season
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Emanuele CIGLIA
Poster P0099
Abstract 2054
A behaviour change techniques analysis, systematic review meta-analysis and meta-regression of communication-mediated interventions supporting influenza vaccination uptake in adults in primary care settings
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Bilal QURESHI
Poster P0100
Abstract 2095
Cost-effectiveness of protective equipment stockpiles for reducing essential worker absenteeism in a pandemic: a modelling study
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Nadia X MONTAZERI
Poster P0101
Abstract 2136
Increased 90 days mortality associated with RSV compared to influenza among adults in Denmark
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Thomas BENFIELD
Poster P0102
Abstract 2285
Isolation of monoclonal antibodies against human parainfluenza virus type 3 strains
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Foong Ying WONG
Poster P0102
Abstract 1948
Galectin-3 regulates viral pathogenesis and inflammation in H5N1 and H7N9 avian influenza virus infections
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Zih-Syuan YANG
Poster P0103
Abstract 2395
Quantitative analysis of FluNet surveillance data: has B Yamagata really gone extinct?
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Laurent COUDEVILLE
Poster P0104
Abstract 2679
Comparison of three commercial nucleic amplification tests for influenza A testing in a symptomatic patient population
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Salma KODSI
Poster P0105
Abstract 2686
RSV circulation in the SARS-Cov-2 pandemic era in the north of Spain (Asturias)
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Marta Elena ALVAREZ-ARGÜELLES
Poster P0106
Abstract 2687
Influenza A and B viral loads are higher in nasopharyngeal swabs compared to mid-turbinate swabs
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Steffen WILDUM
Poster P0107
Abstract 2738
Estimating the health and economic burden of pneumococcal diseases attributable to V116 vs PCV20 serotypes among adults in Spain
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Muloongo SIMUZINGILI
Poster P0108
Abstract 2818
Respiratory syncytial virus as single detection is associated with younger age and worse clinical outcomes
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Anna CREUS-COSTA
Poster P0109
Abstract 2935
Next-generation mRNA-based seasonal influenza vaccines including additional A/H3N2 strains: Phase 1/2 trial findings in adults aged 50-75 years
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Denise HSU
Poster P0110
Abstract 2979
Respiratory syncytial virus incidence trends during omicron COVID pandemic in older adults: a community-based prospective study
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Wendelyn BOSCH
Poster P0111
Abstract 3036
The utility of multiplex real-time PCR screening for viral respiratory infections
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Reda AMRANI-SOUHLI
Poster P0113
Abstract 3257
A comparative study of the incidence, risk factors and outcome of hospitalised adults with RSV vs influenza A infection
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Amos ADLER
Poster P0114
Abstract 3286
Tracking seasonal influenza trends in South Tyrol during season 2022-2023
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Irene BIANCONI
Poster P0115
Abstract 3288
Enterovirus landscape in Barcelona: A virological surveillance journey through the 2020-2023 seasons in the shadow of the COVID-19 pandemics
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Cristina ANDRÉS
Poster P0116
Abstract 3398
Seasonal trends in sentinel surveillance: a seven-year retrospective analysis from the Aegean region, Turkiye (2016-2023)
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Özlem TÜRKMEN RECEN
Poster P0117
Abstract 3415
Unraveling the genetic, antigenic, and antiviral landscape of influenza viruses circulating in Catalonia (Spain) during the 2022-2023 season
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Cristina ANDRÉS
Poster P0118
Abstract 3500
Identification of granzymes as crucial regulators and potential targets of influenza-associated immunopathology and superinfections
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Marcela GARZÓN-TITUAÑA
Poster P0119
Abstract 3656
Severe manifestations of parainfluenza type 4 infections in children
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Kenta KURUMA
Poster P0120
Abstract 3703
Decoding severity: the GIHSN SevScale for hospitalised ARI cases
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Bronke BOUDEWIJNS
Poster P0121
Abstract 3876
Assessing the cost-effectiveness and public health impact of the adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in Canadian older adults
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
George SYDNEY
Poster P0122
Abstract 3877
Do pregnant women get the flu shot? A view over Greece
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Panagiota Georgia MALTEZOU
Poster P0123
Abstract 3999
Mapping the trends of non-SARS-CoV-2 respiratory viruses: a 2016–2023 analysis in a Rome hospital microbiology laboratory
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Rosaria SANTANGELO
Poster P0124
Abstract 4027
Digitally facilitated access to information on influenza complications and its prevention: a multicentric study
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Nagham Léa KHANAFER
Poster P0125
Abstract 4058
Estimation of RSV-attributable mortality in adults in Italy between 2015 and 2019
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Giuseppe Pietro INNOCENTI
Poster P0126
Abstract 4079
Modelling the health and economics benefits of a rapid vaccine intervention in an influenza pandemic in the United Kingdom
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ray LONGSTAFF
Poster P0127
Abstract 4116
Changes in influenzavirus-A/B and human respiratory syncytial virus seasonality and activity during the COVID-19 pandemic in Switzerland
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Karoline LEUZINGER
Poster P0128
Abstract 4278
Estimated impact of delayed influenza vaccine strain selection on vaccine effectiveness: a descriptive and modeling study
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ombeline JOLLIVET
Poster P0129
Abstract 4529
Nosocomial acquisition, a zoom on respiratory viruses (NAZARE): A laboratory-based surveillance study to explore epidemiology and risk factors
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Quentin LE HINGRAT
Poster P0130
Abstract 4580
Impact of community pharmacy vaccination services on vaccination coverage of immunocompromised patients against respiratory tract infections
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Daniel J.G. THIRION
Poster P0131
Abstract 4673
Estimating the health and economic burden of pneumococcal diseases attributable to V116 vs PCV20 serotypes among adults in Switzerland
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Muloongo SIMUZINGILI
Poster P0132
Abstract 4963
Molecular epidemiology of rhinovirus: genotypes detected during and after the COVID-19 pandemic
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
William Fernando CHAPARRO-PICO
Poster P0133
Abstract 4971
Setting the bar for new generation influenza vaccine reactogenicity: expected clinical and cost tradeoffs compared to standard-of-care vaccines
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
José BARTELT-HOFER
Poster P0134
Abstract 4979
Validation of a genome sequencing protocol for influenza B viruses
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Alexandra PRESBITERO
Poster P0135
Abstract 4987
Diversification of the ON1 genotype of HVRS-A on the coast of Peru during 2009-2020
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Wilmer SILVA-CASO
Poster P0136
Abstract 5225
The clinical and economic value of MF59-adjuvanted quadrivalent influenza vaccination in the elderly in Argentina
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Jose MONTES
Poster P0137
Abstract 5516
Hospital and community epidemiology of SARS-CoV-2, influenza and RSV during 2022/2023 season in Auvergne-Rhône-Alpes, France: a comparative analysis
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Benoit VISSEAUX
Poster P0138
Abstract 5600
Economic burden of respiratory syncytial virus (RSV) and unspecified lower respiratory tract infection (UBP) during RSV season in adults in Germany (2015-2018): a health claims analysis
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Caroline BEESE
Poster P0139
Abstract 5723
Subtyping and whole-genome sequencing of influenza A/B viruses using pan-subtype primers, widely-used library prep reagents, and cloud-based data analysis
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Robert SCHLABERG
Poster P0140
Abstract 5738
Impact of COVID-19 pandemic on influenza vaccination rates among healthcare personnel at a tertiary-care centre in Lebanon
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Eid AZAR
Poster P0141
Abstract 5744
Molecular investigation of seasonal viral respiratory outbreaks
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Jack O'NEILL
Poster P0142
Abstract 6186
Respiratory syncytial virus burden in older adults (≥ 60 years): a two-year Italian multicentre study in the late COVID-19 pandemic and early post-pandemic period
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Federica NOVAZZI
Poster P0143
Abstract 6204
Serological investigation of RSV antibody responses in UK healthcare workers (SIREN study)
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ashley OTTER
Poster P0144
Abstract 6211
Co-circulation of influenza, SARS-CoV-2 and RSV (tripledemic) among severe acute respiratory infection cases in the Philippines, 2022-2023
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Vina Lea ARGUELLES
Poster P0145
Abstract 6317
Self-collected saliva demonstrates utility for influenza surveillance by extraction-free PCR
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Janet WILLIAMSON
Poster P0146
Abstract 6605
Overview of adenovirus respiratory infections: preliminary findings of a multicentre study in Italy, 2022-2023
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Federica GIARDINA
Poster P0147
Abstract 6694
Modelling the impact on carbon emissions of using a high dose influenza vaccine instead of standard dose among 65 years and older adults in France
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Hélène BRICOUT
Poster P0148
Abstract 6775
Comparison of burden of respiratory syncytial virus hospitalisation in paediatric population during two consecutive seasons 2021-2023
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Cristina VEINTIMILLA
Poster P0149
Abstract 6790
Early assessment of viral respiratory epidemics for the 2023/2024 season based on community laboratory surveillance network in France
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Benoit VISSEAUX
Poster P0150
Abstract 6798
A novel multiplex, quantitative immunoassay for anti-influenza IgG demonstrates individual variability in binding specificity targeting antigenically distinct haemagglutinin proteins
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Del DSOUZA
Poster P0151
Abstract 6829
Influenza like-illness surveillance using a Belgian sentinel network of nursing homes: results of October 2022 onwards
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Karl MERTENS
Poster P0152
Abstract 6840
Understanding antibody cross-reactivity between seasonal Influenza and H5N1 as a method to conduct H5N1-specific serosurveillance
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ashley OTTER
Poster P0153
Abstract 7117
Serological responses to a boosted tetravalent influenza vaccine regimen in multiple myeloma patients: evaluating the impact of daratumumab treatment.
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Simon GRESSENS
Poster P0154
Abstract 7125
Changing pattern of respiratory virus detection among severe acute respiratory syndrome corona virus: two symptomatic patients in the central province of Sri Lanka
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Shiyamalee ARUNASALAM
Poster P0155
Abstract 7133
Investigating innovative system methods for the diagnosis of respiratory viruses for rapid clinical diagnosis
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Gozde AKKUS KAYALI
Poster P0156
Abstract 7444
Impact of hospitalisations due to respiratory syncytial virus in a highly complex public paediatric hospital in Brazil, between January 2021 and May 2023
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Marcelo OTSUKA
Poster P0157
Abstract 7448
Tasmania's COVID mitigation strategies provide insights into respiratory syncytial virus evolution
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Christopher Thomas ATKINSON
Poster P0158
Abstract 7470
Trends and severity of parainfluenza virus infections over the past decade
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Marta Elena ALVAREZ-ARGÜELLES
Poster P0159
Abstract 7533
Further characterisation of vaccine efficacy in infants from a Phase 3 RCT of a bivalent prefusion F RSV vaccine administered during pregnancy
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Emma SHITTU
Poster P0160
Abstract 7644
Impacts on respiratory viruses among hospitalised children with respiratory diseases after lifting COVID-19 restrictions
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Yo MURATA
Poster P0161
Abstract 7675
Pre-immunisation landscape of human respiratory syncytial virus: genomic insights from Catalonia's SIVIC programme in the era of neutralising monoclonal antibody deployment
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Maria PIÑANA
Poster P0162
Abstract 7986
Neutralising monoclonal antibodies raised against highly conserved influenza hemagglutinin, neuraminidase, and matrix epitopes may offer novel cocktail therapeutic strategies
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Clara J SEI
Poster P0163
Abstract 8031
Oxford Nanopore Sequencing revolutionizes Influenza surveillance in resource-limited settings
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Debasis BISWAS
Poster P0164
Abstract 8050
Impact of influenza-related hospitalisation in Spain: characteristics and risk factor of mortality during five influenza seasons (2016 to 2021)
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
José Manuel RAMOS
Poster P0165
Abstract 8065
CD388, a drug-Fc conjugate, shows long half-life in early clinical studies
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Ruben FAELENS
Poster P0166
Abstract 8066
Using nanopore amplicon sequencing data for rapid analysis of influenza type A
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Oscar ASPELIN
Poster P0167
Abstract 8138
Verification of the Savanna respiratory viral panel-4 as a rapid screening tool for respiratory viral infections
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Marijke REYNDERS
Poster P0168
Abstract 8316
What was the burden of winter pressures on the UK SIREN healthcare worker cohort winter 2022-23?
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Victoria HALL
Poster P0169
Abstract 8605
Forecasting the epidemiological trends of pediatric acute respiratory infections at the community level using time series predictive models: an Italian scenario
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Costanza DI CHIARA
Poster P0170
Abstract 8722
Evaluation of the performance of the Hologic Panther fusion 4 plex-assay
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Robert EHRET
Poster P0171
Abstract 8879
RSV viral load and co-infection in a very large cohort of pediatric patients, which role in the disease severity?
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Rossana SCUTARI
Poster P0172
Abstract 8884
Differences in influenza vaccination among healthcare workers: impact of work task, area of membership and gender
27/04 12:00
1c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance)
Vincenzo PAOLOZZI
Poster P0174
Abstract 1940
Age-sex patterns of human herpesvirus infection seroprevalences among hospitalised patients in Paris area, France, 2016 to 2022
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Olivier SUPPLISSON
Poster P0175
Abstract 2191
Cytomegalovirus reactivation in critically ill mechanically ventilated patients
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Atul GARG
Poster P0176
Abstract 3109
Validation of a herpes zoster conceptual model on quality of life in East Asia
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Cheryl NG
Poster P0177
Abstract 3761
Clinical relevance of human herpesvirus-7 DNA detection in a tertiary care setting over a 13-year period
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Annika BARGETZI
Poster P0178
Abstract 4248
Varicella-zoster virus circulating clades in a French tertiary referral centre, Paris, France, 2018-2023
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
David BOUTOLLEAU
Poster P0179
Abstract 4480
Oedema volume on admission may predict poor outcome in HSV-encephalitis, varies in reliability across aetiologies and lower oedema volumes
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Youssef ALY
Poster P0180
Abstract 4579
Potential relationship between cytomegalovirus and immunosenescence: evidence from observational studies
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
John DIAZ-DECARO
Poster P0181
Abstract 4710
Incidence and risk factors for varicella-zoster virus central nervous system infections
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Tobias TYRBERG
Poster P0182
Abstract 5679
The association between acyclovir-related neurotoxicity and its concentration
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Chia-Chi CHEN
Poster P0183
Abstract 5789
Ganciclovir/valganciclovir therapy in congenital CMV infection: 24-year experience of a tertiary care children hospital in northern Italy
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Erica RICCI
Poster P0184
Abstract 5946
CMV plasma reactivation predicts CMV organ disease in patients with moderate to severe ulcerative colitis needing hospitalisation
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Matteo RINALDI
Poster P0185
Abstract 6356
Immune response to human herpes virus in SARS-CoV-2 mild infection
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Serena VITA
Poster P0186
Abstract 6367
Review of laboratory testing and processing protocols for varicella zoster virus in a north London hospital
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Cavan James O'CONNOR
Poster P0187
Abstract 6451
Trends in hospitalisations related to herpes zoster in Denmark from 1998 to 2021
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Mads Frederik EIBERG
Poster P0188
Abstract 6548
CMV infection in pregnancy: a 5-years clinical experience of the regional reference center for infections in pregnancy in a low-birth Italian region
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Carolina SAFFIOTI
Poster P0189
Abstract 6993
Management of CMV primary infection in pregnancy and neonatal outcome in the era of valacyclovir treatment: a monocentric prospective study
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Carolina SAFFIOTI
Poster P0190
Abstract 7149
Comparison of two IVDR molecular diagnostic assays for the detection of HSV-1, HSV-2 and VZV in lesions and ulcers.
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Michelle LISTER
Poster P0191
Abstract 7188
Cytomegalovirus infection in patients hospitalised in intensive care
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Zohra BENEZZINE
Poster P0192
Abstract 7780
Herpetic gingivostomatitis caused by human herpesvirus type 7: a new entity?
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Agustin ESTEVEZ
Poster P0193
Abstract 8040
The role of Epstein-Barr virus in children with post-acute sequelae of SARS-CoV-2 infection in Taiwan
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Yu-Lung HSU
Poster P0194
Abstract 8688
Development and clinical validation of extraction-free loop-mediated isothermal amplification assays for rapid detection and subtyping of herpes simplex virus
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
Monique ANDERSSON
Poster P0195
Abstract 8862
Antigen-specific immunoassays improve the serological staging of cytomegalovirus infection
27/04 12:00
1d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)
David SPRINGER
Poster P0196
Abstract 193
sST2 is a potential biomarker for early prognostication of severe dengue
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Po Ying CHIA
Poster P0197
Abstract 231
Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients may not improve prognosis: retrospective analysis with overlap weighting using a national inpatient database
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Satoshi KUTSUNA
Poster P0198
Abstract 301
Development of a clinical scoring system to make a presumptive diagnosis of Kyasanur Forest disease: a case-control study from South India
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Nitin GUPTA
Poster P0199
Abstract 524
Autochtonous dengue outbreak in Lombardy region, Italy, 2023: results of a seroprevalence study
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Irene CASSANITI
Poster P0200
Abstract 786
Effect of montelukast in preventing dengue with warning signs among patients with dengue: a multicentre, randomised, double-blind, placebo-controlled trial
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Nattapat NITINAI
Poster P0201
Abstract 853
Exploratory analysis of the knowledge, attitudes and perceptions of healthcare workers about arboviruses in the context of surveillance in the Republic of Guinea
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Salifou Talassone BANGOURA
Poster P0202
Abstract 878
NS1-based IgG FcγR Enzyme-Linked Immunosorbent Assays allow serological differential diagnosis of dengue and zika virus infections in both returning travellers and individuals from endemic regions
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Christina DESCHERMEIER
Poster P0203
Abstract 905
NanoHarmony: unleashing silver's whisper in swift Zika detection
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Mayank GANGWAR
Poster P0204
Abstract 912
Factors associated with mpox vaccination willingness and uptake among men who have sex with men
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Shui Shan LEE
Poster P0205
Abstract 1119
Intensified surveillance for tick-borne encephalitis to identify possible places of infection in Bavaria, Germany, May–October 2023
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Jasmin METZ
Poster P0206
Abstract 1124
Lassa virus: unravelling the within-host evolutionary dynamics of acute and persistent infections and the virulence evolution among hosts
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Liana KAFETZOPOULOU
Poster P0207
Abstract 1216
Correlation between the cycle threshold values of medium- and small-segment severe fever with thrombocytopenia syndrome virus and viral load: prognostic implications
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Lee SEUNGHEE
Poster P0208
Abstract 2152
Do infectious diseases specialists and neurologists manage patients with tick-borne encephalitis differently?
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Dasa STUPICA
Poster P0209
Abstract 2253
A ‘living' rapid research needs appraisal platform for WHO priority diseases: henipavirus evidence-gaps
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Louise SIGFRID
Poster P0210
Abstract 2340
Spatio-temporal distribution of Crimean-Congo hemorrhagic fever and the effect of climate factors and Eid ul Adha in Pakistan: a decade-long experience from tertiary care laboratory network
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Muhammad Abbas ABID
Poster P0211
Abstract 2538
Laboratory results of mpox suspected cases tested by differential diagnostic panel during the mpox outbreak in Hungary in 2022/2023
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Dániel DÉRI
Poster P0212
Abstract 2565
Exploring mpox genome variations amidst the 2022 outbreak
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Michela DEIANA
Poster P0213
Abstract 2592
First detection of the zoonotic rat hepatitis E virus in pigs
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
María CASARES JIMÉNEZ
Poster P0214
Abstract 2628
Clinical importance of Alongshan virus, a new tick-borne Flaviviridae virus: a retrospective serological and molecular study
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Florian TAGINI
Poster P0215
Abstract 2718
Assessing the synergistic insecticidal activity of Syzygium aromaticum and Citrus aurantifolia leaf extract combination against Aedes vectors
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Malshi GALAPPATHTHI
Poster P0216
Abstract 2739
Orthopoxvirus differential diagnosis by neutralising antibodies in mpox patients and vaccinated individuals
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Concetta CASTILLETTI
Poster P0217
Abstract 2770
MCP-3 as a prognostic biomarker for severe fever with thrombocytopenia syndrome: a longitudinal cytokine profile Study
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Zishuai LIU
Poster P0218
Abstract 2900
Prospective evaluation of serum cytokines and musculoskeletal ultrasound as surrogate markers for chronic post-chikungunya rheumatism
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Hugh WATSON
Poster P0219
Abstract 2909
A question from an endemic area: which diseases are included in the differential diagnosis with CCHF?
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Esma ERYILMAZ-EREN
Poster P0220
Abstract 3020
Increased likelihood of leukopenia, thrombocytopenia, and other characteristics in Crimean-Congo haemorrhagic fever patients: a systematic review and analysis of clinical factors that indicate infection
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Joseph ALBERTS
Poster P0221
Abstract 3026
Dengue vaccine: a risk model to prioritise and maximize the impact of a dengue vaccination program in Peru
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Antonio QUISPE
Poster P0222
Abstract 3034
Mayaro virus and chikungunya virus IgM and IgG testing in parallel improves diagnosis of acute mayaro virus infections
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Fabian LINDHORST
Poster P0223
Abstract 3354
Epidemiology trends of infections and outbreaks of Crimean-Congo hemorrhagic fever worldwide, 2017-2023.
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Luca ZWEERS
Poster P0224
Abstract 3385
Strengthening preparedness to arbovirus infections in Europe: a prospective, observational study in southeast Europe
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Xin Hui CHAN
Poster P0225
Abstract 3479
Expression of galectin-3 ameliorates zika virus infection
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Jie-Yu HUANG
Poster P0226
Abstract 4270
Assessing the endemicity of Japanese encephalitis in central India: a comprehensive study of human and animals in Madhya Pradesh
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Ram Kumar NEMA
Poster P0227
Abstract 4563
A meta-analysis and mapping of global mpox infection among children and adolescents
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Tarun Kumar SUVVARI
Poster P0228
Abstract 4854
Clinical presentation and viral shedding in patients with mpox in South Korea
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Min-Kyung KIM
Poster P0229
Abstract 4900
Clinical-laboratory features and predictive factors for sequelae of tick-borne encephalitis virus infection: a retrospective observational study
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Nicole BARP
Poster P0230
Abstract 4909
Tick of the iceberg: using a One Health approach to assess and respond to the threat of tick-borne encephalitis in England
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Berkin HACK
Poster P0231
Abstract 5070
Relation of WNV seroprevalence with ABO and D blood groups among blood donors: implication for transfusion safety
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Rym AYARI
Poster P0232
Abstract 5148
Clinical and microbiological study of bacterial or fungal co-infections in severe fever with thrombocytopenia syndrome
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Hiroyuki TANAKA
Poster P0234
Abstract 5317
Enhancing clinical diagnosis of dengue: performance evaluation of NS1 antigen and IgG/IgM antibody tests
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Kyu Tae CHOI
Poster P0235
Abstract 5335
Mpox in Colombia: an analysis of the 4,114 PCR confirmed cases in June 2022-November 2023
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Alfonso J. RODRIGUEZ-MORALES
Poster P0236
Abstract 5686
Co-detection of RNA and DNA viruses in a single library prep and enrichment workflow
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Robert SCHLABERG
Poster P0237
Abstract 5905
Results from a large-scale dengue diagnostic accuracy systematic review and meta-analysis: NS1 ELISA performs similarly to RT-PCR
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Ellen SUGRUE
Poster P0238
Abstract 5977
TBE vaccination: insights from a KAB survey among Lyme borreliosis cases in Bavaria, Germany, 2019
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Stefanie BÖHM
Poster P0239
Abstract 6027
Children hospitalised with Crimean-Congo haemorrhagic fever in Turkiye have different clinical and diagnostic features and lower mortality than adults, implying that diagnostic criteria and illness severity scoring systems need adaptation for use in children
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Ilkay BOZKURT
Poster P0240
Abstract 6094
Elevated plasma level of IP-10 /CXCL10 is correlated with severity of human West Nile virus (WNV) infection
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Giada ROSSINI
Poster P0241
Abstract 6205
Effect of severe fever with thrombocytopenia syndrome virus genotype on disease severity, viral load, and cytokines in South Korea
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Ji-Soo KWON
Poster P0242
Abstract 6538
Clinical findings and IL-6 levels in patients with dengue
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Anandi GOEL
Poster P0243
Abstract 6566
Arthropod-borned zoonosis in Cádiz, south of Spain: serological prevalence in a high-risk group
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Natalia MONTIEL QUEZEL-GUERRAZ
Poster P0244
Abstract 6643
Development and validation of the PLNA score to predict cytokine storm in patients with acute phase of SFTS: a single-center cohort study
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Zishuai LIU
Poster P0245
Abstract 6773
Hybrid capture-based next-generation sequencing: implementation for Lassa virus for the recovery of in-depth viral genomic data
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Ine BOONEN
Poster P0246
Abstract 6809
Development of a multiplexed serological mpox assay for diagnostics, serosurveillance, and immunology studies
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Scott JONES
Poster P0247
Abstract 6826
Genotypic diversity and molecular characterisation of DENV-2 in endemic areas of Peru during 2016-2021
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Wilmer SILVA-CASO
Poster P0248
Abstract 6867
The clinical characteristics of human mpox disease before and after the 2022 outbreak: any difference? a metaanalysis study
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Parnian JAMSHIDI
Poster P0249
Abstract 7432
Early identification of complex biomarker signatures predicting plasma leakage in dengue patients
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Samaneh MOALLEMI
Poster P0250
Abstract 7758
Genetic characteristics of aigai virus: a recently reclassified orthonairovirus
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Anna PAPA-KONIDARI
Poster P0251
Abstract 7981
Knowledge, risk perception and attitudes about mpox and the implementation of preventive measures in people belonging to the LGTBIQ+ community in Colombia
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Candida Rosa DIAZ BROCHERO
Poster P0252
Abstract 8019
Adjuvanted unconjugated highly conserved multi-epitope influenza peptide vaccine induced broadly reactive antibodies to multiple influenza viruses in pigs
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Kellie Ann KROSCHER
Poster P0253
Abstract 8120
Investigating the pathogenesis of Middle East respiratory syndrome coronavirus infection using a quantitative phosphoproteomics approach
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Jasper CHAN
Poster P0254
Abstract 8327
Evaluation of viral load and neutralising antibody levels in Crimean-Congo hemorrhagic fever patients
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Mert Ahmet KUSKUCU
Poster P0255
Abstract 8393
Nanopore sequencing of RdRp gene used as a genetic marker for characterization of coronaviruses in clinical samples
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Iris SARMIENTO GUÀRDIA
Poster P0256
Abstract 8485
Mpox experience at a tertiary infectious diseases centre in a tropical country between 2022-2023
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Luís Arthur Brasil GADELHA FARIAS
Poster P0257
Abstract 8500
Combining phylogeographic and niche modelling approaches to investigate the ecological drivers of TBEV at the Palearctic scale
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Maria Fernanda VINCENTI GONZALEZ
Poster P0258
Abstract 8532
Chikungunya in Colombia, 2022: An analysis of the cases notified to the National Surveillance System in the midst of South American reemergence
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Alfonso J. RODRIGUEZ-MORALES
Poster P0259
Abstract 8600
Dengue epidemics in Colombia, 2023: an analysis of the cases notified to the national surveillance system
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Alfonso J. RODRIGUEZ-MORALES
Poster P0260
Abstract 8667
Minor clinical sequelae and absence of viral persistence: an 8-month follow-up study of former mpox patients
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Nicole BERENS-RIHA
Poster P0261
Abstract 8776
Sero-catalytic and spatial modeling of dengue force-of-infection from age-stratified seroprevalence data in Timor-Leste
27/04 12:00
1e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)
Paul ARKELL
Poster P0262
Abstract 31
Evaluation of clinical applicability for a novel ultrasensitive ELISA detection of dengue virus
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Po-Kai CHEN
Poster P0263
Abstract 473
Performance analysis of a commercial meningitis/encephalitis panel compared to other microbiological tests and clinical diagnosis at discharge: a retrospective observational study of 1000 consecutive patients
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Gülsen ÖZKAYA SAHIN
Poster P0264
Abstract 851
Consistent differences in analytical and clinical performance for detection of SARS-CoV-2, influenza A/B and RSV between point-of-care tests
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Christel Barker JENSEN
Poster P0265
Abstract 925
Biomarkers and genotypes in patients with central nervous system infection caused by enterovirus
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Karolina ALSÉN
Poster P0266
Abstract 1140
Concurrent assessment of three viral RNA pathogens in MK buffered solution using droplet digital PCR: performance comparison for diagnostic based detection
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Daniel BRAZEAU
Poster P0267
Abstract 1226
Validation of a new molecular assay for the quantification of Epstein-Barr virus load in EDTA-plasma
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Irene CORTÉS PORTERO
Poster P0268
Abstract 1239
A comparison of four molecular assays for the detection of mpox virus DNA
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Henar ALONSO
Poster P0269
Abstract 1292
Comparison between conventional primary HPV cervical screening vs by vaginal self-sampling in France
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Benoît VISSEAUX
Poster P0270
Abstract 1402
JC virus VP1 gene: a more accurate detection and quantification of viral DNA
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Alba GARCÍA-MURILLO
Poster P0271
Abstract 1758
Performance evaluation test on rapid polymerase chain reaction test for mpox without nucleic acid extraction
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Kei YAMAMOTO
Poster P0272
Abstract 2114
Verification of a new molecular point of care system for respiratory viruses for its use with two widely used transportation media
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Juergen BECKER
Poster P0273
Abstract 2697
Enhancing pathogen detection in viral respiratory tract infections among individuals aged >55 years through expanded PCR panel testing
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Jelena FEENSTRA
Poster P0274
Abstract 2801
Comparison of three assays for the detection of human papillomavirus and their correlation with cervical cytology
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Ben VANMASSENHOVE
Poster P0275
Abstract 2874
Validation of a multiplex qRT-PCR assay for RSV, influenza A/B and SARS-CoV-2
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Alihan BULGURCU
Poster P0276
Abstract 2910
Clinical performance evaluation of a real-time PCR-based test for the detection of high-risk HPV genotypes
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Jelena FEENSTRA
Poster P0277
Abstract 3416
Establishing EBV load thresholds for predicting persisting EBV-DNAemia and associated disease
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Svenia SCHMID
Poster P0278
Abstract 3883
Multicenter evaluation of the Standard M10 Influenza, RSV and SARS-CoV-2 assay in nasopharyngeal swabs in liquid Amies medium
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Dagmar OBBELS
Poster P0279
Abstract 4059
Comparison of Allplex HPV28 and Anyplex II HPV28 Assays for the detection and genotyping of human papillomavirus
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Karoline LEUZINGER
Poster P0280
Abstract 4090
Urine-based HPV-DNA screening for cervical cancer prevention in a rural health clinic in Eswatini
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Simone VILLA
Poster P0281
Abstract 4550
A lateral flow test for rapid identification of paediatric viral infection based on host response mRNA transcripts
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Ruth REID
Poster P0282
Abstract 5050
Performance evaluation of the comercial BK virus ASR on the NeuMoDx system
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Amorce LIMA
Poster P0283
Abstract 5067
Clinical evaluation of an adenoviral species-typing model using PCR melt-curve data
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Benjamin GALVIN
Poster P0284
Abstract 5626
Molecular epidemiology of measles virus from measles outbreak in the Philippines, 2023
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Leonibel REYES
Poster P0285
Abstract 6050
New approaches in laboratory surveillance in the face of polio threat for public health, Romania 2023
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Teodora SOLOMON
Poster P0286
Abstract 6208
Implementation of the allplex high risk HPV genotyping assay in a routine clinical lab
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Dagmar OBBELS
Poster P0287
Abstract 6387
Utilising digitally characterised control material to improve comparability of molecular workflows for viral gastroenteritis
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Emily MCKLOUD
Poster P0288
Abstract 7227
Validation of commercial real-time PCR kit for detection of mpox
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Marcus POND
Poster P0289
Abstract 7562
Diagnostic performance of five real-time PCR assays for mpox virus detection
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Aida PEIRO-MESTRES
Poster P0290
Abstract 7626
Urine and vaginal high-risk human papilloma virus (hrHPV) self-sampling among HIV-positive women in Guinea-Bissau is well-accepted: three in four women are HPV-positive
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Kia Lærke MADSEN
Poster P0291
Abstract 7764
Evaluating and expanding measles serological assays: toward an improved diagnostic tool
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Rebecca STURM
Poster P0292
Abstract 8259
Cerebrospinal fluid and plasma biomarkers in patients with central nervous system infections: a retrospective study
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Maria Antonella ZINGAROPOLI
Poster P0293
Abstract 8271
Acute viral gastro-enteritis in infants and toddlers, from the big three to the big five?
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Jos VAN ACKER
Poster P0294
Abstract 8498
Identification of adeno-associated virus type 2 viremia in a large cohort from Berlin, Germany
27/04 12:00
1f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Till D. BEST
Poster P0295
Abstract 394
Viral and inflammatory markers in sudden death caused by myocarditis: a retrospective bicentric study
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Domitille CALLON
Poster P0296
Abstract 1457
HPV genotypes distribution in urethral samples in French men
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Stéphanie HAIM-BOUKOBZA
Poster P0297
Abstract 1554
Molecular epidemiology of Coxsackie A6 strains circulating in Hungary between 2020-2023
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Nóra DEÉZSI-MAGYAR
Poster P0298
Abstract 1935
Epidemiological study of high-risk human papillomavirus before the advent of primary molecular screening in Occitania, France
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Matthieu BERNIER
Poster P0300
Abstract 2594
Cutavirus prevalence in malignant and non-malignant tissues
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Irini Maria ASSIMAKOPOULOU
Poster P0301
Abstract 3191
National diagnostics case series and One Health phylogenetic analysis of Murray valley encephalitis outbreak in Australia
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Howard-Jones ANNALEISE
Poster P0302
Abstract 3593
Molecular epidemiology of human papillomavirus in a lower-middle-income and cervical cancer high-burden country
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Clara FAPPANI
Poster P0303
Abstract 3641
Patterns of enterovirus infections in hospitalisations and outpatient visits in Denmark 2015-2022
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Caroline Klint JOHANNESEN
Poster P0304
Abstract 3661
Detection of different viruses of clinical importance in bone marrow
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Marta Elena ALVAREZ-ARGÜELLES
Poster P0305
Abstract 3832
Norovirus genotype distribution among children with acute gastroenteritis in South-East Austria
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Evelyn STELZL
Poster P0306
Abstract 5554
First results of laboratory surveillance for enteroviruses in Italy (2022-2023)
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Laura PELLEGRINELLI
Poster P0307
Abstract 5926
Comprehensive genotyping supports the epidemiological investigation of Austrian measles virus outbreaks in 2023
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Maria Joao CARDOSO
Poster P0308
Abstract 6039
Rotavirus A epidemiology shifts due to pandemic: 14-year experience of Belgian National Reference Center in the COVID-19 context
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Mustafa KARATAS
Poster P0309
Abstract 6083
Circulation of respiratory viruses in hospitalised children in the post-COVID-19 era
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Angeliki KASSOMENAKI
Poster P0310
Abstract 6178
Negative conversion and recurrence rate of high risk human papillomavirus in cervical infection
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Kyutaeg LEE
Poster P0311
Abstract 6323
Rotavirus clinical and genomic surveillance reveals predominance of equine-like G3 strains, antigenic mismatches with vaccines, NSP2-reassortants and multiple vaccine breakthrough cases, 2021-2023, Madrid, Spain
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Rocio SANCHEZ LEON
Poster P0312
Abstract 6567
Male human papillomavirus genital infection: a focus on non-vaccine genotypes
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Michela BUTTÀ
Poster P0313
Abstract 6889
Analysis of human papillomavirus 51 (HPV51) genetic variations detected in women with cervical dysplasia
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Marianna MARTINELLI
Poster P0314
Abstract 7742
Evaluation of biomarkers associated with human papillomavirus 16 (HPV16) persistent infection
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Chiara GIUBBI
Poster P0315
Abstract 8473
Understanding Measles Comeback
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Berksan SIMSEK
Poster P0316
Abstract 8539
Establishing a 24/7 mpox outbreak helpline: an overlooked source of early epidemiological data?
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Sowsan ATABANI
Poster P0317
Abstract 8553
Descriptive study of the distribution of human papillomavirus genotypes in a hospital in southern Spain
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Yolanda GARCÍA COLLADO
Poster P0318
Abstract 8803
Echovirus 11 reported in emilia-romagna region during 2023
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Alessia CANTIANI
Poster P0319
Abstract 8832
Contribution of rotavirus infections to child mortality in the Cchild health and mortality prevention (CHAMPS) network
27/04 12:00
1g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)
Inacio MANDOMANDO
Poster P0320
Abstract 3861
Dengue virus infection elicits galectin-3 expression with inhibitory impact on dengue viral infectivity
27/04 12:00
1i. Basic and applied virology (incl in vitro and in vivo models, novel methods)
Sheng-Fan WANG
Poster P0321
Abstract 4604
Detection of human polyomaviruses in oral samples supports the oral transmission route
27/04 12:00
1i. Basic and applied virology (incl in vitro and in vivo models, novel methods)
Maria DOLCI
Poster P0322
Abstract 8213
Identification of viral inhibitors: evaluating Himalayan herbs as alternatives for dengue treatment
27/04 12:00
1i. Basic and applied virology (incl in vitro and in vivo models, novel methods)
Gaurav BADONI
Poster P0323
Abstract 20
Recently published randomised controlled trials investigating treatments against COVID-19 displayed lower risk of bias: a systematic review and critical appraisal
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Kavina KUDHAIL
Poster P0324
Abstract 116
Real-world safety and effectiveness of molnupiravir during the Omicron wave: a final report of a post-marketing surveillance in Japan
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Kimata MASAHIRO
Poster P0325
Abstract 130
Drug interactions with nirmatrelvir/ritonavir in hospitalised patients: prevalence, severity and management strategies
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sohair SWAID
Poster P0326
Abstract 161
Influence of cytokine levels on the effect of tocilizumab on mortality or ICU admission in COVID-19 pneumonia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Guiomar HERNÁNDEZ-GARCÍA
Poster P0327
Abstract 181
Long COVID looks like other post-viral syndromes 12 months after infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Matthew BROWN
Poster P0328
Abstract 225
Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka Prefecture, Japan
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Satoshi KUTSUNA
Poster P0329
Abstract 239
The impact of the COVID-19 pandemic on adult vaccination, with emphasis on influenza and pneumococcal vaccination in India: a comprehensive report
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sureshkumar DORAIRAJAN
Poster P0330
Abstract 350
Healthcare workers' attitude toward COVID-19 vaccination campaign in Armenia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Goulia OHAN
Poster P0331
Abstract 415
The predictors of COVID-19 immunogenicity elicited by vaccines against SARS-CoV-2 in bone marrow transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Oguz Resat SIPAHI
Poster P0332
Abstract 437
Improved SARS-CoV-2 molecular detection in European expert public health laboratories: results of the third external quality assessment, 2023
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Kamelia STANOEVA
Poster P0334
Abstract 509
Normalisation of eosinophil count is predictive of reduced oxygen requirement during COVID-19 infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Benjamin DAVIDO
Poster P0335
Abstract 511
Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Piotr RZYMSKI
Poster P0336
Abstract 519
Influence of anti-spike protein antibody levels on tocilizumab efficacy in hospitalised patients with severe COVID-19 pneumonia: a post-hoc analysis of the COVACTA trial
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Pablo GUISADO-VASCO
Poster P0337
Abstract 543
Unraveling the past: analysing the effects of COVID-19 on hematological malignancy patients - observations from 2020 to 2022
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jon SALMANTON-GARCIA
Poster P0338
Abstract 552
Circulating antibody titres predict infection and severity in COVID-19 close contacts
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Joanne BYRNE
Poster P0339
Abstract 567
First serological study of MERS-CoV on dromedary camels from Algeria
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mammar KHAMES
Poster P0340
Abstract 573
Cost-effectiveness of oral nirmatrelvir/ritonavir in patients at high risk for progression to severe COVID-19 in the United States
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tendai MUGWAGWA
Poster P0341
Abstract 607
Enhancing respiratory disease diagnosis: a comparative analysis of multiplex point-of-care PCR and antigen testing for SARS-CoV-2, influenza, and respiratory syncytial virus in Germany
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jordan CHASE
Poster P0343
Abstract 693
Antibody responses against recently emerged SARS-CoV-2 variants: a population-based cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Annelies J. H. DE ROOIJ
Poster P0344
Abstract 703
For COVID vaccination choices in Germany or the United Kingdom, efficacy ranks first followed by common side effects
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Matthew ROUSCULP
Poster P0345
Abstract 706
Comparison of characteristics between patients who received COVID-19 non-mRNA and mRNA vaccines in Germany
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Lucie KUTIKOVA
Poster P0346
Abstract 825
Systematic review and meta-regression analysis of clinical therapeutic responses and viral clearance in early symptomatic COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Shivani SINGH
Poster P0347
Abstract 850
Prognostic of COVID-19 in ICU-admitted COPD patients: the impact of high-flow nasal cannulas and other factors
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Laia FERNÁNDEZ-BARAT
Poster P0348
Abstract 859
Robust immune response to COVID-19 vaccination in Greenlanders: an observational study in an island population
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mie MØLLER
Poster P0349
Abstract 863
To die with or to die for COVID-19 infection during the Omicron era
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Marco BONGIOVANNI
Poster P0350
Abstract 876
Recurrent ventilator-associated pneumonia in severe COVID-19 ARDS patients requiring ECMO support
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Charles-Edouard LUYT
Poster P0351
Abstract 900
Protective effect of previous omicron BA.2 infection and fourth dose vaccination on SARS-CoV-2 XBB infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nicole Ngai Yung TSANG
Poster P0352
Abstract 913
External validations of prognostic COVID-19 scores: an innovative mass validation using the multi-center ORCHESTRA cohort
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Katharina APPEL
Poster P0353
Abstract 949
Real-world evidence comparing the risk of Delta and Omicron infection outcomes by SARS-CoV-2 antibody levels
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yue JIN
Poster P0354
Abstract 950
Remdesivir reduces mortality in immunocompromised patients hospitalised for COVID-19 across the pandemic and endemic eras
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Essy MOZAFFARI
Poster P0355
Abstract 977
Efficacy of tofacitinib as add-on therapy to remdesivir and corticosteroids in COVID-19 infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tahsine MAHFOUZ
Poster P0357
Abstract 1111
Proteomic and cellular characterisation of Omicron breakthrough infections and a third homologous or heterogenous boosting vaccination by a longitudinal cohort
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yi ZHANG
Poster P0358
Abstract 1232
Levels of inflammatory and cardiac biomarkers as a predictor factor for complications and outcomes in hospitalised COVID-19 patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Catia CILLONIZ
Poster P0359
Abstract 1237
Changes in Pneumocystis jirovecii pneumonia (PCP) before and during COVID-19 pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Julen ARMENDARIZ GAYRAUD
Poster P0360
Abstract 1251
SARS-CoV-2 breakthrough infections in healthcare workers of an Italian university hospital: an update three years after the start of the vaccination campaign
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Luigi DE MARIA
Poster P0361
Abstract 1258
Cracking the SARS-CoV-2 Omicron variants: unveiling the sensitivity of rapid antigen tests and optimal sampling sites
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Piubelli CHIARA
Poster P0362
Abstract 1290
Vaccination shapes within-host SARS-CoV-2 diversity of Omicron BA.2.2 breakthrough infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yi ZHANG
Poster P0363
Abstract 1323
In vitro neutralisation of VYD222 against Omicron sublineages
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Pamela HAWN
Poster P0364
Abstract 1405
Clinical outcomes of COVID-19 vaccine breakthrough infections: a single-centre study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Claudine Dayle MARANAN
Poster P0365
Abstract 1437
Descriptive analysis of self-reported HRQoL using EQ-5D-5L among symptomatic outpatients with COVID-19 in the US during an Omicron predominant period
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ashley CHA-SILVA
Poster P0366
Abstract 1447
Clinical presentation of COVID-19 among healthcare workers across the early COVID-19 pandemic, Peru
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Diana PONCE
Poster P0367
Abstract 1460
Sentinel cohort safety of AZD5156/AZD3152 from the phase 1/3 SUPERNOVA trial for COVID-19 prevention in participants with immune impairment
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Taylor S. COHEN
Poster P0368
Abstract 1467
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients (PEACH Study)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Joanne EUDEN
Poster P0369
Abstract 1494
Descriptive epidemiology of adverse events following mRNA COVID-19 vaccination in Curacao
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jonathan LAMBO
Poster P0370
Abstract 1500
Assessing transmission of SARS-CoV-2 via the aerosol and contact routes using a direct human totransgenic K18-hACE2 mouse model
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
John CONLY
Poster P0371
Abstract 1514
Antimicrobial resistance before, during, and after the COVID-19 pandemic, 120 U.S. Hospitals
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yek CHRISTINA
Poster P0372
Abstract 1548
Retrospective study of baseline co-medication potential DDI in COVID-19 hospitalised patients in Spain: the COCOS Study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Manuel COTARELO
Poster P0373
Abstract 1572
The gut microbiota as an early predictor of COVID-19 severity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Marco FABBRINI
Poster P0374
Abstract 1625
Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: the PEACH study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Emma THOMAS-JONES
Poster P0375
Abstract 1655
Effect of co-formulation on pharmacokinetics of AZD7442, a monoclonal antibody combination against COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Taylor S. COHEN
Poster P0376
Abstract 1679
COVID-19 pandemic encourages childhood vaccination in Japan: findings from the VENUS study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yusuke ASAI
Poster P0377
Abstract 1705
Comparative biodistribution study of baculoviral and adenoviral vector based-vaccines against SARS-CoV-2
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Hee-Jung LEE
Poster P0378
Abstract 1752
COVID-19 hospitalisations amongst immunocompromised individuals receiving 300 mg AZD7442 (tixagevimab/cilgavimab) pre-exposure prophylaxis: real-world effectiveness data from Israel's largest health maintenance organisation
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Samah HAYEK
Poster P0379
Abstract 1789
Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitro IC50 values predict SARS-CoV-2 neutralising antibody (nAb) titres
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Anastasia A. AKSYUK
Poster P0380
Abstract 1793
COVIDRIVE: a European public-private partnership for generating real-world evidence on the effectiveness of COVID-19 vaccines
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Kaatje BOLLAERTS
Poster P0381
Abstract 1796
High prevalence of immunocompromising conditions among patients with severe acute respiratory infection, including SARS-CoV-2: results from a multicentre, test-negative case-control study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Wilhelmine MEERAUS
Poster P0382
Abstract 1800
Immunocompromise, cancer and other comorbidities in patients with severe acute respiratory infection testing positive versus negative for SARS-CoV-2: a post hoc analysis of COVIDRIVE data from May 2021 to May 2023
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Wilhelmine MEERAUS
Poster P0383
Abstract 1801
Prospective study on clinical and biochemical parameters in post-COVID fatigue and myalgia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sunit SIKDAR
Poster P0384
Abstract 1864
Evaluation of a saliva home collection kit and temperature stability demonstrates the utility of home-collected saliva specimens for laboratory-based COVID-19 diagnostic testing
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Julie CARSTENS
Poster P0385
Abstract 1883
Clinical outcomes and safety of remdesivir use in hospitalised COVID-19 patients with and without severe renal impairment
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yi-Tsung LIN
Poster P0386
Abstract 1903
Can a correlate of protection against SARS-CoV-2 infection be established in cancer patients: a statistical modeling perspective
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yana DEBIE
Poster P0387
Abstract 1967
Limited effectiveness of adding remdesivir to dexamethasone in COVID-19 pneumonia during the evolution of SARS-CoV-2: a comparative study using a clinical data warehouse
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yeunji LEE
Poster P0388
Abstract 1988
Adding hyponatraemia to “rule-of-six” prediction tool improves performance in identifying hospitalised patients with COVID-19 at risk of adverse clinical outcomes
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Meng Ying SIM
Poster P0389
Abstract 2068
Persisting differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Keon Young LEE
Poster P0390
Abstract 2098
Immunogenicity of a single booster dose of Soberana Plus (FINLAY-FR-1A) vaccine in adults with different previous history of COVID-19 vaccination
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Igor STOMA
Poster P0391
Abstract 2110
De-mystifying the double danger of COVID-19 and dengue co-infection in India
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sonam SINGLA
Poster P0392
Abstract 2122
Integrated severe acute respiratory infection (SARI) sentinel surveillance of influenza, SARS-CoV-2 and RSV in Serbia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Dragana DIMITRIJEVIC
Poster P0393
Abstract 2172
Comparison of clinical characteristics and outcomes in candidemic patients with and without COVID-19: a multicentre, propensity score-matched analysis
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sung Un SHIN
Poster P0394
Abstract 2180
SARS-CoV-2 Spike fusion peptide (FP) mutation P812S unique to the nasal compartment in a 101-day persistent infection shows infectivity reduction and context-dependent neutralisation evasion of vaccinee sera
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tsz Kin Mark CHENG
Poster P0395
Abstract 2184
The high expression of PD-1 defines a subpopulation of T follicular helper cell responding to COVID-19 vaccine in humans
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jingxin GUO
Poster P0396
Abstract 2189
Cell-free DNA as a promising non-invasive marker for predicting critical COVID-19 cases: a pilot study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Senulyte AUGUSTE
Poster P0397
Abstract 2206
Usage of oral contraceptives among healthcare workers: impact on COVID-19 booster vaccine immunogenicity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Manuel KRONE
Poster P0398
Abstract 2254
Local and systemic reactogenicity after mRNA and protein-based COVID vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomised phase 2 trial (COV-BOOST)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Seth TOBACK
Poster P0400
Abstract 2316
Survival impact of comorbidities on the one-year mortality among hospitalised COVID-19 patients in a vaccinated Omicron-infected multicentre cohort
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tsai MING-TAO
Poster P0401
Abstract 2328
Bivalent Omicron BA1 vaccine booster increases the breadth and potency of memory-B and T cell response and protects against emerging SARS-CoV-2 variants
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Lok Bahadur SHRESTHA
Poster P0402
Abstract 2344
Hospital-acquired COVID-19 at The Northern Hospital, 2021-2022, an outcome and costs analysis
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
George DREWETT
Poster P0403
Abstract 2366
Increased MP/CP co-infection in COVID-19 positive kidney transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Zhonghao WANG
Poster P0404
Abstract 2380
Risk of severe COVID-19 in SARS-CoV-2 vaccinated individuals with hematologic malignancies: a nationwide cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sabine HAGGENBURG
Poster P0405
Abstract 2472
Comercial Sars-CoV-2 test: performance evaluation on bronchoaspirates and broncholavages
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Elena NICOLINI
Poster P0406
Abstract 2535
Risk factors for SARS-CoV-2 infection among healthcare workers in 168 hospitals: a multi-centre study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Wang MEIXIA
Poster P0407
Abstract 2600
Longitudinal shifts in gut microbiota during mild COVID-19 are linked to post-acute COVID-19 syndrome (PACS)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Marco FABBRINI
Poster P0408
Abstract 2626
A Randomized, Double-Blinded, Cohort Clinical Trial on Evaluating the Safety and Immunogenicity of Sequential Immunization of Two Doses of Omicron Specific Inactivated COVID-19 Vaccines as Boosters in Adults
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ruiqi ZHANG
Poster P0409
Abstract 2688
Continued increased risk of COVID-19 hospitalisation and death in immunocompromised individuals despite receipt of ≥4 vaccine doses: updated 2023 results from INFORM, a retrospective health database study in England
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sabada DUBE
Poster P0410
Abstract 2699
Comparison of COVID-19 vs non-COVID-19 patients without haematological malignancies treated for invasive pulmonary aspergillosis: a 5 years retrospective cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sara VOLPI
Poster P0411
Abstract 2721
Pulmonary function in patients with dyspnea in the post-acute phase of COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Olha SHCHUDRO
Poster P0412
Abstract 2723
Healthcare resource use and overall costs of COVID-19 during the Omicron-predominant period in immunocompromised individuals: results from INFORM, a retrospective health database study in England
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sabada DUBE
Poster P0413
Abstract 2751
Tracking SARS-CoV-2 Omicron VOC and sub-variants in Odisha, India November 2021 to May 2023
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ira PRAHARAJ
Poster P0414
Abstract 2785
Prospects for reducing the risk of emergence of SARS-CoV-2 variants from infections in immunocompromised individuals: a modelling approach
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Lisa J WHITE
Poster P0415
Abstract 2788
Optimising a novel treatment strategy for COVID-19-related ARDS: a randomised, placebo-controlled clinical trial on supplementary therapies
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mehrdad MOSADEGH MARVASTI
Poster P0416
Abstract 2805
Pooled analysis of randomised trials comparing the clinical efficacy of early treatments of COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Fulvia MAZZAFERRI
Poster P0417
Abstract 2847
Duration of viral shedding in immunocompromised patients with SARS-CoV-2 infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Matthias VON ROTZ
Poster P0418
Abstract 2856
Clinical characteristics and outcomes of hospitalised patients with SARS-CoV-2 infection in three different epidemic periods, Milan, Italy
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Martina ZACHEO
Poster P0419
Abstract 2927
A Phase 1, concentration-QTc analysis shows bemnifosbuvir does not alter cardiac repolarisation
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Xiao-Jian ZHOU
Poster P0420
Abstract 2928
Sotrovimab in severely ill COVID-19 immunocompromised patients: multicentre retrospective cohort
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Rubén LOBATO CANO
Poster P0421
Abstract 2943
Pharmacokinetics, safety, and tolerability of ensitrelvir, a novel oral inhibitor of 3C-like protease of SARS-CoV-2, in participants with hepatic impairment
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Takayuki KATSUBE
Poster P0422
Abstract 2963
The mRNA-1273 COVID-19 vaccine induces CD4+ T cell responses among solid organ transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Bethany GIRARD
Poster P0423
Abstract 2980
Efficacy and safety of EDP-235 in non-hospitalised adults with mild or moderate COVID-19: results from the phase 2 SPRINT study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Scott ROTTINGHAUS
Poster P0424
Abstract 3009
A decoy strategy of using plant-based virus-like-particles (VLPs) against SARS-CoV-2 Infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Hsin (Jady) LIANG
Poster P0425
Abstract 3024
Bayesian analysis of a randomised trial comparing the clinical efficacy of early treatments of COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Fulvia MAZZAFERRI
Poster P0426
Abstract 3071
Canadian healthcare and education workers' hesitance to receive original and bivalent COVID-19 vaccines
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Brenda L COLEMAN
Poster P0427
Abstract 3075
Viral, immunologic, and laboratory evaluations in patients with and without post-acute sequelae of SARS-CoV-2 infection (PASC)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sang Hyun RA
Poster P0428
Abstract 3122
Fingerstick blood shows excellent correlation with plasma for SARS-CoV-2 antibody detection with a novel multiplex immunoassay
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Dylan GEORGE
Poster P0429
Abstract 3207
Hamster model to evaluate post-COVID-19 condition treated with ensitrelvir: smell disorder
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ryoichi TASHIMA
Poster P0430
Abstract 3266
Bivalent COVID-19 vaccination enhances neutralising antibody responses against Omicron subvariants up to nine months, except for EG.5
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Hakjun HYUN
Poster P0431
Abstract 3270
Detection and surveillance of SARS-CoV-2 genomic variants in Georgia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nino MITAISHVILI
Poster P0432
Abstract 3295
SARS-CoV-2 vaccination is not associated with involuntary childlessness - results of a prospective multicentre cohort
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tamara Kathrin DÖRR
Poster P0433
Abstract 3313
Safety and immunogenicity of the investigational CV0501 mRNA COVID-19 vaccine administered to adults ≥18 years of age
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nicolas VANHOUTTE
Poster P0434
Abstract 3345
Post-acute symptoms of COVID-19 in healthcare workers: temporal course, impact on daily life, and therapeutic measures
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tamara Kathrin DÖRR
Poster P0435
Abstract 3350
Characteristics and outcomes of old and oldest-old hospitalised patients with COVID-19 during the late phase of the pandemic in central Taiwan
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Po-Ren HSUEH
Poster P0436
Abstract 3358
Reduction of post-acute COVID-19 sequelae after SARS-CoV-2 wild-type infection in healthcare workers over a 30-month period
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tamara Kathrin DÖRR
Poster P0437
Abstract 3394
Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2 Omicron vs Delta infection: a retrospective cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Liang En Ian WEE
Poster P0438
Abstract 3407
Wastewater monitoring as an early warning system for SARS-CoV-2 variants: a comparison of clinical and wastewater samples in Hesse, Germany, Sep 2021-Dec 2022
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Syamend SAEED
Poster P0439
Abstract 3468
Rapid recovery from SARS-CoV-2 infection among immunocompromised children despite limited neutralising antibody response: a virologic and sero-immunologic analysis of a single-centre cohort
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jin Yang BAEK
Poster P0440
Abstract 3533
Long-term risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during Omicron
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
David Chien LYE
Poster P0441
Abstract 3564
Development of a high-sensitivity fluorescence in situ hybridisation method for detecting SARS-CoV-2
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Agnieszka KRAWCZYK
Poster P0442
Abstract 3625
Recent COVID-19 is associated with reduced cytokine response to LPS ex vivo and in vivo
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Anselm JORDA
Poster P0443
Abstract 3628
Performance of a novel dual marker RT-qPCR-based whole-blood assay for the detection of SARS-CoV-2-reactive T cells
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Franziska Maria KANIS
Poster P0444
Abstract 3672
Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women in Kampala, Uganda
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Lauren HOOKHAM
Poster P0445
Abstract 3704
Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Calvin J CHIEW
Poster P0446
Abstract 3707
Evidence of exposure to the SARS-CoV-2 virus in UK healthcare workers who reported no known COVID-19 infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yanie TAYIPTO
Poster P0447
Abstract 3715
Live single-cycle SARS-CoV-2 vaccine elicits high protection and sterilising immunity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
David HAUSER
Poster P0448
Abstract 3732
Real-world performance of a single-use, analyser-free, molecular point-of-care test for COVID-19 used in the emergency department: results of a prospective trial (ED-POC)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mary E CHAPMAN
Poster P0449
Abstract 3734
Investigating factors associated with the economic cost of healthcare worker COVID-19-related absenteeism
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Liam TOWNSEND
Poster P0450
Abstract 3758
Development and characterisation of a novel SARS-CoV-2 macrodomain (Mac1) targeting inhibitor
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Susanne PFEFFERLE
Poster P0451
Abstract 3900
Long-term trajectories of COVID-19 symptoms and their associations with quality of life: results from the 2-year-follow-up of the prospective Predi-COVID study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Aurélie FISCHER
Poster P0452
Abstract 3941
Clinical trajectory of post COVID-19 condition during different SARS-CoV-2 variant periods
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Pontus HEDBERG
Poster P0453
Abstract 3961
Surfaces environmental monitoring of SARS-CoV-2: loop mediated isothermal AMPlification (LAMP) and droplet digital PCR (ddPCR) in comparison with standard real time PCR (RT-PCR)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Simona SPITERI
Poster P0454
Abstract 4004
Impact of treatment of COVID-19 with sotrovimab on post-acute COVID-19 syndrome: an analysis of national COVID cohort collaborative (N3C) data
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jennifer HAN
Poster P0455
Abstract 4025
Quasi-species prevalence and evolution of mutations in SARS-CoV-2 variants in European COVID-19 cohorts
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mathias SMET
Poster P0456
Abstract 4118
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalised patients during the first wave of COVID-19 (PEACH study)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jonathan SANDOE
Poster P0457
Abstract 4122
A longitudinal description of the health-related quality of life among high-risk individuals with COVID-19: a Dutch multicentre observational cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Magda VERGOUWE
Poster P0458
Abstract 4135
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: A retrospective cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Salvatore ROTUNDO
Poster P0459
Abstract 4172
Extended remdesivir use in haematological patients with malignancies and prolonged COVID-19 in omicron era: tolerance and outcomes
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Emmanuelle GRAS
Poster P0460
Abstract 4177
Dual SARS-CoV-2 infections: genomics-based approach for detection of SARS-CoV-2 co-infections and diverse viral populations
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Bryan Stiven JIMÉNEZ ARAYA
Poster P0461
Abstract 4285
Ultrasonological predictors of severity of dengue in a teaching hospital in South India
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Vishnu . V NAIR
Poster P0462
Abstract 4335
COVID-19 and network medicine: utilising multi-omic approaches in response to future pandemics
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Bradley WARD
Poster P0463
Abstract 4352
Persistent DNA methylation changes up to 7 months after SARS-CoV-2 infection: initial findings from population-based studies
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Pamela MATIAS GARCIA
Poster P0464
Abstract 4384
Anti-RBD IgG titres after a primary vaccination course with BNT162b2 and after a third booster dose with a first-generation m-RNA vaccine in a cohort of people living with HIV
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Anna Maria AZZINI
Poster P0465
Abstract 4475
Dynamics of Streptococcus pneumoniae non-PCV13 lineages in Spain during SARS-CoV-2 pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sara CALVO SILVERIA
Poster P0466
Abstract 4493
Unraveling the role of casein kinase II in the SARS-CoV-2 lifecycle: implications for host-targeted antiviral development
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Dennis Salomon LOPEZ MOLINA
Poster P0467
Abstract 4510
Clinical manifestations of SARS-CoV-2 infection in Omicron subvariants
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jayanthi SHASTRI
Poster P0468
Abstract 4511
Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Javier Tomás SOLERA RALLO
Poster P0469
Abstract 4541
Surveillance of invasive pulmonary aspergillosis in COVID and non-COVID patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Simona KARABELA
Poster P0470
Abstract 4557
SARS-CoV-2 infection and re-infection by Delta and Omicron variants in a population with low vaccine coverage
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Rhys WENLOCK
Poster P0471
Abstract 4562
Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: a single-centre experience
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Biagio PINCHERA
Poster P0472
Abstract 4573
Molecular epidemiology of Pneumocystis jirovecii in patients with and without COVID-19, based on real time PCR assay
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Faezeh ROUHI
Poster P0473
Abstract 4599
Effect of tixagevimab-cilgavimab on viral shedding kinetics in immunocompromised patients with breakthrough COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jaijun HAN
Poster P0474
Abstract 4632
Impact of multiple-dose remdesivir, a COVID-19 antiviral, on CYP3A4 activity: a clinical drug-drug interaction (DDI) study with midazolam
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Abdul Naveed SHAIK
Poster P0475
Abstract 4703
A cost and resource utilisation study of COVID-19 patients treated in German tertiary care hospitals
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Shimita SIKDAR
Poster P0476
Abstract 4727
Divergent SARS-CoV-2-induced immunity signals in the upper and lower respiratory tract in severe COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Bryan Stiven JIMÉNEZ ARAYA
Poster P0477
Abstract 4831
Pharmacokinetics, safety, and tolerability of single-dose obeldesivir in healthy Japanese and Caucasian participants
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Chi-Chi PENG
Poster P0478
Abstract 4860
Prevalence of and factors associated with long COVID among diverse healthcare workers in the United Kingdom: a cross-sectional analysis of a nationwide study (UK-REACH)
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Amani AL-ORAIBI
Poster P0479
Abstract 4861
Characteristics and outcomes of hospitalised patients across five waves of the COVID-19 pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Khetam HUSSEIN
Poster P0480
Abstract 4880
SARS-CoV-2 point-of-care antibody testing: a cross sectional study in healthy people and individuals at high-risk for severe COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ioannis GRIGOROPOULOS
Poster P0481
Abstract 4882
Use of antibiotics in patients hospitalised for COVID-19: no beneficial effect on clinical outcome or course of disease
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Anette FRIEDRICHS
Poster P0482
Abstract 4897
Increasing antimicrobial resistance rates in relation to antibiotic misuse and overuse during COVID-19 pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Omar LOAY
Poster P0483
Abstract 4925
Long-term impairment of working ability in subjects under 60 years of age hospitalised for COVID-19 at 2 years of follow-up: a cross-sectional study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Luisa FRALLONARDO
Poster P0484
Abstract 4929
Comparison of a novel concentration method for SARS-CoV-2 wastewater monitoring
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tom KORITNIK
Poster P0486
Abstract 5015
Bacterial co-infection and secondary infection in SARS-CoV-2 (COVID-19) adult patients in a national tertiary infectious disease hospital
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Maria Yvez Erika UGALE
Poster P0487
Abstract 5058
Surveillance and detection of SARS-CoV-2 in four national university campuses, the UniCoV Project: apps, antigens, saliva, wastewater, and participation
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
John MAC SHARRY
Poster P0488
Abstract 5082
Brief cognitive assessment for long COVID-19 sequelae and its significance
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Seo DA-YOUNG
Poster P0489
Abstract 5088
Dual antiviral therapy can be effective for treatment of protracted SARS-CoV-2 infection in immunocompromised hosts
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jessica LITTLE
Poster P0490
Abstract 5107
Sub-populations of critically ill COVID-19 patients exist with distinct antibody responses to SARS-CoV-2
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
David BRETT-MAJOR
Poster P0491
Abstract 5113
Missed opportunities of early SARS-CoV-2 therapy among hospitalized patients: a retrospective observational cohort study, Milan, Italy
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Andrea RABBIONE
Poster P0493
Abstract 5135
Safety and tolerability of tocilizumab for COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Meriam DEEB
Poster P0494
Abstract 5159
Safety and tolerability of baricitinib for COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Meriam DEEB
Poster P0495
Abstract 5179
Epidemiology of bacterial co-infections in COVID-19 associated pulmonary aspergillosis patients in a tertiary-care teaching hospital in Mexico City.
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Benjamin VALENTE ACOSTA
Poster P0496
Abstract 5194
Evaluation of the digital lightcycler in monitoring SARS-CoV-2 RNA in sewage
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tung-Yuan LEE
Poster P0497
Abstract 5259
Impact of COVID-19 infection in quality of life of hospitalised patients with autoimmune conditions: experience from a single-center in Greece
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Amalia PAPANIKOLOPOULOU
Poster P0498
Abstract 5274
Safety of tocilizumab and baricitinib for treatment of COVID-19 in hospitalised patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Meriam DEEB
Poster P0499
Abstract 5319
Reinfection of SARS-CoV-2 variants in immunocompromised patients with prolonged or relapsed viral shedding
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ji Yeun KIM
Poster P0500
Abstract 5324
Associations of COVID-19 control measures, the incidence of pneumonia and various respiratory pathogens in Finland, 2020-2023
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Hanna M. NOHYNEK
Poster P0501
Abstract 5388
Clinical characteristics and factors associated with in-hospital post-surgical mortality in COVID-19 patients at a tertiary care center in Karachi, Pakistan
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nosheen NASIR
Poster P0502
Abstract 5389
Changes in antibiotic consumption due to COVID-19 pandemic in tertiary-care hospitals in Costa Rica: a five year interrupted time series study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Cristina FERNANDEZ-BARRANTES
Poster P0503
Abstract 5409
T-cell mediated response and post-COVID-19 syndrome
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Elda RIGHI
Poster P0504
Abstract 5412
Antibiotic use in outpatients with COVID-19 diagnosed with point of care tests in an integrated healthcare network in Utah, USA
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Rj WILLIAMS
Poster P0505
Abstract 5420
Evaluation of humoral immune responses against SARS-CoV-2 variants after receiving booster doses
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yu-Cheng CHENG
Poster P0506
Abstract 5474
Adding a SARS-CoV-2 RT-PCR on a faecal sample to a RT-PCR on a nasopharyngeal sample augments diagnostic sensitivity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nathalie VAN DER MOEREN
Poster P0507
Abstract 5531
COVID-19 and influenza- role of haematological parameters in assesing the disease severity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Aida-Isabela ADAMESCU
Poster P0508
Abstract 5590
Is early empiric antibiotherapy in patients hospitalised in ward settings with COVID-19 pneumonia beneficial?
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Aude KOPP-DEROUET
Poster P0509
Abstract 5691
Proteomic insights into the impact of COVID-19 on peripheral blood mononuclear cells in kidney transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Giuseppe G. F. LEITE
Poster P0510
Abstract 5757
Increased risk of invasive aspergillosis in immunocompromised patients with persistent SARS-CoV-2 viral shedding > eight weeks, a retrospective case-control study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Cléa MELENOTTE
Poster P0511
Abstract 5803
The association of platelet-to-lymphocyte ratio with COVID-19 and acute ischemic stroke in admitted adult patients in Zamboanga City Medical Center
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Abdusattar ABDURAUP
Poster P0512
Abstract 5826
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in patients with multiple sclerosis on disease modifying therapies
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Alessandra AIELLO
Poster P0513
Abstract 5953
Increased risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in a case-control study in France, 2020-2022
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Simon GALMICHE
Poster P0514
Abstract 5959
Comparing the disease burden of COVID-19 in-patients with and without high risk factors for severe outcomes: a retrospective study using routine hospital data
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nicole BIHRER
Poster P0515
Abstract 5961
Genomic detection of SARS-CoV-2 reinfections in the SIREN cohort study: has the 90-day interval endured?
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Dominic SPARKES
Poster P0516
Abstract 5995
Longitudinal anti-SARS-CoV-2 antibody responses reveal cross-reactive boosting following vaccination
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Dylan GEORGE
Poster P0517
Abstract 5997
Prevalence and impact of persistent symptoms following SARS-CoV-2 infections in UK healthcare workers in the SIREN cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sarah FOULKES
Poster P0518
Abstract 6020
Concomitant vaccination uptake of the COVID-19 booster and influenza vaccine in the United States during the 2021/22 and 2022/23 seasons
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Aung Pone MYINT
Poster P0519
Abstract 6046
Impact of age on SARS-CoV-2 transmission in French households: comparison of Alpha and Omicron variants
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sophie CHERVET
Poster P0520
Abstract 6128
Tracking SARS-CoV-2 RNA in urban wastewater through diverse biomarkers
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Rosario MUSUMECI
Poster P0521
Abstract 6168
Immunosupressive treatment and CD4/CD8 T-cell exhaustion impact SARS-CoV-2-specific adaptive responses after vaccination in solid organ transplant
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Laura DONADEU
Poster P0522
Abstract 6212
Genomic characterization of SARS-CoV-2 outbreak during international scientific workshop: evidence of cross-border transmission
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
María Paula VARGAS DURÁN
Poster P0523
Abstract 6216
Different effect of anti-s monoclonal antibodies on immunity depending on SARS-CoV-2 vaccination status
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Luca MADDALONI
Poster P0524
Abstract 6224
Enhanced SARS-CoV-2 surveillance in Slovenia through wastewater analysis: a comprehensive community-level approach
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tea JANKO
Poster P0525
Abstract 6245
Safety of a self-amplifying mRNA COVID-19 vaccine, ARCT-154
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Igor SMOLENOV
Poster P0526
Abstract 6295
Treatment strategies to avoid residents' isolation in nursing home: modelling analysis
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Hind ZAARAOUI
Poster P0527
Abstract 6303
The impact Of COVID-19 on healthcare utilization associated with antibiotic resistance among inpatients at a tertiary hospital in Vietnam
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nga NGUYEN TQ.
Poster P0528
Abstract 6348
Nasopharyngeal microbial dysbiosis in COVID-19 patients revealed by 16S metagenomics
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Filippos KARDARAS
Poster P0529
Abstract 6352
IgG anti SARS-CoV-2 spike levels and vaccination on a cohort of hospital healthcare workers
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Miriam LATORRE-MILLÁN
Poster P0530
Abstract 6370
Multi-tissue immune analysis of severe COVID-19 patients indicates differential adaptive immune response enrichment in secondarylymphoid tissues
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Eduardo SOARES
Poster P0531
Abstract 6374
SARS-CoV-2 infection accompanied by gastrointestinal symptoms elicits antibodies with significantly higher avidity as compared to infections without gastrointestinal symptoms
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Wegene BORENA
Poster P0532
Abstract 6408
A polymersome COVID-19 booster is safe and immunogenic in pre-vaccinated healthy volunteers and confers exceptional thermostability
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Katherine SCHULTHEIS
Poster P0533
Abstract 6443
Ceftazidime-avibactam in the treatment of bacterial superinfection in COVID-19 patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tu HA THI CAM
Poster P0534
Abstract 6508
Infection of macrophages by SARS-CoV-2: implications for viral spreading and immune response
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Lucia SIGNORINI
Poster P0535
Abstract 6520
Machine learning models based on exhaled volatile organic compounds combined with serum cytokine profile for severity prediction in COVID-19 and other respiratory infections
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Patricia ESTEBAN SÁNCHEZ
Poster P0536
Abstract 6581
COVID-19 mRNA vaccines may also boost immunity to seasonal coronaviruses and influenza
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Vennila GOPAL
Poster P0537
Abstract 6584
Is there still room for COVID-19 pre-exposure prophylaxis? A real-world case-control effectiveness study in high-risk patients with hematologic malignancies during the emerging Omicron surge
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Emilia TRUCILLO
Poster P0538
Abstract 6604
Safety and immunogenicity of SARS-CoV-2 mRNA-based vaccines in a cohort of lung transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sara Colonia UCEDA RENTERIA
Poster P0539
Abstract 6647
Long COVID among people living with HIV (PLWH): a real-life study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Melania DEGLI ANTONI
Poster P0540
Abstract 6654
Diffuse transcriptional upregulation of human endogenous retroviruses in the bronchoalveolar lavage fluid of patients with severe COVID-19 pneumonia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Konstantina KITSOU
Poster P0541
Abstract 6657
Impact of COVID-19 on the incidence of nosocomial pneumonia in two intensive care units
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Nagham Léa KHANAFER
Poster P0542
Abstract 6671
Complicating bacterial pulmonary infections in critical COVID-19 pneumonia
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Miroslava HTOUTOU SEDLAKOVA
Poster P0543
Abstract 6688
Prediction of transmission inhibition based on the antiviral effect of ensitrelvir and simulation of its impact on epidemics
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Shogo MIYAZAWA
Poster P0544
Abstract 6699
Evolutionary timeline of SARS-CoV-2
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Rishika KAUSHAL
Poster P0545
Abstract 6739
Cross-neutralising activity and durability of antibody responses against BA.4/5 and XBB 1.5 variant after BA.4/5 bivalent vaccination according to the previous SARS-CoV-2 infection: a three-month prospective cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Hye Hee CHA
Poster P0546
Abstract 6801
Adaptive immunity-derived epitope profiles as indicators of COVID-19 severity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Poster P0547
Abstract 6805
Impact of the COVID-19 pandemic on the resistance of bacterial agents isolated from the lower respiratory tract in ICU patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Miroslava HTOUTOU SEDLAKOVA
Poster P0548
Abstract 6819
Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Wan In WEI
Poster P0549
Abstract 6846
Immunogenicity of SARS-CoV-2 mRNA-based vaccines in a cohort of lung and liver transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sara Colonia UCEDA RENTERIA
Poster P0550
Abstract 6851
Driving selection of target populations to design RCT assessing therapies for the prevention and treatment of the post-COVID-19 syndrome
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Evelina TACCONELLI
Poster P0551
Abstract 6859
Estimating the effect of vaccination and previous infection on Ct values as a proxy of viral load
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Stijn ANDEWEG
Poster P0552
Abstract 6911
Neurosensorial cluster of the post-COVID 19 syndrome: prospective psychophysical assessment of smell and taste impairment and impact on quality of life
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Elisa GENTILOTTI
Poster P0553
Abstract 6913
Comparative effectiveness of the mRNA-1273 and BNT162b2 COVID-19 vaccines among older adults: a systematic literature review and meta-analysis using the GRADE framework
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ekkehard BECK
Poster P0554
Abstract 6916
Safety and immunogenicity of SARS-CoV-2 mRNA-based vaccines in a cohort of liver transplant recipients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Giovanni GIACOMEL
Poster P0555
Abstract 6933
Monitoring protection from SARS-CoV-2 infection and COVID-19 vaccination in the UK SIREN healthcare worker cohort 2020-2024: assessing the impact of vaccine boosters
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Peter Douglas KIRWAN
Poster P0556
Abstract 6986
In-house software development reveals insights into 'closed system' diagnostics - a lesson from rapid development of high-throughput SARS-CoV-2 screening
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Michael KIDD
Poster P0557
Abstract 7088
Bio-humoral characterisation of patients by clusters of post-COVID-19 syndrome at 18-month follow-up: the multicentre, prospective ORCHESTRA study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Elisa GENTILOTTI
Poster P0558
Abstract 7202
Seroprevalence of Omicron BA.2 neutralising antibodies among residents in residential care homes for the elderly in Hong Kong, February – November 2022
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Wan In WEI
Poster P0559
Abstract 7210
Effectiveness and safety of favipiravir versus standard of care in adult COVID-19 patients in a tertiary hospital setting: a retrospective cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Carla Nicole DAYAO
Poster P0560
Abstract 7223
Impact of COVID-19 on home healthcare agencies and nursing homes in the United States
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Monika POGORZELSKA-MAZIARZ
Poster P0561
Abstract 7313
Reduction of post COVID-19 condition during the Omicron wave: results from the EuCARE POSTCOVID Study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Andrea SANTORO
Poster P0562
Abstract 7331
Increasing prevalence of comorbidities in patients hospitalised with COVID-19 across variant eras
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mark BERRY
Poster P0563
Abstract 7351
Rates of long COVID-related symptoms and diagnoses in patients hospitalised with COVID-19 increased across variant eras
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mark BERRY
Poster P0564
Abstract 7424
Risk factors for morbidity and mortality among adult patients with COVID-19 and pulmonary tuberculosis co-infection admitted at a national infectious disease referral hospital in Manila, Philippines
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Catherine Denise MENDOZA
Poster P0565
Abstract 7480
Gut microbiota composition in COVID-19 patients during the Delta and Omicron variant predominance in Uzhhorod, Ukraine
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Pavlo PETAKH
Poster P0566
Abstract 7482
Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a multicentre observational cohort study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Meital ELBAZ
Poster P0567
Abstract 7528
Clinical prediction model for bacterial coinfection in hospitalised COVID-19 patients during four waves of the pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Meital ELBAZ
Poster P0568
Abstract 7541
Expansion of the laboratory surveillance of respiratory viruses in the Philippines: a response to the COVID-19 pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Catherine DACASIN
Poster P0569
Abstract 7566
Identification of new host-directed antiviral targets by proteome analysis of cysteamine anti-SARS-CoV-2 activity
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Tonino ALONZI
Poster P0570
Abstract 7598
Evaluation of SARS-CoV-2 spike mutations in immunocompromised and immunocompetent patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Alessandra D'ABRAMO
Poster P0571
Abstract 7599
Remdesivir 30-days-COVID-19-related mortality, length of hospitalization and time until negative swab test in severely immunocompromised patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Riccardo POL
Poster P0572
Abstract 7606
Nirmatrelvir/ritonavir in the management of COVID-19: a retrospective study in a highly vaccinated population
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sofia JORDAO
Poster P0573
Abstract 7633
Distinct variation pattern between consensus sequences and mutant spectra during the COVID-19 pandemic
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Brenda MARTÍNEZ GONZÁLEZ
Poster P0574
Abstract 7640
Extinction of SARS-CoV-2 by synergistic lethal mutagenesis exerted by remdesivir and ribavirin
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Carlos GARCÍA-CRESPO
Poster P0575
Abstract 7708
Independent online medical education significantly increases physician knowledge and confidence regarding real-world data for COVID-19 antiviral therapy in high-risk patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Julia DUFFEY
Poster P0576
Abstract 7720
Antiviral use in mild to moderate SARS-CoV-2 infections during the Omicron wave in geriatric patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Virginie PRENDKI
Poster P0577
Abstract 7753
Resurgence of SARS-CoV-2 viral load following antiviral therapy cessation in haematologic patients with COVID-19
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Mariana CHUMBITA
Poster P0578
Abstract 7815
Nasopharyngeal microbiome in COVID-19 infection.
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jorge RODRÍGUEZ-GRANDE
Poster P0579
Abstract 7833
Investigating the impact of vaccination and reinfection dynamics on the XBB variant of SARS-CoV-2 ???
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Priscila TRINDADE
Poster P0580
Abstract 7838
Nirmatrelvir/ritonavir or remdesivir for COVID-19 in patients with B-cell malignancies and plasma cell dyscrasias
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Pantazis-Michael VOUTSINAS
Poster P0581
Abstract 7870
Determinants of recorded SARS-CoV-2 vaccine uptake among ART-compliant people living with HIV
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Grazia ALESSIO
Poster P0582
Abstract 7903
Discordant results in the Xpert® Xpress SARS-CoV-2/ Flu/RSV assay: The importance of an accurate assessment at curve analysis in PCR testing
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Cristina VEINTIMILLA
Poster P0583
Abstract 7992
Type I interferon pathway-related hub genes as a potential therapeutic target for SARS-CoV-2 omicron variant-induced symptoms
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Sun BAOQING
Poster P0584
Abstract 8028
Multicomplex pharmacophore based virtual screening, docking, and molecular dynamics to discover novel inhibitors against main protease (Mpro) of coronaviruses
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Prerna RAJORIA
Poster P0585
Abstract 8123
Monitoring anti-SARS-CoV-2 antibodies and variant-specific neutralization in healthy children by dried blood spots
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Matteo Domenico MARSIGLIA
Poster P0586
Abstract 8140
Clinical epidemiology and biomarker identification in patients with novel coronavirus infection (severe/critical) secondary to bacterial infection
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Zhongyu HAN
Poster P0587
Abstract 8161
Risk of SARS-CoV-2 infection and severe COVID-19 in haematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation during Omicron BA.5 dominated wave
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Giusy TISEO
Poster P0588
Abstract 8174
Global rate of antibiotic use, co-infections, resistance and clinical outcomes in COVID-19 patients receiving antibiotics in 65 countries worldwide
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Daniele DONA'
Poster P0589
Abstract 8185
Anion exchange woven fabric ensures a most efficient concentration of SARS-CoV-2 from wastewater
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Yuliya KALTUNOVA
Poster P0590
Abstract 8246
Increased viral loads of Omicron EG.5.1 compared to co-circulating SARS-CoV-2 lineages
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Timo FROYEN
Poster P0591
Abstract 8284
Broad immunity to SARS-CoV-2 mediated by a Vaccine Formulation Based on the receptor binding domain (RBD)-Nucleoprotein cocktail Co-Administered with an AddaVax adjuvant
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Amir GHAEMI
Poster P0592
Abstract 8291
Surveillance of SARS-COV2 variants in wastewater of aircraft
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Elke WOLLANTS
Poster P0593
Abstract 8432
Household transmission dynamics of SARS-CoV-2 in the north of the Netherlands: the COVID-HOME study
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Maria Fernanda VINCENTI GONZALEZ
Poster P0594
Abstract 8548
Evaluation of immune response to anti-SARS-CoV-2 vaccination in cancer patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Ombretta TURRIZIANI
Poster P0595
Abstract 8619
COVID-19 does not increase the risk of invasive fungal infection in hematopoietic stem-cell transplanted patients
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Bruno RANDI
Poster P0596
Abstract 8675
Coinfection of SARS-Cov-2 with other respiratory viruses in a large cohort study: the UnCoVER-Brazil project
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Felipe Santos De CARVALHO
Poster P0597
Abstract 8696
Lessons for future pandemic preparedness: The SIREN experience
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Jasmin ISLAM
Poster P0598
Abstract 8697
Promotion of SARS-CoV-2 vaccination in at-risk sectors: methods and impact of an intervention in jail health care
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Maxence ROUYER
Poster P0599
Abstract 8807
Concomitant administration of seasonal influenza and COVID-19 mRNA
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Teresa AYDILLO
Poster P0600
Abstract 8829
T cell receptor sequencing allows monitoring longitudinal T cell clonal responses and antigen-specificity to COVID-19 vaccination
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Isabel FERREIROS-VIDAL
Poster P0602
Abstract 8913
The acquisition of SARS-CoV-2 immunity from sequential Spike exposures via infection or vaccination
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Marianne SHAWE-TAYLOR
Poster P0603
Abstract 8916
Post-acute sequalae of COVID-19 three to twelve months after infection: Delta versus Omicron
27/04 12:00
1j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)
Siméon DE BRUIJN
Poster P1924
Abstract 165
Urine collection practices analysis and the impact of boric acid tubes on quantitative urinary bacterial cultures in hospitalised patients
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Debby BEN-DAVID
Poster P1925
Abstract 461
Pre-analytical delays in blood culture pathway do not always postpone actionable results
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Tim INGLIS
Poster P1926
Abstract 610
GDH/toxin assay plus PCR vs PCR for the diagnosis and treatment of Clostridioides difficile infection
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Hossein SALIMNIA
Poster P1927
Abstract 874
Urine culture reflex implemented to reduce inappropriate testing and treatment of UTIs
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Erika ORNER
Poster P1928
Abstract 1107
Can IgM predict IgG avidity values for Toxoplasma and CMV?
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Laura VERDURME
Poster P1929
Abstract 1304
Same-day reporting of blood cultures in gram-negative sepsis: achieving holy grail of microbiology sans MALDI-TOF
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Ayush GUPTA
Poster P1930
Abstract 1359
Development of a cost-effective rapid detection of carbapenem-resistance Gram-negative bacteria laboratory workflow
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Kangjun SUN
Poster P1931
Abstract 1408
Preliminary evaluation of a rapid lateral flow immunoassay for the detection of Candida albicans, Trichomonas vaginalis, or Gardneralla vaginalis antigen kit using clinical vaginal swab specimens
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Kangjun SUN
Poster P1932
Abstract 1509
Evaluation of a novel chromogenic culture medium for the detection and enumeration of Pseudomonas aeruginosa
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Jose DEGROSSI
Poster P1933
Abstract 1665
Evaluation of the analytical and clinical performance of a new diagnostic test for the detection of Campylobacter antigens in stool specimen
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Juergen BECKER
Poster P1934
Abstract 2059
Performance comparison of a new GDH antigen chemiluminescent immunoassay for the diagnosis of Clostridioides difficile infection
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Ana LÓPEZ GONZÁLEZ-SALIDO
Poster P1935
Abstract 2168
Blood volume is the key determinant of paediatric blood culture performance: results from a pre- and post-intervention study
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Sean Olann WHELAN
Poster P1936
Abstract 2260
Impact of laboratory processing delays on microbiological diagnostics
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Valentina DE SARIO
Poster P1937
Abstract 2273
Rates of Gram-positive blood culture contamination in El Paso Texas: a comparative assessment between nuclic acid diagnostic test & conventional method
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Nouf ALMAGHLOUTH
Poster P1938
Abstract 2454
Blood cultures in resource-limited settings: extended stability testing in simulation experiments
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Liselotte HARDY
Poster P1940
Abstract 2990
The impact of implementing a new blood culture system for coagulase-negative staphylococci contamination
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Hiroki KITAGAWA
Poster P1941
Abstract 3156
Enhancing microbiology laboratory organisation: first WASPLab installation in Romania
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Bota MARCELA
Poster P1942
Abstract 3338
Efficient ELISA tests for early diagnosis of plague
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Herve BOUTAL
Poster P1943
Abstract 3375
Direct Gram staining replaced by a flow cytometer automate to save time
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Mathilde DUBUC
Poster P1944
Abstract 3726
Evaluation of laser light scattering method for urine culture screening in outpatients
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Amina OBRADOVIC BALIHODZIC
Poster P1945
Abstract 3733
Comparing optical microscopy with table-top scanning electron microscopy in a clinical bacteriology laboratory: a cost-effectiveness analysis
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Omar ZMERLI
Poster P1946
Abstract 3860
Evaluation of a 16 hour incubation for urine culture using wasp/wasplab imaging analysis
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Mark GASKIN
Poster P1947
Abstract 3887
Understanding routine laboratory practices for C. ulcerans and C. diphtheriae culture in primary clinical testing providers in the United Kingdom: a mixed-methods evaluation
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Charlotte ROBIN
Poster P1948
Abstract 4260
Fast-track algorithm for the early detection of microorganisms in urine in patients with suspected sepsis
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Belén RODRÍGUEZ MÁRQUEZ
Poster P1949
Abstract 4283
Changing the culture around blood cultures
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Amy READ
Poster P1950
Abstract 4373
Evaluation of a new diagnostic system that identifies microorganisms from clinical samples
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Lisa SCHECHTER
Poster P1951
Abstract 4643
Comparison of two culture strategies for the diagnostic of vulvovaginal candidiasis leading to reduction of the turnaround time and consumption of media
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Annette SKOVBY
Poster P1952
Abstract 4729
Comparing enrichment broths and plates for detection of MRSA in screening samples
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Annette SKOVBY
Poster P1954
Abstract 4933
Contribution of anaerobic culture in semen samples in medically assisted reproduction
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Joséphine VASSE
Poster P1955
Abstract 5098
Performance of a novel chromogenic agar for primary isolation of pathogenic beta-hemolytic streptococci from throat swabs
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Abdulrahman ALMODAHKA
Poster P1956
Abstract 5211
Retrospective analysis post-implementation of a novel lab-developed multiplex RT-PCR/MALDI-TOF MS syndromic test for infectious diarrhea
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Robert LIAO
Poster P1957
Abstract 5753
The optimal storage conditions of faeces for detection of bacterial pathogens
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Vishal HIRA
Poster P1958
Abstract 5828
Significance of Bristol value in the finding of gastrointestinal pathogens
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Marina VICENTE CIURANS
Poster P1959
Abstract 6130
Legionella diagnosis: comparison between two urinary antigen commercial tests
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Valentina LEPERA
Poster P1960
Abstract 6839
European evaluation of 16 assays for the detection of Legionella pneumophila antigen in urine samples from patients with pneumonia
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Sophie JARRAUD
Poster P1961
Abstract 7192
Evaluation of an immunochromatographic test for the detection of Streptococcus pneumoniae in pleural fluids
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Souha MOKNI
Poster P1962
Abstract 7483
Correlation between manual and automated treponemal assays in serum and spinal fluid samples
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Veselka Petrova DIMOVA-SVETOSLAVOVA
Poster P1963
Abstract 7707
Are you choosing the right colony? Exploring phenotypic and genomic variability between colonies from clinical Enterococcus faecium and Enterococcus faecalis pure cultures
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Ana Raquel FREITAS
Poster P1964
Abstract 7725
Detection of diphtheria toxin production by Elek test: interlaboratory proficiency testing among three laboratories in three different countries
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Anja BERGER
Poster P1965
Abstract 7775
Improved performance in diagnosis of Lyme disease utilising a novel multiplexed modified two-tier test when compared with the standard two-tier test
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Thomas R. FRITSCHE
Poster P1966
Abstract 7845
Evaluation of the influence of different blood volumes and inoculum size on the time to positivity detection in a system for continuous monitoring of blood cultures
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Maja BOGDAN
Poster P1967
Abstract 8082
Production of monoclonal antibodies against quorum sensing molecule HQNO to diagnose P. aeruginosa infections
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Irene ROVIRA
Poster P1968
Abstract 8341
Performance of a new lipid enriched blood agar to detect catheter colonization by Malassezia spp. and by other commonly associated microorganisms
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Pablo MARTÍN-RABADÁN
Poster P1969
Abstract 8416
Infection-related stillbirths: a detailed examination of a nine-year multidisciplinary study
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Matteo PAVONI
Poster P1970
Abstract 8689
Improving yield of peritoneal dialysis effluent cultures: an LMIC experience
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Anusha ROHIT
Poster P1971
Abstract 8918
The first IVDR-certified Treponema pallidum haemagglutination assay was accurate and reliable to confirm and quantify T. pallidum antibodies in sexual health attendees and pregnant women
27/04 12:00
4a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)
Hafsa DUALE
Poster P1972
Abstract 39
Evaluation of performance of early identification of urinary pathogens using combination of an automated picker and chromogenic medium at 12h incubation
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Corine FULCHIRON
Poster P1973
Abstract 1079
External quality assurance (EQA) network in south and southeast Asia: experience and results from an international EQA program in One Health sector reference laboratories
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Tomislav KOSTYANEV
Poster P1974
Abstract 1192
Inter and intra-lot variance precludes use of manufacturer's kit controls for quality monitoring
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Yuan Yi Constance CHEN
Poster P1975
Abstract 2330
Impact and benefits of implementing the Nagoya protocol regulation in microbiological collection for research & development activities
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Caroline MIRANDE-MEUNIER
Poster P1976
Abstract 2571
Preliminary performance assessment of automated individual blood volume measurement system for blood culture instrument
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Joshua HERR
Poster P1977
Abstract 3930
Comparison of AI-assisted and manual interpretation of dics diffusion test from 12 antibiotics of Pseudomonas aeruginosa
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Hilmar WISPLINGHOFF
Poster P1978
Abstract 4394
Use of a data analytic platform for the determination and tracking of blood culture contamination at an academic health care system.
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Heinz SALAZAR
Poster P1979
Abstract 4904
Validation of an automated instrument for handling specimen preparation
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Michael CHAN
Poster P1980
Abstract 4968
Environmental impact of urine analyses: comparison of manual, semi and fully automatised analytical workflow
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Olivier DAUWALDER
Poster P1981
Abstract 5583
LEAN optimisation with two track integrated InoqulAs
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Mariska OKKEMA-VAN DER LEI
Poster P1982
Abstract 5618
Human papillomavirus: external quality assessment, 2009-2023 a review
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Deane BYERS
Poster P1983
Abstract 5711
Educational preanalytical cases support end-to-end EQA in bacteriology laboratories
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Kristel VIRTANEN
Poster P1984
Abstract 5850
Can a fast call to the microbiology laboratory improve the diagnosis and management of patients with sepsis alert?
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Ana ÁLVAREZ-URÍA
Poster P1985
Abstract 7476
Assessing E.coli antimicrobial resistance detection proficiency: insights from EQASIA matrix external quality assessment (EQA) in south and southeast Asia
27/04 12:00
4b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)
Hiba ALMIR
Poster P1986
Abstract 774
Experimental study on factors associated with low identification rates of Streptococcus pneumoniae using commercial enrichment kit for direct MALDI-TOF MS identification
27/04 12:00
4c. MALTI-TOF and other proteomic methods
You-Keun KO
Poster P1987
Abstract 897
Optimal commercial enrichment kit protocol for rapid bacterial pathogen identification from blood positive culture by matrix-assisted laser desorption ionization-time of flight mass spectrometry system
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Hyun-Seung LEE
Poster P1988
Abstract 1063
The importance of using two complementary mass spectrometry databases in the resolution of complex pathogens
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Florencia ROCCA
Poster P1989
Abstract 1162
Is the correct identification directly from blood culture bottles just a dream?
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Dilan KARADAG
Poster P1990
Abstract 1517
Rapid classification of Staphylococcus lugdunensis sequence type 3 based on MALDI-TOF mass spectrometry
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Lee-Chung LIN
Poster P1991
Abstract 1570
Evaluation of a rapid MALDI-TOF protocol for the detection of pathogenic microorganisms on positive blood cultures in an MDRO-endemic hospital environment
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Angeliki KASSOMENAKI
Poster P1992
Abstract 1628
Performance and workflow comparison between two MALDI TOF MS systems in microbiology routine laboratory settings
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Ulrich EIGNER
Poster P1993
Abstract 2274
Performance evaluation of Vitek MS PRIME compared to Vitek MS
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Sae Am SONG
Poster P1994
Abstract 2543
MALDI-TOF MS database expansion for robust and improved diagnostics in microbiology
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Valérie CHALANSONNET
Poster P1995
Abstract 2777
Detection of Escherichia coli O157:H7 using MALDI-TOF mass spectrometry
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Florencia ROCCA
Poster P1996
Abstract 3123
Performance of the VITEK MS PRIME was equivalent to the VITEK MS in microbial identification with improved time to result
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Crystal WONG
Poster P1997
Abstract 3921
Use of FT-IRS to detect in-patient diversity of vancomycin-resistant Enterococcus faecium
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Paul G HIGGINS
Poster P1998
Abstract 3931
Legionella spp. identification by MALDI-TOF mass spectroscopy: improvement of technique and species relationship
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Luna GIROLAMINI
Poster P1999
Abstract 4406
Evaluating MALDI-TOF for differentiation of Streptococcus pneumoniae from viridans group streptococci in blood cultures
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Eliza GIL
Poster P2000
Abstract 4687
New insights on Serratia spp. taxonomy: are we doing our best?
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Blanca PÉREZ VISO
Poster P2001
Abstract 4913
Bacterial identification by direct MALDI-TOF MS from blood culture bottles
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Santiago MUNILLA
Poster P2002
Abstract 5770
Evaluation of fast direct MALDI-TOF identification of organisms from positive blood-culture bottles (BCB): the saponin method vs full extraction
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Dennis Schröder HANSEN
Poster P2003
Abstract 5895
Determination of the globally most common Streptococcus agalactiae strain, ST1, using MALDI-TOF mass spectrometry
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Kwanchai ONRUANG
Poster P2004
Abstract 6001
Evaluation of MALDI-TOF MS to identify Acinetobacter spp. circulating in a Danish tertiary hospital
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Lekovic SONJA
Poster P2005
Abstract 6059
A simple protocol for rapid bacterial identification by MALDI-TOF MS directly from positive blood cultures
27/04 12:00
4c. MALTI-TOF and other proteomic methods
João SIMÕES MARRAZES
Poster P2006
Abstract 6195
Application of Fourier transform infrared spectroscopy to discriminate B. anthracis from B. cereus sensu stricto
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Viviana MANZULLI
Poster P2007
Abstract 7024
Assessing diagnostic methods: MOLDI TOF Direct vs. ePlex BCID panels in detecting bacteremia and fungemia from positive blood cultures in a tertiary level hospital
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Sofia NARVÁEZ MORALES
Poster P2008
Abstract 7679
Evaluation of VITEK MS prime bacterial identification performance in conjunction with a fully automated slide preparation system in urine cultures
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Jana ROVIRA-PLUJÀ
Poster P2009
Abstract 8268
Detection of cfiA gene in Bacteroides fragilis using MALDI-TOF
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Nurver ULGER TOPRAK
Poster P2010
Abstract 8692
Comparison between direct MALDI-TOF MS method and a commercial multiplex PCR panel for rapid identification of bacteria directly from positive blood cultures
27/04 12:00
4c. MALTI-TOF and other proteomic methods
Ivana VELIMIROVIC
Poster P2011
Abstract 41
Diagnostic accuracy of pooling samples for the detection of N. gonorrhoeae and C. trachomatis using a commercial CT/NG assay
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Amy SHANLEY
Poster P2012
Abstract 530
Argentine multicentre study on the usefulness of multiplex PCR in the diagnosis of septic arthritis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Rolando SOLOAGA
Poster P2013
Abstract 640
High diagnostic accuracy of pooled samples analysed with a commercial PCR for detecting MRSA carriage
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Ditte BANG OTURAI
Poster P2014
Abstract 785
Prospective evaluation of a commercial multiplex PCR system to identify microorganisms in explanted heart valves from suspected infective endocarditis cases
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Benjamin BERINSON
Poster P2015
Abstract 839
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae (and its resistance to ciprofloxacin): a molecular biology solution for rapid diagnosis and treatment
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Blanca DEHESA-GARCÍA
Poster P2016
Abstract 854
A novel filarial-multiplexed probe-quantitative PCR for the advance in the diagnosis of co-infected human filariasis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Raquel CAPOTE-MORALES
Poster P2017
Abstract 862
Towards better treatment of bacterial endophthalmitis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Tim SCHUURMAN
Poster P2018
Abstract 879
Duplex Salmonella spp. qPCR for screening of poultry environmental samples
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Durda SLAVIC
Poster P2019
Abstract 922
Molecular approaches to the rapid and accurate diagnosis of bone and joint infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Kiyofumi OHKUSU
Poster P2020
Abstract 1027
Comparison of three multiplex PCR assays for Chlamydia trachomatis and Neisseria gonorrhoeae detection in symptomatic genital infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Ali ZEROUKI
Poster P2021
Abstract 1105
Filmarray syndromic diagnostics strengthens clinical outcomes, biosecurity and response in eight small island states
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
John LEE
Poster P2022
Abstract 1116
Prospective evaluation of the performance and clinical impact of a commercial PCR panel in patients with suspected joint infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Benjamin BERINSON
Poster P2023
Abstract 1227
The relevance of SCCmec-orfX junction target in the accurate detection of methicillin-resistant Staphylococcus aureus: a comparative study of interpretation criteria in a real-time PCR kit
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Esther FRANCO
Poster P2024
Abstract 1257
Would a rapid response be possible in developing countries for the diagnosis of hepatitis B and malaria using DBS samples?
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
María MARTÍNEZ-SANTOLARIA
Poster P2025
Abstract 1259
Quick lysis reagent: a rapid alternative to automatic extraction
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
María MARTÍNEZ-SANTOLARIA
Poster P2026
Abstract 1280
T2 magnetic resonance technology identifies 3.55 times more on-panel Candida species compared to conventional blood culture
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Oscar GUZMAN
Poster P2027
Abstract 1302
Method validation: spike!
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Sabine TROMBERT-PAOLANTONI
Poster P2028
Abstract 1367
Using protein microarrays to enhance lateral flow development for detecting multiplex beta-lactam and colistin resistance
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Sascha D. BRAUN
Poster P2029
Abstract 1431
Reagent decontamination needed to develop microorganism's qPCR assays with a mammalian endogenous control
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
María GISTAS LOSCOS
Poster P2030
Abstract 1432
qPCR Reagent decontamination needed for 16S rDNA qPCR and Sanger sequencing
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
María GISTAS LOSCOS
Poster P2031
Abstract 1470
Detection of bacteria directly from synovial fluid using digital PCR: proof of concept
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Marthe CHARLES
Poster P2032
Abstract 1560
Improved meningitis diagnostics of culture-negative CSF samples with molecular culture
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lauren REMIJAS
Poster P2033
Abstract 1565
Comparison of two automatic methods for the identification of pathogens isolated from clinical samples
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Stavroula BAKA
Poster P2034
Abstract 1683
Causative microorganisms of sexually transmitted infections in a STI clinic during the year 2023
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jorge-Alfredo PEREZ-GARCIA
Poster P2035
Abstract 1756
Evaluation of a multiplex real time PCR assay for the diagnosis of vaginal candidiasis: a comparison with conventional laboratory culture methods
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Laura VANDERVORE
Poster P2036
Abstract 1776
What have we learned from COVID-19 global health emergency?
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Laura PASTOR-BERNARD
Poster P2037
Abstract 1784
Fast, multiplexed, and automated diagnosis of sexual transmitted infections (STIs) in different human specimens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Laura PASTOR-BERNARD
Poster P2038
Abstract 1817
Kitoma, extraction kit microbiome
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Laura PASTOR-BERNARD
Poster P2039
Abstract 1856
Rapid PCR-based syndromic testing improved pathogen identification in lower respiratory tract infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Kerry FALCONER
Poster P2040
Abstract 1909
Evaluation of a culture-independent gastrointestinal multiplex PCR panel for detection of gastrointestinal pathogens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Erdal ÖZBEK
Poster P2041
Abstract 2009
Evaluation of the Abbott Alinity m STI assay for the diagnosis of sexually transmitted diseases
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Mercedes PÉREZ RUIZ
Poster P2042
Abstract 2039
Use of T2Bacteria panel in pediatric hematopoietic stem cell transplant patients: a single centre experience
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lisa HISKEY
Poster P2043
Abstract 2306
Clinical usefulness of the rapid bacterial identification panel at a tertiary hospital
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Woo KWANG-SOOK
Poster P2044
Abstract 2551
Evaluation of molecular culture for pleural infection diagnosis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lauren REMIJAS
Poster P2045
Abstract 2610
Non-classical pathogens involved in proctitis among frequent sex-group and chemsex participants
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Miguel PEREZ-POLANCO
Poster P2046
Abstract 2617
Assessment of various transport media for compatibility with a novel molecular point-of-care system for respiratory viruses
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Juergen BECKER
Poster P2047
Abstract 2749
BCID2 vs phenotypic culture: good, but not perfect, interim analysis from an Indian ICU
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Umang AGRAWAL
Poster P2048
Abstract 2797
One script, many actors: multiplex-PCR meningitis/encephalitis syndromic panel acceptance level among pediatric and adult physicians
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Patricio FAVIER
Poster P2049
Abstract 2841
NGS-based pathogen diagnostic in patients after allogeneic haematopoietic stem cell transplantation: a prospective single-centre study
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Sophie WEIL
Poster P2050
Abstract 2845
GI pathogen detection using multiplexed PCR assay in kidney transplant recipients with diarrhea - before after study
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Alaa ATAMNA
Poster P2051
Abstract 2854
Implementation of the first-of-its-kind high-throughput molecular testing platform for sexually transmitted infections into a national health service laboratory
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Anita JUSTICE
Poster P2052
Abstract 3006
Misidentification of coagulase negative Staphylococcus species as Staphylococcus epidermidis by the blood culture identification panel 2 (BCID2)
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Stella ANTONARA
Poster P2053
Abstract 3046
Etiologies of children digestives infections by syndromic molecular diagnosis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Doria BENSERSA-NEDJAR
Poster P2054
Abstract 3058
Diagnosis of community-acquired meningitis and meningo-encephalitis through syndromic PCR
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Doria BENSERSA-NEDJAR
Poster P2055
Abstract 3173
A commercial molecular diagnostic test: clinical case series of the top six bloodstream infection and sepsis causing bacteria
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lisa SIMMS
Poster P2056
Abstract 3176
Value of a commercial multiplex PCR panel for the diagnosis of cholera in an outbreak setting in Hammanskraal, Tshwane, South Africa
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Mohamed SAID
Poster P2057
Abstract 3179
Effects of a colloidal gold immunochromatographic assay for carbapenemase detection on the clinical outcomes of patients with bloodstream infection caused by carbapenem-resistant Enterobacterales
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jiajie WANG
Poster P2058
Abstract 3183
Evaluation of a commercial multiplex PCR assay as a routine screening method for the detection of stool pathogens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Sarona LENGANA
Poster P2059
Abstract 3243
Detects the main sexually transmitted pathogens plus Candida albicans and Gardnerella vaginalis by one-step real-time PCR
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Blanca DEHESA-GARCÍA
Poster P2060
Abstract 3316
Evaluation of a commercial PCR-panel for detection of lower respiratory-tract infection pathogens compared to standard bacterial culture
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Julija GERM
Poster P2062
Abstract 3389
Multiplex molecular testing reveals the burden of Vibrio cholerae infection in travellers
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Victoria K. OWEN
Poster P2063
Abstract 3437
Development of a strain-specific PCR as a diagnostic tool for surveillance, detection, and monitoring of vancomycin-resistant Enterococcus faecium during outbreak
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Artur SABAT
Poster P2064
Abstract 3522
Identification of bacterial pathogens in brain abscesses by metagenomic approach using nanopore 16S amplicon sequencing
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Yoonhyuk JANG
Poster P2065
Abstract 3530
Microbiological culture vs molecular techniques: what is the best for the diagnosis of gastrointestinal infections?
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Mireia IGLESIAS ALGILAGA
Poster P2066
Abstract 3633
Comparison of two diagnostic techniques for the detection of sexually transmitted infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Berta PINO CALM
Poster P2067
Abstract 3833
High-throughput development of multiple qPCR and RT-qPCR diagnostic kits for comprehensive pathogen detection
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Ana ALVES CONCEIÇÃO
Poster P2068
Abstract 4060
The role of Streptococcus pneumoniae polymerase chain reaction (PCR) in the diagnosis of pleural effusion due to pneumonia
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Laura Eva FRANCO FOBE
Poster P2069
Abstract 4065
Optimising microbiological diagnosis and antimicrobial therapy of suspected osteoarticular infections using a syndromic molecular panel in paediatric patients
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Marilena AGOSTA
Poster P2070
Abstract 4095
Comparison of the QIAstat-Dx and the BioFire for the detection of viral and bacterial respiratory tract pathogens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Karoline LEUZINGER
Poster P2071
Abstract 4143
Standardisation of a rapid tool for the detection of bacterial pneumonia in children.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Arturo MARTÍNEZ TREJO
Poster P2072
Abstract 4279
Culture-free rapid identification of bacterial strains in urinary tract infections (UTI) using RapidID, a novel multiplex, ribosomal RNA-based hybridization assay.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Joseph M. BLONDEAU
Poster P2073
Abstract 4613
Evaluation of a novel commercial RT-PCR assay for the detection of Helicobacter pylori and clarithromycin resistance
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Ursa KOLENC
Poster P2074
Abstract 4684
Severe pneumonia monitoring: dynamics of culture and of multiplex PCR according to bacterial type
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Sarah TIMSIT
Poster P2075
Abstract 4754
Evaluation of respiratory multiplex panel performance at a large teaching hospital in the United Kingdom
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Deepak PATHIYIL
Poster P2076
Abstract 4766
Evaluation of four pneumococcal urinary antigen tests in patients with community-acquired pneumonia
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Rosa M PACHECO-GONZALEZ
Poster P2077
Abstract 4793
Development and application of non-toxigenic Clostridioides difficile quantitative polymerase chain reaction assay
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jinhee JO
Poster P2078
Abstract 4813
The use of a syndromic panel in the diagnosis of septic arthritis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Ana MARTÍN
Poster P2079
Abstract 4837
Implementation of a multiplex RT-PCR for the rapid detection of pathogens in neonatal sepsis.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Helena GIL CAMPESINO
Poster P2080
Abstract 4844
Impact of rapid molecular diagnosis on the clinical-therapeutic management of severe pneumonia
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Alicia GALAR
Poster P2081
Abstract 4874
Performance of new rapid multiplex real-time PCR kit detecting sexually transmitted pathogens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Florence DOUCET POPULAIRE
Poster P2082
Abstract 5031
Emergence of OXA-48-producing Klebsiella pneumoniae ST5994: a subclone of ST307 high-risk clone
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jorge RODRÍGUEZ-GRANDE
Poster P2083
Abstract 5044
Molecular diagnostic techniques are useful in ruling out native vertebral osteomyelitis: a systematic review and meta-analysis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Omar MAHMOUD
Poster P2084
Abstract 5117
Retrospective analysis of a multiplex vaginitis panel reveals diagnostic uncertainty in high cycle threshold positive specimens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lucas OSBORN
Poster P2085
Abstract 5144
Evaluation of a custom NAAT gastrointestinal panel for syndromic testing of infectious diarrhea
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Yim GRACE
Poster P2086
Abstract 5181
Detection of Helicobacter pylori and clarithromycin-resistance prediction by real-time PCR in paediatric stool specimens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Molly BUTLER
Poster P2087
Abstract 5236
Impact of multiplex polymerase chain reaction test in patients with meningitis or encephalitis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Daisuke KITAGAWA
Poster P2088
Abstract 5249
Quantitative PCR: a novel clinical tool for patients with bloodstream infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
David FARLOW
Poster P2089
Abstract 5353
Impact on hospital length of stay and antimicrobial usage in aseptic meningitis patients dignosed by rapid multiplexed PCR assay at a pediatric hospital
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lu JACKY
Poster P2090
Abstract 5555
Development of a dipstick-based diagnostic assay for rapid detection of AMR genes in critical and high-priority bacterial pathogens
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Deepjyoti PAUL
Poster P2091
Abstract 5608
Correlation of FilmArray pneumonia panel plus assay results with conventional diagnostic methods in determining the microbiological aetiology of nosocomial lower respiratory tract infections and antibiotic resistance profiles
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Tercan US
Poster P2092
Abstract 5624
Evaluation of clinical performance and usability of a new automatic assay for gastrointestinal syndromic testing
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jasmin KÖFFER
Poster P2093
Abstract 5765
Implementation of molecular syndromic testing in routine laboratory diagnosis of infectious gastroenteritis
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Tjasa CERAR KISEK
Poster P2094
Abstract 5825
Application of rapid molecular technology in precision medicine tackling Gram-negative bacteraemia
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Murnihayati HASSAN
Poster P2095
Abstract 5900
Comparison of self-collected and physician-collected rectovaginal swabs for the detection of Group B Streptococcus colonisation in pregnancy using PCR from commercial enrichment broth swabs
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Samo JEVERICA
Poster P2096
Abstract 5952
Assessing five methods that utilise host depletion methods to target bacterial DNA from synovial joint fluid.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Hermione WEBSTER
Poster P2097
Abstract 6063
Evaluation of four PCR Allplex gastrointestinal panel for the detection of bacterial, parasitical and viral pathogens in faeces.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Pauline PITTI
Poster P2098
Abstract 6173
Quantification of bacterial loads using interspace profiling (IS-Pro)
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Anne-Xander VAN DER STEL
Poster P2099
Abstract 6175
Evaluation of a multiplex PCR panel for the diagnosis of community acquired meningitis/encephalitis and its integration in the laboratory diagnostic algorithm
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Max THOBURN
Poster P2100
Abstract 6264
Added value of syndromic PCR panels for diagnosis in patients with ventilator-associated pneumonia with or without chronic respiratory diseases
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Davide CALABRETTA
Poster P2101
Abstract 6280
Small amount of precious sample: can qPCR eye panel be helpful for rapid diagnosis of infections in keratitis patients?
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Bedia DINC
Poster P2102
Abstract 6422
Syndromic point of care respiratory testing is clinically impactful and cost-effective compared to laboratory-based respiratory PCR
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jonathan WILD
Poster P2103
Abstract 6579
Evaluation of a multiplex PCR platform to enhance antimicrobial stewardship through rapid infection and antimicrobial resistance diagnostics in liver disease
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Veena RAMACHANDRAN
Poster P2104
Abstract 6607
Detection by real-time PCR of Helicobacter pylori and clarithromycin resistance compared to histology on gastric biopsies
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Guillaume PITTIE
Poster P2105
Abstract 6736
Evaluation of the multiplex PCR rapid testing for diagnosis of central nervous system infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Banu BAYRAKTAR
Poster P2106
Abstract 6919
Effects of rapid detection of bloodstream infections using molecular method in developing country
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Eduardo CASTRO
Poster P2107
Abstract 6996
Ten minutes from collection to final result: a novel nucleic acid detection technology
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Kyle GERBER
Poster P2108
Abstract 6997
Molecular diagnostics for pathogen identification in joint infections
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Petra KMETIC
Poster P2109
Abstract 7326
Engineered reverse transcriptases and Taq DNA Polymerases deliver robust yields in the presence of clinically relevant inhibitors ?????
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Julie WALKER
Poster P2110
Abstract 7431
Evaluation of the microbiological performance of the FilmArray BCID2 in a developing country
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Eduardo CASTRO
Poster P2111
Abstract 7530
16S ribosomal and ITS gene PCR in osteoarticular infections: is it useful for all types of samples?
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Manuel PINA SÁNCHEZ
Poster P2112
Abstract 7560
Streptococcus pyogenes carriage detection with primary diagnostic and with qPCR-guided cultures in oropharyngeal and nasopharyngeal samples collected from children
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Rob MARIMAN
Poster P2113
Abstract 7600
Analytical and clinical equivalence study of a syndromic panel for gastroenteritis on a alternative extraction platform
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Julie GREEN
Poster P2114
Abstract 7736
Novel molecular assays for detection of the opportunistic pathogen Kalamiella piersonii.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Louise O'CONNOR
Poster P2115
Abstract 7792
Value of syndromic multiplex PCR in epidemiology of respiratory infections in lung transplant patients
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Noémie PEREZ MUNOZ
Poster P2116
Abstract 8069
An optimised protocol for cost-efficient and rapid sequencing of bacterial 16S rDNA in clinical samples using nanopore
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Jozef DINGEMANS
Poster P2117
Abstract 8136
Is 16S rRNA approach an option to improve molecular diagnosis in bacterial infections?
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Olivier DAUWALDER
Poster P2118
Abstract 8698
Risk management of false positives with using multiplex PCR blood culture panels
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Sophie GREGG
Poster P2119
Abstract 8745
Can PCR replace culture for diagnosing gastro-intestinal pathogens? Validation of Seegene's Allplex GI-EB panel.
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Astrid HOLDERBEKE
Poster P2120
Abstract 8848
Prevalence of gastrointestinal pathogens detected by multiplex PCR in a third-level teaching hospital in Mexico City
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Lucia MARTINEZ-HERNANDEZ
Poster P2121
Abstract 8896
Large diagnostic gap for hospitalized acute febrile illness admissions
27/04 12:00
4d. Molecular diagnostics (incl POCT and syndromic testing)
Kalpa KARIYAWASAM
Poster P2122
Abstract 284
Evaluation and proof of concept study for timely antimicrobial resistant organisms tacking (TAROT)
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Kotaro AOKI
Poster P2123
Abstract 926
Burden and serotype distribution of Streptococcus pneumoniae associated with pediatric invasive pneumococcal disease (IPD): a prospective surveillance study in Japan
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Katsunori YANAGIHARA
Poster P2124
Abstract 970
MRSA nasal carriage in Taiwanese senior high school students and narrative comparison with local metadata
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Cheng Yu LEE
Poster P2125
Abstract 1021
National FTIR surveillance allows for early detection of outbreak of high risk Klebsiella pneumoniae ST307 in several hospitals in the north of Israel
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Mor LURIE-WEINBERGER
Poster P2126
Abstract 1370
A fast and economic protein-microarray based approach for serotyping of Salmonella enterica strains
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Sascha D. BRAUN
Poster P2127
Abstract 1624
Machine learning-based typing of Clostridium botulinum by FT-IR spectroscopy: preliminary results
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Ilenia DRIGO
Poster P2128
Abstract 2286
Investigation of multidrug resistant Acinetobacter baumannii using IR Biotyper, a Fourier transform infrared spectroscopy system
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Felipe TUON
Poster P2129
Abstract 2768
Early identification of a nosocomial outbreak of vancomycin-resistant Enterococcus faecium by Fourier-transform infrared spectroscopy and performance comparison with PFGE and WGS
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Ignasi ROCA
Poster P2130
Abstract 3227
Big data genomic analysis of multidrug-resistant Acinetobacter baumannii in indian clinical isolates carrying different types of CRISPR/Cas systems
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Aishwarya DAS
Poster P2131
Abstract 3386
Complete genomic analysis of Korean ST72-spa t324 community-associated methicillin-resistant Staphylococcus aureus SCCmec type IVa isolates from blood cultures
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Jae-Seok KIM
Poster P2132
Abstract 3989
Comparison between cultural method and isothermal loop mediated amplification (LAMP) in hospital environment monitoring
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Federica MARINO
Poster P2133
Abstract 4061
Differentiation of Pseudomonas aeruginosa clinical outbreaks by Fourier transform infrared spectroscopy
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Paul G HIGGINS
Poster P2134
Abstract 4137
Evaluating FT-IRS in outbreak detection of vancomycin-resistant Enterococcus faecium
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Paul G HIGGINS
Poster P2135
Abstract 4286
Evaluation of FT-IR spectroscopy and machine learning for the discrimination of Escherichia coli and Shigella spp.
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Miriam CORDOVANA
Poster P2136
Abstract 4409
Accelerating diagnosis by streamlining Klebsiella pneumoniae typing from blood culture bottles with Fourier transform infrared spectroscopy
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Poster P2137
Abstract 5347
Discrepancies between cultural and molecular methods for carbapenem-resistant Enterobacterales in active surveillance: an experience of a Italian large tertiary Hospital
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Selene Rebecca BONCOMPAGNI
Poster P2138
Abstract 5586
Genomic surveillance of multidrug-resistant organisms based on long-read sequencing
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Antoni P.A. HENDRICKX
Poster P2139
Abstract 5709
Successive Staphylococcus aureus isolates from cystic fibrosis patients: clonal lineages, resistance, virulence and detection of CC398 isolates
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Paula EGUIZÁBAL
Poster P2140
Abstract 5788
Evaluation of a genotypic method for detection of ESBL and carbapenemase-producing-Gram-negative bacteria directly from rectal and pharyngeal swabs in a tertiary hospital
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
María Paula VARGAS DURÁN
Poster P2141
Abstract 5835
Profiling the diversity of Scottish Staphylococcus pseudintermedius clinical isolates by development of a novel core genome multilocus typing scheme
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Imogen JOHNSTON-MENZIES
Poster P2142
Abstract 6065
Application of Fourier transform infrared spectroscopy for a neonatal Kluyvera ascorbata clinical outbreak
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Miriam CORDOVANA
Poster P2143
Abstract 6078
Exploring the Streptococcus genus composition in nasopharynx of adult patients with pneumococcal pneumonia: a marker gene study
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Miguel BLANCO FUERTES
Poster P2144
Abstract 6206
Subtyping Legionella pneumophila using MLVA-8, MALDI-TOF MS and whole genome sequencing
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Lana MADAGI
Poster P2145
Abstract 6238
Genomic surveillance of multidrug-resistant bacteria: first results of the SLOSEQ project
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Urska KRAMAR
Poster P2146
Abstract 6514
Comparability and reproducibility of bacterial genotyping is affected by species- and isolate-dependent issues in long read assemblies: a multi-centre performance study
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Johanna DABERNIG-HEINZ
Poster P2147
Abstract 6545
Specimen pooling for cost-sparing PCR-based surveillance of methicillin resistant Staphylococcus aureus (MRSA)
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Glenn PATRIQUIN
Poster P2148
Abstract 6571
Community spread of Staphylococcus aureus ST398 in patients at risk of sexually transmitted infections
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Maxime DANJEAN
Poster P2149
Abstract 6603
Genomics insights into the complexity of Staphylococcus epidermidis transmission in a neonatal intensive care units (NICU)
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Maria MIRAGAIA
Poster P2150
Abstract 6761
Molecular characterisation of O157, O26 and O103 Shiga toxin-producing Escherichia coli (STEC) Slovenian isolates using whole genome sequencing
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Tjasa CERAR KISEK
Poster P2151
Abstract 6841
Limitations of sequence typing for isolate inclusion in outbreak investigations
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Karolina JACKOWSKA
Poster P2152
Abstract 7177
Fourier-transform infrared spectroscopy for low-cost and real-time vancomycin-resistant Enterococcus faecium outbreak investigation
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Asma ZOUARI SASSI
Poster P2153
Abstract 7370
Evaluation of three high molecular weighted DNA extraction kits and in silico assemblers for circularization of Listeria monocytogenes genomes using third generation sequencing
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
François GRAVEY
Poster P2154
Abstract 7643
Real-time outbreak investigation of OXA-48-producing Escherichia coli using Fourier-transform infrared spectroscopy
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Jalal TARABEIA
Poster P2155
Abstract 8035
Rapid profiling of Helicobacter pylori carcinogenic toxin antibodies in serum via deep learning analysis of label-free SERS spectra
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Liang WANG
Poster P2156
Abstract 8111
Molecular surveillance of group A streptococcal infections in the Netherlands: clonal sweep by the M1UK lineage
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Lidewij RUMKE
Poster P2157
Abstract 8143
Six months of experience with day-to-day sequencing of Listeria monocytogenes for outbreak investigation in an entire Danish region and concordance between changing chemistries
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Laus KREMS VEJRUM
Poster P2158
Abstract 8158
be.Prepared to increase integration of health data as a way of strengthening the surveillance of infectious diseases
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Heleen MASSET
Poster P2159
Abstract 8300
City lights, microbial insights: unmasking the urban challenges of group A Streptococcus
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Rachel KETTLES
Poster P2160
Abstract 8378
Exploring the potential of FT-IR spectroscopy and machine learning to discriminate between Enterococcus faecium and Enterococcus lactis
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Angela NOVAIS
Poster P2161
Abstract 8707
Use of biotyper to distinguish Klebsiella pneumoniae sequence types 16 and 11: preliminary data
27/04 12:00
4e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)
Patrícia BARTH
Poster P2162
Abstract 790
Study of the resistome and virulome of H. pylori by NGS approach using DNA capture technology
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Léo GILLET
Poster P2163
Abstract 1067
Molecular characterisation of lugdunin inactivation mechanisms and their association with Staphylococcus lugdunensis genetic types
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Jang-Jih LU
Poster P2164
Abstract 1295
WGS-based characterisation of putative hypervirulent Klebsiella pneumoniae identified in a tertiary care hospital in Germany
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Bernd NEUMANN
Poster P2165
Abstract 3190
Streptococcus equi invasive isolates in Belgium between 2014 and 2022: characterisation and subspecies identification using MALDI-TOF MS and whole genome sequencing
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Sien DE KOSTER
Poster P2166
Abstract 3584
Automation of the library preparation for whole-genome sequencing of bacterial genomes using an open-source programming liquid-handler robot
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Erin MEIJERS
Poster P2167
Abstract 3620
Unravelling adaptation of Pseudomonas aeruginosa in cystic fibrosis patients: a longitudinal genomic analysis
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Martina ROSSITTO
Poster P2169
Abstract 3975
Hyper-transmissible Klebsiella pneumoniae carbapenemase (KPC): unravelling multi-species transmission within a single patient using whole genome sequencing
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Xena LI
Poster P2170
Abstract 4250
Comparing Illumina and Nanopore for bacterial whole genome sequencing in clinical microbiology
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Srinithi PURUSHOTHAMAN
Poster P2171
Abstract 4257
How whole genome sequencing shed new light on Staphylococcus hominis subsp. novobiosepticus
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Kassandra WOLK
Poster P2172
Abstract 4775
Occurrence of hypervirulent Klebsiella pneumoniae clones in Santander, Spain
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Jorge RODRÍGUEZ-GRANDE
Poster P2173
Abstract 5968
Prevalence and characteristics of plasmid-encoded serine protease EspP in clinical Shiga toxin-producing Escherichia coli strains from Sweden
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Andreas MATUSSEK
Poster P2175
Abstract 6470
Economic effects of next-generation-sequencing diagnostics: a budget impact analysis from the healthcare providers' perspective
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Ann-Cathrine SIEFEN
Poster P2176
Abstract 6585
Genotypic characterisation of Staphylococcus aureus isolates associated with invasive infections in children
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Panagiota-Christina GEORGIOU
Poster P2177
Abstract 6957
Comparative study of gDNA-extraction from clinically relevant species for third generation sequencing
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Tobias PEDERSEN
Poster P2179
Abstract 8617
Invasive and non-invasive Group A Streptococcus (GAS) identified in a paediatric cohort differ for emm type, virulence factors and mobilome
27/04 12:00
4f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)
Valeria FOX
Poster P2180
Abstract 221
Urinary tract infections and microbiome
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Ekaterina MALAEVA
Poster P2181
Abstract 678
Gut microbiota and recompensation liver cirrhosis
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Ekaterina MALAEVA
Poster P2182
Abstract 1613
Gut microbiota in preterm infants: changes associated with bacterial and fungal bloodstream infections
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Yubeen OH
Poster P2183
Abstract 1778
The effects of probiotic Bifidobacterium breve Bif195 for diarrhoea-predominant irritable bowel syndrome
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Ida Marie Bruun GRØNBÆK
Poster P2184
Abstract 1955
Gut microbiome dynamics in human melioidosis: a comprehensive analysis from early infection through recovery
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Chiranjay MUKHOPADHYAY
Poster P2185
Abstract 2109
Comparative metagenomic study of vaginal microbiota in women infected with HPV 16/18 and other high-risk HPV subtypes: multi-kingdom microbiota approach
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Ji Young PARK
Poster P2186
Abstract 2320
Antibiotic treatment delayed gut microbiome recovery in children with watery diarrhoea
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Hao CHUNG THE
Poster P2187
Abstract 2413
Comparison of faecal sample collection methods in gut microbiome research
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Ida Marie Bruun GRØNBÆK
Poster P2188
Abstract 2456
Nasopharyngeal microbiome composition in SARS-CoV-2 infected patients, with relation to COVID-19 clinical outcome
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Jean-Luc TISON
Poster P2189
Abstract 2480
Structural variations in microbiome after prolonged cryopreservation of faecal samples
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Josip UJEVIC
Poster P2190
Abstract 2606
Evaluating the correlation between the vaginal microbiome and clinical outcomes: is our data analysis accurate?
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Courtney POVEY
Poster P2191
Abstract 2635
The urinary microbiome is highly diverse: shotgun metagenomics of urine samples from 1,000 individuals of the population-based SCAPIS cohort
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Tiscar GRAELLS
Poster P2192
Abstract 2820
Whole-genome sequencing and 16s metabarcoding analysis provide new insights in the relationship between the composition of gut microbiota and colonization by Klebsiella pneumoniae.
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Roberto ROSATO
Poster P2193
Abstract 2879
Faecal microbiota differences in patients with HIV, chronic hepatitis C and HIV/HCV coinfection
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Monta MADELANE
Poster P2194
Abstract 3430
Higher total bacterial load in vagina is associated with endometrial hyperplasia
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Ekaterina VOROSHILINA
Poster P2195
Abstract 4087
Dead or alive? Novel strategy for the differential analysis of the microbiome composition
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Clémence ROBERT
Poster P2196
Abstract 4308
Comparing the lung microbiome across COPD GOLD stages
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Leticia BUENO FREIRE
Poster P2197
Abstract 4328
The effect of recurrent urinary tract infections on the proteome
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Adrià CRUELLS GASCON
Poster P2198
Abstract 4375
Vaginal and gut phageomes and microbiomes in recurrent urinary tract infection
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Adrià CRUELLS GASCON
Poster P2199
Abstract 4403
The influence of age on the stability of the gut microbiota composition as a factor determining the faecal microbiota transplantation effectiveness in a rat model
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Agnieszka KRAWCZYK
Poster P2200
Abstract 4572
The microbiome from diabetic foot ulcers: are there particular patterns to take care in clinical practice?
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Laura SOLDEVILA-BOIXADER
Poster P2201
Abstract 5497
Quantitative detection of short-chain fatty acids in the fecal metabolome
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Gaute HOVDE BØ
Poster P2202
Abstract 5530
Analyses of nasopharyngeal microbiota patterns associated to pneumococcal pneumonia in adults: a prospective double case-control study in COVID-19 pandemic period
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Beatriz DIETL
Poster P2203
Abstract 5619
Nanopore-based 16S rRNA gene sequencing improves bacterial identification in clinical samples compared to Sanger-sequencing
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Karina GRAVGAARD THOMSEN
Poster P2204
Abstract 6047
Refinement of the microbiome analysis for low-microbial biomass biospecimens
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Andreas MATUSSEK
Poster P2205
Abstract 6074
Early development and dynamics of nasopharyngeal microbiota in infants during the COVID-19 pandemic: a 2-year prospective cohort study
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Aleix LLUANSÍ
Poster P2206
Abstract 6788
Optimization of urinary microbiome analysis from 16S sequencing data
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Camille VILLENAVE
Poster P2207
Abstract 7129
Next-generation sequencing improves diagnostic 16S rRNA amplicon-based microbiota analyses of clinical samples compared to Sanger sequencing
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Huma AFTAB
Poster P2208
Abstract 7132
Gut microbiota and COVID19: descriptive and comparative analysis in hospitalised patients
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Maria Vittoria MAURO
Poster P2209
Abstract 8431
Effect of prophylactic antibiotics in breast milk on the meconium microbiota and 6th month fecal microbiota of newborns born vaginally or by cesarean section
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Gulsum KAYA
Poster P2210
Abstract 8934
Medication-induced osteonecrosis of the jaw: the role of oral microbiota and antibiotics
27/04 12:00
4g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects)
Jacopo MULA
Poster P2211
Abstract 18
Characteristics of whole genome sequencing of multi-drug-resistant clinical Escherichia coli O99 H30 ST38 isolated from wound infection in intensive care unit
27/04 12:00
4h. Clinical metagenomics
Ali DASHTI
Poster P2213
Abstract 1108
Thoughts and perspectives of metagenome sequencing as a diagnostic tool for infectious diseases: an interpretive phenomenological study
27/04 12:00
4h. Clinical metagenomics
Hannah TRIVETT
Poster P2214
Abstract 1859
Clinical metagenomics by nanopore sequencing to improve the success rate of respiratory pathogen identification
27/04 12:00
4h. Clinical metagenomics
Amélia RODRIGUES
Poster P2215
Abstract 2099
Development of a comprehensive genomics (NGS) based test for the detection of anti-microbial resistance and sepsis
27/04 12:00
4h. Clinical metagenomics
Suresh THAKUR
Poster P2216
Abstract 2774
Rapid detection of pathogens directly from paediatric clinical specimens using an automated amplicon-based next generation sequencing pipeline
27/04 12:00
4h. Clinical metagenomics
Lucas OSBORN
Poster P2217
Abstract 3136
Analytical and clinical evaluation of tNGS and mNGS performance on suspected pulmonary infections in HIV patients
27/04 12:00
4h. Clinical metagenomics
Ling ZHANG
Poster P2218
Abstract 3723
Updated diagnostic performance of metagenomic next-generation sequencing in brain abscess
27/04 12:00
4h. Clinical metagenomics
Xinyun ZHANG
Poster P2219
Abstract 3746
Rapid pan-metagenomics: improving pneumonia diagnosis and responding swiftly to mpox outbreak.
27/04 12:00
4h. Clinical metagenomics
Adela ALCOLEA MEDINA
Poster P2220
Abstract 4265
16S targeted metagenomics in the diagnosis of bone and joint infections: it's not just magic!
27/04 12:00
4h. Clinical metagenomics
Olivier DAUWALDER
Poster P2221
Abstract 4981
Plasma cell-free DNA metagenomic sequencing in paediatric cancer patients
27/04 12:00
4h. Clinical metagenomics
Sandra CASTEJON RAMIREZ
Poster P2222
Abstract 5232
Prospective whole-genome sequencing in the era of precision infection prevention
27/04 12:00
4h. Clinical metagenomics
Rossana ROSA
Poster P2223
Abstract 5359
Assessing the diagnostic performance of cell-free DNA sequencing in routine bloodstream infection diagnostics: a retrospective single centre study of the first 300 cases
27/04 12:00
4h. Clinical metagenomics
Marijo PARCINA
Poster P2224
Abstract 5547
Pilot study and cost-effectiveness analysis of an ultra-rapid metagenomic sequencing test for pathogen detection in adult patients with sepsis
27/04 12:00
4h. Clinical metagenomics
Yuyao YIN
Poster P2225
Abstract 5625
Pathogen detection by metagenomic next-generation sequencing in people living with HIV/AIDS.
27/04 12:00
4h. Clinical metagenomics
Daniel GRIMM
Poster P2226
Abstract 5666
Diagnosing visceral leishmaniasis using the microbiome 16S/18S test
27/04 12:00
4h. Clinical metagenomics
Kaziwa RASOUL
Poster P2228
Abstract 5879
Quality control (QC) metrics for hybrid capture-based NGS enrichment workflows
27/04 12:00
4h. Clinical metagenomics
Robert SCHLABERG
Poster P2229
Abstract 5987
NGS enrichment panels as a surveillance tool to monitor the growing burden of drug-resistance pathogens and antimicrobial resistance genes
27/04 12:00
4h. Clinical metagenomics
Robert SCHLABERG
Poster P2230
Abstract 6155
Metagenomic analysis of cell-free DNA from whole blood specimens of patients with suspected infections: performance and therapeutic impact in clinical routine
27/04 12:00
4h. Clinical metagenomics
Jürgen HELD
Poster P2231
Abstract 6167
Evaluation of decentralised Salmonella serovar prediction by whole genome sequencing
27/04 12:00
4h. Clinical metagenomics
Kat STEINKE
Poster P2232
Abstract 6786
Genetic diversity and virulence factors in Escherichia coli: a comparative study between neonatal sepsis, adults and environmental sources
27/04 12:00
4h. Clinical metagenomics
Lucia BARCELLINI
Poster P2233
Abstract 7286
Impact of an in-house metagenomic test for diagnostic of tropical and neglected infectious diseases: three years of experience
27/04 12:00
4h. Clinical metagenomics
Andre DOI
Poster P2234
Abstract 8660
Systematic review on surveillance systems integrating whole-genome sequencing and epidemiological information worldwide, 2012-2023
27/04 12:00
4h. Clinical metagenomics
Felix REICHERT
Poster P2235
Abstract 293
Advancing Streptococcus pneumoniae capsular typing: MALDI-TOF mass spectrometry and machine learning algorithms
27/04 12:00
4i. Bioinformatics tools & pipelines
Jonathan ZINTGRAFF
Poster P2236
Abstract 1415
Evaluation of a real-time plasmid transmission detection pipeline
27/04 12:00
4i. Bioinformatics tools & pipelines
Natalie SCHERFF
Poster P2237
Abstract 1478
Using NCBI's pathogen detection system to determine the distribution of KPC-family carbapenemases in Klebsiella pneumoniae isolates from China and the U.S.
27/04 12:00
4i. Bioinformatics tools & pipelines
Michael FELDGARDEN
Poster P2238
Abstract 1749
Reference guided clustering for the identification of bacteria using 16S long reads
27/04 12:00
4i. Bioinformatics tools & pipelines
Korneel DUMON
Poster P2239
Abstract 1808
Costs of an infection risk scan in a hospital
27/04 12:00
4i. Bioinformatics tools & pipelines
Miranda VAN RIJEN
Poster P2240
Abstract 2393
Design of a plasmid classification workflow for local bacterial population analysis
27/04 12:00
4i. Bioinformatics tools & pipelines
Markéta NYKRÝNOVÁ
Poster P2241
Abstract 2604
Mega pipeline: an automated pipeline for easy microbial whole genome sequencing analysis
27/04 12:00
4i. Bioinformatics tools & pipelines
Marc FINIANOS
Poster P2242
Abstract 4028
Batch effect correction in MALDI-TOF spectra for microorganism classification
27/04 12:00
4i. Bioinformatics tools & pipelines
Erica PADIAL FUILLERAT
Poster P2243
Abstract 4852
Deciphering global patterns of antimicrobial resistance in key gram-negative pathogens using indirect predictors
27/04 12:00
4i. Bioinformatics tools & pipelines
Sneha KOTIAN
Poster P2244
Abstract 5988
A comprehensive database for the direct identification of plasmid transfer genes
27/04 12:00
4i. Bioinformatics tools & pipelines
Csongor FREYTAG
Poster P2245
Abstract 6860
Metagenomic sample composition explains variance in taxonomic classification performance
27/04 12:00
4i. Bioinformatics tools & pipelines
Iris GOLD RODAL
Poster P2246
Abstract 1109
Raman spectroscopy-based characterisation of immunocyte responses to in vitro stimulation with pathogen-associated molecular patterns
27/04 12:00
4j. Other novel diagnostic technologies
Max NAUMANN
Poster P2247
Abstract 1433
Breath biopsy reveals promising VOC biomarkers for early detection and monitoring of acute pulmonary exacerbations in people with cystic fibrosis
27/04 12:00
4j. Other novel diagnostic technologies
Hsuan CHOU
Poster P2248
Abstract 2824
The association of host signature based on TRAIL, IP-10, and CRP with paediatric pneumonia
27/04 12:00
4j. Other novel diagnostic technologies
Sriram RAMGOPAL
Poster P2249
Abstract 3196
New generation table-top scanning electron microscope: a robust tool in clinical microbiology for direct specimen examination
27/04 12:00
4j. Other novel diagnostic technologies
Omar ZMERLI
Poster P2250
Abstract 3290
Evaluation of Sysmex fluorescence flow cytometry analyser in rapid diagnosis of urinary tract infections
27/04 12:00
4j. Other novel diagnostic technologies
Baran IRMAK
Poster P2251
Abstract 3767
Quorum sensing molecular signatures to diagnose P. aeruginosa infections
27/04 12:00
4j. Other novel diagnostic technologies
Juan RAYA
Poster P2252
Abstract 5166
Application of AI vision for the rapid automatic counting of microbial colonies on agar
27/04 12:00
4j. Other novel diagnostic technologies
Li XUE
Poster P2253
Abstract 5247
Evaluation of early stage implementation results of a cellular host-response test in an emergency department setting
27/04 12:00
4j. Other novel diagnostic technologies
Hollis O'NEAL
Poster P2254
Abstract 5413
The hydrogel-based gram staining method with no wastewater
27/04 12:00
4j. Other novel diagnostic technologies
Mijin KIM
Poster P2255
Abstract 5422
Neonatal sepsis diagnosis: dual assay platforms utilising aptamer-labelled electrochemical and fluorescent chips
27/04 12:00
4j. Other novel diagnostic technologies
Chaitali SINGHAL
Poster P2256
Abstract 6631
Identification of bacteria in mixed infections from urinary tract of patient's samples using Raman spectroscopy
27/04 12:00
4j. Other novel diagnostic technologies
María José GONZÁLEZ VÁZQUEZ
Poster P2257
Abstract 7187
A rapid, sensitive, and specific detection of carbapenem-resistant Acinetobacter baumannii by CRISPR Cas-based detection system
27/04 12:00
4j. Other novel diagnostic technologies
Sreekanthreddy BASIREDDY
Poster P2258
Abstract 7697
Detection of Helicobacter pylori infection in human gastric fluid through surface-enhanced Raman spectroscopy coupled with machine learning algorithms
27/04 12:00
4j. Other novel diagnostic technologies
Liang WANG
Poster P3717
Abstract 310
Clinical profile and outcomes in patients with melioidois and uncontrolled diabetes mellitus (MeloDi): a retrospective cohort study from South India
27/04 12:00
10a. Host genetics: susceptibility to infection & primary immunodeficiency
Nitin GUPTA
Poster P3718
Abstract 2954
Single nucleotide polymorphisms in Toll-like receptors and their association with susceptibility to recurrent vulvovaginal candidiasis
27/04 12:00
10a. Host genetics: susceptibility to infection & primary immunodeficiency
Maria MAVROULI
Poster P3719
Abstract 6343
Polymorphism in BoLA DRB3 and BoLA A genes lead to increased susceptibility to foot-and-mouth disease virus in vaccinated cattle
27/04 12:00
10a. Host genetics: susceptibility to infection & primary immunodeficiency
Yash CHAUDHARY
Poster P3720
Abstract 190
Solid organ transplantation in SARS-CoV-2 positive candidates: a survey among ESGICH members
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Andrea LOMBARDI
Poster P3721
Abstract 448
From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: less is better
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Giovanna MELICA
Poster P3722
Abstract 722
Population dynamics and molecular epidemiology of Staphylococcus epidermidis ST2 from patients with haematological malignancies 1980-2022
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Raphael SIEBER
Poster P3723
Abstract 742
Torque teno virus as an indicator of infectious complications in the first year after lung transplantation: first results from Croatia
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Ivana MAREKOVIC
Poster P3724
Abstract 757
Impaired T and “memory-like” NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Chris David LAURUSCHKAT
Poster P3725
Abstract 778
Risk factors for hepatitis B reactivation and effectiveness of hepatitis B vaccination after solid organ transplantation: a matched case-control study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Yongseop LEE
Poster P3726
Abstract 846
Metagenomic next-generation sequencing of plasma cell-free DNA in clinical practice: improving infection diagnosis and antimicrobial therapy in immunocompromised patients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Guankun YIN
Poster P3727
Abstract 1157
Incidence and risk factors of cytomegalovirus reactivation after autologous stem cell transplantation: a retrospective single-centre study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Giuseppe GENTILE
Poster P3728
Abstract 1181
Chimeric antigen receptor T cell post-infusion fever: infection profile, clinical parameters and biomarkers trends to assist antibiotic stewardship
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Olivier PEYRONY
Poster P3729
Abstract 1299
A prospective analysis of cytomegalovirus-specific cell-mediated immunity (CMV-CMI) in a multicentre Phase 3 randomised placebo-controlled trial of letermovir prophylaxis in CMV-seropositive recipients (R+) of an allogeneic haematopoietic cell transplant (HCT)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Genovefa PAPANICOLAOU
Poster P3730
Abstract 1300
Prophylaxis against pneumocystis pneumonia and toxoplasmosis with low-dose trimethoprim-sulfamethoxazole (cotrimoxazole 20/100mg) in heart transplant patients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Alexandre BLEIBTREU
Poster P3731
Abstract 1383
Clinical characteristics and prognostic factors in patients with fever of unknown origin who developed secondary haemophagocytic lymphohistiocytosis
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Yuan GUANMIN
Poster P3732
Abstract 1385
The value of 18F-FDG PET/CT in clinical etiological diagnosis of secondary hemophagocytic lymphohistiocytosis
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Yuan GUANMIN
Poster P3733
Abstract 1413
Hyperammonemia syndrome in immunocompromised patients: a systematic review on patient populations, clinical manifestations and outcome
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Laura WALTI
Poster P3734
Abstract 1502
Effectiveness of cefiderocol in immunosuppressed patients with serious Gram-negative bacterial infections in the PERSEUS study in Spain
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Sarda JESSICA
Poster P3735
Abstract 1662
Follow-up, diagnosis, and outcomes of fever of unknown origin cases with an erythrocyte sedimentation rate of 100 mm/h or more: an international ID-IRI study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Oguz Resat SIPAHI
Poster P3736
Abstract 1680
Low pan-immune-inflammation value predicts Gram negative bacteremia-related 30-day mortality in solid organ transplant recipients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Caglayan Merve AYAZ
Poster P3737
Abstract 1688
Recurrent cytomegalovirus reactivations: frequency, viral dynamic and risk factors in allogeneic stem cell transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Sylvia DALCOLMO
Poster P3738
Abstract 1695
Quantiferon-cytomegalovirus after allogeneic stem cell transplantation: prediction of CMV reactivation and clinically significant infection
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Sylvia DALCOLMO
Poster P3739
Abstract 1704
The impact of pre-transplant cultures screening on the risk of infection after kidney transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maristela P FREIRE
Poster P3740
Abstract 1881
Risk factors associated with Clostridioides difficile infection in the first 100-days after allogeneic hematopoietic stem cell transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Cameron GMEHLIN
Poster P3741
Abstract 1913
Does secondary prophylaxis prevent recurrent episodes of Clostridioides difficile in allogeneic transplant patients?
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maria Alejandra MENDOZA
Poster P3742
Abstract 1919
Norovirus in allogeneic hematopoietic stem cell transplant recipients: does nitazoxanide help?
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maria Alejandra MENDOZA
Poster P3743
Abstract 1953
Antibiotic resistance patterns in dialysis patients: a comprehensive epidemiological study on 1,174 strains in Occitania (France)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Matthieu BERNIER
Poster P3744
Abstract 2123
Kinetics and role of pancreatic stone protein as predictor of sepsis and bacteremia in children with haematological malignancies
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Tragiannidis ATHANASIOS
Poster P3745
Abstract 2225
Clinical features, diagnostic, aetiology and outcome of hospitalised solid organ recipients with community-acquired pneumonia: a cohort analysis over ten years
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Oana JOEAN
Poster P3746
Abstract 2240
Secondary infections and clinical outcomes after respiratory syncytial virus (RSV) infections in heart and lung transplant recipients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Mitchell DUMAIS
Poster P3747
Abstract 2297
Role of human cytomegalovirus (HCMV) reactivation in causing pneumonia in immunocompetent mechanically ventilated patients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Chhavi GUPTA
Poster P3748
Abstract 2312
Correlation of cytomegalovirus specific cell-mediated immunity (CMV CMI) with subclinical CMV DNAemia in allogeneic haematopoietic cell transplant recipients (HCT)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Kodama RICH
Poster P3749
Abstract 2401
High burden of non-serious infections during biological use for rheumatoid arthritis
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Barbara Janina Maria BERGMANS
Poster P3750
Abstract 2406
Burden of herpes zoster in adults aged ≥18 years and patients with immunodeficiencies, autoimmune diseases, and chronic conditions in Taiwan: A population-based database study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Jing CHEN
Poster P3751
Abstract 2812
Discontinuation of fluoroquinolone prophylaxis for neutropenia after bone marrow transplantation in a setting with high prevalence of multidrug-resistant pathogens
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Valeria CASTELLI
Poster P3752
Abstract 2813
Seven versus 14 days of antibiotic treatment for acute pyelonephritis (APN) in kidney transplant recipients: a cohort study (SHOUT study)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Chiara FANELLI
Poster P3753
Abstract 2839
Exploring the utility of unsupervised machine learning for bacteraemia forecasting in neutropenic fever patients with haematological malignancies: a pilot study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Antonio GALLARDO-PIZARRO
Poster P3755
Abstract 3084
Adult-onset immunodeficiency due to neutralizing anti-(IFN)-γ autoantibodies: a syndrome that extends beyond opportunistic intracellular infections
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Wan-Ting TSAI
Poster P3756
Abstract 3090
Incidence and progression of granulomatous lesions following Bacillus Calmette-Guérin immunotherapy
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maristela P FREIRE
Poster P3757
Abstract 3242
Clinical characteristics, outcomes and causative organism distribution of respiratory infection of second lung transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Min HAN
Poster P3758
Abstract 3360
Transplant-related risk factors for the development of retinitis due to cytomegalovirus in allogeneic stem cell transplant recipients: an international case-control study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Romain GUENEAU
Poster P3759
Abstract 3442
Epidemiology and clinical outcome of paediatric liver transplant recipients with multidrug-resistant gram-negative bacteria colonization: a 10-year observational study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Andrea CONA
Poster P3760
Abstract 3574
Changing seroprevalence of viral diseases among young adults in Izmir
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Oguzhan ACET
Poster P3762
Abstract 3925
Risk of serious infections in patients treated with biological disease modifying anti-rheumatoid drugs (b-DMARDs) in Qatar
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Sreethish SASI
Poster P3763
Abstract 4078
Toward improved monitoring the cellular immune response against cytomegalovirus in transplants recipients: comparative analysis of ELISA-QuantiFERON-CMV and CLIA-LIAISON-QuantiFERON-TB Gold Plus
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maria ARNEDO MUÑOZ
Poster P3764
Abstract 4130
Previous infection with resistant organisms may not predispose to surgical site infection following liver transplantation: a retrospective cohort study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Sarah SHALHOUB
Poster P3765
Abstract 4191
A robust SARS-CoV-2-specific T and B cell response is associated with early viral clearance in SARS-CoV-2 Omicron infected immunocompromised individuals
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Magda VERGOUWE
Poster P3766
Abstract 4288
Pre-emptive management of Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disorders after paediatric kidney transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maia DE LUCA
Poster P3767
Abstract 4489
Uptake and yield of immunological investigation in patients with invasive infections with encapsulated bacteria: high yield and missed opportunities
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Maria Concepcion GIL MERINO
Poster P3768
Abstract 4556
Secondary anti-viral prophylaxis in solid organ transplant recipients for the prevention of CMV relapse: a systematic review and meta-analysis
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
David MOYNAN
Poster P3769
Abstract 4708
Strongyloides stercoralis westernblot for serologic screening of solid organ transplant candidates
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Alexander OBERLI
Poster P3770
Abstract 4711
Infectious risk stratification expands the solid organ donors pool: activity of the Italian national transplant centre in 2022-2023
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Elena GRAZIANO
Poster P3771
Abstract 4716
Herpes simplex virus prophylaxis in adult patients undergoing haematopoietic stem cell transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Atheer ALDAIREM
Poster P3772
Abstract 4807
Pseudomonas aeruginosa bloodstream infections presenting with septic shock in neutropenic cancer patients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Cristina ROYO-CEBRECOS
Poster P3773
Abstract 4898
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in hematologic patients: a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Julia LAPORTE-AMARGOS
Poster P3774
Abstract 4955
Tobramycin systemic absorption in lung transplant recipients treated with inhaled tobramycin: a cohort study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Abiu SEMPERE
Poster P3775
Abstract 4997
Real-world utilisation of maribavir for cytomegalovirus infection in transplant recipients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Kassandra MARSH
Poster P3776
Abstract 5025
Real-world single centre analysis of virological response to third-party CMV-specific T cell lymphocyte (CTL) for refractory CMV infection following allogeneic haematopoietic cell therapy (HCT)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Michelle YONG
Poster P3777
Abstract 5069
Infection risk in relapsed refractory multiple myeloma: The impact of BCMA-targeted bispecific antibody therapy
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Jessica LITTLE
Poster P3778
Abstract 5147
Therapeutic drug monitoring of piperacillin in patients with neutropenic fever after allogeneic hematopoietic stem cell transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Güzin SURAT
Poster P3779
Abstract 5344
Early viral suppression less likely among solid organ transplant recipients with drug-resistant cytomegalovirus infection
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Aaron HUNT
Poster P3780
Abstract 5535
Pneumonia and bloodstream infections during intensive care unit stay after heart transplant
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Silvia RODA
Poster P3781
Abstract 5681
Filmarray pneumonia panel plus vs standard culture in lung transplant recipients: preliminary results of the PNEUMOARRAY STUDY
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Giulia RENISI
Poster P3782
Abstract 5755
Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant: single center experience
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Alessandra RICCIARDI
Poster P3783
Abstract 5878
Human herpesvirus 8 infection in solid organ transplant recipients: results of the implementation of a protocol for risk stratification and early treatment of HHV8-related disease
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Andrea CONA
Poster P3784
Abstract 6042
Multiparameter mass spectrometry deciphers specific circulating natural killer T cell subsets protecting kidney transplant patients from CMV infection
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Laura DONADEU
Poster P3785
Abstract 6109
Colonisation resistance to carbapenem-resistant Pseudomonas aeruginosa in acute myeloid leukemia patients in induction, consolidation, and relapse/refractory phases
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Xiaomeng FENG
Poster P3786
Abstract 6552
Incidence of infections in patients with acute myeloid leukemia during remission induction chemotherapy: a monocentric retrospective analysis of 78 patients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Sabine EHRLICH
Poster P3787
Abstract 6639
Risk factors and clinical characteristics of CMV reactivation in allogeneic hematopoietic stem cell transplant recipients
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Siwar FRIGUI
Poster P3788
Abstract 6677
Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenem-resistant Enterobacterales in onco-hematologic neutropenic patients: A real-life experience (TARZAN study)
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Enric SASTRE-ESCOLÀ
Poster P3789
Abstract 6744
Going with the STREAM: a quality improvement intervention in solid organ transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Alessandro VISENTIN
Poster P3790
Abstract 6950
High incidence of breakthrough viremia in lung transplant recipients despite valganciclovir prophylaxis: a retrospective analysis
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Ester MÁRQUEZ ALGABA
Poster P3791
Abstract 7414
Efficacy of oral fosfomycin trometamol as empirical therapy for acute cystitis in kidney transplant recipients: an open-label randomised controlled trial
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Pongsathorn SAENKOTARA
Poster P3792
Abstract 7612
Cytomegalovirus disease in children after allogeneic hematopoietic stem cell transplantation
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Siwar FRIGUI
Poster P3793
Abstract 7709
Exploring the impact of a targeted antibiotic prophylaxis in orthotopic liver transplant recipients colonised by carbapenem-resistant Enterobacterales: a multicentre retrospective study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Beatrice MIANI
Poster P3794
Abstract 7859
Higher bacterial profile and antibiotic resistance pattern of sepsis among adult Human Immunodeficiency Virus (HIV) – infected patients assessing care in a Nigerian tertiary hospital
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Chukwudi UMENZEKWE
Poster P3795
Abstract 7949
Hospitalisation status at the time of organ acceptance and its impact to bloodstream infections
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Jacques SIMKINS
Poster P3796
Abstract 8130
Should the QuantiFERON-CMV cut-off point be modified in order to predict risk of CMV replication in solid organ transplant recipients? QuantiCor-CMV study
27/04 12:00
10b. Infections in immunocompromised hosts (incl epidemiology, clinical features, diagnosis, treatment, excl fungal infections)
Elisa RUIZ ARABÍ
Poster P3797
Abstract 481
Driving uptake of missed routine vaccines in adult migrants to Europe: a prospective observational pilot study in primary care
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Sally HARGREAVES
Poster P3798
Abstract 860
Defining the role of primary care in hepatitis B elimination in the UK
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Jessica CARTER
Poster P3799
Abstract 1059
Lessons learned from national COVID-19 testing strategies in Germany: a qualitative study of key stakeholder perspectives
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Katarzyna SKIPIOL
Poster P3800
Abstract 1131
Vaccination coverage and barriers and facilitators to vaccine uptake amongst migrant populations in the Middle East and North Africa: a systematic review and qualitative study
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Bouaddi OUMNIA
Poster P3802
Abstract 1475
Impact of vaccine tolerability on shingles vaccine decision-making
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Guy DE LA ROSA
Poster P3803
Abstract 4200
Antibody response and decay following COVID-19 inactivated vaccine in adults and its influencing factors
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Song JIEYU
Poster P3804
Abstract 5467
Assessing vaccine recommendations and attitudes towards vaccination among people living with HIV
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Oguzhan ACET
Poster P3805
Abstract 6588
Barriers and facilitators for receiving mpox vaccines among men who have sex with men: a mixed-methods study
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Tsz Ho KWAN
Poster P3806
Abstract 6980
Older adult and physician preferences for respiratory syncytial virus vaccination in Germany and Italy: a discrete choice experiment
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Alen MARIJAM
Poster P3807
Abstract 6982
Myths and misinformation associated with vaccine incompleteness: a survey study
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Lucas KALLÁS SILVA
Poster P3808
Abstract 7581
What is the number of missed opportunities for pneumococcal vaccination among at-risk adults in France?
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Elisabeth BOTELHO-NEVERS
Poster P3809
Abstract 8512
Investigating vaccine coverage in Timor-Leste in a population-representative serological survey
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Paul ARKELL
Poster P3810
Abstract 8663
Maximizing LGBTQ+ vaccination adherence: counseling impact in the mpox epidemic
27/04 12:00
10c. General vaccinology (incl.in vitro and in vivo studies, policy, social aspects)
Francesca STELLA
Poster P3811
Abstract 1198
Patient preferences towards herpes zoster vaccination among adults aged 50 to 64 years in Australia: findings from a discrete choice experiment
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Raunak PARIKH
Poster P3812
Abstract 2983
Can receipt of the HPV vaccine increase recommendation for HPV vaccine?
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Ana Karina MASCARENHAS
Poster P3813
Abstract 3643
Mice mucosal immunisation with vaccine vector Streptococcus gordonii expressing the RBD of SARS-CoV-2 spike protein elicits antigen-specific systemic immune response with persistent long-lived plasma cells
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Mariana TIRZIU
Poster P3814
Abstract 4748
Measles vaccine RNA shedding in children after receiving measles, mumps and rubella vaccination
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Huanyu WANG
Poster P3815
Abstract 4818
BNT162b2 vaccine is well tolerated and efficient in children with acute leukemia
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Fanny ALBY-LAURENT
Poster P3816
Abstract 4994
Safety and immunogenicity of fractional doses of modified vaccinia Ankara-Bavarian nordic
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Sharon FREY
Poster P3817
Abstract 5362
The willingness of physicians and nurses to receive mpox vaccine at a tertiary-care educational university hospital: a cross-sectional study
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Oguz Resat SIPAHI
Poster P3818
Abstract 5774
Long-term immunity of yellow fever vaccination: a systematic review and meta-analysis
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Jenny Lea SCHNYDER
Poster P3819
Abstract 5938
Knowledge and attitudes regarding human papillomavirus (HPV) infection and vaccine among university students: a cross-sectional study
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Christelle ELIAS
Poster P3820
Abstract 6174
Assessment of retrospective measles serology based on routine vaccination and natural immunity status: is vaccination insufficient?
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Ali Gökhan AKÇAY
Poster P3821
Abstract 6563
Cost-effectiveness of the herpes zoster vaccine in Korea
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Won Suk CHOI
Poster P3822
Abstract 6690
Development of a high-throughput screening pipeline to identify candidate antivirals against mpox virus
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Winston CHIU
Poster P3823
Abstract 7003
Subcutaneous versus intradermal routes of administration of MVA-BN vaccine
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Valentina MAZZOTTA
Poster P3824
Abstract 7142
Assessment of post-vaccination specific T-cell responses to varicella zoster virus glycoprotein E in people with multiple sclerosis receiving disease-modifying therapies
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Marco IANNETTA
Poster P3825
Abstract 7321
Development of bipolymer-based novel nanoparticles in microsphere system as vaccine adjuvant
27/04 12:00
10d. Antiviral vaccines (excl influenza, respiratory and bloodborne viruses and COVID-19)
Varun BHARGAVA
Poster P3826
Abstract 750
S. pneumoniae serotypes causing invasive pneumococcal disease after the introduction of the 13-valent pneumococcal conjugate vaccine in Navarra, Spain
27/04 12:00
10e. Antibacterial vaccines
Irati ARREGUI GARCIA
Poster P3827
Abstract 892
Sequential versus simultaneous pneumococcal vaccination with the 13-valent conjugate vaccine (PCV13) and the 23-valent polysaccharide vaccine (PPSV23) in unvaccinated older adults: a randomised controlled trial on serotype-specific memory B-cell and humoral immune response
27/04 12:00
10e. Antibacterial vaccines
Christina BAHRS
Poster P3828
Abstract 1095
A novel recombinant adenovirus-based vector vaccine for plague tested in a Phase 1b trial in Uganda, appears safe and immunogenic
27/04 12:00
10e. Antibacterial vaccines
Arabella S V STUART
Poster P3829
Abstract 1582
Evaluation of antibody response before and after meningococcal vaccine and determination meningococcal carriage rates
27/04 12:00
10e. Antibacterial vaccines
Dilsah BASKOL ELIK
Poster P3830
Abstract 2319
Exploring the pre- and post-functional immune response of 23-valent pneumococcal polysaccharide vaccine in Indian Adults
27/04 12:00
10e. Antibacterial vaccines
Sravani DHARMAVARAM
Poster P3831
Abstract 2769
A bacterial vaccine composition against recurrent urinary tract infections stimulates the innate immune system
27/04 12:00
10e. Antibacterial vaccines
Roland NAU
Poster P3832
Abstract 2784
Estimating the health and economic burden of pneumococcal diseases attributable to V116 Vs. PCV20 serotypes among adults in the Netherlands
27/04 12:00
10e. Antibacterial vaccines
Zinan YI
Poster P3833
Abstract 2843
Estimating the health and economic burden of pneumococcal diseases attributable to V116 vs PCV20 serotypes among adults in Sweden
27/04 12:00
10e. Antibacterial vaccines
Zinan YI
Poster P3834
Abstract 2949
Serotype distribution of invasive disease-causing Streptococcus pneumoniae after 13 years of systematic vaccination
27/04 12:00
10e. Antibacterial vaccines
Pedro Miguel JUIZ GONZÁLEZ
Poster P3835
Abstract 3010
A multi-epitope protein composed of PcrV and OmpE virulence factors from Pseudomonas aeruginosa induces protective immunity against respiratory tract infection
27/04 12:00
10e. Antibacterial vaccines
Mohammadreza ASADIKARAM
Poster P3836
Abstract 4457
Low pneumococcal vaccination coverage in France: would a vaccination in the 65+ would help identifying at-risk population?
27/04 12:00
10e. Antibacterial vaccines
Benjamin WYPLOSZ
Poster P3837
Abstract 5358
Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below two years: a systematic review and meta-analysis
27/04 12:00
10e. Antibacterial vaccines
Alfonso J. RODRIGUEZ-MORALES
Poster P3838
Abstract 5482
In vivo evaluation of a novel multiepitope vaccine against uropathogenic Escherichia coli
27/04 12:00
10e. Antibacterial vaccines
Maryam REZAEI
Poster P3839
Abstract 5630
Using immunobioinformatic tools to design a multiepitope subunit vaccine against Klebsiella pneumoniae
27/04 12:00
10e. Antibacterial vaccines
Zeinab ABBASNEZHAD FARSANGI
Poster P3840
Abstract 5671
Aetiology of acute otitis media in children: impact of vaccination and SARS-CoV-2 pandemic
27/04 12:00
10e. Antibacterial vaccines
Lucia FERNANDEZ DELGADO
Poster P3841
Abstract 5749
Updating anti-pneumococcal vaccination coverages among adults in Catalonia before COVID19 pandemic era
27/04 12:00
10e. Antibacterial vaccines
Cinta DE DIEGO-CABANES
Poster P3842
Abstract 5985
Deep intraclonal analysis for development of multivalent vaccines against drug resistant Klebsiella pneumoniae lineages
27/04 12:00
10e. Antibacterial vaccines
Ana TAJUELO MORENO-PALANCAS
Poster P3843
Abstract 6847
Invasive pneumococcal disease in adults after the introduction of pneumococcal vaccination: a retrospective study in the metropolitan area of Zagreb, Croatia (2010–2022)
27/04 12:00
10e. Antibacterial vaccines
Karla DRAZENOVIC
Poster P3844
Abstract 6927
One- or Two-dose of 13-valent conjugated pneumococcal vaccine (PCV13) for patients with multiple myeloma (MM)
27/04 12:00
10e. Antibacterial vaccines
Hsin-Yun SUN
Poster P3845
Abstract 7068
Effect of introduction of MenACWY vaccination on circulating Neisseria meningitidis carriage strains in the Netherlands
27/04 12:00
10e. Antibacterial vaccines
Rob MARIMAN
Poster P3846
Abstract 7215
Breakthrough rectal gonorrhoea after meningococcus B vaccination: microbiologic and clinical characteristics
27/04 12:00
10e. Antibacterial vaccines
Angelo Roberto RACCAGNI
Poster P3848
Abstract 8236
Did you get your shot? A prospective study on recommended vaccination coverage in older adults in Greece
27/04 12:00
10e. Antibacterial vaccines
Evdoxia DOUMOULIAKA
Poster P3849
Abstract 424
Highly-neutralising anti-PcrV antibodies as clinical candidates against Pseudomonas aeruginosa
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Jan RYBNIKER
Poster P3850
Abstract 2075
Immune effects of membrane vesicle on elimination of pneumococcal colonisation in the nasopharynx
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Soichiro KIMURA
Poster P3851
Abstract 3938
Repurposing daratumumab for patients with anti-interferon-gamma autoantibodies: a case series.
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Tsai MING-TAO
Poster P3852
Abstract 4704
The safety and efficacy of guluronic acid (G2013) in ankylosin spondylitis: a randomised controlled parallel clinical trial
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Sepideh NAZERI
Poster P3853
Abstract 5490
A novel physical inactivation method based on high hydrostatic pressure for the production of whole inactivated virus vaccines
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Martina BRANDOLINI
Poster P3854
Abstract 6156
Development of a plasmidic DNA vaccine platform: from in silico design to in vivo testing
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Sonia PRIETO MARTIN GIL
Poster P3855
Abstract 6489
Development of a novel chikungunya self-amplifying RNA vaccine platform
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Krunal POLRA
Poster P3856
Abstract 7391
Murine monoclonal antibodies against secreted Staphylococcus aureus prothrombin-activating virulence factors induce macrophage opsonophagocytosis
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Ting WONG
Poster P3857
Abstract 8250
Intravenous immunoglobulins (IVIG) inhibit Streptococcus pneumoniae-induced macrophage activation and death in vitro, but lack beneficial effects in a mouse meningitis model in vivo
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Susanne DYCKHOFF-SHEN
Poster P3858
Abstract 8501
Opsonic IgG2a and IgG2b monoclonal antibodies targeting HSP16.3 and peptidoglycan cell wall components recognise and effectively bind to clinical strains of Mycobacterium tuberculosis
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Bong-Akee SHEY
Poster P3859
Abstract 8809
In vitro models to assess auto-Abs neutralizing the protective effect of type I IFNs against WNV infection
27/04 12:00
10f. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)
Alessandro FERRARI
Poster P3860
Abstract 122
Different cytokines responses after treatment with benzathine penicillin in patients with syphilis primary infection or reinfection
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Hung-Chin TSAI
Poster P3861
Abstract 157
Biological effect of cell-free DNA extracted from septic mice in vitro, in vivo and its mechanism
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Hyungdon LEE
Poster P3862
Abstract 861
Host-pathogen interactions: Galleria mellonella-Candida albicans infection model to study the virulence and efficacy of antifungal drugs
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Margy Alejandra ESPARZA MORA
Poster P3863
Abstract 1020
Distinct clinical characteristics and cerebrospinal fluid tissue-based assay staining pattern between infectious and autoimmune encephalitis: IMPROVE trial study (2022-01)
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Ke LIN
Poster P3864
Abstract 1104
Evaluation of the local and the peripheral immune response in patients with cystic echinococcosis
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Linda PETRONE
Poster P3865
Abstract 1129
The impact of interferon lambda polymorphisms on influenza vaccine responses in treated HIV
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Rachel MAC CANN
Poster P3866
Abstract 1158
Pgm-1 contributed to macrophage function in murine pneumococcal meningitis
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Rutger KONING
Poster P3867
Abstract 1206
AIM impact on immune checkpoints in Mycobacterium avium infection
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Chiaki KAJIWARA
Poster P3868
Abstract 1445
Accuracy of a host response test for diagnosis of bacterial and viral infections and prediction of illness severity
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Oliver LIESENFELD
Poster P3869
Abstract 1700
Decreased intracellular killing of Escherichia coli by blood phagocytes from Clostridioides difficile-infected patients
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Roland NAU
Poster P3871
Abstract 1956
CRP velocity as a biomarker for bacterial virulence
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Tal LEVINSON
Poster P3872
Abstract 2178
Influence of parasitic infections on clinical outcomes in patients with tuberculosis and their contacts
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Augstine YEBOAH
Poster P3873
Abstract 2433
Investigation of baseline functional antibody immune response to 23 pneumococcal vaccine serotypes in Indian healthy Naïve adults
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Sravani DHARMAVARAM
Poster P3875
Abstract 2867
Immune checkpoint inhibitor therapy restores neutrophil response against Candida albicans in patients with malignancy
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Anna APOSTOLOPOULOU
Poster P3876
Abstract 2917
Study of the lung protective immunomodulation induced by Streptococcus mitis in pulmonary colonised mice
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Clément LEMAIGRE
Poster P3877
Abstract 2944
Potential of a host-response diagnostic test for differentiating bacterial from viral infections to improve the lower respiratory tract infections care pathway in the NHS: a qualitative evaluation.
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Sara GRAZIADIO
Poster P3878
Abstract 2974
Interferon-gamma responses to Chlamydia trachomatis vaccine candidate antigens and relation to infection outcomes in women
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
William GEISLER
Poster P3879
Abstract 3141
Establishment of flow cytometry-based opsonophagocytosis assay: an efficient platform for assessing of functional antibodies against Streptococcus pneumoniae
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Sravani DHARMAVARAM
Poster P3880
Abstract 3167
Estradiol and progesterone modulate expression of Toll-like receptors(TLRs) in peripheral blood cells infected by HIV-1 subtypes G and A
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Marina NOSIK
Poster P3881
Abstract 3228
UL44 protein as a potential candidate for a vaccine against Cytomegalovirus
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Carmen SERRANO RÍSQUEZ
Poster P3882
Abstract 3599
High mortality of Acinetobacter baumannii infection is attributed to macrophage-mediated induction of cytokine storm but preventable by naproxen
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Han WANG
Poster P3883
Abstract 3808
Differential host immune response during malarial and bacterial acute febrile illness: circulating inflammatory markers and extracellular vesicles
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Natalia TIBERTI
Poster P3884
Abstract 4151
Immunomodulatory activity of omadacycline in vitro and in a murine model of acute lung injury (ALI)
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Madeline SANDERS
Poster P3887
Abstract 5386
Zebrafish as a model for Staphylococcus aureus infection treatment and immune response
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Cecilia VOLK
Poster P3888
Abstract 5468
A potential biomarker in symptomatic West-Nile virus (WNV) infections: monocyte CD169 (mCD169) expression in peripheral blood
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Massimo CRAPIS
Poster P3889
Abstract 5944
Cysteamine as a host-directed therapy for tuberculosis: first in vitro assessment of the immunomodulatory effects
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Saeid NAJAFI-FARD
Poster P3890
Abstract 6318
The tricarboxylic acid cycle regulates fibroblast-driven tissue remodelling during Mycobacterium tuberculosis infection
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Ramla CUSMAN
Poster P3891
Abstract 6393
Cytokine Patterns in 250 Patients with Alveolar Echinococcosis
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Lynn PETERS
Poster P3892
Abstract 6984
Real-world Impact of MeMed BV, a rapid host response test for distinguishing bacterial and viral infections, in an urgent care network
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Shirley SHAPIRO BEN DAVID
Poster P3893
Abstract 7116
Role of cmv-IL-10 in a HCMV-Aspergillus-Co-infection model
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Lydia BUSSEMER
Poster P3894
Abstract 8390
Adverse events following immunization with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda — preliminary report
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Ellon TWINOMUHWEZI
Poster P3895
Abstract 8684
SeptiCyte rapid, a new biomarker for the diagnosis of ventilator-associated pneumonia in polytrauma patients
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Lisa NEUTRE
Poster P3896
Abstract 8737
Varicella zoster virus antibody titer is not a good marker of the clinical protection driven by chickenpox vaccine
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Lorena FORQUÉ RODRIGUEZZ
Poster P3897
Abstract 8866
Implications of ageing on cancer immunotherapy treatment using mycobacteria
27/04 12:00
10g. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)
Paula HERRERO-ABADÍA
Poster P0604
Abstract 71
Tuberculosis severity predictive model using Mtb variants and serum biomarkers in a Colombian cohort of APTB patients
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Andres BAENA
Poster P0605
Abstract 87
Cerebrospinal fluid adenosine deaminase levels are non-discriminatory for the diagnosis of tuberculous meningitis in moderate TB incidence Singapore
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jinghao Nicholas NGIAM
Poster P0606
Abstract 103
Phylogenomics of Mycobacterium avium complex from clinical respiratory samples
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Ka Lip CHEW
Poster P0607
Abstract 164
Treatment success rate of nontuberculous mycobacteria was low in Arkhangelsk region of Russia in 2010-2020
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Platon ELISEEV
Poster P0608
Abstract 167
An easy and rapid method for differentiating Mycobacterium ulcerans from M. marinum based on lipid spectra
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Komine TAKESHI
Poster P0609
Abstract 304
Omadacycline alone and in combination as a treatment option for Mycobacterium avium infections
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Saskia Emily MUDDE
Poster P0610
Abstract 605
Multicentre in vitro susceptibility of nontuberculous mycobacteria to apramycin and amikacin: comparing MIC distributions and tentative epidemiological cutoffs
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Nguyen MINH-VU
Poster P0611
Abstract 609
Increased risk of all cause-mortality in active tuberculosis patients attributed to SARS-CoV-2 infection: time-dependent survival analysis in Chile
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Salvador VARGAS GARCIA
Poster P0612
Abstract 663
Biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Abrar SENHAJI
Poster P0613
Abstract 762
Transmission dynamics and genotypic diversity of Mycobacterium tuberculosis in Colombian persons deprived of liberty
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Ashley HEILMANN
Poster P0614
Abstract 770
Mycobacterium abscessus infection in children: a six year study in Singapore
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Chia Yin CHONG
Poster P0615
Abstract 788
Extrapulmonary nontuberculous mycobacteria infections: a ten-year review in a tertiary care hospital in Belgium
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Larranaga Lapique EVA
Poster P0616
Abstract 1058
Video-observed therapy (VOT) vs directly observed therapy (DOT) for tuberculosis treatment: a systematic review on adherence, cost of treatment, time spent observing treatment and patient satisfaction
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Thiago NETTO
Poster P0617
Abstract 1189
The discordant diagnostic dilemma: analysis of the anyplex II MTB/MDR and BACTEC MGIT 960 system to assess the susceptibility of Mycobacterium tuberculosis from clinical specimens
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Kanphai WONGJARIT
Poster P0618
Abstract 1199
Risk of tuberculosis among recent arrived minor migrants: A nationwide cohort study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Kristina Langholz KRISTENSEN
Poster P0620
Abstract 1483
Occurrence of mutations associated with rifampicin and isoniazid resistant in Mycobacterium tuberculosis isolates from patients in Kaduna state Nigeria
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Kasimu MAMUDA
Poster P0622
Abstract 1508
Doxycycline normalises vasculatures to enhance TB drug delivery in CNS-tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Fei Kean LOH
Poster P0623
Abstract 1684
Effect of aminoglycoside-induced ototoxicity on NTM guideline-based therapy (NTM-AGOTO) (ESGMYC)
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Francis DROBNIEWSKI
Poster P0624
Abstract 1851
Optimizing the preparation of non-tuberculous mycobacterial (NTM) isolates for MALDI-TOF (VITEK) MS identification and speciation
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Kruthi MALUR
Poster P0625
Abstract 1968
Contezolid demonstrated equivalent efficacy to linezolid in tuberculosis treatment in an early bactericidal activity study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Mengqiu GAO
Poster P0626
Abstract 1970
Rifampicin resistant Mycobacterium tuberculosis complex strains with rpoB I491F mutation missed by GenoType MTBDRplus in Mozambique
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Stefan NIEMANN
Poster P0627
Abstract 2041
Contribution of commercial test in the diagnosis of extra-pulmonary tuberculosis: first experience in Algeria
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Ali ZEROUKI
Poster P0628
Abstract 2131
Bedaquiline and clofazimine synergy against Mycobacterium abscessus clinical strains
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Priya SOLANKI
Poster P0629
Abstract 2255
Occupational latent tuberculosis infection among healthcare workers in Vietnam: prevalence and risk factors
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Van NGUYEN
Poster P0631
Abstract 2509
A dose escalation study to evaluate the safety of aerosol BCG infection in previously BCG-vaccinated UK adults
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Timothy FREDSGAARD-JONES
Poster P0632
Abstract 2692
Targeted pan-mycobacterial PCR increases diagnostic yield compared to 16S rRNA gene PCR and culture alone
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Laura ATKINSON
Poster P0633
Abstract 2698
Clinical and genomic features of M. avium complex: a multi-national European study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Nils WETZSTEIN
Poster P0634
Abstract 2795
Occurrence of nontuberculous mycobacteria in households and urbanised environments
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Paulina WÓJTOWICZ
Poster P0635
Abstract 2814
Evaluation of the NTM Elite agar for cultivation of nontuberculous mycobacteria from different types of environmental samples
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Paulina WÓJTOWICZ
Poster P0636
Abstract 2825
Blood-based mRNA test for tuberculosis shows promising diagnostic accuracy
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Seda YERLIKAYA
Poster P0637
Abstract 2830
C-terminal region of Rv1039c (PPE15) of Mycobacterium tuberculosis induces mitochondria mediated macrophage apoptosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
PRIYANKA
Poster P0639
Abstract 2977
Evaluation of an automated molecular assay for the detection of Mycobacterium tuberculosis in cerebrospinal fluid (CSF)
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Marthe CHARLES
Poster P0640
Abstract 3042
Detection of T-cell responses in tuberculosis patients using a new prototype interferon-gamma release assay
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Irene LATORRE
Poster P0641
Abstract 3053
Development of a multiplex droplet digital PCR method for detection and monitoring of Mycobacterium tuberculosis and drug-resistant tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Yu Jeong CHOI
Poster P0642
Abstract 3083
Modern Mycobacterium tuberculosis lineages are driving cross-border transmission of multidrug-resistant tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Pedro GOMES
Poster P0643
Abstract 3087
Clinical characteristic and mortality of tuberculosis in adult people living with HIV/AIDS: a single centre retrospective cohort study in Thailand
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Hariwong CHAICHAROEN
Poster P0644
Abstract 3105
Mycobacterium smegmatis: a case series and review of antimicrobial susceptibility patterns
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Patrick CROWLEY
Poster P0645
Abstract 3195
The challenge of tuberculosis diagnosis in malnourished children: employing clinical scores in Tosamaganga Hospital, Tanzania
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Anna Hermine MARKOWICH
Poster P0646
Abstract 3342
Solving the gap between molecular and genomic epidemiology in tuberculosis: inferring MIRU-VNTR patterns from genomic data
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Sergio BUENESTADO-SERRANO
Poster P0647
Abstract 3374
In vitro evaluation of inhaled pentamidine for the treatment of pulmonary M. tuberculosis H37Rv
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jelmer RAAIJMAKERS
Poster P0648
Abstract 3456
Culture-free sequencing reveals high correlation in Mycobacterium tuberculosis genomic variability compared to culture
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Carla MARINER-LLICER
Poster P0649
Abstract 3615
A recombinant adenylate cyclase toxoid expands HLA-E-restricted cytotoxic CD8+ T cells against Mycobacterium tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Giusto Davide BADAMI
Poster P0650
Abstract 3646
Increasing problem of drug-resistant tuberculosis in Nepal
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Prabin SHRESTHA
Poster P0651
Abstract 3665
Blood-based three-gene TB host response score is predictive of TB disease or 30-day mortality in hospitalised Ugandans with advanced HIV disease: a prospective cohort study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jayne ELLIS
Poster P0652
Abstract 3682
In vitro susceptibility testing of BTZ-043 against Mycobacterium tuberculosis complex isolates to establish the epidemiological cut-off values and MIC distribution
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Ilaria IANNUCCI
Poster P0653
Abstract 3788
Improved detection of mycobacteria in CF and tissue samples cultivated in mycobacterium growth indicator tube incubated at 30°C compared to conventional growth conditions of liquid and solid media
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jan KEHRMANN
Poster P0654
Abstract 3836
Increased risk of malignancy in patients with tuberculosis: a nationwide cohort study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jinnam KIM
Poster P0655
Abstract 3990
Simplified strategy to update tuberculosis transmission situation in Madrid by rationalisating molecular and genomic sequential analysis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Cristina RODRÍGUEZ
Poster P0657
Abstract 4029
PanSpoTyping: fast and accurate in silico Mycobacterium spoligotyping with pangenome
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Cheng Yee TANG
Poster P0658
Abstract 4035
Tuberculosis infection control in Nepal
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Prabin SHRESTHA
Poster P0659
Abstract 4064
Genomic variations in Mycobacterium tuberculosis from pulmonary and extrapulmonary isolates: Insights into compartmentalization
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Gérard LINA
Poster P0660
Abstract 4113
Tuberculosis-associated hemophagocytic lymphohistiocytosis: diagnostic challenges and determinants of outcome
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Lisa KURVER
Poster P0661
Abstract 4182
Management of latent tuberculosis infections: national survey among French physicians
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Nathalie DOURNON
Poster P0662
Abstract 4227
Mycobacterium chimaera: a respiratory pathogen to be considered
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Alicia ARNAIZ-NIEVA
Poster P0663
Abstract 4236
Speciation of nontuberculosis Mycobacteria and implication for disease management in Sheffield
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Emily WARD-WILLIAMS
Poster P0664
Abstract 4356
Diagnostic performance of a two new molecular assays for Mycobacterium tuberculosis complex and non-tuberculous mycobacteria detection from respiratory tract specimens
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Alba LLOP-ALGUERO
Poster P0665
Abstract 4361
Deeplex Myc-TB: performance evaluation and integration in diagnostic workflow for tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Elena NICOLINI
Poster P0666
Abstract 4525
Application of Fourier-transform infrared spectroscopy for differentiation of Mycobacteroides abscessus complex subspecies
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Norman MAUDER
Poster P0667
Abstract 4535
TB-SEQ: a new strategy to complement tuberculosis contact tracing in Catalonia
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Elisa MARTRO
Poster P0668
Abstract 4764
A global perspective: the gene expression profile of tuberculosis disease among people living with HIV
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Erwin John TAGUIAM
Poster P0669
Abstract 4771
Integrative analysis of blood transcriptomes and machine learning models, unveiling potential biomarkers for discriminating high-risk tuberculosis infection
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Maryam OMRANI
Poster P0670
Abstract 4842
Mycobacterium abscessus resistance to beta-lactams in cystic fibrosis outbreak strains
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Adrian ZELAZNY
Poster P0671
Abstract 4870
Point-of-care ultrasound and urine lipoarabinomannan testing to identify disseminated tuberculosis among patients with HIV at a teaching hospital in Accra, Ghana
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Johanna ÅHSBERG
Poster P0672
Abstract 4872
Completion rate and side effects of two regimens for the treatment of tuberculosis infection: a randomised controlled trial
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Alberto MATTEELLI
Poster P0673
Abstract 4878
Effect of clarithromycin in the viability of Mycobacterium avium complex species biofilms
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jaime ESTEBAN
Poster P0674
Abstract 4932
Improved identification of Mycobacterium avium complex by MALDI-TOF coupled with machine learning
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Alexandra AUBRY
Poster P0675
Abstract 5079
Increase in cases of nontuberculous mycobacterial lymphadenitis presenting to Children's Health Ireland: results of a 15-year retrospective case review
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Cilian ?MAOLDOMHNAIGH
Poster P0676
Abstract 5109
Dynamic PET facilitated development of antibiotic regimens for tuberculous meningitis due to multidrug-resistant strains
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Sanjay JAIN
Poster P0677
Abstract 5121
Low tuberculosis interferon-gamma release assay conversion rate among exposed healthcare workers
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Geehan SULEYMAN
Poster P0678
Abstract 5157
Comparison of MIC results obtained with EUCAST BMD and MGIT for levofloxacin, moxifloxacin, D-cycloserine and linezolid
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Christopher MASSEY
Poster P0679
Abstract 5277
Comparison study of mutations in a drug-resistant Mycobacterium tuberculosis isolates with rifampicin, fluoroquinolones, bedaquiline, delamanid, pretomanid and linezolid MICs in Korea using whole genome sequencing & 2023 WHO mutation catalogue
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Lee HEE JOO
Poster P0680
Abstract 5345
Systematic evaluation of clarithromycin resistance-associated mutations in Mycobacterium abscessus species based on whole genome sequencing and drug susceptibility testing
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Mitsunori YOSHIDA
Poster P0681
Abstract 5401
Point-of-care ultrasound in evaluation of people living with HIV with disseminated infection due to non-tuberculous mycobacteria: a multicentre case-series
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Francesco TACCARI
Poster P0682
Abstract 5562
Biomarkers to differentiate between tuberculosis and conditions mimicking tuberculosis: a prospective diagnostic accuracy study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Anne ØSTERGAARD AHRENS
Poster P0683
Abstract 5591
Increasing nontuberculous mycobacteria recovery rate and regional difference of mycobacterial species over 11 years in a Korean tertiary care hospital
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Jae Hyeon PARK
Poster P0684
Abstract 5604
When atypical does not mean uncommon. Mycobacterium fortuitum infection in breast surgery with prosthesis implant: case report and literature review
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Lucia BONATO
Poster P0685
Abstract 5651
Improving tuberculosis diagnosis using a hidden Markov model-based decision model for multiple testing strategy
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Onya OPOTA
Poster P0686
Abstract 5680
Culture-free whole genome sequencing of Mycobacterium tuberculosis using ligand-mediated bead enrichment method
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Shruthi VASANTHAIAH
Poster P0687
Abstract 5687
Diagnostic performance of a WHO-recommended rapid diagnostic test in detecting rifampicin susceptibility in a low drug-resistant setting
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Tai-Hua CHAN
Poster P0688
Abstract 5702
Modifications in chronic colonisation by nontuberculous mycobacteria after CFTR-modulator treatment in cystic fibrosis patients
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
María Paula VARGAS DURÁN
Poster P0689
Abstract 5730
99mTechnetium labelled ethambutol scintigraphy with SPECT/CT in patients with abdominal tuberculosis: a pilot study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Sunit SIKDAR
Poster P0690
Abstract 5791
Reassessing ongoing risk of Mycobacterium chimaera infection following exposure to heater cooler units during cardiothoracic surgery in the UK
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Laura MAYNARD-SMITH
Poster P0692
Abstract 5847
Evaluation of rapid molecular MTB/XDR assay in England: a low incidence drug resistant TB setting
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Elena FERRAN
Poster P0693
Abstract 5852
The first evaluation of targeted nanopore-based sequencing for tuberculosis drug resistance detection
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Kiarash MOGHADDASI
Poster P0694
Abstract 5863
Tuberculosis contact investigation: a 20 year experience from a third-level hospital in Girona
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Martin QUINTANA GRIJALVO
Poster P0695
Abstract 6117
Burden of tuberculosis in migrant populations in the Middle East and North Africa: a systematic review
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Taha MAATOUG
Poster P0696
Abstract 6308
Culprit or coloniser? To treat or ignore? Clinical relevance of nontuberculous mycobacteria (NTM) isolated in a tertiary care hospital in Western Rajasthan: time to go from bench side to bed side
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Nikhil JOHN
Poster P0697
Abstract 6382
Exploring the link between psychosocial stress, mental health, and tuberculosis: a mixed methods study
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Sally HAYWARD
Poster P0698
Abstract 6448
Adjunctive host-directed therapy to improve tuberculosis treatment outcomes: a systematic review
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Gemma SKELLERN
Poster P0699
Abstract 6471
Mycobacterium kansasii in cancer patients: a 15-case series
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Patricia Rodrigues BONAZZI
Poster P0700
Abstract 6502
Short course treatment strategy for the treatment of rifampicin resistant tuberculosis: comparison between a bedaquiline-based regimen and a bedaquiline-free regimen
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Joan MARTINEZ CAMPRECIOS
Poster P0701
Abstract 6723
Comparative evaluation of sampling methods for detection of Mycobacterium leprae in suspected leprosy patients by RLEP-PCR
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Manjot KAUR
Poster P0702
Abstract 6772
Rapid prediction of drug susceptibility using targeted NGS analysis of sputum from active TB patients in Japan
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Akiko TAKAKI
Poster P0703
Abstract 6821
A novel, high-content imaging-based phenotypic screening assay to advance drug discovery for nontuberculous mycobacteria (NTM)
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Winston CHIU
Poster P0704
Abstract 6856
1-day phenotypic drug susceptibility testing for Mycobacterium bovis BCG using single-cell imaging and a deep neural network
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Buu Minh TRAN
Poster P0705
Abstract 6864
16S rRNA as a pathogen-directed biomarker of early treatment response in patients with susceptible tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Siphiwe MATUKANE
Poster P0706
Abstract 6882
Rapid nanomotion-based phenotypic antibiotic susceptibility testing for the detection of bedaquiline resistance in MDR- and XDR-TB
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Anthony VOCAT
Poster P0707
Abstract 6883
Quantiferon-TB Gold Plus in children: its role in discriminating latent from active Tuberculosis and monitoring LTB prophylaxis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Francesco BISOGNIN
Poster P0708
Abstract 6894
An individual-level pooled analysis of pyrazinamide toxicity and weight-based dosing in pulmonary tuberculosis in adults
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Navaneeth NARAYANAN
Poster P0709
Abstract 6985
Development of tuberculosis in biological treated patients and evaluation of a screening strategy for latent tuberculosis infection based on QuantiFERON-TB Gold
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Sandra PÉREZ-RECIO
Poster P0710
Abstract 7039
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in the province of Pavia: an overview
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Mariangela SICILIANO
Poster P0711
Abstract 7051
Integration of whole genome sequencing data for cluster analysis as part of the tuberculosis surveillance in Germany: results from three cities
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Teresa DOMASZEWSKA
Poster P0712
Abstract 7056
New genome wide association study for tuberculosis meningitis and other extra-pulmonary clinical forms using different algorithms and statistical ranking
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Kevin LA
Poster P0713
Abstract 7398
Analytical and clinical assessment of the PATHFAST TB LAM Ag assay for tuberculosis treatment monitoring
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Yassir Adam SHUAIB
Poster P0714
Abstract 7667
The protection role and mechanism of intestinal Prevotella-induced differentiation of Th17 in latent tuberculosis infection
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Yuan HUANG
Poster P0715
Abstract 7696
Implementation of the Bandim TBscore and routine testing of urine samples improves diagnostic efficacy amongst treatment naïve HIV patients
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Savannah DUUS
Poster P0716
Abstract 7730
Mycobacterium abscessus genomic epidemiology in Northern Ireland, UK
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Zoe JOHNSTON
Poster P0717
Abstract 7823
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including treatment of latent infection with moxifloxacin
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Marina FAYOS
Poster P0718
Abstract 7900
Repeating the borderline interferon-gamma release assay (IGRA) test one month later in a general hospital: benefits and controversies
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Flor De María VALENZUELA MEDINA
Poster P0719
Abstract 7978
Determining the effects on fitness of all mutations in the rifampicin resistance-determining region of mycobacteria
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Hui ZHAO
Poster P0720
Abstract 7985
The correlation of phenotypic and genotipic methods, including the WGS, for detection of drug resistance of Mycobacterium tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Nelly CIOBANU
Poster P0721
Abstract 8012
SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Ashima BHASKAR
Poster P0722
Abstract 8056
Analysing decadal trends in nontuberculous mycobacteria prevalence and diversity in South Korea: insights from a large-scale clinical laboratory dataset
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Cho JINHEE
Poster P0723
Abstract 8194
The diagnosis, management and outcome of bone and joint tuberculosis infections in UK adults
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Charlotte HALL
Poster P0724
Abstract 8251
Tuberculous meningitis: a retrospective study in a Portuguese Hospital
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Francisco Neto NOVELA
Poster P0725
Abstract 8429
Coinfections in patients with nontuberculous mycobacteria
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Pedro Ítalo OLIVEIRA GOMES
Poster P0726
Abstract 8557
Ultrasound findings in patients with peritoneal tuberculosis: a proposal for improving a protocol of “point-of-care” ultrasound
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Alessia FRATER
Poster P0727
Abstract 8573
First insights into the genetic composition of Mycobacterium tuberculosis strains circulating in Kosovo with Deeplex Myc-TB
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Rrezarta BAJRAMI HALILI
Poster P0728
Abstract 8604
Mass spectrometry-based metabolite profiling to explain differential inhibitory effect of gallium levofloxacin and gallium linezolid combinations on drug-resistant Mycobacterium tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Olena RZHEPISHEVSKA
Poster P0729
Abstract 8620
Spontaneous mutations conferring antibiotic resistance to new aroylhydrazones at a range of concentrations in Mycobacterium tuberculosis
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Simeon DIMITROV
Poster P0730
Abstract 8683
Therapeutic drug monitoring of rifampin in a cohort of patients with pulmonary and extrapulmonary TB
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Bianca GRANOZZI
Poster P0731
Abstract 8905
Performance evaluation of the FluoroType® MTBDR VER 2.0 with dual target detection of Mycobacterium tuberculosis complex from native sputum and culture
28/04 12:00
2a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)
Vera ALLERHEILIGEN
Poster P0732
Abstract 96
Characteristics of bloodstream infections in patients with liver cirrhosis in a general hospital
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sophie NGUYEN
Poster P0733
Abstract 109
Patterns of lymphocyte count as a predictor of early mortality among adult patients with sepsis admitted at a tertiary hospital June 2020 - January 2022
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Stephannie Angel RICAFRENTE
Poster P0734
Abstract 217
Mucositis-associated bloodstream infections in haematology patients with fever during neutropenia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nick DE JONGE
Poster P0735
Abstract 271
Reliability of differential time to positivity technique in the diagnosis of catheter-related bloodstream infection: a retrospective analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Alvaro IRIGOYEN VON SIERAKOWSKI
Poster P0736
Abstract 393
Follow-up, diagnosis, and outcomes of fever of unknown origin cases in which no diagnosis was established after initial evaluation: an international ID-IRI study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Oguz Resat SIPAHI
Poster P0737
Abstract 433
Importance of source control in the subgroup of intra-abdominal infections for septic shock patients: analysis of 390 cases
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ugur ÖNAL
Poster P0738
Abstract 439
Prompt identification of etiologic microorganisms and their susceptibilities in bloodstream infections using a novel filtration concentration method
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yung-Chieh FU
Poster P0739
Abstract 466
Code sepsis: incidence, prognosis and risk factors of sepsis-associated mortality
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Maria Eugenia MARTINEZ-NUÑEZ
Poster P0740
Abstract 476
A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ugur ÖNAL
Poster P0741
Abstract 484
Emergence of invasive group A streptococcal (iGAS) bloodstream infections (BSIs) in a French general hospital
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sophie NGUYEN
Poster P0742
Abstract 494
Time to positivity is a risk factor for death among patients with bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kevin LAUPLAND
Poster P0743
Abstract 499
Gram-negative bloodstream infections in hospitalised Australian children: epidemiology, antimicrobial resistance and clinical outcomes
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sophie Chien-Hui WEN
Poster P0744
Abstract 3680
The effects of appropriate and inappropriate diagnosis and treatment of urinary tract tnfections on patient outcomes
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Rebecca OETTLE
Poster P0745
Abstract 528
Blood culture contamination in a tertiary care hospital: a three-year study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Banan AIESH
Poster P0746
Abstract 531
Contezolid, a novel oxazolidinone, is non-inferior and safer comparing with linezolid in treating Gram-positive sepsis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Chen DAYU
Poster P0747
Abstract 538
Direct identification of microorganisms by MALDI-TOF MS from positive blood cultures and rapid antibiotic susceptibility testing
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Bilgehan ERGAN
Poster P0748
Abstract 638
The effect of P2Y12 inhibitor in addition to anti-staphylococcal therapy on microbiologic clearance in patients with Staphylococcus aureus bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nobuaki MORI
Poster P0749
Abstract 667
Multidrug-resistant pathogens and predictors of all-cause mortality in healthcare-associated bloodstream infections in intensive care unit at the University Hospital Center Zagreb over five-year period
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Dijana VARDA BRKIC
Poster P0750
Abstract 803
Epidemiological and molecular insights into P. aeruginosa bloodstream infections: pre- and post-COVID comparison
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yolanda SAENZ
Poster P0751
Abstract 855
Neonatal early-onset sepsis bacterial etiology correlates with placental bacterial culture results
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Manon JABOYEDOFF
Poster P0752
Abstract 880
Anaerobic growth as an independent prognostic factor of mortality in Pseudomonas aeruginosa blood stream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Daniel Nicolás MARCO
Poster P0753
Abstract 928
Risk factors for healthcare-associated Enterobacter spp. bacteremia: a case-case-control study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Shikai WU
Poster P0754
Abstract 973
Follow-up blood cultures in Streptococcal and Enterococcal bacteremia, are they of any value?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Romkje Sjoukje DE BOER
Poster P0755
Abstract 978
Onset of nosocomial bloodstream infection in intestinal carriers of multidrung-resistant enterobacterales: a retrospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Noureddine HENOUN LOUKILI
Poster P0756
Abstract 983
Infective endocarditis and discovertebral infections in older adults: complications and functional decline
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Elise CASSAND
Poster P0757
Abstract 1038
Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: a multicentre retrospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Marianne HENDRIKS
Poster P0758
Abstract 1160
Feasibility study of hyperbaric oxygen treatment for left-sided infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Christian Johann LERCHE
Poster P0759
Abstract 1850
A quantitative point-of-care device based on measurement of sTREM-1 levels for risk-stratification of febrile patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Barbara BARO SASTRE
Poster P0760
Abstract 1222
Computational map of disease showed new aspects of severe systemic infections due to P. aeruginosa
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Francesco MESSINA
Poster P0761
Abstract 1297
Community-acquired Staphylococcus aureus bacteraemia among people who inject drugs: a national cohort study in England, 2017-2020
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Emma MCGUIRE
Poster P0762
Abstract 1339
Prevalence and molecular epidemiology of carbapenem-resistant Acinetobactor baumannii isolates from bloodstream infections: the first report of NDM-1 producing A. baumannii in Korea
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Young Ah KIM
Poster P0763
Abstract 1349
Comprehensive analysis of myeloid nuclear differentiation antigen in urinary tract infection and urosepsis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Zhenglin CHANG
Poster P0764
Abstract 1379
Obesity paradox does not apply to young adult patients with sepsis: analysis of the MIMIC-IV database
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yongseop LEE
Poster P0765
Abstract 1399
Benchmarking hospitals for comparing and understanding differences in antimicrobial resistance and hospital-acquired bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Rishma AMARSY
Poster P0766
Abstract 1407
Serum cytokine levels in early neonatal sepsis identify IL-27 as a predictive clinical biomarker
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Claudius MEYER
Poster P0767
Abstract 1418
Nomenclature, definitions, and methodological approaches to estimate the impact of inappropriate antimicrobial treatment on drug-resistant bloodstream infection outcomes
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nasreen HASSOUN-KHEIR
Poster P0768
Abstract 1484
Exploring neutrophil migration dynamics in severe UTIs: Longitudinal analysis and clinical correlations
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lena KARWATH
Poster P0769
Abstract 1493
Ceftobiprole is safe and efficacious in treating renal impaired patients with complicated Staphylococcus aureus bacteraemia (SAB), including those on dialysis: results from the ERADICATE Phase 3 study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Marc ENGELHARDT
Poster P0770
Abstract 1556
Does age matter? Risk factors, complications, and outcomes among patients with infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Caglayan Merve AYAZ
Poster P0771
Abstract 1559
An analysis of baseline conditions or complications of S. aureus bacteraemia from a double-blind, randomised Phase 3 study (ERADICATE) comparing ceftobiprole vs daptomycin
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Thomas HOLLAND
Poster P0772
Abstract 1563
An easy and cheap prognostic factor: does the hematocrit-corrected erythrocyte sedimentation rate to albumin ratio predict mortality in infective endocarditis patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Caglayan Merve AYAZ
Poster P0773
Abstract 1568
Characteristics of urosepsis caused by ESBL producing Enterobacterales in Croatia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ana LONCAR
Poster P0774
Abstract 1577
Comparison of ceftobiprole versus daptomycin for time to S. aureus bloodstream clearance in the recent double-blind randomised Phase 3 study (ERADICATE)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Thomas HOLLAND
Poster P0775
Abstract 1603
Rectal colonisation by carbapenem-resistant Gram-negative bacteria and subsequent occurrence of bloodstream infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Angeliki KASSOMENAKI
Poster P0776
Abstract 1646
Exploring antibiotic combinations in the treatment of prosthetic valve endocarditis and prosthetic osteoarticular infections: prevalence and clinical impact of drug interactions
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nikolaos FATSIS-KAVALOPOULOS
Poster P0777
Abstract 1668
Characteristics and prognosis of patients following complete surgical removal of infected vascular graft
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Runza Buznego PAULA
Poster P0778
Abstract 1685
Sepsis knowledge and management proficiency of nurses and physicians in tertiary care neonatal units of Switzerland
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sylvain MEYLAN
Poster P0779
Abstract 1739
Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015-2022: secular trends and association with the COVID-19 pandemic
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lauro DAMONTI
Poster P0780
Abstract 1740
Different evolutions in incidence of invasive bacterial infections in Belgium
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Stefanie DESMET
Poster P0781
Abstract 1751
E.faecium bloodstream infections and vancomycin resistance role: a five-year retrospective analysis in an Italian tertiary care hospital
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lucia GRAZIANI
Poster P0782
Abstract 1755
Real-world data on the use of intravenous (IV) fosfomycin for the treatment of critically ill patients: an update from a European, multicentre, non-interventional and prospective clinical study (FORTRESS)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Klaus-Friedrich BODMANN
Poster P0783
Abstract 1821
Risk factors for Aerococcus bloodstream infection: a nationwide observational case-control study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
John WALLES
Poster P0784
Abstract 1823
Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Mark KHURANA
Poster P0785
Abstract 1835
Electric field-mediated sample preparation for accelerated sepsis diagnosis: an innovative approach for blood cell lysis while keeping pathogens viable
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sandra REISCHL
Poster P0786
Abstract 1852
Update of the leading causative organisms in community-acquired sepsis in a French paediatric emergency department
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Leon JAHDAUTI
Poster P0787
Abstract 1862
Retrospective review of Streptococcus bovis-Streptococcus equinus complex bacteraemia over a 5-year period in Greater Glasgow and Clyde
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Samuel HARWOOD
Poster P0788
Abstract 2040
Characteristics and outcomes of Stenotrophomonas maltophilia bacteremia: An 18-year study at two tertiary hospitals in South Korea
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sarah KIM
Poster P0789
Abstract 2093
Evaluation of empirical treatment coverage in native valve endocarditis: are two antibiotics better than one?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Oguzhan ACET
Poster P0790
Abstract 2209
Prevalence of extracardiac vascular complications in Abiotrophia spp. and Granulaticatella spp. infective endocarditis: a single-centre experience and a systematic review of the literature
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Giacomo POZZA
Poster P0791
Abstract 2224
Time to positivity as a mortality and source predictor in adults with Pseudomonas aeruginosa bloodstream infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Daniel Nicolás MARCO
Poster P0792
Abstract 2303
A hidden factor to healthcare-associated bloodstream infections: collection and technique of blood culture sampling
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Guan-Jhou CHEN
Poster P0793
Abstract 2314
Intensive care unit-onset bloodstream infections represent a distinct category of hospital-onset infections: a retrospective cohort study of bloodstream infections in ICU patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kevin LAUPLAND
Poster P0794
Abstract 2331
Two clades involved in a cluster of invasive group B streptococcal infection in non-pregnant adults in Hong Kong public hospitals in 2021 and 2023
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Carmen LI
Poster P0795
Abstract 2350
Poly-microorganisms detected by droplet digital PCR and increased pathogen load a week after sepsis diagnosis were associated with poor prognosis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Zhang HAOCHENG
Poster P0796
Abstract 2362
Risk factors and binary prediction models for bacteremia in patients with persistent neutropenic fever
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kyung-Ran KIM
Poster P0797
Abstract 2373
Impact of daptomycin dosing on mortality for vancomycin resistant enterococcal bloodstream infections in an Australian teaching hospital
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kelly CAIRNS
Poster P0798
Abstract 2398
How do experts classify sepsis cases for sepsis surveillance? Lessons learned from a behavioural artificial intelligence technology approach
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Renée TUINTE
Poster P0799
Abstract 2424
High prevalence of hypogammaglobulinemia and B-cell malignancies in adults with invasive pneumococcal disease
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Karin BERGMAN
Poster P0800
Abstract 2447
Tracking the evolution of antimicrobial resistance: whole genome sequencing for monitoring recurrent bacteremia caused by carbapenem-resistant Enterobacteriaceae
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ahmed BAYOUMI
Poster P0801
Abstract 2455
Predicting antimicrobial resistance in Gram-negative bacterial bloodstream infections through evaluation of dynamic host responses and deep learning
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Vasin VASIKASIN
Poster P0802
Abstract 2559
SepsiSTAT: automated microbial extraction and enrichment for rapid BSI detection and AST, direct from blood
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Daniel LOCKHART
Poster P0803
Abstract 2566
Epidemiology and outcomes of invasive group A Streptococcal bacteraemias 2017-2022: an increasing prevalence
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jacinta NG
Poster P0804
Abstract 2611
Early oral switch in endocarditis: an international cross-sectional survey by ESGBIES – results of the interim-analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Philipp MATHÉ
Poster P0805
Abstract 2643
Identifying populations at increased risk of E. coli bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Emma PRITCHARD
Poster P0806
Abstract 2716
Follow-up blood cultures do not reduce mortality in hospitalised patients with Gram-negative bloodstream infection: a population-wide cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sean Wei Xiang ONG
Poster P0807
Abstract 2752
Implication of Staphylococcus aureus isolation from intravenous catheter tips in the absence of positive blood cultures
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yoleidys Milagros MARTÍNEZ YSASIS
Poster P0808
Abstract 2842
Understanding the burden of group A streptococcus bloodstream infections over an 8-year period in an Irish tertiary hospital
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Louise KELLY
Poster P0809
Abstract 2908
Bacterial endocarditis: is the oral switch the optimal future strategy? A systematic review and meta-analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Beatrice BARDA
Poster P0810
Abstract 2941
Inappropriate empirical antibiotic therapy does not adversely affect outcome for patients with bacteraemia caused by ESBL-producing Enterobacterales
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Daniel BREMELL
Poster P0811
Abstract 2965
Piperacillin/tazobactam-resistant, ceftriaxone-susceptible E. coli bacteremia: a single centre experience
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Tommaso ALBANO
Poster P0812
Abstract 2975
Ceftaroline vs vancomycin monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a matched cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Roni BITTERMAN
Poster P0813
Abstract 2996
Hypervirulent Klebsiella pneumoniae bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Moufida HAMIDI
Poster P0814
Abstract 3002
Epidemiology of infective endocarditis: data from a reference centre with cardiac surgery (2016-2022)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Francisca ARTIGUES SERRA
Poster P0815
Abstract 3027
Enterobacter invasive infections and their antimicrobial susceptibility patterns in children at a rural Kenyan hospital: a 10-year analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jemima NYANDWARO
Poster P0816
Abstract 3111
Impact of evidence-based quality-of-care processes from clinical trial (CAMERA2) participation on methicillin-resistant Staphylococcus aureus bacteraemia outcomes: an international, multicentre, retrospective study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Russel LEE
Poster P0817
Abstract 3139
Defining clinical success in methicillin-resistant Staphylococcus aureus bacteremia patients treated with daptomycin and ceftaroline combination therapy
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Hanna SCHULTZ
Poster P0818
Abstract 3158
Biofilm formation ability is not associated with worse outcome in Acinetobacter nosocomialis bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yi-Tzu LEE
Poster P0819
Abstract 3272
Increase in bloodstream infections caused by MDR Staphylococcus haemolyticus during the COVID-19 pandemic
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
María BONILLA-MORENO
Poster P0820
Abstract 3390
Approach to febrile neutropenia in Belgian hospitals
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yuri VANBIERVLIET
Poster P0821
Abstract 3428
Novel sequence types, carbapenem resistance, virulence, neonatal sepsis: the Acinetobacter non-baumannii story
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sulagna BASU
Poster P0822
Abstract 3549
Multi-modal strategy reduces paediatric blood culture contamination rates and costs at a regional hospital in South Africa
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kgaogelo MASEMOLA
Poster P0823
Abstract 3571
Impact of a bundle intervention on clinical outcomes and adherence to quality of care indicators of Staphylococcus aureus bacteremia in non-referral community hospitals
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Francesc ESCRIHUELA-VIDAL
Poster P0824
Abstract 3648
Impact of de-escalation in prognosis of patients with bloodstream infection by Enterobacterales presenting with sepsis or septic shock: a post-hoc analysis of a prospective multicentre cohort
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Francesc ESCRIHUELA-VIDAL
Poster P0825
Abstract 3684
Emulating a target trial of early compared to late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Abdullah Tarik ASLAN
Poster P0826
Abstract 3697
Molecular evidence of Coxiella burnetii and Bartonella quintana endocarditis in Iran: a cross-sectional study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Saber ESMAEILI
Poster P0827
Abstract 3711
Decrease in hospital-acquired bloodstream infection rates in very low birth weight infants: data from 14 years of country-wide surveillance in Germany
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ferenc Darius RUETHER
Poster P0828
Abstract 3717
Short duration for the treatment of carbapenemase-producing Enterobacterales bloodstream-infections: is an effective treatment?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Celia SÁNCHEZ-MARTÍNEZ
Poster P0829
Abstract 3748
Body mass index and waist circumference increase the incidence of infective endocarditis in patients with diabetes mellitus: nationwide cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jinnam KIM
Poster P0830
Abstract 4073
The excess burden of antibiotic-resistant bloodstream infections among hospital patients: evidence from a retrospective cohort study in Chile, 2018-2022
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kasim ALLEL
Poster P0831
Abstract 4121
Clinical, microbiological and treatment features of infective endocarditis caused by Cardiobacterium spp. in a general hospital over 15 years
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Agustin ESTEVEZ
Poster P0832
Abstract 4159
Epidemiology of ICU-acquired bloodstream infections in Italian intensive care units: data from the Italian network for the evaluation of ICU interventions
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Camilla GENOVESE
Poster P0833
Abstract 4173
Adherence to 2022 IDSA guidance for the treatment of Stenotrophomonas malthophilia bloodstream infections: a multicentre cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Renato PASCALE
Poster P0834
Abstract 4180
Evaluation of outpatient parenteral antimicrobial therapy (OPAT) for infective endocarditis patients in a Belgian tertiary care centre
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Helena Cornelia VAN DEN HOUT
Poster P0835
Abstract 4195
Severity of disease in Streptococcus dysgalactiae subspecies equisimilis bacteremia: a prospective 4-year study, Finland
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Viivi NEVANLINNA
Poster P0836
Abstract 4203
The impact of risk factors for mortality in persistent Staphylococcus aureus bacteremia over time
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Annette WESTGEEST
Poster P0837
Abstract 4289
Post-operative treatment regimens in patients with native valve endocarditis due to Staphylococcus aureus who undergo valve replacement or repair
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Silpita KATRAGADDA
Poster P0838
Abstract 4295
Hypervirulent Klebsiella pneumoniae causing bloodstream infection in Hungary
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Fatma MOHAMED
Poster P0839
Abstract 4316
Granulicatella adiacens penicillin-binding proteins (PBPs) ceftobiprole inhibition: time for double beta-lactam treatment in combination with ampicillin for infective endocarditis (IE)?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Alberto PAGOTTO
Poster P0840
Abstract 4339
Coagulase-negative Staphylococcus endocarditis: risk factors and outcome
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Milagros SUAREZ
Poster P0841
Abstract 4358
Bacteremia in Denmark from 2010-2022: A population based nationwide cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ram B. DESSAU
Poster P0842
Abstract 4374
Partnership with a commercial bloodstream infection service team significantly improves blood culture volumes in one Spanish hospital emergency department
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lauren COOPER
Poster P0843
Abstract 4376
An anti-infective immunotherapy against Klebsiella pneumoniae
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sweta PANDEY
Poster P0844
Abstract 4388
Time to positivity re-evaluation and local epidemiology of blood cultures in Romagna, Italy
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Anna MARZUCCO
Poster P0845
Abstract 4393
Septris2.0: an updated, free, mobile, online simulation game that improves sepsis recognition and management
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sylvain MEYLAN
Poster P0846
Abstract 4416
Comparison of Qvella's Fast ID BSI with standard blood culture for the recovery of pathogens from blood of bacteremic patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Hossein SALIMNIA
Poster P0847
Abstract 4423
Cut the contaminants: improving blood culture contamination rates in a tertiary centre emergency department
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sarah KENNY
Poster P0848
Abstract 4425
Incidence risk of hospital-acquired infections due to carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa spp. in patients treated in intensive care units in Italy (INCREASE-IT Study)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Matteo RINALDI
Poster P0849
Abstract 4426
Transcatheter valve replacement as a salvage treatment for heart failure in infective endocarditis: a multicentre case series
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Miguel VILLAMARÍN MELIO
Poster P0850
Abstract 4455
Prevalence of Escherichia coli resistant to piperacillin/tazobactam causing bloodstream infections in human adults after treatment with piperacillin/tazobactam: systematic review of literature and experience of a tertiary level hospital in Italy
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Rita MURRI
Poster P0851
Abstract 4496
Investigation of the epidemiology, causative pathogens, complications and outcomes of infective endocarditis in cancer, transplantation and patients receiving immunosuppressive therapy.
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Özlem Kurt AZAP
Poster P0852
Abstract 4517
Bacterial and fungal etiologies of bloodstream infections in children in a reference center in Yaounde, Cameroon
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Basilice Mireille MINKA OBAMA
Poster P0853
Abstract 4596
Fusobacterium invasive infections: a ten-year overview of hospitalised patients in a tertiary healthcare centre
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Branimir GJURASIN
Poster P0854
Abstract 4607
Emergence of carbapenemase-producing Enterobacterales and clinical characteristics of carbapenem-resistant invasive infections in Chile (2018-2023)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Anne Sophie PETERS
Poster P0855
Abstract 4616
Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteremia and endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sunish SHAH
Poster P0856
Abstract 4627
Decision-support artificial intelligence models to predict the pattern of antimicrobial resistance in Gram-negative bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Cecilia BONAZZETTI
Poster P0857
Abstract 4709
The role of valve culture in the prognosis of patients with infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Pablo RUBINAN
Poster P0858
Abstract 4735
Characteristics of infections due to subspecies of Streptococcus gallolyticus identified in two Romanian hospitals
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Endre-Csaba PÁL
Poster P0859
Abstract 4786
Temporal trends in sepsis incidence and outcomes in Latvia (2015-2020): a retrospective administative data study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Laura PUCETA
Poster P0860
Abstract 4811
Long-term outcomes and health care utilisation in sepsis survivors in Latvia: a retrospective observational study using nationwide administrative data
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Laura PUCETA
Poster P0861
Abstract 4853
Activity of ceftobiprole alone versus ampicillin plus ceftriaxone against clinical Enterococcus faecalis blood isolates in 24-hour time-kill assays
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jaclyn CUSUMANO
Poster P0862
Abstract 4867
New β-lactam/β-lactamases inhibitor combinations can improve prognosis of KPC-producing Enterobacterales bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ana Cláudia CARVALHO
Poster P0863
Abstract 4891
A systematic review of dalbavancin use as a sequential therapy for infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Gabriele Maria LEANZA
Poster P0864
Abstract 4916
Factors associated with treatment failure of Stenotrophomonas maltophilia bloodstream infections from a single-centre study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sunish SHAH
Poster P0865
Abstract 4930
EPIDEMIOLOGY OF BACTEREMIA AMONG ALLOGENEIC TRANSPLANTATION THROUGHOUT 12-YEAR PERIOD
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Rosa M PACHECO-GONZALEZ
Poster P0866
Abstract 4935
Blood cultures contamination rate: overview of an Italian hospital
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Giulia RENISI
Poster P0867
Abstract 4958
Comparison of ceftriaxone versus ceftaroline in combination with ampicillin or penicillin against Enterococcus faecalis bloodstream isolates
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Olivia FUNK
Poster P0868
Abstract 4959
Early transition to oral antibiotics in uncomplicated Enterobacterales bloodstream infections: a retrospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Aina MATEU SUBIRÀ
Poster P0869
Abstract 4980
Burden and temporal trend of endocarditis in the Greater Antilles from 1990-2019
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Rafael CORTORREAL JAVIER
Poster P0870
Abstract 4990
Staphylococcus aureus bacteremia: a monocentric, retrospective study comparing geriatric to non-geriatric patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sami SERRAJ
Poster P0871
Abstract 4996
Bloodstream infections in patients with splenectomy
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Abiu SEMPERE
Poster P0872
Abstract 5043
Predictors of bacteremia in patients with solid and hematologic neoplasms
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Julián Andres HOYOS PULGARIN
Poster P0873
Abstract 5185
Clinical outcomes and bacterial characteristics of hospital-acquired bloodstream infections in Turkiye
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Abdullah Tarik ASLAN
Poster P0874
Abstract 5282
The impact of rapid microbial identification report on the clinical and health economics of hospitalised patients with bloodstream infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Xinmin CHU
Poster P0875
Abstract 5463
Gram-negative bacteremia in different types of immunocompromised patients: single centre observational study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Renato PASCALE
Poster P0876
Abstract 5507
Trends in the epidemiology of infective endocarditis in Spain during the XXI century
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jorge CALDERON PARRA
Poster P0877
Abstract 5534
Comparison of bacteremia incidence in COVID-19 vs. non-COVID-19 wards, before and during the Omicron wave: a single-centre, retrospective, comparative study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Aikaterini GKOUFA
Poster P0878
Abstract 5565
Evaluation of clinical utility of procalcitonin as a diagnostic marker in nonbacterial sepsis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jaya GARG
Poster P0879
Abstract 5614
Outstanding performance of XGBoost in predicting bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Zhonghao WANG
Poster P0880
Abstract 5640
Bacteriological and immunological characteristics of hospital-associated and community-associated methicillin-resistant Staphylococcus aureus
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Yeong Geon CHO
Poster P0881
Abstract 5727
Nosocomial bacteremia in a cohort of 63 French neonatal wards, 2019-2023
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nathalie VAN DER MEE-MARQUET
Poster P0882
Abstract 5728
Does infectious disease consultation have any impact on patients with sepsis alert?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ana ÁLVAREZ-URÍA
Poster P0883
Abstract 5736
Predictive factors for carbapenemase production and mortality in Enterobacteriaceae bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Maximiliano Gabriel CASTRO
Poster P0884
Abstract 5754
Higher effectiveness of new anti-pseudomonas cephalosporins versus piperacillin/tazobactam or carbapenems for the treatment of Pseudomonas aeruginosa bloodstream infections in intensive care unit: a multicentric retrospective propensity score adjusted study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Davide Fiore BAVARO
Poster P0885
Abstract 5817
Rising resistance of invasive infant Group B Streptococcus in Western Australia over 15 years
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lucy FURFARO
Poster P0886
Abstract 5837
Patient outcomes of MBL-producing CRE infections: interim results from a retrospective observational study in two centres from the Kingdom of Saudi Arabia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Bassem ALRADADI
Poster P0887
Abstract 5925
Carbapenem-resistant Klebsiella pneumoniae emerging as the most prevalent MDR organism in bloodstream infections at the ICU: the experience of Saint George Hospital University Medical Center in Lebanon
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Eid AZAR
Poster P0888
Abstract 5951
Non-fecalis enterococci should also be kept in mind as causative agents of infective endocarditis!
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Özlem Kurt AZAP
Poster P0889
Abstract 5980
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Matteo RINALDI
Poster P0890
Abstract 6110
Think sepsis? Think diagnostics and source identification
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Frances GARRAGHAN
Poster P0891
Abstract 6256
[18F]FDG-PET/CT utility in catheter-related Staphylococcus aureus bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Miguel Ángel VERDEJO GÓMEZ
Poster P0892
Abstract 6305
The potential predictive role of the neutrophil-to-lymphocyte ratio in patients with infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lorenzo BERTOLINO
Poster P0893
Abstract 6330
Prediction models on early identification of multidrug-resistant and carbapenems-resistant pseudomonas aeruginosa bloodstream infections in hematology patients prior to antimicrobial susceptibility testing: a multicentre cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Xiaomeng FENG
Poster P0894
Abstract 6335
Soluble immune receptors as severity markers in a multicentric group A Streptococcus pyogenes invasive disease paediatric cohort in Spain
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
José AVENDAÑO-ORTIZ
Poster P0895
Abstract 6362
Bacteremia associated with Staphylococcus haemolyticus in a cohort of 24 French neonatal intensive care units, 2019-2023
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nathalie VAN DER MEE-MARQUET
Poster P0896
Abstract 6368
Combination antibiotic therapy in hematological patients with Pseudomonas aeruginosa bloodstream infections: friend or foe?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Xiaomeng FENG
Poster P0897
Abstract 6376
Early oral treatment of infective endocarditis in real-world settings: prospectively evaluated data from the German DERIVE network
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Johannes CAMP
Poster P0898
Abstract 6495
Characterisation of hypervirulent Klebsiella pneumoniae strains causing blood stream infections or showing carbapenem resistance in Germany: a multicentre study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jürgen HELD
Poster P0899
Abstract 6535
The clinical and molecular characteristics of invasive Streptococcus agalactiae diseases in nonpregnant adults in Taiwan
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ming Horng TSAI
Poster P0900
Abstract 6536
Timing of extraction in patients with cardiac implantable electronic device infection: the sooner the better?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Raffaella GALLO
Poster P0901
Abstract 6708
Outcomes and factors associated with mortality for Enterococcus faecalis and Enterococcus faecium bloodstream infections: a prospective multicentre cohort study from the PROBAC project
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Fenna SCHARLOO
Poster P0902
Abstract 6712
Reducing economic cost and carbon footprints through sequential antimicrobial therapy in bacterial infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ana MARTÍNEZ-URREA FORTUÑO
Poster P0903
Abstract 6721
Clinical characterisation of Bacteroides bloodstream infection: a 5-year multi-centre analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Cottom LAURA
Poster P0904
Abstract 6735
Risk factors for mortality among elderly individuals hospitalised in the intensive care unit with hospital-acquired bloodstream infections: a multicenter cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Tomer HOFFMAN
Poster P0905
Abstract 6835
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam-based therapies
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Paolo GAIBANI
Poster P0906
Abstract 6857
Class 3 immune semaphorins: new biomarkers of sepsis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Lara SAMADAN MARKOVIC
Poster P0907
Abstract 6858
Optimising diagnostic stewardship interventions: a 5-year multi-centre analysis of antimicrobial resistance and clinical outcome of Bacteroides blood stream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Cottom LAURA
Poster P0908
Abstract 6863
Pseudomonas aeruginosa bloodstream infections: is it time for combo-therapy?
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nicholas GEREMIA
Poster P0910
Abstract 6899
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Antonio VENA
Poster P0911
Abstract 6912
Bacteremias due to NDM-1 and KPC-producing carbapenem-resistant Enterobacteriaceae in a high-prevalence area hospital: a comparative, single-centre, retrospective study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nikolaos SIPSAS
Poster P0912
Abstract 6930
Patients' experiences during hospitalization for Staphylococcus aureus bacteremia: a qualitative study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Marianne HENDRIKS
Poster P0913
Abstract 6962
Mortality risk factors and antimicrobial resistance in E. coli bacteremia associated with urinary tract infections (UTI)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Filip STEVANOVSKI
Poster P0914
Abstract 7018
Epidemiology, clinical characteristics and outcome of Group B Streptococcal bacteraemia in non-pregnant adults in Denmark from 2007-2016: A population-based study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Thilde FABRICIUS
Poster P0915
Abstract 7036
Clinical characteristics and outcomes of ST72 Staphylococcus aureus: comparison with S. aureus of other sequence types
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jaijun HAN
Poster P0916
Abstract 7042
Adequacy, escalation, and de-escalation of empirical therapy in patients with bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ljiljana LUKIC
Poster P0917
Abstract 7066
Mortality impacts of inappropriate empirical antibiotic therapy in patients with bloodstream infections in Chile: a retrospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kasim ALLEL
Poster P0918
Abstract 7094
Infective endocarditis: 13 years of experience in epidemiological and microbiological profile in a public cardiovascular tertiary centre, São Paulo, Brazil
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Cely ABBOUD
Poster P0919
Abstract 7100
Focus on streptococcal endocarditis: a snapshot of ten years
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Özlem Kurt AZAP
Poster P0920
Abstract 7230
Clinical utility of melatonin in the treatment of sepsis: a systematic review and meta-analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Alfonso J. RODRIGUEZ-MORALES
Poster P0921
Abstract 7289
Community and hospital-acquired Gram-negative bloodstream infections in non-ICU patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Maria KYZIROGLOU
Poster P0922
Abstract 7291
Culture-free rapid identification of bacterial pathogens in sepsis using RapidID, a novel real time multiplex, ribosomal RNA-based hybridization assay.
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Joseph M. BLONDEAU
Poster P0923
Abstract 7305
Usability of procalcitonin to detect asymptomatic central line associated blood stream infections in children with chronic kidney disease
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sampath JAYAWEERA
Poster P0924
Abstract 7316
Clinical outcomes, epidemiology and risk factors associated with peripherally inserted central venous catheter-associated bloodstream infection: a matched case-control study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Federico ROMANI
Poster P0925
Abstract 7325
Bloodstream infections in allogeneic hematopoietic cell recipients: trends of incidence, susceptibility and risk factors for multidrug resistance
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sara SANTOS FERNANDES
Poster P0926
Abstract 7339
Spatial distribution of hospitalisations and lethality with sepsis in San Paulo State, Brazil: a ten year-period population-based study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Carlos KIFFER
Poster P0927
Abstract 7373
Comparison of trough vs point estimate area-under-curve vancomycin dosing for methicillin-resistant Staphylococcus aureus bacteremia in the midwest United States
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Christen ARENA
Poster P0928
Abstract 7401
Risk factors and clinical outcomes associated with vancomycin-resistant vs vancomycin-susceptible Enterococcus faecium bloodstream infections: a five-year retrospective matched cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Martina DEL MONTE
Poster P0930
Abstract 7511
Mortality impact of microbiological factors in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Natalia MALDONADO
Poster P0931
Abstract 7563
Impact of baseline sociodemographic and drug use profile on short- and long-term outcomes in intravenous drug users following infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Inmaculada LÓPEZ MONTESINOS
Poster P0932
Abstract 7570
Impact of lab automation and reorganisation on bloodstream infections management
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Maxime PALUCH
Poster P0933
Abstract 7618
Clinical and microbiological risk factors for 30-day mortality associated with bloodstream infections caused by OXA-48-producing Klebsiella pneumoniae
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Javier FERNÁNDEZ
Poster P0934
Abstract 7622
Microbiological characteristics of infectious endocarditis from heart valves with positive culture during the last ten years
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
María Paula VARGAS DURÁN
Poster P0935
Abstract 7648
A bedside tool to predict the risk of mortality in internal medicine patients with Pseudomonas aeruginosa bloodstream infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Silvia CORCIONE
Poster P0936
Abstract 7711
The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Niccolo BUETTI
Poster P0937
Abstract 7715
Ampicillin-susceptible Enterococcus faecium bloodstream infections: a 5-year retrospective cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Valentina MENOZZI
Poster P0938
Abstract 7761
European antimicrobial resistance surveillance of Bacteroides fragilis from blood cultures 2022 (ReSuBacfrag)
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Michael BUHL
Poster P0939
Abstract 7787
Does early appropriate empirical antibiotic therapy reduce 30-day mortality among hospitalised patients with Klebsiella spp. bacteremia? A retrospective study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Tanya BABICH
Poster P0940
Abstract 7855
Standard deviation of the monocyte distribution width as a prognostic indicator of death in septic patients
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Dimitrios THEODORIDIS
Poster P0941
Abstract 7885
Epidemiology of sepsis in trauma patients in Kharkiv, Ukraine
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Mariia MATVIEIENKO
Poster P0942
Abstract 7912
Community acquired bacteremia due to multi-drug resistant organisms: risk factors and outcomes. A single centre prospective study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Pantazis-Michael VOUTSINAS
Poster P0943
Abstract 7938
The skip phenomenon in Staphylococcus lugdunensis infective endocarditis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Luis GASCA
Poster P0944
Abstract 7994
Short-course versus long-course antibiotic treatment in patients with uncomplicated Pseudomonas aeruginosa bacteremia: a systematic review and meta-analysis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Juan Pablo GARCIA MARMOLEJO
Poster P0945
Abstract 8014
Hafnia alvei (HA) bacteremia is secondary to biliary infection in most cases
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Jacques TANKOVIC
Poster P0946
Abstract 8017
Assessment of klotho as an early but non-invasive biomarker for septic acute kidney injury
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Xiaoyan WANG
Poster P0947
Abstract 8030
Carbapenem resistant Gram-negative rods bloodstream infections in oncologic patients from Bogotá, Colombia, clinical characteristics and outcomes
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Maria Jose LOPEZ
Poster P0948
Abstract 8045
Spatio-temporal evolution and mechanism of drug resistance and pathogenicity for carbapenem-resistant Klebsiella pneumoniae causing bloodstream infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Shen PING
Poster P0949
Abstract 8062
Clinical impact of a rapid diagnostic bundle for the management of patients with suspected sepsis of urinary origin
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ana ÁLVAREZ-URÍA
Poster P0950
Abstract 8074
Vertebral osteomyelitis in patients with infective endocarditis: incidence, risk factors and mortality
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sabrine DOUIYEB
Poster P0951
Abstract 8076
Staphylococcus aureus bacteraemia in the aged population in Australia: A retrospective cohort study reviewing outcomes and antimicrobial resistance
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Bryan TAN
Poster P0952
Abstract 8154
Optimising echocardiogram requests: validating the VIRSTA score in a Spanish cohort of Staphylococcus aureus bacteremia
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Daniela MALANO BARLETTA
Poster P0953
Abstract 8180
The risk of subsequent cardiovascular events among sepsis survivors in Sweden: a population-based matched cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Hanna WETTERBERG
Poster P0954
Abstract 8256
Impact of the COVID-19 pandemic on healthcare-associated bloodstream infections, between April 2017 to March 2023, in England
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sobia WASTI
Poster P0955
Abstract 8331
Characteristics of infective endocarditis due to non-HACEK gram-negative bacilli in adults.
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Özlem Kurt AZAP
Poster P0956
Abstract 8332
Epidemiology, risk factors and outcomes of bloodstream infections in critically-ill burn patients: an observational study from a burn referral center in Italy
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Niccolò RICCARDI
Poster P0957
Abstract 8401
Invasive group A streptococcal infection: incidence, clinical presentation and outcomes, Catalonia 2022-2023
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Marta MARTORELL
Poster P0958
Abstract 8403
Impact of delayed active targeted antibiotic treatment in bloodstream infections: a prospective, multicentre cohort (PROBAC).
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sandra DE LA ROSA RIESTRA
Poster P0959
Abstract 8444
Prospective evaluation of the SeptiCyte® Rapid assay for the identification of systemic infectious diseases in patients with suspected sepsis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sören Leif BECKER
Poster P0960
Abstract 8446
Fosfomicyn in urinary tract infections caused by multiresistant Escherichia coli bacteraemia: post hoc analysis applying DOOR methodology
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sandra DE LA ROSA RIESTRA
Poster P0961
Abstract 8455
Next-generation sequencing in comparison to blood culture based diagnostic
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Marius HEGNER
Poster P0962
Abstract 8470
Evaluation of the Film Array BCID2 system for the detection of pathogenic bacteria in bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Konstantinia KONTOPOULOU
Poster P0963
Abstract 8494
Clinical experience with ceftaroline fosamil in infective endocarditis due to methicillin-resistant Staphylococcus aureus
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Kaylee CANIFF
Poster P0964
Abstract 8577
Impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections: a retrospective multicentre cohort study
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Linda BUSSINI
Poster P0965
Abstract 8578
Demographic data and follow-up of patients with infectious endocarditis (IE) by Enterococcus faecalis
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Rosa María BENITEZ DIAZ
Poster P0966
Abstract 8634
Usefulness of the FilmArray blood culture identification two panel for pathogen detection in Limpopo South Africa
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ivy RUKASHA
Poster P0967
Abstract 8647
Linezolid or daptomycin as alternative to vancomycin for the treatment of vancomycin-susceptible Enterococcus faecium bloodstream infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Anne-Sophie BRUNEL
Poster P0968
Abstract 8656
Clinico-microbiological analysis and molecular typing of Stenotrophomonas maltophilia isolated from bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Sushree SARATHI
Poster P0969
Abstract 8710
Increased incidence of methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections in England
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Zahin AMIN-CHOWDHURY
Poster P0970
Abstract 8813
Klebsiella spp. bacteraemia surveillance-collaborative strategies required to reduce the risk of infection
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Nabeela MUGHAL
Poster P0971
Abstract 8835
Emergence of multidrug-resistant bloodstream infections in cancer patients: insights from a Bangladesh oncology center
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Ruksana RAIHAN
Poster P0972
Abstract 8904
Early adequate antimicrobial regimen allows short-course treatment in Pseudomonas aeruginosa bloodstream infections
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Marco MERLI
Poster P0973
Abstract 8929
Dilution of positive blood culture samples does not impact the microscopic examination
28/04 12:00
2b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host bio-markers, treatment and outcome prediction)
Giulia GATTI
Poster P0974
Abstract 228
Epidemiological analysis of Legionella pneumonia in Japan: a national inpatient database study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Satoshi KUTSUNA
Poster P0975
Abstract 230
Analysis of the effectiveness of combination antimicrobial therapy for Legionella pmeumonia: a nationwide inpatient database study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Satoshi KUTSUNA
Poster P0976
Abstract 234
Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among healthy children and their cohabiting relatives: a cross-sectional study from LMIC
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Tushar SHAW
Poster P0978
Abstract 1255
Factors associated with antibiotic prescription for lower respiratory tract infections in nursing homes in Switzerland
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Virginie PRENDKI
Poster P0979
Abstract 1347
Nonalcoholic fatty liver disease increases the risk of lung abscess: insights from a nationwide cohort study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Jungok KIM
Poster P0980
Abstract 1375
Quality of life associated with pneumococcal disease: a targeted literature review
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Min HUANG
Poster P0981
Abstract 1880
Effects of adjunctive corticosteroid treatment for adults with severe Mycoplasma pneumoniae pneumonia
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Karl HAGMAN
Poster P0982
Abstract 2045
Current epidemiology of invasive bacterial diseases in Japan: investigation from the national surveillance data
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Hideharu HAGIYA
Poster P0983
Abstract 2603
Invasive pneumococcal disease in children: a post COVID-19 increase
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Rebecca MCHUGH
Poster P0984
Abstract 2717
Contribution of higher valency pneumococcal conjugate vaccines to reduce the burden of community-acquired pneumonia in adults by age group in Spain, 2016-2022: the CAPA study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Rosario MENENDEZ VILLANUEVA
Poster P0985
Abstract 2851
Idiopathic pulmonary fibrosis (IPF) exacerbations, microbiology and management
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Louise KELLY
Poster P0986
Abstract 2891
Distribution of pneumococcal vaccines serotypes in adults with community-acquired pneumonia and chronic conditions in Spain, 2016-2022: the CAPA study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Rosario MENENDEZ VILLANUEVA
Poster P0987
Abstract 3030
Complicated community-acquired pneumonia before and after COVID-19 pandemic: the experience of a paediatric Italian tertiary care hospital
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Maia DE LUCA
Poster P0988
Abstract 3219
Effect of exercise training on physical activity, functional ability, and body composition in community-acquired pneumonia
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Camilla RYRSØ
Poster P0989
Abstract 3554
Gram-positive bacteria: the leading cause of pleural infections
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Ghariani ASMA
Poster P0990
Abstract 3701
Malignant otitis externa: microbiology and implications on antimicrobial treatment
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Christen ARENA
Poster P0991
Abstract 3792
Optimising ceftolozane/tazobactam therapy for respiratory-related infections caused by multidrug-resistant Gram-negative pathogens: insights from SPECTRA
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Emre YUCEL
Poster P0992
Abstract 4168
Non-invasive pneumococcal disease in Portugal: serotype distribution and comparison with invasive pneumococcal disease (2019-2022)
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Catarina SILVA-COSTA
Poster P0993
Abstract 4202
Dominance of serotypes 3 and 8 in adult invasive pneumococcal disease and the importance of non-PCV13 serotypes in antimicrobial resistance (Portugal 2019-2023)
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Catarina SILVA-COSTA
Poster P0994
Abstract 4258
Community acquired pneumococcal pneumonia in adults: diagnostic sensitivity of pneumococcal urinary antigen and serotypes.
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Patricia GARCÍA GARCÍA
Poster P0995
Abstract 4540
A 15-year review of children with pertussis shows the need for a multidisciplinary strategy to prevent this infection in Slovenia also
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Anna GORBUNOVA
Poster P0996
Abstract 4636
Contact with school-aged children is a major risk factor for pneumococcal colonisation in older adults
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Anne WYLLIE
Poster P0997
Abstract 4788
Patient discharge pathways for primary hospitalisation and readmission cases due to all-cause community-acquired pneumonia (CAP) in Canada
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Jelena VOJICIC
Poster P0998
Abstract 5712
Video-assisted thoracoscopic surgery (VATS) for pleural empyema: evaluation of bacterial aetiology and prescribing practices at a thoracic surgery tertiary centre, London, UK
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Amy CARROLL
Poster P0999
Abstract 6026
The decrease in pneumococcal carriage in Belgian children attending daycare centres contrasts to the stable carriage of other pathogens two years after the COVID-19 containment measures
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Esra EKINCI
Poster P1000
Abstract 6104
Phenotypic and genotypic characterisation of Pseudomonas aeruginosa strains coming from non-cystic fibrosis bronchiectasis patients
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Irene CADENAS JIMÉNEZ
Poster P1001
Abstract 6229
Fixed-dose combination of cephalexin extended release and clavulanate potassium in subset of patients with upper respiratory tract infection: a phase IV study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Dipak PATIL
Poster P1002
Abstract 6293
Treatment with elexacaftor/tezacaftor/ivacaftor leads to an increase in culture negativity of P. aeruginosa in cystic fibrosis sputum samples
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Maria PALS BENDIXEN
Poster P1003
Abstract 6479
Aetiology of community-acquired pneumonia (CAP): impact of molecular techniques
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Concepción CAMPILLO MARTÍN
Poster P1004
Abstract 6595
Enterobactin siderophore from Klebsiella pneumoniae manipulates inflammatory response during lung infection
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Julien VERLAGUET
Poster P1005
Abstract 6625
Differential diagnoses of community-acquired pneumonia in the emergency department
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Susanne SIMON
Poster P1006
Abstract 6806
Sequencing-based surveillance of circulating Bordetella pertussis strains in the Netherlands from 2015-2023
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Rob MARIMAN
Poster P1007
Abstract 7049
Ceftobiprole treatment for pneumonia in internal medicine wards: a real-world single-centre study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Silvia CORCIONE
Poster P1008
Abstract 7201
Estimating the health and economic burden of pneumococcal diseases attributable to V116 vs PCV20 serotypes among adults in france
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Peter MUELLER
Poster P1009
Abstract 7222
Molecular characterisation of non-invasive Haemophilus influenzae disease in Portugal: 2015-2022
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Maria Paula BAJANCA-LAVADO
Poster P1010
Abstract 7550
Population structure, dynamics and spatial-temporal evolution of Bordetella pertussis producing pertussis in Spain, 1986-2020
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Alba MIR
Poster P1011
Abstract 7572
Assessing the impact of COVID-19 pandemic on invasive pneumococcal disease in Catalonia (2017-2022)
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Sonia BRONER
Poster P1012
Abstract 7627
Genomic characterisation and vaccine reactivity prediction to 4CMenB of Neisseria meningitidis collected from respiratory samples in Spain
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Josep ROCA-GRANDE
Poster P1013
Abstract 7752
Adherence to antimicrobial guidelines for the treatment of Legionnaires' disease in Switzerland: data from the SwissLEGIO multicentre study
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Werner C. ALBRICH
Poster P1014
Abstract 7921
Discerning regional Legionella test positivity rates: a study of increasing Legionnaires' disease trends in Denmark, 2014 – 2021
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Kelsie CASSELL
Poster P1015
Abstract 8152
Persistent colonisation of Haemophilus influenzae in patients with non-cystic fibrosis bronchiectasis
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Paula CAMPS-MASSA
Poster P1016
Abstract 8630
Peak incidence of atypical pneumonia in the paediatric population caused by Mycoplasma pneumoniae at Consorci Sanitari de Terrassa: accumulation of cases in November 2023
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Luis BRUSCA
Poster P1017
Abstract 8763
Retrospective analysis of hospitalised pneumonia cases in Sicily from 2009 to 2021
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Domenico MARRALI
Poster P1018
Abstract 8825
Pseudomonas aeruginosa and Aspergillus fumigatus infections in COPD patients at Bordeaux teaching Hospital
28/04 12:00
2c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Sebastien IMBERT
Poster P1019
Abstract 49
Whole genome sequencing of phenotypically detected quinolone and tetracycline co-resistant Campylobacter jejuni and Campylobacter coli and emergence of multidrug-resistant C. coli in the University Hospital of Split, Croatia
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Anita NOVAK
Poster P1020
Abstract 249
Monitoring intestinal carriage in preterm newborns reveals intense acquisition of carbapenemase-producing Klebsiella pneumoniae co-harboring OXA-48, VIM, KPC, and NDM in a Moroccan neonatal intensive care unit
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Moussa BENBOUBKER
Poster P1021
Abstract 309
Enteroaggregative Escherichia coli (EAEC) isolated from under-five children with diarrhoea in Ethiopia: genomic and phylogenetic analysis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Tizazu ZELELIE
Poster P1022
Abstract 486
Prevalence and characterisation of ESBL-producing Escherichia coli in healthy pregnant women and hospital environments in Benin: an approach based on Tricycle
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Kevin Mael Patrick Zinsou SINTONDJI
Poster P1023
Abstract 687
Evidence gaps in the burden of complicated urinary tract infection (cUTI)
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Kristi KUPER
Poster P1024
Abstract 818
Increase in the incidence of Campylobacter spp. isolates in stool cultures at a tertiary hospital
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Victoria CASTAÑO
Poster P1025
Abstract 961
Temporal evolution of isolates and antibiotic susceptibility patterns in pediatric urine cultures from a university hospital over 13 years
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Felipe PÉREZ-GARCÍA
Poster P1026
Abstract 1269
Estrogen alters the virulence of uropathogenic E. coli
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Carolina PETTERSSON
Poster P1027
Abstract 1273
A novel functional food protein alleviates diarrheal symptoms in experimental cholera infection
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Marcus PETERSSON
Poster P1028
Abstract 1332
Unraveling the tapestry: tracking sexually transmitted infections (STIs) in HIV pre-exposure prophylaxis (HIV PrEP) users, a journey from 2019 to 2023
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Jose Ignacio MATEO GONZALEZ
Poster P1029
Abstract 1364
Clinical characteristics and antimicrobial resistance of uncomplicated acute pyelonephritis caused by Escherichia coli and Klebsiella pneumoniae
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Keon Young LEE
Poster P1030
Abstract 1411
What is chronic urinary tract infection: a systematic review
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Janni HJELMAGER
Poster P1031
Abstract 1532
Risk factors of infection cause by multidrug-resistant pathogens in kidney transplant pyelonephritis patients
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Sergey ANDREEV
Poster P1032
Abstract 1578
Streptococcus agalactiae in pregnant women: prevalence, serotypes and in vitro antimicrobial resistance
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Stavroula BAKA
Poster P1033
Abstract 1612
The relationship between antimicrobial consumption and resistance may be saturated in high antimicrobial consumption populations: implications for Doxy PEP studies
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Sheeba MANOHARAN-BASIL
Poster P1034
Abstract 1701
Antimicrobial use and prescription for urinary tract infections by care physicians in Japanese general nursing homes
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Kumiko SUZUKI
Poster P1035
Abstract 1753
Surveillance of typhoid fever following a typhoid conjugate vaccine trial in Nepal
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Suchita SHRESTHA
Poster P1036
Abstract 1766
Increase in group A Streptococcus associated with vulvovaginitis in Spain (2011-2023)
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Eric LOPEZ
Poster P1037
Abstract 1830
Patient characteristics associated with fluoroquinolone-resistant uropathogens: pooled results from two clinical trials of gepotidacin for the treatment of uncomplicated urinary tract infection
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Amanda SHEETS
Poster P1038
Abstract 1857
Antibiotic treatment patterns in patients with evidence of oral antibiotic treatment failure (TF) for uncomplicated urinary tract infection (uUTI) in the United States
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Madison PREIB
Poster P1039
Abstract 1876
Neisseria meningitidis prevalence in male urine by nucleic acid amplification testing in Northeast Ohio
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Hannah WANG
Poster P1040
Abstract 1927
Clinical characteristics and risk factors for pyogenic liver abscess caused by multidrug-resistant organisms: a ten-year retrospective study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Min HAO
Poster P1041
Abstract 2008
Treatment of urinary tract infections in general practice and risk of recurrent urinary tract infection
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Katrine Hartung HANSEN
Poster P1042
Abstract 2142
Asymptomatic bacteriuria and urological surgery: risk factor or not? Results from the national and multicentre TOCUS database
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Maxime VALLÉE
Poster P1043
Abstract 2412
Risk factors and molecular epidemiology of intestinal colonisation by carbapenem-resistant Gram-negative bacteria in patients with haematological diseases: a multicentre case-controlled study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Huangdu HU
Poster P1044
Abstract 2428
Does the duration of antibiotic treatment of preoperative asymptomatic bacteriuria in urological surgery influence the occurrence of postoperative infectious complications? Results from the retrospective and multicentre TOCUS cohort
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Maxime VALLÉE
Poster P1045
Abstract 2473
Mycoplasma genitalium: one year experience on macrolide and fluoroquinolone resistance
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Elena NICOLINI
Poster P1046
Abstract 2515
High burden of syphilis and other sexually transmitted infections among international visitors practicing chemsex tested at Checkpoint BLN, Germany
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Lorenzo RABBI
Poster P1047
Abstract 2630
A tree-year surveillance study in Split-Dalmatia County, Croatia: a new pattern in Salmonella species infections
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Merica CAREV
Poster P1048
Abstract 2773
Syphilis patients undergoing HIV pre-exposure prophylaxis (PrEP) display a proportion of serofast comparable to that of HIV patients
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Miriam CAMPOS-RUIZ
Poster P1049
Abstract 2792
The role of Mycoplasma genitalium infection in women diagnosed with pelvic inflammatory disease and/or tubo ovarial abcess
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Nikki ADRIAENS
Poster P1050
Abstract 2857
Performance evaluation of an expanded PCR panel for uropathogen identification in urinary tract infections compared to standard urine culture
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Jelena FEENSTRA
Poster P1051
Abstract 2936
Prognostic model for mortality assessment in patients with cirrhotic liver and infected ascites
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Silvia WÜRSTLE
Poster P1052
Abstract 2940
Genetic relationship and mechanisms contributing to reduced gepotidacin susceptibility in isolates from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Rodrigo E. MENDES
Poster P1053
Abstract 3005
Epidemiology of self-presenting users to a sexually transmitted infections clinic in Milan, Italy
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Lorenzo BIASIOLI
Poster P1054
Abstract 3033
Molecular characterisation of fosfomycin-resistant uropathogens isolated from patients attended at 34 primary care units (PCUs)
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Silvia FIGUEIREDO COSTA
Poster P1055
Abstract 3045
Mycoplasma genitalium: from neglected STI to worrying STD
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Mikel URRUTIKOETXEA-GUTIERREZ
Poster P1056
Abstract 3054
Prevalence of antimicrobial-resistant Mycoplasma genitalium among men who have sex with men: a systematic review and meta-analysis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Michael SCIAUDONE
Poster P1057
Abstract 3226
Changing trends of microbiological characteristics and antimicrobial susceptibility of Klebsiella pneumoniae in community-acquired liver abscess of 2014-2015 and 2020-2021 in South Korea
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Keon Young LEE
Poster P1058
Abstract 3253
Infectious causes of stillbirths: a descriptive aetiological study of 581 Ugandan women
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Lauren HOOKHAM
Poster P1059
Abstract 3516
Prevalence, antibiotic resistance, virulence potential, and Enterobacterial repetitive intergenic consensus (ERIC)-PCR profiling of clinical and environmental Vibrio cholerae strains isolated in Qom, Iran
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Saeed SHAMS
Poster P1060
Abstract 3616
No sustained decrease in chlamydia and gonorrhoea testing and notification trends during the COVID-19 pandemic, Finland, 2015-2022
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Wioleta KITOWSKA
Poster P1061
Abstract 3679
Aeromonas-associated gastroenteritis in northern Israel: incidence and clinical-epidemiological characteristics
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Dana SAGAS
Poster P1062
Abstract 3835
Comparison of serologic responses of early syphilis to treatment with single-dose ceftriaxone plus doxycycline versus single-dose benzathine penicillin G plus doxycycline among people with HIV: interim analysis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Tzong Yow WU
Poster P1063
Abstract 3842
Challenges in predicting ESBL intrabdominal infection in critically ill patients in Europe: a post-hoc analysis of the AbSeS cohort study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Niccolo BUETTI
Poster P1064
Abstract 4043
Efficacy of linezolid in enterococcal urinary tract infection: a multicentre study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Kevin BOUILLER
Poster P1065
Abstract 4084
Chlamydia trachomatis and lymphogranuloma venereum in HIV pre-exposure prophylaxis era: an inquiry into potential alterations
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Patricio FAVIER
Poster P1066
Abstract 4306
Genital mycoplasma detection among pregnant women admitted to a university hospital with adverse pregnancy outcomes
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Cristina VEINTIMILLA
Poster P1067
Abstract 4367
Clinical impact of antibiotic treatment of patients with acute pyelonephritis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Joan ROIG SANCHIS
Poster P1068
Abstract 4433
Impact of 2020 EUCAST criteria on antibiotic prescription for urinary tract infections due to Pseudomonas aeruginosa: a retrospective observational study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Paolo MILANI
Poster P1069
Abstract 4606
Unmasking colistin therapy for urinary tract infections due to multidrug-resistant bacteria: experience at a tertiary academic medical centre
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Atheer ALDAIREM
Poster P1070
Abstract 4649
Factors associated with a severe form of acute obstructive pyelonephritis: preliminary results from the RAMP multicentre cohort
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Coline RICOLLEAU
Poster P1071
Abstract 4718
Assessing the within-patient and within-household diversity of V. cholerae in a cholera endemic area
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Aline CUÉNOD
Poster P1072
Abstract 4942
Pyogenic liver abscess in elderly patients: predictive factors of unfavorable outcome
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Ioannis BOURDALIS
Poster P1073
Abstract 5210
Evolution of antimicrobial resistance in urinary tract infections, a nine-year analysis of a Mexican referral centre
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Aaron MOLINA JAIMES
Poster P1074
Abstract 5394
Probiotic-based decolonisation of multidrug-resistant Klebsiella pneumoniae from the gut of diabetic mice
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Md Nannur RAHMAN
Poster P1075
Abstract 5441
Prevalence estimation of Tropheryma whipplei in diarrheal stools and duodenal biopsy tissues of Koreans
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Mi-Kyung LEE
Poster P1076
Abstract 5457
Epidemiology, antimicrobial resistance and outcomes of intra-abdominal infections in China (PRIME): protocol of a prospective observational study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Sai TIAN
Poster P1077
Abstract 5537
Impact of border closures on the molecular epidemiology of Neisseria gonorrhoeae during the COVID-19 pandemic in Western Australia
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Christopher MULLALLY
Poster P1078
Abstract 5704
Efficacy and safety of antibiotics on asymptomatic bacteriuria in kidney transplant recipients: a systematic review and meta-analysis of randomised controlled trials
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Lokman Hekim TANRIVERDI
Poster P1079
Abstract 5764
Epidemiology, characteristics and clinical predictors of Chlamydia trachomatis LGV and non-LGV serovars among men who have sex with men
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Alessia SIRIBELLI
Poster P1080
Abstract 5851
Efficacy and safety of cefepime/enmetazobactam compared to novel antibiotics in patients with cUTI/AP: a Bayesian network meta analysis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Verónica RICO CABALLERO
Poster P1081
Abstract 6043
A Bayesian Network Meta Analysis of the efficacy for cefepime/enmetazobactam compared to established antibiotics in patients with complicated urinary tract infections including acute pyelonephritis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Florian WAGENLEHNER
Poster P1082
Abstract 6118
Urine sampling rates of general practice patients in England, 2015-2022
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Laura CIACCIO
Poster P1083
Abstract 6144
Evaluation of the vivalytic one analyser for detecting uropathogenic bacteria and antimicrobial resistances in urines samples of urological patients
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Jessica HARTMANN
Poster P1084
Abstract 6185
Gonorrhea on the rise in Denmark: distinct clones are driving the dramatic increase in heterosexual communities
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Thomas ROLAND PEDERSEN
Poster P1085
Abstract 6339
STIs in a Portuguese university population: why testing is crucial
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Joana OLIVEIRA
Poster P1086
Abstract 6678
Arcobacter spp: an emerging enteropathogen; clinical profile of patients, antibiotic susceptibility and genotypic characterisation in a referral microbiology laboratory in Spain
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Lidia GOTERRIS BONET
Poster P1087
Abstract 6753
Investigating transmission patterns during an outbreak of necrotizing enterocolitis related to Clostridium butyricum using whole genome sequencing
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Youssra MIKRAT
Poster P1088
Abstract 6763
Thomasclavelia ramosa is a specific signature of hepatocellular carcinoma among patients with alcohol-related liver disease: a culturomics and metagenomics case-control study
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Reham MAGDY WASFY
Poster P1089
Abstract 6964
Revolutionising UTI diagnosis: lateral flow test demonstrates impressive performance across diverse patient profiles
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Emily ADAMS
Poster P1090
Abstract 7300
Three-arm comparison of fidaxomicin monotherapy, fidaxomicin plus bezlotoxumab, and vancomycin plus bezlotoxumab on 90-day C. difficile clinical success
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Madison SALAM
Poster P1091
Abstract 7343
Co-infection rate of sexually transmitted infections from a United States cohort
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Barbara VAN DER POL
Poster P1092
Abstract 7350
Five years of spontaneous intra-abdominal infections: what are you doing here, Pseudomonas?
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Maria AMOROTO-BENGOETXEA
Poster P1093
Abstract 7456
Vonoprazan-amoxicillin dual therapy vs bismuth-containing quadrable therapy for Helicobacter pylori eradication: a systematic review and meta-analysis of randomised controlled trials
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Omar ELKOUMI
Poster P1094
Abstract 7478
Central and eastern Europe needs more attention and support for better management of sexually transmitted infections
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Merve MERT VAHABI
Poster P1095
Abstract 7655
ChiA: a major player in the virulence of Crohn's disease-associated adherent and invasive Escherichia coli (AIEC)
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Margot FARGEAS
Poster P1096
Abstract 7688
The 30-day in-hospital outcomes of patients with liver cirrhosis admitted with spontaneous bacterial peritonitis: a retrospective cohort study in a tertiary government hospital in the Philippines
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Jose Orlando NICOLAS
Poster P1097
Abstract 7895
Evaluation of Ureaplasma spp. resistance status at a single-centre: are minocycline, josamycin and pristinamycin the new “sexys”?
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Ali Gökhan AKÇAY
Poster P1098
Abstract 7989
Genomic insights into Klebsiella pneumoniae strains responsible for urinary tract infections in Indian isolates
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Akanksha HEGDE
Poster P1099
Abstract 8113
Chlamydia trachomatis coinfection with multiple pathogens causing sexually transmitted infections: time course and epidemiological features
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Elisa GONZALEZ DE HERRERO MARTINEZ
Poster P1100
Abstract 8365
The identification of inappropriate empiric antimicrobial therapy for urinary tract infection following an emergency department discharge: a computerised approach
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Greet VAN DE SIJPE
Poster P1101
Abstract 8419
Lymphogranuloma venereum: an increasingly common anorectal infection among men who have sex, clinical and epidemiological characteristics
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Yolanda GARCÍA COLLADO
Poster P1102
Abstract 8649
Non-typhi Salmonella urinary tract infection: review in a tertiary hospital
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Iris Sharon PÉREZ RAMOS
Poster P1103
Abstract 8746
Revolutionising UTI treatment: machine learning models for predicting empirical antibiotic treatment failure and enhancing patient outcomes in the era of antimicrobial resistance
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Bhavika SHARMA
Poster P1104
Abstract 8821
Evaluation of new and old drugs for the management of complicated urinary tract infection
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Nawal AL SHIZAWI
Poster P1105
Abstract 8856
Isolation of Haemophilus parainfluenzae in urethral exudates from men with acute urethritis
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Konstantinia KONTOPOULOU
Poster P1106
Abstract 8922
Cost and burden of recurrent urinary tract infection in patients with antibiotic treatment failure
28/04 12:00
2d. Community-acquired abdominal/gastrointestinal, urinary tract & genital infections (incl epidemiology, clinical, imaging, treatment & prevention)
Madison PREIB
Poster P1107
Abstract 180
Assessing the role of healthcare-seeking behaviours in the development of small-area health inequalities in EHR data using complex systems science methods
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Brittany MORGAN BUSTAMANTE
Poster P1108
Abstract 192
Multicentre evaluation of clinical outcomes in patients with obesity using different ceftriaxone dosing strategies for serious infections
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Jack MCHUGH
Poster P1109
Abstract 453
High risk of treatment failure in patients with vertebral osteomyelitis and an underlying malignancy
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Dorothee JOCHIMSEN
Poster P1110
Abstract 581
Clinical and microbiological characteristics of purulent bacterial pericarditis in adults: experience in a tertiary care hospital in Thailand
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Rujipas SIRIJATUPHAT
Poster P1111
Abstract 796
Psychiatric aspect of diabetic foot ulcers
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Oguzhan ACET
Poster P1112
Abstract 1314
Infectious complications of the orthopedic injuries in earthquake survivors
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Imran HASANOGLU
Poster P1113
Abstract 2154
Correlation of pathology, microbiology and virology of non-neoplastic vitrectomy specimens: a single-centre retrospective study
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Kristina SCHMAUDER
Poster P1114
Abstract 2399
Virulence factors and genetic variability in Staphylococcus aureus colonising the skin microbiota of adult patients with severe atopic dermatitis
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Francesca SIVORI
Poster P1115
Abstract 3126
Epidemiology and outcome trends for adult native joint septic arthritis in South Auckland, New Zealand
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Stephen MCBRIDE
Poster P1116
Abstract 3138
Clinical characteristics and factors associated with treatment failure in non-Mycobacterial pyogenic vertebral osteomyelitis
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Runza Buznego PAULA
Poster P1117
Abstract 3445
Regional assessment of paediatric bone and joint infection management in tertiary centres in North-West London, UK
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Rebecca FABER
Poster P1118
Abstract 3745
Pediatric osteomyelitis: what are the predictors of sequelae?
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Francesca PIGNATELLI
Poster P1119
Abstract 3847
Molecular epidemiology, antibiotic susceptibility and pathogenicity of Staphylococcus aureus from wound and soft tissue infection
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Huang HSIN-NI
Poster P1120
Abstract 3893
Safety and efficacy of tedizolid phosphate versus comparators in patients <12 years of age with acute bacterial skin and skin structure infections (ABSSSI)
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Pamela SEARS
Poster P1121
Abstract 4215
Assessment of outcomes and risk factors for Pseudomonas aeruginosa necrotizing soft tissue infections
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Anthony GERLACH
Poster P1122
Abstract 4259
Changes in the bacterial epidemiology of paediatric mastoiditis over 10 years
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Vichita OK
Poster P1123
Abstract 4292
Cohort cutaneous diphteriae in France
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Helene MASCITTI
Poster P1124
Abstract 4303
The Atlantic route, an investigation of infections by Shewanella spp. in individuals who arrive irregularly by sea to the Canary Islands
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Laudy RIVERO RODRÍGUEZ
Poster P1125
Abstract 4498
Is there an increasing number of infections by Group-A-Streptococcus in Tenerife, Spain?
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Berta PINO CALM
Poster P1126
Abstract 4571
Thrice-weekly teicoplanin as outpatient parenteral antibiotic therapy (OPAT): experience at Infectious Disease Unit of Lecco Hospital (Italy)
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Valentina MORENA
Poster P1127
Abstract 5216
Characteristics of resurgent invasive group A streptococcal infection post-pandemic in Toronto, Canada
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Halima DABAJA YOUNIS
Poster P1128
Abstract 5220
Associations between types of skin and soft tissue infections and genotypes of MRSA isolated from these infections
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Hiroshi KANEKO
Poster P1129
Abstract 5472
Clinical characteristics and management of vertebral osteomyelitis with known versus unknown aetiology: a single-centre retrospective study between 2017-2023
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Chiara MACI
Poster P1130
Abstract 6025
Staphylococcus aureus the predominant pathogen in diabetes-related foot infections: a subtropical perspective
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Kate MORTON
Poster P1131
Abstract 6645
In vitro evaluation of delafloxacin against Staphylococcus aureus in bone and joint infections
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Céline DUPIEUX-CHABERT
Poster P1132
Abstract 6701
The changing face of septic bursitis
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Michal DEKEL
Poster P1133
Abstract 7097
Demographic characteristics, clinical presentation and outcome of Gram-negative pyogenic vertebral osteomyelitis
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Susan OLAF LINDVIG
Poster P1134
Abstract 7419
A year observation of hospital management of Native Vertebral Osteomyelitis/Discitis in Northumbria, United Kingdom
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Maria CALDERON CAHUA
Poster P1135
Abstract 7658
Microbial analysis and fungi–bacteria correlation in chronic infectious wound
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Qingqing WANG
Poster P1136
Abstract 7695
Fixed-dose combination of cephalexin extended release and clavulanate potassium in subset of patients with uncomplicated skin and soft tissue infection: a Phase 4 study
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Dipak PATIL
Poster P1138
Abstract 7960
Burden and temporal trend of cellulitis in the United Kingdom from 1990-2019
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Michelle LUIS SIERRA
Poster P1139
Abstract 8736
Vertebral osteomyelitis in adults: clinical, microbiology and outcome in 117 patients hospitalised in the province of Modena, Italy (2017-2022)
28/04 12:00
2e. Community acquired skin, soft tissue, bone & joint infections ((incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)
Mariachiara PELLEGRINO
Poster P1140
Abstract 156
Fluoroquinolone treatment failure higher in patients with BMI ≥ 30
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Brandon HAWKINS
Poster P1141
Abstract 339
Brain abscess complicating bacterial meningitis: a prospective cohort study from the Netherlands
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Fabian D LIECHTI
Poster P1142
Abstract 652
Functional prognosis of older adults with tetanus: a single-centre retrospective study
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Takeru YAMAMOTO
Poster P1143
Abstract 754
Impact of SARS-CoV-2 pandemic on invasive pneumococcal disease in Navarra, Spain
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Irati ARREGUI GARCIA
Poster P1144
Abstract 938
Neurofilament light chain levels as a diagnostic marker in European lyme neuroborreliosis
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Cédric HIRZEL
Poster P1145
Abstract 953
Is additional treatment needed after completion of treatment for neurosyphilis? A retrospective bayesian analysis
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Shunkichi IKEGAKI
Poster P1146
Abstract 1296
Streptococcus intermedius: a pathogen of increasing significance?
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Eliza GIL
Poster P1147
Abstract 1687
Characteristics and prognostic factors of bacterial meningitis in the intensive care unit: a prospective nationwide cohort study
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Nora CHEKROUNI
Poster P1148
Abstract 2151
Mind the switch: the use of oral antibiotics in deep-seated central nervous system (CNS) infections
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Alexander RICHARDS
Poster P1149
Abstract 2215
Conservative vs neurosurgical treatment of brain abscess
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Emilie ERIKSEN
Poster P1150
Abstract 2652
Clinical microbiology and management of brain abscess: a five-year retrospective study
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Piseth SENG
Poster P1151
Abstract 3199
The trend of childhood bacterial meningitis in Vietnam
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Nam XUAN HA
Poster P1152
Abstract 3675
Infective ring-enhancing brain lesions in a tertiary hospital in Singapore: a comparison of the clinical and radiological features between pyogenic and tuberculous brain abscesses
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Edwin SNG
Poster P1153
Abstract 4347
Review of recurrent pneumococcal meningitis diagnosed in Gipuzkoa, Northern Spain
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Ayla MANZANAL PEREZ
Poster P1154
Abstract 4639
Rising incidence of community-onset paediatric brain abscess and empyema post COVID-19 pandemic: a nine-year retrospective cohort study at a tertiary neurosurgical centre in Nottingham, UK
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Francesca HEARD
Poster P1155
Abstract 5213
Nationwide population-based epidemiological study for maternal and neonatal risk factors of meningitis in infants in Taiwan
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Yu-Lung HSU
Poster P1156
Abstract 6209
Efficacy and safety of intrathecal immunoglobulin administration in adult patients with tetanus – a systematic review
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Jao Jarro GARCIA
Poster P1157
Abstract 6752
Non-compressive myelopathy complicating acute bacterial meningitis
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Evelien Hendrika Gerarda Maria DROST
Poster P1158
Abstract 7059
Clinical and molecular characteristics of bacterial meningitis in children aged one to 59 months in Southern Vietnam (2012-2021): insights from hospital-based sentinel surveillance
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Hieu Cong TRUONG
Poster P1159
Abstract 8077
Phylogenetic characterisation and analysis of virulence genes in invasive Listeria monocytogenes isolates
28/04 12:00
2f. Community acquired nervous system and other multi-system bacterial infections (incl epidemiology, clinical, imaging, treatment & prevention)
Petra KMETIC
Poster P1160
Abstract 95
Listeria monocytogenes adenylosuccinate synthetase PurA is required for entry into eukaryotic cells
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Ângela ALVES
Poster P1161
Abstract 272
Carbapenem-resistant Pseudomonas aeruginosa from patients, hospital environment, and water in Jakarta, Indonesia: distribution of antimicrobial resistance genes across domains
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Selvi Nafisa SHAHAB
Poster P1162
Abstract 948
Potential pathogenicity of Enterococcus collected from surfaces of a veterinary biological isolation and containment unit
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Catarina GERALDES
Poster P1163
Abstract 1098
Comprehensive meta-analysis of the global epidemiology of critically resistant Pseudomonas aeruginosa in livestock, wild and domestic animals
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Sirine MEJRI
Poster P1164
Abstract 1110
Unravelling signals underlying Listeria monocytogenes cadC regulation
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Diana MEIRELES
Poster P1165
Abstract 1118
Assessing the impact of erythromycin residues in food on the development of Streptococcus pneumoniae resistance: an in vivo investigation using wax moth larvae
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Sheeba MANOHARAN-BASIL
Poster P1166
Abstract 1218
Burden of Lyme disease (BOLD) study: manifestations of clinically diagnosed Lyme borreliosis in six European countries
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Kate HALSBY
Poster P1167
Abstract 1234
Frequency of occurrence of zoonotic tick-borne pathogens in ticks: Latvian 2023 year experience
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Beatrise ORLOVA
Poster P1168
Abstract 1235
A One Health approach to the ocular surface microbiome of dogs and their owners
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Suzanne Bianca CLOUGHER
Poster P1169
Abstract 1342
Epidemiology, management, and outcomes of Listeria monocytogenes infection: a tertiary centre experience in the Unites States
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Ayesha SAMREEN
Poster P1170
Abstract 1373
Clinical and radiographic symptoms associated with spinal brucellosis
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Vigen ASOYAN
Poster P1171
Abstract 1376
Diagnosis of scrub typhus by multiplex real-time PCR targeting groEL and 47kDa genes of Orientia tsutsugamushi and comparison with indirect immunofluorescence assay
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Moonsuk BAE
Poster P1172
Abstract 1453
Leptospirosis and tularemia in a rural mountain valley in Switzerland and Italy: an underestimated burden?
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Flavio BRUNI
Poster P1173
Abstract 1516
Streptococcus agalactiae ST283 bacteraemia dropped to zero in 2021, despite ongoing isolation from seafood samples
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Timothy BARKHAM
Poster P1174
Abstract 1588
Refining the extraintestinal Escherichia coli foodborne zoonotic hypothesis: the ST117 lineage
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Andre BECKER SAIDENBERG
Poster P1175
Abstract 1622
Prevalence of tick-borne pathogens in ticks collected from humans in the province of Verona during 2018-2022
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Lucia MORO
Poster P1176
Abstract 1643
Molecular characterisation of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae among children and chicken in rural Korogwe, Tanzania
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Md Neyaz Ahmed KHAN
Poster P1177
Abstract 1657
Unmasking the deadliest bite: exploring the upsurge disparity of female mortality in dengue virus in Bangladesh in 2023
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Supta SARKER
Poster P1178
Abstract 2436
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among diarrhoea and non-diarrhoea children and farm animals in peri-rural Ghana
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Charity Wiafe AKENTEN
Poster P1179
Abstract 2690
The microbiome and resistome of golden jackals in Israel
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Katherine WINNER
Poster P1180
Abstract 2896
Leptospirosis at the modern stage in Georgia
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Tamar MEGRELISHVILI
Poster P1181
Abstract 3135
One Health antimicrobial resistance surveillance system in an urban-rural complex integrating human, animal, environment and food sectors for comprehensive analysis
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Dokyun KIM
Poster P1182
Abstract 3245
Usefulness of serology for the diagnosis of lyme borreliosis in an endemic area
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Zaira MOURE
Poster P1183
Abstract 3269
Ruminants as potential reservoir for the emerging Shiga toxin-producing Escherichia coli O113:H4?
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Denis PIERARD
Poster P1184
Abstract 3315
Predominance of the previously uncommon Clostridioides difficile PCR ribotype 695 (ST 11) in calves and cattle from Dutch dairy farms.
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Tryntsje CUPERUS
Poster P1185
Abstract 5257
Comparison of Clostridium difficile isolated from human patients and companion animals in South Korea
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Su Min KWAK
Poster P1186
Abstract 3393
Emergence of non-O1, non-O139 Vibrio cholerae infections in Hungary
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Judit HENCZKÓ
Poster P1187
Abstract 3400
β-lactam, carbapenem, and colistin-resistant Klebsiella in healthy and diseased companion animals in northern Italy
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Andrea GRASSI
Poster P1188
Abstract 3589
Salmonella Paratyphi B: Update on the two-faced Salmonella serovar from non-human sample surveillance in Germany
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Maria BOROWIAK
Poster P1189
Abstract 3875
Comparison of prevalence and antimicrobial resistance of Salmonella isolated from raw chicken and duck meat in Korea
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Yeona KIM
Poster P1191
Abstract 4522
Emergence of carbapenem-resistant Klebsiella pneumoniae in companion animals: unveiling a growing public health concern and the need for surveillance in veterinary medicine
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Laura FERNANDES
Poster P1192
Abstract 4619
Clinical course and outcomes of severe leptospirosis treated in the intensive care unit: a retrospective cohort study
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Branimir GJURASIN
Poster P1193
Abstract 4620
Human infections by Bordetella bronchiseptica in a university hospital in northern Spain
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Domingo FERNÁNDEZ VECILLA
Poster P1194
Abstract 4641
Incidence of lyme carditis and lyme carditis as a cause of permanent pacemaker implantation: a registry-based study
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Sanna AVELLAN
Poster P1195
Abstract 4701
Occurrence and characterization of Klebsiella aerogenes, Serratia marcescens, Enterobacter spp. and highly-susceptible Pseudomonas aeuroginosa and Acinetobacter baumannii from white storks foraged at two landfills in Spain
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Sandra A MARTÍNEZ ÁLVAREZ
Poster P1196
Abstract 4857
Most patients referred to a british infectious disease clinic with possible Lyme disease have a different final diagnosis: no change in the last decade
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Fatimah SULIMAN
Poster P1197
Abstract 4903
Mediterranean spotted fever: current status
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Najet MOUFFOK
Poster P1198
Abstract 5042
11-year surveillance of clinical Listeria monocytogenes samples in Slovenia
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Tom KORITNIK
Poster P1199
Abstract 5048
Whole genome sequencing reveals antibiotic resistance and genetic diversity of Listeria monocytogenes in food and related environments: implications for public health and food safety
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Adriana SILVA
Poster P1200
Abstract 5089
Detection of IgM antibodies against Orientia tsutsugamushi for diagnosis of scrub typhus meningoencephalitis
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Bishal GUPTA
Poster P1201
Abstract 5141
Surveillance of bovine tuberculosis in Taiwan, 2008-2023
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Hsin-Yi LIU
Poster P1202
Abstract 5204
The role of One Health in understanding the transmission of Clostridioides difficile
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Su-Chen LIM
Poster P1203
Abstract 5256
Carbapenem-Resistant Aeromonas hydrophila harboring blaCphA7 and ESBL-Producing E. coli isolated from seagulls in Nova Scotia, Canada
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Rym BEN SALLEM
Poster P1204
Abstract 5284
Evaluation on acute, chronic and latent brucellosis based on brucellosis-specific ELISPOT assay through a large-scale epidemiological survey in northern China
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Hongyu WANG
Poster P1205
Abstract 5300
Identifying key genes and pathways associated with acute brucellosis based on bioinformatics analysis of RNA-sequencing data
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Yuan GUANMIN
Poster P1206
Abstract 5376
Clinical comparison between human granulocytic anaplasmosis and scrub typhus in Korea
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Da Young KIM
Poster P1209
Abstract 5873
First report on pet food contamination by MR-CoNS presenting the MLS-B phenotype in South America
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Ikechukwu Benjamin MOSES
Poster P1210
Abstract 5893
High-risk strains of CTX-M extended-spectrum β-lactamase-producing Escherichia coli: antibiotic resistance in rabbit farming
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Adriana SILVA
Poster P1211
Abstract 5913
Prevalence and epidemiology of Rickettsia species in ticks of patients with tick bites in a tertiary-care hospital from Madrid, Spain
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Alfredo MALDONADO BARRUECO
Poster P1212
Abstract 5948
Gut microbiome and resistome characterisation of pigs treated with commonly used post-weaning diarrhea treatments
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Judith GUITART-MATAS
Poster P1213
Abstract 6005
In-depth characterisation and cluster analysis of Salmonella Muenchen isolates from non-human sources in Germany
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Jennie FISCHER
Poster P1214
Abstract 6089
Whole genome sequencing-based microbiological investigation of a nationwide outbreak of Salmonella enteritidis linked to steak tartare
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Tjasa CERAR KISEK
Poster P1215
Abstract 6213
Pathogenic leptospira in rats from Barcelona, Spain
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Aida PEIRO-MESTRES
Poster P1216
Abstract 6257
Occurrence and characterisation of extended-spectrum beta-lactamase-producing Escherichia coli ST69 from free-living Dalmatian pelicans (Pelecanus crispus)
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Teresa CARDONA-CABRERA
Poster P1217
Abstract 6289
Persistence of cefotaxime resistant Escherichia coli in semi-intensive broiler farms in Uganda during two consecutive production cycles
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Dickson NDOBOLI
Poster P1218
Abstract 6306
The impact of misdiagnosis and inappropriate antimicrobial administration by healthcare providers on the prognosis of Japanese spotted fever
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Ryusuke KOIKE
Poster P1219
Abstract 6437
High-priority resistant-Klebsiella pneumoniae in pets poses public health concerns: a systematic review and meta-analysis
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Ghada OCHI
Poster P1220
Abstract 6609
Impact of Borrelia spirochetes on macrophages: unveiling gene expression amid oxidative stress in Lyme disease
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Ana ARMADA
Poster P1221
Abstract 6789
A One Health approach to monitoring antimicrobial consumption in Belgium 2012-2021
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Lucy CATTEAU
Poster P1222
Abstract 6949
Safety of traditional foods – detection and characterization of E. coli from Montenegrin artisanal salami and cheese
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Beatriz DAZA
Poster P1223
Abstract 7065
Zoonotic Escherichia coli strains derived from food animals are linked to substantial E. coli bloodstream infections worldwide
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Lance PRICE
Poster P1224
Abstract 7091
Looking systematically for Chlamydia psittaci: kill four birds with one stone?
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Elke VANLAERE
Poster P1225
Abstract 7148
Characterization of virulence determinants of pathogenic Vibrio isolated from clinical samples in a hotspot in the South of Spain
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Sandra TAPIA-POZA
Poster P1226
Abstract 7162
Revolutionising microbial monitoring: assessing the efficacy of an environmental kit in preserving and neutralising across diverse industrial settings
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Simone PAGHERA
Poster P1227
Abstract 7200
Occurrence of the emerging pathogen Escherichia albertii in human clinical stools in Ghent, Belgium
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Klara DE RAUW
Poster P1228
Abstract 7312
Streptococcus halichoeri: animal isolates of an emerging zoonosis
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Geoffrey FOSTER
Poster P1229
Abstract 7488
Estimating the incidence of medically-attended Lyme borreliosis and its disseminated manifestations in Norway from 2015-2022
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Gordon BRESTRICH
Poster P1230
Abstract 7516
Melioidosis in eastern Thailand: unraveling patient profiles, outcomes, and predictors of ICU admission
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Natthaphol CHAICHANASAK
Poster P1231
Abstract 7543
Using genotyping to investigate transmission of Chlamydia psittaci between birds and humans
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Øystein ANGEN
Poster P1232
Abstract 7685
Coxiella burnetii in ruminants from a Caribbean area, Colombia: a potential risk for public health
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Veronica CONTRERAS
Poster P1233
Abstract 7722
Machine learning for forecasting daily Vibrio vulnificus cases in the US coasts
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Jordi Manuel CABRERA GUMBAU
Poster P1234
Abstract 7748
Occurrence of Salmonella enterica in sewage from public toilets in Nigeria, and antimicrobial resistance and genetic relatedness of sewage isolates with strains associated with human infections in Africa
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Abdurrahman Hassan JIBRIL
Poster P1235
Abstract 7813
Characteristics of 104 patients with confirmed human granulocytic anaplasmosis
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Tereza ROJKO
Poster P1236
Abstract 7891
Genetic diversity of Bartonella rpoB haplotypes in domestic cats from Chile
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Patrick BUTAYE
Poster P1237
Abstract 8204
First report of OXA-48 and OXA-244-producing Enterobacterales in captive wildlife and in sedentary/migrants Birds (Cinclus cinclus) and White Wagtail (Motacilla cinerea) in Algeria
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Imene MEHIDI
Poster P1238
Abstract 8279
Genomic context of piperacillin-tazobactam resistance in clinical isolates from companion animals in an Italian University Veterinary Hospital
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Mario PULIDO-VADILLO
Poster P1239
Abstract 8381
Revolutionising brucellosis defense: a combined recombinant subunit vaccine (CRSV) for enhanced safety and immunogenicity in pursuit of One Health excellence
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Qaiser AKRAM
Poster P1240
Abstract 8404
Comparative analysis of single gene PCRs Vs STIC in scrub typhus diagnostics
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Kamlesh BISHT
Poster P1241
Abstract 8676
Typing of clinical and environmental Legionella strains by Fourier transform infrared spectroscopy (FT-IR)
28/04 12:00
2g. Zoonotic bacterial infections (incl foodborne, waterborne and vector-borne pathogens, veterinary microbiology and One Health aspects, excl AMR)
Stefan ZIMMERMANN
Poster P1242
Abstract 1050
Genomic insights into local scale evolution of ocular Chlamydia trachomatis strains within and between individuals in Gambian trachoma-endemic villages
28/04 12:00
2h. Other intracellular or rare bacteria
Ehsan GHASEMIAN
Poster P1243
Abstract 1947
126 Lactobacillus delbrueckii strains identified as agents in urinary tract infections, and others 2,221 Lactobacillus isolates in Occitania (France) during 2021
28/04 12:00
2h. Other intracellular or rare bacteria
Matthieu BERNIER
Poster P1244
Abstract 2084
Epidemiology, clinical manifestations, and outcomes of patients with Burkholderia pseudomallei bacteremia in eastern Thailand: a five-year single-centre retrospective cohort study
28/04 12:00
2h. Other intracellular or rare bacteria
Pichanon MINGCHAY
Poster P1245
Abstract 2195
Nocardiosis and poor prognostic factors: retrospective observational study
28/04 12:00
2h. Other intracellular or rare bacteria
Carolina MONTEIRO
Poster P1246
Abstract 2283
Origins of Bacillus subtilis strains isolated from blood cultures: insights from a single-centre retrospective study on traditional Japanese fermented soybeans Natto
28/04 12:00
2h. Other intracellular or rare bacteria
Sada RYUICHI MINODA
Poster P1248
Abstract 3828
Description of four novel Anaerococcus spp., isolated from clinical human samples
28/04 12:00
2h. Other intracellular or rare bacteria
Kathleen BOITEN
Poster P1249
Abstract 5393
Geospatial and genomic epidemiology of clinical Burkholderia pseudomallei isolates in Cambodia
28/04 12:00
2h. Other intracellular or rare bacteria
Yek CHRISTINA
Poster P2259
Abstract 63
Enhancing NAM delivery with dendritic lipids
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Mariana GOMES
Poster P2260
Abstract 126
Establishment of epidemiological cut-off values for etimicin sulfate, a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Acinetobacter baumannii and Staphylococcus aureus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Luo ZHENGYU
Poster P2261
Abstract 153
Potential susceptibility of OXA-48-producing Enterobacterales to flomoxef
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Victoria K. OWEN
Poster P2263
Abstract 174
Internalisation of ethanol in porous silica nanoparticles as an aim to improve catheter lock therapy
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Marta DÍAZ-NAVARRO
Poster P2264
Abstract 280
Bridge nucleic acid gapmers: changing the EGS technology paradigm
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Angel MAGANA
Poster P2265
Abstract 302
A novel diarylquinoline, TBAJ-587, is active against Mycobacterium abscessus in vitro
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Junsheng FAN
Poster P2266
Abstract 556
High level of performance of two anti-Staphylococcus aureus phages on clinical strains (PST CE-IVD)
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Rafael GOMES VON BOROWSKI
Poster P2267
Abstract 578
A novel β-lactamase inhibitor, FL058, improves the in vitro efficacy of imipenem against Mycobacterium abscessus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Zhili TAN
Poster P2268
Abstract 606
Determination of the PK/PD driver for the LepB inhibitor, GDC-5780, a novel gram-negative antibiotic against Enterobacteriaceae infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Min XU
Poster P2269
Abstract 626
Hospital multiresistant strains of Pseudomonas aeruginosa sensitivity to newly synthesised compounds based on diindolylmethane
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Svitlana MALANCHUK
Poster P2270
Abstract 733
Synergistic effects of phage-antibiotic combinations against Enterococcus faecalis
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Minakshi SAHU
Poster P2271
Abstract 935
Preclinical screening using zebrafish (Danio rerio) reveals the safety of microbisporicin (NAI-107) lantibiotic
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sheeba MANOHARAN-BASIL
Poster P2272
Abstract 985
Cefoxitin as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Tanguy DEQUIDT
Poster P2273
Abstract 1042
Identification of candidate in vitro susceptibility test interpretive criteria (STIC) for oral cephalosporin antimicrobial agents against Escherichia coli and Staphylococcus aureus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sujata BHAVNANI
Poster P2274
Abstract 1073
Enhancing phage delivery: exploring three-fluid nozzle spray-drying of PLGA microparticles for sustained release
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Chengxi LIU
Poster P2275
Abstract 1092
Combining phages with antibiotics lowers minimal inhibitory concentrations for Klebsiella oxytoca
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Elisabed ZALDASTANISHVILI
Poster P2276
Abstract 1170
Discovery of new antimicrobial thiophene derivatives with activity against colistin-resistant Gram-negative bacilli
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Irene MOLINA PANADERO
Poster P2277
Abstract 1171
Use of tamoxifen derivatives in combination with colistin against colistin-resistant Acinetobacter baumannii
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Irene MOLINA PANADERO
Poster P2278
Abstract 1214
Lysin exebacase demonstrates potent bactericidal activity against intraosteoblastic Staphylococcus aureus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Frederic LAURENT
Poster P2279
Abstract 1228
Comparing assays for clinical phage microbiology in Pseudomonas aeruginosa biofilm
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Ron BRAUNSTEIN
Poster P2280
Abstract 1264
Evaluation of toxicity and efflux inhibitory activity of candidate drugs for repurposing against Neisseria gonorrhoeae
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Liliana RODRIGUES
Poster P2281
Abstract 1272
Bacteriocins as a potential alternative to eradicate untreatable intracellular S. aureus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Frédéric GOORMAGHTIGH
Poster P2282
Abstract 1312
New antibacterial agent against nosocomial pathogens
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Elizaveta ROGACHEVA
Poster P2283
Abstract 1389
A new peptIn with potent and broad-spectrum antimicrobial activity to combat ESKAPE pathogens
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Laleh KHODAPARAST
Poster P2284
Abstract 1401
In vitro activity of lactone ketolide nafithromycin (WCK 4873) against Streptococcus pneumoniae isolates enriched with macrolide-resistance phenotype collected from mainland China
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Meng-Lan ZHOU
Poster P2285
Abstract 1474
A novel cholesterol-conjugated antimicrobial peptide nucleic acid (PNA) against Mycoplasma genitalium
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Michael BEETON
Poster P2286
Abstract 1539
Filamentous phages and its role in the phage defence in CF isolates of P. aeruginosa
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Olga PACIOS SANTAMARÍA
Poster P2287
Abstract 1720
Aztreonam/avibactam effectiveness for aztreonam resistant Stenotrophomonas maltophilia strains
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Ozlem OYARDI
Poster P2288
Abstract 1731
Venomous versatility: crafting a potent cationic peptide for wide-spectrum antimicrobial defense, rapid wound healing, and effective disinfection
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Samya SEN
Poster P2289
Abstract 1744
APC148-avibactam restores meropenem susceptibility in multi-drug resistant Gram-negative bacteria in vitro
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Carina MATIAS
Poster P2290
Abstract 1792
Factors influencing mortality in Staphylococcus aureus bacteremia and in vitro bacteriophage efficacy
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Fatma Irem YESILER
Poster P2291
Abstract 1829
Relative inhibitory activities of the broad-spectrum ß-lactamase inhibitor xeruborbactam against metallo-ß-lactamases
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Christophe LE TERRIER
Poster P2292
Abstract 1844
In vitro activity of newly-developed ß-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with broad-spectrum cephalosporins against AmpC overproducing clinical isolates of Pseudomonas aeruginosa
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Christophe LE TERRIER
Poster P2293
Abstract 1847
Bacteriophages as innovative compounds against Pseudomonas aeruginosa infections in pets
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Eva CUNHA
Poster P2294
Abstract 1854
In vitro activity of rifabutin combined with polymyxin B in Acinetobacter baumannii
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Christian KEMMER
Poster P2295
Abstract 1996
In vivo efficacy of BV100 in combination with polymyxin B (POL) in neutropenic murine thigh infection models of Acinetobacter baumannii
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Glenn E DALE
Poster P2296
Abstract 2065
An evolution approach for enhancing phage efficacy and minimising phage resistance
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Braira WAHID
Poster P2297
Abstract 2171
In vitro activity of cefepime/zidebactam (WCK 5222) against a panel of MDR/XDR Pseudomonas aeruginosa isolates from India enriched with resistance to novel β-lactam/ β-lactamase inhibitor combinations
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Anouk Edwina MULLER
Poster P2298
Abstract 2270
Antimicrobial activity of ceftriaxone 1 g twice versus 2 g once daily against Streptococcus pneumoniae in murine pneumonia model
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hideo KATO
Poster P2299
Abstract 2280
A novel dibenzodiazepine derivative reduces bacterial resistance to oxidative stress to inhibit intracellular Salmonella typhimurium
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hao-Chieh CHIU
Poster P2300
Abstract 2345
Bacteriophage-antibiotic combinations as an alternative treatment option for carbapenem-resistant Pseudomonas aeruginosa (CRPA)
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Andrea Lay Hoon KWA
Poster P2301
Abstract 2351
Evaluating efficacy of bacteriophage-antibiotics combinations against clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Andrea Lay Hoon KWA
Poster P2302
Abstract 2414
Post-β-lactamase-inhibitor effect of nacubactam in combination with aztreonam and cefepime on ESBL, AmpC, KPC, or OXA-48-producing Enterobacterales
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hayato OKADE
Poster P2303
Abstract 2648
Evaluation of antibacterial properties of ionic liquids against Escherichia coli
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Jyothi EMBEKKAT KAVIYIL
Poster P2304
Abstract 2678
Immunostimulatory effect of flagellin on multidrug-resistant Klebsiella pneumoniae infected human airway epithelial cells
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Christine VAN LINGE
Poster P2305
Abstract 2696
Potential of an antimicrobial peptide and a polyurea pharmadendrimer for treating mild superficial diabetic foot infections by S. aureus and P. aeruginosa
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Manuela OLIVEIRA
Poster P2306
Abstract 2743
Antimicrobial effect of antisense PNA conjugated with a CPP on different bacteria
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Joana SANTOS OLIVEIRA
Poster P2307
Abstract 2757
A tomatidine derivative with significant bactericidal activity against methicillin-resistant Staphylococcus aureus and small colony variants
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Camélie MAILHOT
Poster P2308
Abstract 2780
Identification of two new cecropin A/melittin hybrid peptides with wide-range antimicrobial activity against multidrug-resistant pathogens
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Mireia LÓPEZ-SILES
Poster P2309
Abstract 2817
The use of metal ions and graphene-based compounds as novel antimicrobials against multidrug-resistant chlorhexidine adapted Klebsiella pneumoniae
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Nathalie KARAKY
Poster P2310
Abstract 2890
Novel synthetic EGCG analogs potentiate intracellular killing of Staphylococcus aureus within liver-resident macrophages
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Riley GROSSO
Poster P2311
Abstract 2899
Unlocking the role of neurosteroids in bacterial infection
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Daniela BRDOVA
Poster P2312
Abstract 2953
Analysis of oritavancin in vitro activity against vancomycin-resistant Enterococcus faecium isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Natalia BURILLO
Poster P2313
Abstract 3130
In vitro potency of ceftibuten combinations with xeruborbactam, ledaborbactam or avibactam against recent European isolates of Enterobacterales
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Olga LOMOVSKAYA
Poster P2314
Abstract 3146
Ciprofloxacin-aztreonam combination provides synergistic killing against Pseudomonas aeruginosa PAO1 and isogenic strains showing AmpC or MexAB-OprM hyperproduction
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Jessica TAIT
Poster P2315
Abstract 3161
Determination of the PK/PD driver for the LepB inhibitor, GDC-0829, a novel broad-spectrum antibiotic against Gram-negative bacterial infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Min XU
Poster P2316
Abstract 3162
Optimising a synergistic phage cocktail: development of a multiplex dPCR system
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sue Chin NANG
Poster P2317
Abstract 3198
Antimicrobial activity of biodegradation products of the magnesium-based alloy
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Dmytro KYRYK
Poster P2318
Abstract 3210
Polymyxins differentially remodel human macrophage proteomic landscape in the presence and absence of bacterial infection
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Zhi Ying KHO
Poster P2320
Abstract 3268
In vitro combination of phages with antibacterial agents against carbapenemase-producing K. pneumoniae clinical isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Paschalis PARANOS
Poster P2321
Abstract 3311
Optimisation of double-layer agar for phage quantification
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Paschalis PARANOS
Poster P2322
Abstract 3352
A novel leucyl-tRNA synthetase inhibitor, MRX-5 is active against Mycobacterium abscessus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Bing LI
Poster P2323
Abstract 3420
A new phage-antibiotic strategy for restoring MDR Acinetobacter baumannii susceptibility
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Stefano STRACQUADANIO
Poster P2324
Abstract 3457
Determination of the role of a novel synthetic cyclic peptide to revert resistance to tetracycline-like antimicrobials in Pseudomonas aeruginosa.
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Natalia ROSON-CALERO
Poster P2325
Abstract 3485
A platform for screening of inhibitors of bacterial antibiotic resistance mechanisms
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Jitka VIKTOROVA
Poster P2326
Abstract 3570
Enhancing the delivery efficiency of nucleic acid mimics into bacteria: influence of liposome composition/functionalisation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
João Pedro FERREIRA DOS SANTOS
Poster P2327
Abstract 3676
Antibacterial activity of ibezapolstat against antimicrobial resistant clinical strains of Clostridioides difficile
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Eugenie BASSERES
Poster P2328
Abstract 3737
Prioritisation of potential drug targets using protein-protein interaction network analysis in uropathogenic Escherichia coli and insights for finding inhibitors through molecular docking studies
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Harpreet KAUR
Poster P2329
Abstract 3933
A novel Klebsiella pneumoniae bacteriophage kpn17 with depolymerase activity: it's efficacy on biofilm formation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sezin UNLU
Poster P2330
Abstract 3977
Overcoming intrinsic resistance of Enterobacterales with a novel molecule adjuvant (MD-124) by improving antibiotic activity through increased membrane permeability
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Jayden ROBERTS
Poster P2331
Abstract 4119
Copper (II) compounds with enhanced photodynamic properties as antimicrobials for the treatment of wound infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Kaja TURZANSKA
Poster P2332
Abstract 4193
Phage-mediated reduction of extensively drug-resistant (XDR) Klebsiella pneumoniae ST16 on hard surfaces for decontamination
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Michael Henrique LENZI
Poster P2333
Abstract 4246
Study of the antimicrobial and biological properties of two cationic carbosilane dendrimers against extended-spectrum beta-lactamase-producing Escherichia coli
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Marcos HERNANDO GOZALO
Poster P2334
Abstract 4372
Glyphosate sensibility screening on an extensive collection of microfungi and bacteria
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hanane ZERROUKI
Poster P2335
Abstract 4459
In vitro synergistic effect and mutant prevention concentration of eravacycline alone or in combination with various antibiotics against OXA-48 producing Enterobacterales
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Emel MATARACI-KARA
Poster P2336
Abstract 4592
Low frequency of spontaneous resistance to LepB inhibitors, GDC-5780 and GDC-0829, in target Gram-negative bacterial species
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hany GIRGIS
Poster P2337
Abstract 4634
Subcutaneous administration of beta-lactams: a systematic review
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Beatrice LIGUORO
Poster P2338
Abstract 4647
Using in vivo local chronic infection model to validate Pseudomonas aeruginosa clinical phage microbiology (cpm)
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Amit RIMON
Poster P2339
Abstract 4706
In vivo evaluation of CZ-02188: PK and in vivo efficacy for a new class of antibacterial agent
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Chad TESTA
Poster P2340
Abstract 4723
In vitro killing kinetics of GDC-5780, a novel Gram-negative antibiotic, against a panel of Enterobacteriaceae isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Guennaelle DIEPPOIS
Poster P2341
Abstract 4755
Antimicrobial photodynamic therapy of bacterial pneumonias and drug design to overcome the lung surfactant barrier
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Giulia KASSAB
Poster P2342
Abstract 4814
High activity and specificity of bacteriophage cocktails against carbapenem-resistant Klebsiella pneumoniae belonging to high risk clones CG258 and ST307
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
J Natalia JIMENEZ
Poster P2343
Abstract 4964
Assessing synergistic interactions of newly isolated phages in combination with antibacterial agents against MBL-producing P. aeruginosa clinical isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Paschalis PARANOS
Poster P2344
Abstract 4984
Combination of minocycline and ciprofloxacin enhances the inhibitory effect of TNF alpha production in LPS-stimulated THP-1 cells
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Ippei SAKAMAKI
Poster P2345
Abstract 5019
Utilising non-antibiotic compounds to increase intracellular killing of Staphylococcus aureus through immunomodulation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Riley GROSSO
Poster P2346
Abstract 5051
Relebactam improves the efficacy of imipenem against Burkholderia cepacia complex in a neutropenic mouse lung infection model
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Katherine YOUNG
Poster P2347
Abstract 5137
A novel antimicrobial peptide against multiple drug-resistant bacteria improves infection outcomes in mice
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
John VITUCCI
Poster P2348
Abstract 5168
Evaluating the environmental stability of HtrA, a novel bacterial protease that protects mice from Clostridioides difficile disease
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Jill GREENLAW
Poster P2349
Abstract 5188
Sulopenem: feasibility of an oral penem in tackling urinary Enterobacterale isolates in Indian population
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sukriti YADAV
Poster P2350
Abstract 5238
Phage-antibiotic synergistic effects on genetic and phenotypic changes in multidrug-resistant Pseudomonas aerguinosa (MDR-PA)
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Andrea Lay Hoon KWA
Poster P2351
Abstract 5251
Characterisation of F. nucleatum FabK as a narrow-spectrum target for antibacterial chemotherapy?
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Kristiana AVAD
Poster P2352
Abstract 5288
In silico selection and in vivo validation of new uropathogenic Escherichia coli inhibitors
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Harpreet KAUR
Poster P2353
Abstract 5298
Optimising in vitro phage-ciprofloxacin combination formulation for respiratory therapy of multidrug-resistant Pseudomonas aeruginosa infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Qixuan HONG
Poster P2354
Abstract 5331
Exploring the potential of thymoquinone-based organic nanoparticles in combating methicillin-resistant Staphylococcus aureus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Nehal Aasem SAIF
Poster P2355
Abstract 5338
Assessment of bacteriological profile and susceptibility pattern of multidrug-resistant Gram-negative bacteria to an innovative antibiotic combination: ceftriaxone-sulbactam plus EDTA
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Haritha MADIGUBBA
Poster P2356
Abstract 5433
Optimised arylomycins GDC-5780 and GDC-0829 represent a promising novel class of antibiotics against Gram-negative pathogens
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Michael KOEHLER
Poster P2357
Abstract 5445
Developing the arylomycins into novel antibiotics against Gram-negative bacteria
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Michael KOEHLER
Poster P2358
Abstract 5495
Optimising buffer composition and salt concentration in a three-step workflow for bacteriophage purification in therapeutic applications
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hadil ONALLAH
Poster P2359
Abstract 5529
Evaluation of synergic activity between bacteriophage PSE1720 and meropenem against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Giulia TOCCACIELI
Poster P2360
Abstract 5533
Assessment of zosurabalpin activity in combination with other antibiotics
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Isabelle ERBETTI
Poster P2361
Abstract 5683
Evaluation of phage SAU 1593 activity combined with antibiotics against Staphylococcus aureus strains isolated from diabetic foot ulcers
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Giulia TOCCACIELI
Poster P2362
Abstract 5689
In vitro evaluation of cefiderocol and the combination of ceftazidime/avibactam and aztreonam, against extensively drug-resistant Pseudomonas aeruginosa isolates producing serine and metallo-β-lactamases
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Maria Milagro MONTERO
Poster P2363
Abstract 5739
MIC distributions and activity of the novel anti-Acinetobacter agent zosurabalpin (RG6006)
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Stephen HAWSER
Poster P2364
Abstract 5815
Activity of cefepime/enmetazobactam against clinical isolates of carbapenem-resistant OXA-48-producing Enterobacterales
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Juan C. VAZQUEZ-UCHA
Poster P2365
Abstract 5853
Development and in vitro bioevaluation of gentamicin-bacteriophage-loaded biodegradable dressing with antimicrobial prospects against Pseudomonas aeruginosa
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Lavanya KHULLAR
Poster P2366
Abstract 5911
Antimicrobial activity of Staphylococcus isolates from free-living pelicans and potential role in microbiota modulation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Carmen GONZÁLEZ-AZCONA
Poster P2367
Abstract 5927
Microbiological characteristics of experimental long-term non-healing purulent wounds treated with silver nanoparticles and low-frequency ultrasound
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Petro MYRONOV
Poster P2368
Abstract 5993
Prospects for the use of bacteriophages for the treatment of wound infection caused by MDR, XDR, PDR Klebsiella pneumoniae
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Vadym PONIATOVSKYI
Poster P2369
Abstract 6143
Quinoline amphipaths: a promising frontier for enhancing beta-lactam efficacy against MRSA through synergistic potentiation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Samya SEN
Poster P2370
Abstract 6154
Exploring phage-antibiotic synergy: phage selection can restore antibiotic sensitivity to treat urinary tract infections in a preclinical study
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Naveen CHAUDHARY
Poster P2371
Abstract 6217
Fluorinated selenoesters as novel inhibitors of bifunctional enzyme AAC/APH
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Michal DVORÁK
Poster P2372
Abstract 6288
In vivo bacteriophage therapy in Pseudomonas aeruginosa burn wound infection
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Aylin USKUDAR-GUCLU
Poster P2373
Abstract 6319
Rational in vitro design of a two-phage cocktail against a contemporary A. baumannii strain recovered from a burned patient at CHUV
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Hugues DE VILLIERS DE LA NOUE
Poster P2374
Abstract 6400
Strain variability in pharmacodynamic responses to antibiotic-phage combination treatments in Pseudomonas aeruginosa
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Laura Rianne BAARS
Poster P2375
Abstract 6564
In vitro effectiveness of new generation drugs on resistant Acinetobacter baumannii
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Yasemin BOLUKBASI
Poster P2376
Abstract 6627
Novel β-lactamase inhibitors for combating OXA-48 carbapenemase-mediated resistance in Enterobacterales: a microbiological and biochemical evaluation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Outeda MICHELLE
Poster P2377
Abstract 6766
Cefepime/sulbactam versus multi drug resistant Gram-negative Enterobacterales infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Agata SOLTYSINSKA
Poster P2378
Abstract 6780
Investigating potential of phage therapy to target Staphylococcus aureus orthopaedic infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sheetal PATPATIA
Poster P2379
Abstract 6807
Mechanism of in vitro resistance to zosurabalpin (RG6006) in Acinetobacter baumannii
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Andrej TRAUNER
Poster P2380
Abstract 6875
Antibiotic susceptibility of Cutibacterium acnes in orthopedic patients and alternative treatments
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Alkmini ANGELOPOULOU
Poster P2381
Abstract 7141
Blocking bacterial communication process with quorum sensing specific antibodies as a new therapeutic strategy to treat Pseudomonas aeruginosa infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Lluïsa VILAPLANA
Poster P2382
Abstract 7145
Cyclometallated gold(III) dithiocarbamate complexes: searching for a clinical metalloantibiotic
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sara Maria SOTO
Poster P2383
Abstract 7170
Metformin's double duty: from antidiabetic hero to antibiotic dilemma
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Lina MAAROUF
Poster P2384
Abstract 7243
Mechanisms of action of RW5, a Poly(Trp-Arg) peptide
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Ester FUSTE
Poster P2385
Abstract 7292
Mechanisms of action of the Poly(Arg-Trp) peptide (RW2)
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Eric FERNANDEZ DE LA CRUZ
Poster P2386
Abstract 7311
In vitro cefiderocol activity against multiple multidrug-resistant Gram-negative bacteria
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Rubén LOBATO CANO
Poster P2387
Abstract 7377
SPR206: a novel polymyxin with broad-spectrum Gram-negative efficacy has potent synergy with macrolide and tetracycline antibiotics
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Ashelyn SIDDERS
Poster P2388
Abstract 7498
Comparison of phage cocktail vs single phages against carbapenemase-producing K. pneumoniae clinical isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Paschalis PARANOS
Poster P2389
Abstract 7510
In vitro comparison of phage cocktail vs single phages against MBL-producing P. aeruginosa clinical isolates using growth curves
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Paschalis PARANOS
Poster P2390
Abstract 7698
Let it flow: microfluidics to deliver antimicrobial nanoparticles for Helicobacter pylori management
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Diana FONSECA
Poster P2391
Abstract 7713
New peptide-based constructs for wound healing
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Mariana FERREIRA
Poster P2392
Abstract 7721
Synergistic bactericidal effect of phage therapy and pulsed blue light in planktonic and biofilm pseudomonas aeruginosa
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Amit RIMON
Poster P2393
Abstract 7745
Virulent jumbo phage vB_Kpn_MSAZC, against carbapenemase-producing Klebsiella pneumoniae
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Bishoy ZAKI
Poster P2394
Abstract 7861
Bacteriophage efficacy against Staphylococcus aureus in burn wounds, using an ex vivo human skin model
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Michele MOLENDIJK
Poster P2395
Abstract 7982
Development of a novel class of ribosomal inhibitors with potent activity against MDR bacterial pathogens to treat wound infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Daniel ZURAWSKI
Poster P2396
Abstract 7995
Antibiotic-loaded liposome armed on bacteriophage surface for combating methicillin-resistant Staphylococcus aureus infection by bio-orthogonal functionalisation strategy
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Lei WANG
Poster P2397
Abstract 8299
Resistance reversing effect of azaindole and indole derivatives in bacteria
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Nikoletta SZEMERÉDI
Poster P2398
Abstract 8353
Searching for antimicrobial-producing bacteria from soils and their potential as biocontrol agents
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Mario Sergio PINO HURTADO
Poster P2399
Abstract 8359
MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Christian ROEHRIG
Poster P2400
Abstract 8420
Host defence peptides as promising strategy against multidrug resistant bacteria
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Anna DE FILIPPIS
Poster P2401
Abstract 8527
Synthesis of silver and gold nanoparticles using the leaf extract of M.esculenta and their antibacterial activity against pan-resistant clinical isolates of patients with urinary tract infections
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Diksha DIKSHA
Poster P2402
Abstract 8638
Timely tactics: optimising bacteriophage and antimicrobial efficacy against daptomycin non-susceptible (DNS) and MRSA clinical isolates
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Callan BLEICK
Poster P2403
Abstract 8642
A thoughtful combination of Tequatrovirus/Vectrevirus bacteriophages allows mice gut decolonisation of a multidrug-resistant ST131 Escherichia coli strain
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Floriane LAUMAY
Poster P2404
Abstract 8693
Adaptation of a novel phage to enhance its lytic activity against multidrug-resistant Staphylococcus aureus
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Sara BOLOGNINI
Poster P2405
Abstract 8709
Target identification and mode of action studies of zosurabalpin
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Claudia ZAMPALONI
Poster P2406
Abstract 8718
Human serum lipids might affect Staphylococcus aureus sensitivity to phages
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Mariagrazia DI LUCA
Poster P2407
Abstract 8735
Novel Klebsiella pneumoniae bacteriophages active against multi-drug resistant clinical strains for hospitalized patient decolonisation
28/04 12:00
5a. Mechanisms of action & spectrum, new compounds, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)
Elisa FAUSTI
Poster P2409
Abstract 206
Bayesian AUC-based dosing of vancomycin in pediatrics: a single centre experience
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Rachel MEYERS
Poster P2410
Abstract 238
Tissue distribution of ceftazidime-avibactam in kidney tissue in healthy rats and pigs using a microdialysis technique.
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Maxime VALLÉE
Poster P2411
Abstract 303
A systematic review of pulmonary pharmacokinetic/pharmacodynamic characteristics of beta-lactam antibiotics used to treat pneumonia caused by carbapenem-resistant Gram-negative bacteria
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Emanuele RANDO
Poster P2412
Abstract 327
Development, validation and application of an LC-MS/MS method for the simultaneous quantitative determination of four triazole antifungal concentrations in human plasma
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Yun CAI
Poster P2413
Abstract 425
Population pharmacokinetic model selection based on patient's characteristics improves the predictive performance of vancomycin individualised dosing
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Hanna Kadri LAAS
Poster P2414
Abstract 631
Potential synergy of fluoxetine with antimicrobials
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Samar AHMED
Poster P2415
Abstract 784
Therapeutic monitoring of dalbavancin concentrations in the long-term treatment of osteoarticular or periprosthetic joint infections: a single-centre experience
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Chiara MARIANI
Poster P2416
Abstract 844
Dried blood spot analysis for the quantification of vancomycin and creatinine using liquid chromatography-tandem mass spectrometry: method development and validation
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Soma HERBERS BAHMANY
Poster P2417
Abstract 857
Pharmacodynamics of fosfomycin in combination with meropenem: impact on the size of the fosfomycin pharmacodynamic index for Klebsiella pneumoniae
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Marie ATTWOOD
Poster P2418
Abstract 936
Therapeutic drug monitoring of ceftazidime/avibactam supports continuous infusion administration: a retrospective analysis of pharmacological, microbiological, and clinical outcomes
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sara FERIN
Poster P2419
Abstract 1078
Pharmacokinetics and safety in ICU patients and healthy participants following single dose administration of zosurabalpin (RG6006), a novel pathogen-specific antibiotic for the treatment of serious Acinetobacter infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Emmanuelle COTTREEL
Poster P2420
Abstract 1210
A six-year experience of therapeutic drug monitoring of linezolid: more evidence favouring the need to individualise dosage regimens
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sonia LUQUE
Poster P2421
Abstract 1275
Probability of target attainment analysis of orally administered amoxicillin using a physiology-based pharmacokinetic model
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Christopher DARLOW
Poster P2422
Abstract 1398
Therapeutic drug monitoring of antibiotics in exhaled breath
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sarah DRÄGER
Poster P2423
Abstract 1421
Predictive performance of population pharmacokinetic models for model-informed precision dosing of meropenem in critically ill patients varied across different study settings
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Iris K MINICHMAYR
Poster P2424
Abstract 1553
Pharmacokinetics of zoliflodacin in healthy participants in the presence of itraconazole suggest no clinically meaningful CYP3A4-mediated drug-drug interactions
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alison LUCKEY
Poster P2425
Abstract 1650
Influence of continuous infusion on the plasma exposure of novel betalactams: does it really reduce the interindividual pharmacokinetic variability in different populations?
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sonia LUQUE
Poster P2427
Abstract 1743
Short and extended infusion of beta-lactams: predicted impact on target attainment and risk for toxicity in intensive care patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Maria SWARTLING
Poster P2428
Abstract 1786
Pharmacodynamic index driver of NOSO-502: conclusions from in vivo and in vitro studies
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sanne VAN DEN BERG
Poster P2429
Abstract 1819
Pharmacokinetics and safety of BV100 in subjects with mild and moderate hepatic impairment
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Glenn E DALE
Poster P2430
Abstract 1831
In vivo efficacy of enmetazobactam combined with cefepime in a neutropenic murine OXA-48 Klebsiella pneumoniae pneumonia model
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Delphine CROISIER
Poster P2431
Abstract 1993
BV100 displays potent efficacy against Acinetobacter baumannii in neutropenic murine thigh and lung infection models
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Michel PIEREN
Poster P2432
Abstract 2034
Rapid design of combination antimicrobial therapy against Acinetobacter baumannii
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Brianna EALES
Poster P2433
Abstract 2048
In vitro activity of gepotidacin and comparator agents against a collection of K. pneumoniae urine isolates collected from Europe during 2019-2022
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
S. J. Ryan ARENDS
Poster P2434
Abstract 2073
Clinical efficacy of attaining aggressive PK/PD targets with beta-lactams in critically ill patients with Gram-negative infections: a systematic review and meta-analysis
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Milo GATTI
Poster P2435
Abstract 2076
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sarah DRÄGER
Poster P2436
Abstract 2081
A pre-post quasi-experimental study assessing the impact of a real-time TDM-guided expert clinical pharmacological advice programme for optimising continuous infusion beta-lactam PK/PD target attainment on clinical/microbiological outcome of documented Gram-negative infections among critical OLT recipients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Milo GATTI
Poster P2437
Abstract 2105
Classification of patients into subpopulations with different best-fitting population pharmacokinetic models to improve model-informed precision dosing
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Hiie SOEORG
Poster P2438
Abstract 2145
The higher, the worse? Increasing antibiotic exposure is associated with mortality in critically ill patients: an unexpected finding in a secondary analysis of the DOLPHIN trial
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sarah DRÄGER
Poster P2439
Abstract 2238
Teicoplanin regimens for the treatment of osteoarticular infection: an observational study
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alessandra Helen BEHRING
Poster P2440
Abstract 2329
Simultaneous and fast UPLC-UV assay to quantify multiple triazole antifungal drugs for antifungal therapeutic drug monitoring (TDM)
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Tze-Peng LIM
Poster P2441
Abstract 2332
Consideration of polymyxin B (PB) components matters when determining AUC values for accurate PB dose adjustments in patients with (extensively drug-resistant Gram-negative bacteria) XDR-GNB infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Tze-Peng LIM
Poster P2442
Abstract 2343
Therapeutic drug monitoring of beta-lactams among hospitalised patients in Singapore: a prospective, single-centre, observational study (BLAST-2)
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Tze-Peng LIM
Poster P2443
Abstract 2363
Development of an online tool for the management of drug-drug interactions with the novel anti-cytomegalovirus (CMV) agents letermovir and maribavir
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Laura NIJBOER
Poster P2444
Abstract 2403
Pharmacokinetics of ethionamide and ethionamide sulfoxide in patients established on treatment for tuberculosis
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Michel PIEREN
Poster P2445
Abstract 2423
Therapeutic drug monitoring of meropenem in critically ill patients during ECMO support: a single-centre prospective study
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Manuel SOSA
Poster P2446
Abstract 2476
Pharmacokinetics of ceftazidime/avibactam in bile fluid: an in vivo study
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Lars PALMOWSKI
Poster P2447
Abstract 2483
Impact of efflux transporters on fluoroquinolone accumulation in eukaryotic cells and activity against intracellular Staphylococcus aureus
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Gwenaëlle MAHIEU
Poster P2448
Abstract 2503
Optimising dosing strategies of temocillin for systemic infections using pharmacokinetic-pharmacodynamic modelling and simulation
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Wisse VAN OS
Poster P2449
Abstract 2547
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Acinetobacter baumannii murine infection models
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sanne VAN DEN BERG
Poster P2450
Abstract 2563
The addition of polymyxin B to minocycline may increase the antibacterial activity against Klebsiella pneumoniae in a murine infection model
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sanne VAN DEN BERG
Poster P2451
Abstract 2607
Safety and pharmacokinetic results from the first-in-human study with intravenously administered OMN6, a novel antimicrobial peptide for Acinetobacter baumannii (AB), conducted in healthy volunteers
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Andrew SHORR
Poster P2452
Abstract 2667
Preliminary zosurabalpin broth microdilution quality control ranges using Clinical and Laboratory Standards Institute M23 criteria
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Michael HUBAND
Poster P2453
Abstract 2714
Lower temocillin doses are required in septic intensive care patients as compared to patients with mild urinary tract infections due to differences in protein binding
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Anouk Edwina MULLER
Poster P2454
Abstract 2740
Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasis
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Omar ELKAYAL
Poster P2455
Abstract 2755
Addition of urine NGAL to serum creatinine improves prediction of cefepime clearance in pediatric ICU patients at high risk of acute kidney injury
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Horace Rhodes HAMBRICK
Poster P2456
Abstract 2875
A promising antimicrobial peptide against some virulence features of Acinetobacter baumannii clinical strains
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Irene PARIS
Poster P2457
Abstract 3066
Mechanism-based mathematical modelling predicts the effects of ciprofloxacin and meropenem on Pseudomonas aeruginosa with different resistance mechanisms in cases where PK/PD indices cannot
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alice TERRILL
Poster P2458
Abstract 3097
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilising a national stability protocol framework
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Fekade SIME
Poster P2459
Abstract 3143
High rates of augmented renal clearance identified in critically ill paediatric patients leads to poor attainment of antimicrobial PK/PD targets
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Suzanne PARKER
Poster P2460
Abstract 3159
Pharmacokinetic/pharmacodynamics target attainment rate of β-lactam antibiotic in low body weight patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Chien Chih WU
Poster P2461
Abstract 3200
In vivo efficacy of humanized pulmonary exposures of WCK 5222 (cefepime/zidebactam) in neutropenic murine lung infection caused by carbapenemase-producing Klebsiella pneumoniae (KP) and Acinetobacter baumannii (AB) with WCK 5222 MICs of 16/16 to 64/64 mg/L
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Anouk Edwina MULLER
Poster P2462
Abstract 3223
Exploring antibacterial potential of Withania coagulans: GC-MS profiling, molecular docking and in vitro studies
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Aqeela ASHRAF
Poster P2463
Abstract 3279
Plasma and prostatic tissue pharmacokinetics of gepotidacin in patients undergoing prostatectomy: an ex vivo microdialysis study
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Valentin AL JALALI
Poster P2464
Abstract 3282
Pharmacokinetics of ceftazidime-avibactam in critically ill patients undergoing continuous venovenous hemodiafiltration
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Amaury O'JEANSON
Poster P2465
Abstract 3305
Different therapeutic schemes influence PK/PD target attainment in patients administered with cefiderocol
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Jacopo MULA
Poster P2466
Abstract 3439
Continuous versus intermittent piperacillin-tazobactam infusion against low and high inoculum of ESBL-producing Escherichia coli infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Marion GIRY
Poster P2467
Abstract 3476
Pharmacodynamics of minocycline combined with rifampicin against Staphylococcus aureus and Acinetobacter baumannii in a neutropenic murine lung infection model
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Anouk Edwina MULLER
Poster P2468
Abstract 3541
Key factors influencing phage pharmacokinetics in healthy rodents through a model-based approach
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Yu-Wei LIN
Poster P2469
Abstract 3567
Exploring drug-exposure and therapeutic drug monitoring (TDM) in an outpatient antimicrobial therapy (OPAT) service
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Richard WILSON
Poster P2470
Abstract 3779
Meropenem and linezolid plasma and subcutaneous tissue pharmacokinetics in septic patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Maria SANZ CODINA
Poster P2471
Abstract 3794
Fosfomycin and amikacin show a highly synergistic interaction against resistant Escherichia coli: a promising antibiotic combination therapy
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Nicole ZIMMERMANN
Poster P2472
Abstract 3807
A pooled population pharmacokinetic study of oral and intravenous clavulanic acid in neonates and infants: too many ratios?
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Stef SCHOUWENBURG
Poster P2473
Abstract 3966
The instantaneous minimum inhibitory concentration as promising pharmacodynamic metric to optimise dosing strategies of piperacillin/tazobactam
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Malin ANDERSSON
Poster P2474
Abstract 4062
Determination of the pharmacodynamic driver of efficacy of a novel type-3 secretion system inhibitor MBX-5452 against Pseudomonas aeruginosa
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alexander LEPAK
Poster P2475
Abstract 4183
High target attainment for B-lactam antibiotics in patients with Gram-negative blood stream infections when actual minimum inhibitory concentrations are applied
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Ilja ARESKOG LEJBMAN
Poster P2476
Abstract 4190
The pharmacokinetics of cloxacillin in the intensive care unit depend on the glomerular filtration rate and the plasma protein concentration
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sophie PERINEL RAGEY
Poster P2477
Abstract 4284
TDM-guided thrice weekly versus once daily administrations to optimise teicoplanin use in real-life settings
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Martina GERBI
Poster P2478
Abstract 4676
Analysis of ceftazidime-avibactam concentrations in critically ill patients under extracorporeal membrane oxigenation support: a prospective single-centre observational study
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Manuel SOSA
Poster P2479
Abstract 4707
Activity of gepotidacin against molecularly characterized Klebsiella pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2019-2022)
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Rodrigo E. MENDES
Poster P2480
Abstract 4749
Spine-tastic revolutions: tailoring dalbavancin treatment for infectious spondylodiscitis with a therapeutic drug monitoring (TDM) twist
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Fabiana DELLAI
Poster P2481
Abstract 4849
Subcutaneous and intravenous ceftriaxone show similar PK/PD in older patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sylvain GOUTELLE
Poster P2482
Abstract 4859
Effect of fosfomycin minimal inhibitory concentration determined by agar dilution on outcomes of ceftazidime/avibactam plus fosfomycin combination for the treatment of KPC-producing K. pneumoniae bloodstream infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alessandra OLIVA
Poster P2483
Abstract 5054
Pharmacokinetic/pharmacodynamic characteristics of the new monobactam AIC499 in murine thigh and lung infection models against Gram-negative pathogens
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Panagiota-Christina GEORGIOU
Poster P2484
Abstract 5101
Pharmacodynamics of the new monobactam AIC499 in combination with tazobactam against Gram-negative pathogens in an experimental thigh infection murine model
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Panagiota-Christina GEORGIOU
Poster P2485
Abstract 5339
Antimicrobial dosing in augmented renal clearance: a scoping review
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Aysel PEHLI?VANLI
Poster P2486
Abstract 5579
Time-dependent amoxicillin concentrations in infected tissue of deep-seated musculoskeletal infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Joana ERDMANN
Poster P2487
Abstract 5612
Serial nitrite measurement to evaluate antimicrobial pharmacodynamics (PD) in urinary tract infections (UTIs): a proof-of-concept for precision antimicrobial therapy
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Ellen STADLER
Poster P2488
Abstract 5615
Pharmacokinetics/pharmacodynamics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Size LI
Poster P2489
Abstract 5672
Interspecies variability in protein binding of antibiotics as basis for translational PK/PD studies: a case study using cefazolin and clindamycin
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Hifza AHMED
Poster P2490
Abstract 5678
Spotting method as a high throughput alternative to the conventional spread plating method for bacterial time-kill experiments
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Vincent ARANZANA-CLIMENT
Poster P2491
Abstract 5747
A six-year study examining the correlation between daptomycin exposure, clinical outcomes, and toxicity
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Luisa SORLÍ
Poster P2492
Abstract 5785
Development and validation of a PBPK model of gepotidacin in rats to predict exposure in human prostate
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Vincent ARANZANA-CLIMENT
Poster P2493
Abstract 5800
Exposure to rifampicin and its metabolite 25-deacetylrifampicin rapidly decreases during tuberculosis therapy
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sylvain GOUTELLE
Poster P2494
Abstract 5824
Pulmonary penetration of high doses ceftobiprole administered by continuous infusion in critically ill patients with community-acquired pneumonia
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Claire ROGER
Poster P2495
Abstract 5936
Optimising linezolid therapy in critical care: combining therapeutic drug monitoring and model-based approaches enhances target attainment
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Johannes STARP
Poster P2496
Abstract 5955
Enhanced ceftolozane-tazobactam exposure improved eradication of resistant bacteria: implications for revised S, I, and R classification
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alina NUSSBAUMER-PRÖLL
Poster P2497
Abstract 5973
Model-informed drug development for antimicrobials: translational pharmacokinetic-pharmacodynamic modelling of apramycin to facilitate prediction of efficacious dose in complicated urinary tract infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Irene HERNANDEZ-LOZANO
Poster P2498
Abstract 6342
Loading dose of ceftazidime need to be increased in critically ill patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Manon LAUNAY
Poster P2499
Abstract 6454
Comparative assessment of renal function estimating equations as surrogates for amoxicillin clearance in geriatric inpatients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Arnaud DE CLERCQ
Poster P2500
Abstract 6475
Bayesian LeiCNS PBPK modeling for acyclovir dose optimisation for central nervous system viral infection
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sun MING
Poster P2501
Abstract 6510
Population pharmacokinetics and model-informed precision dosing of unbound teicoplanin in intensive care and hematology patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Jaap MOUTON
Poster P2502
Abstract 6516
Cotrimoxazole pharmacokinetics in critically-ill patients with impaired or augmented renal function
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sophie PERINEL RAGEY
Poster P2503
Abstract 6613
Near real-time dose adjustment of benzylpenicillin: a proof-of-concept for closed-loop control in healthy volunteers
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Ryan ARMIGER
Poster P2504
Abstract 6634
Pharmacokinetics of amoxicillin/clavulanate in pediatric patients with severe community acquired pneumonia: a preliminary analysis from the PediCAP trial
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Jennie VAN DYK
Poster P2505
Abstract 6702
Therapeutic drug monitoring and model-informed precision dosing are highly effective for optimising duration of dalbavancin exposure in long-term treatment of staphylococcal infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Pier Giorgio COJUTTI
Poster P2506
Abstract 6756
Pharmacokinetic/pharmacodynamic target attainment of beta-lactam antibiotics in geriatric inpatients using standard-of-care dosing regimens
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Arnaud DE CLERCQ
Poster P2507
Abstract 7165
In vitro activity of cefepime/enmetazobactam,and comparators, against OXA carbapenemase-positive Acinetobacter baumannii
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Nathalie DUNKEL
Poster P2508
Abstract 7205
A small step in target site concentrations analysis, a big leap for prosthetic joint infection patients
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Gerbert Coen DE WAARD
Poster P2509
Abstract 7318
What clindamycin dose for which administration route in case of combination with rifampicin?
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Vincent JULLIEN
Poster P2510
Abstract 7379
Pharmacokinetics, safety, and tolerability of funobactam alone or in combination with imipenem/cilastati in healthy subjects
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Jianguo LI
Poster P2511
Abstract 7529
Probability of target attainment and neurotoxic concentration of broad spectrum β-lactams in critically ill patients receiving continuous kidney replacement therapy
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Chihhsun TAI
Poster P2512
Abstract 7590
Comparison of two different methods for measuring unbound concentrations of daptomycin in patients with proven or suspected gram-positive bacterial infections
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Sonia LUQUE
Poster P2513
Abstract 7863
Cefepime/enmetazobactam dose adjustments for renal function in patients using population pharmacokinetic simulations
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Anne SANTERRE HENRIKSEN
Poster P2514
Abstract 7947
Global standardisation of the preclinical translational murine pneumonia model: influence of starting inoculum on viability and reproducibility of Klebsiella pneumoniae in vivo growth
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Fratoni ANDREW
Poster P2515
Abstract 7948
Humanised plasma profiles in a standardised preclinical murine infection model miss the mark on replicating pulmonary epithelial lining fluid (ELF) concentrations
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Fratoni ANDREW
Poster P2516
Abstract 8198
Systematic review of antimicrobial pharmacokinetic/pharmacodynamic indices in murine thigh and hollow fibre infection models
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Najla ALABDULKARIM
Poster P2517
Abstract 8412
Low early vancomycin target attainment: failing implementation or failing dosing recommendation?
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Dorian VANNESTE
Poster P2518
Abstract 8680
In vitro evaluation of the inoculum effect of various β-lactamase-producing Klebsiella pneumoniae isolates on ceftazidime-avibactam
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Alexia CHAUZY
Poster P2519
Abstract 8720
Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: interim analysis of a randomised, controlled clinical trial
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Pieter DE COCK
Poster P2520
Abstract 8902
Isavuconazole pharmacokinetics in critically ill patients on extracorporeal membrane oxygenation
28/04 12:00
5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)
Manuel SOSA
Poster P2521
Abstract 222
Cefiderocol either in monotherapy or combination vs best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Lorenzo ONORATO
Poster P2522
Abstract 887
Outcomes at test of cure by baseline pathogen and cefepime-taniborbactam or meropenem MIC in the Phase 3 CERTAIN-1 study of patients with complicated urinary tract infection (cUTI)
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Greg MOECK
Poster P2523
Abstract 1497
Real-world effectiveness and safety of cefiderocol in patients with Gram-negative bacterial infections in the early access programme in Spain: results of the PERSEUS study
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Sarda JESSICA
Poster P2524
Abstract 1499
Real-world effectiveness and safety of long-term (>28 days) cefiderocol treatment in patients with Gram-negative bacterial infections in the PERSEUS study in Spain
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Sarda JESSICA
Poster P2525
Abstract 1501
Effectiveness of cefiderocol in patients with intra-abdominal infections caused by Gram-negative bacteria in the PERSEUS study in Spain
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Sarda JESSICA
Poster P2526
Abstract 1631
Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of ANT3310, a novel serine beta-lactamase inhibitor, in healthy volunteers
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Christian ZWINGELSTEIN
Poster P2527
Abstract 1634
Antimicrobial susceptibility of baseline Neisseria gonorrhoeae isolates from participants recruited in the global zoliflodacin Phase 3 randomised controlled trial
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Esther BETTIOL
Poster P2528
Abstract 1761
Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled data from two pivotal Phase 3 studies
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Keith KAYE
Poster P2529
Abstract 1767
Ceftazidime/avibactam versus other antimicrobial agents for treatment of multidrug-resistant Pseudomonas aeruginosa: a systematic review and meta-analysis
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Chhavi GUPTA
Poster P2530
Abstract 2495
Efficacy of gepotidacin vs nitrofurantoin for uncomplicated urinary tract infections: outcomes in EUCAST-based analysis populations from two Phase 3 noninferiority trials
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Amanda SHEETS
Poster P2531
Abstract 2650
Gepotidacin and nitrofurantoin efficacy by baseline uropathogen phenotypes and genotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Nicole SCANGARELLA-OMAN
Poster P2532
Abstract 2674
In vitro activity of gepotidacin against baseline uropathogenic phenotypes and genotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Nicole SCANGARELLA-OMAN
Poster P2533
Abstract 2705
Colistin/meropenem: the impact of synergy on outcomes in the OVERCOME trial
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Mariya HURALSKA
Poster P2534
Abstract 3164
A randomised trial evaluating a novel individualised treatment strategy for carbapenem-resistant Gram-negative infections
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Jocelyn TEO
Poster P2535
Abstract 3563
Normobaric oxygen therapy augments killing of slow growing Pseudomonas aeruginosa by quinolones
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Mette KOLPEN
Poster P2536
Abstract 3830
Efficacy of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS) among immunocompromised patients
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Ryan SHIELDS
Poster P2537
Abstract 4185
Pivmecillinam for oral transition therapy in Gram-negative bacteraemia
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Neil STEVENSON
Poster P2538
Abstract 4254
Efficacy of cefiderocol for the treatment of Stenotrophomonas maltophilia infections: a case series from the SUSANA cohort
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Marco FOIS
Poster P2539
Abstract 4605
Dalbavancin in the treatment of osteoarticular infections: real-world data from the Italian cohort SUSANA
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Luca MEZZADRI
Poster P2540
Abstract 4675
Dalbavancin as consolidation therapy of enterococcal infective endocarditis: preliminary results of Spanish-French cohort
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Svetlana SADYRBAEVA-DOLGOVA
Poster P2541
Abstract 4846
Real-world use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics)
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Sara TORDI
Poster P2542
Abstract 5017
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multi-drug resistant Pseudomonas aeruginosa
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Lodise THOMAS
Poster P2543
Abstract 5227
Establishment and application of evaluation criteria for the clinical use of ceftazidime-avibactam
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Tianping CHEN
Poster P2544
Abstract 5464
IPTC standardised phage matching, treatment, and monitoring protocol for compassionate bacteriophage use in non-resolving infections
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Hadil ONALLAH
Poster P2545
Abstract 6081
Effectiveness of fifth-generation-cephalosporins plus daptomycin compared to other-antimicrobial-regimens for methicillin-resistant Staphylococcus aureus bacteraemia: a multicentre retrospective cohort study (Staphy-DOOR)
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Alessandra BELATI
Poster P2546
Abstract 6148
Chronic Pseudomonas aeruginosa pulmonary infection treated with a nebulised phage cocktail in patients with cystic fibrosis: a phase 1b/2a randomised, double-blind, placebo-controlled, multicentre study
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Urania RAPPO
Poster P2548
Abstract 6644
Nano boost: enhancing antibacterial efficacy of ceftriaxone with magnesium oxide nanoparticles to tackle antimicrobial resistance
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Qaiser AKRAM
Poster P2549
Abstract 6813
Cefiderocol for the treatment of resistant Gram-negative infections: preliminary results from the Italian multicentre CEFI-BAC study
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Benedetta VARISCO
Poster P2550
Abstract 7413
A Phase 1 study of the safety, tolerability, and pharmacokinetics of the beta-lactamase inhibitor xeruborbactam (XER) administered as the isobutyryloxymethyl oral prodrug to healthy adult subjects
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Jason ROBERTS
Poster P2551
Abstract 7549
An interim analysis of fovocip: a multicentre randomised trial of fosfomycin vs ciprofloxacin for febrile neutropenia prevention in haematological patients
28/04 12:00
5c. New or repurposed antibacterial agents: clinical studies and randomised trials
Javier FERNÁNDEZ
Poster P2552
Abstract 90
Antimicrobial dosing optimisation during continuous renal replacement therapy: a comparison of clinical decision support systems
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Helin SAHINTURK
Poster P2553
Abstract 200
De-escalation of antibiotics in critically-ill patients with negative clinical cultures
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sruthi MENON
Poster P2554
Abstract 299
Stronger together? Potential of combining AMR industry datasets and comparison with WHO GLASS
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Quentin LECLERC
Poster P2555
Abstract 402
Successful intervention in intensive care unit (ICU) of a private hospital in Rio de Janeiro: decreasing MDR bugs and keeping the patient´s safety
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Wania FREITAS
Poster P2556
Abstract 417
Hospital-based antimicrobial stewardship in Denmark, Greenland, and the Faroe Islands: current landscape and barriers
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Christian KRAEF
Poster P2557
Abstract 482
Adherence to the recommendations of the antimicrobial stewardship program audits in a university hospital: what can we do better?
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Alvaro IRIGOYEN VON SIERAKOWSKI
Poster P2558
Abstract 533
Improving appropriate empiric antibiotic treatment through the use of antibiotic standardised treatment packages
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Kristina ÖBRINK-HANSEN
Poster P2559
Abstract 539
Mixed-method approach to determine additional off-label indications for specific antimicrobials: an example with ceftaroline
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Hester STOORVOGEL
Poster P2560
Abstract 541
Opportunities for self-administered outpatient parenteral antimicrobial therapy: a systematic literature review
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Hester STOORVOGEL
Poster P2561
Abstract 579
Need for proactive antimicrobial stewardship and effective infection control measures to address the escalating threat of antimicrobial resistance in Pakistan: A five-year analysis of carbapenem-resistant Gram-negative bacterial infections
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sadia ISHAQUE
Poster P2562
Abstract 660
National colistin prescribing practices in neonates and children in South Africa: clinician survey
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Vindana CHIBABHAI
Poster P2563
Abstract 677
Impact of antibiotic stewardship program on hospital antibiotic consumption in an Italian hospital: an observational study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Giacomo STROFFOLINI
Poster P2564
Abstract 737
Successful implementation of an antimicrobial stewardship program in an oncology center in Lima, Peru
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Carlos SEAS
Poster P2565
Abstract 749
Prospective pharmacist-led interventional study with multidisciplinary antimicrobial stewardship (AMS) programs among neonatal intensive care units (NICU) in South Africa
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Debbie GOFF
Poster P2566
Abstract 895
Study of prescribing patterns and effectiveness of ceftolozane/tazobactam real-world analysis (SPECTRA): results on Australian utilisation and outcomes
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emre YUCEL
Poster P2567
Abstract 965
Implementation of a tailored made multimodal strategy to reduce health care associated infections (HAI) in ten hospitals from two Latin-American countries: a challenge to overcome inequities
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Wanda CORNISTEIN
Poster P2568
Abstract 967
Designing theory-driven behaviour change interventions to reduce unnecessary antibiotic prescribing in primary care in Vietnam: a systematic approach using the theoretical domains framework and behaviour change wheel
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Minh Duy VU
Poster P2569
Abstract 1010
Optimising antibiotic via direct antibiotic susceptibility testing and stewardship among bacteraemic critically ill
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Chee Lan LAU
Poster P2570
Abstract 1049
Impact of multiplexed upper respiratory panels on antimicrobial stewardship
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Mesut YILMAZ
Poster P2571
Abstract 1055
Impact of implementing repeated clinical audits and feedback on outpatient antibiotic prescribing in the paediatric emergency department at Nancy University Hospital, France
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Mariem BEN YAGHLANE
Poster P2572
Abstract 1159
A multi-centre quantitative and qualitative evaluation following removal of a linezolid formulary restriction
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Thomas LIU
Poster P2573
Abstract 1308
Oral doxycycline for bacterial cystitis: an underutilised tool for antimicrobial stewardship programs
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emily ONEILL
Poster P2574
Abstract 1321
Assessment of a rapid diagnostic assay and antimicrobial stewardship intervention on treatment of Gram-negative bacteremia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Julian VENTRES
Poster P2575
Abstract 1360
Reporting the results of qualitative assessment of antibiotics prescribed in urinary tract infections improves appropriate antibiotic use
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Yoon Soo PARK
Poster P2576
Abstract 1466
Antimicrobial prescription rate in Japan reduced significantly following the implementation of the national action plan on antimicrobial resistance
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Hideki HASHIMOTO
Poster P2577
Abstract 1558
Implementing antimicrobial stewardship and infectious diseases specialist activities in non-university hospitals in Germany: the multicentre, clustered, two-arm interventional ID ROLL-OUT study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Siegbert RIEG
Poster P2578
Abstract 1644
Targeted Clostridioides difficile infection antimicrobial stewardship ward round improves patient care: an Irish experience
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sadhbh GASH
Poster P2579
Abstract 1712
Building a roadmap for antimicrobial stewardship by assessment of prevailing practices in India: SWOT analysis from 40 hospitals
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Kashish CHHOTARIA
Poster P2580
Abstract 1832
Excessive duration of antibiotic therapy in patients with common infections in Tergooi MC
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sharon VAN DEN EIJNDE
Poster P2581
Abstract 1841
Factors associated with antibiotic use in long-term care facilities: a systematic review of quantitative studies
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Aurélie BOCQUIER
Poster P2582
Abstract 1879
Achievement of an optimal vancomycin plasma concentration according to different loading dose regimens, a prospective observational multicentre cohort study, VANCOCINEMA
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Adrien GALY
Poster P2583
Abstract 1915
Patterns of outpatient antibiotic prescribing in older adults by social determinants of healthcare access before and during the COVID-19 pandemic: a population-based cohort study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Mia SAPIN
Poster P2584
Abstract 1926
Antimicrobial stewardship outcomes improve after infectious disease pharmacist integration with infectious disease consultation teams
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jacqueline BORK
Poster P2585
Abstract 2010
Impact of proactive antimicrobial stewardship (AS) intervention with a computerised microbiological alert system in patients with bloodstream infections (BSI): a pre-post intervention study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Arianna DI MARCELLO
Poster P2586
Abstract 2036
Engaging health workers and the public to take action to tackle AMR: the antibiotic guardian campaign
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Diane ASHIRU-OREDOPE
Poster P2587
Abstract 2047
Jabs to tabs goes global: point-prevalence of doses of intravenous antibiotic administered as a function of daily census
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Abi JENKINS
Poster P2588
Abstract 2074
Impact of an antimicrobial stewardship programme on empiric colistin usage in a paediatric ICU in a tertiary care hospital
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Divya NANDAKUMAR
Poster P2589
Abstract 2120
Prospective audit of piperacillin-tazobactam prescriptions in a university hospital
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Christelle MEURIS
Poster P2590
Abstract 2268
Fungicap: knowledge, attitudes, and practices survey on prescribing antifungals by physicians in Colombia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Laura Cristina NOCUA BAEZ
Poster P2591
Abstract 2284
Antibiotic prescribing patterns and associated factors in hospitals across three Asian countries: results from a point prevalence survey and focus group discussions with prescribers
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Yen DUONG
Poster P2592
Abstract 3287
Effect of oral fosfomycin compared to the intravenous beta lactam/beta-lactamase inhibitor or carbapenem in step-down treatment of patients with complicated urinary tract infection due to extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae: a multicentre, open-label, randomised controlled, non-inferiority trial
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jun-Won SEO
Poster P2593
Abstract 2482
Implementation of pathogen independent, model informed AUC-based dosing of vancomycin at university hospital Würzburg (UKW)
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Laura GUNDLACH
Poster P2594
Abstract 2496
Quantifying the carbon cost of intravenous antibiotics
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Phillip REAY
Poster P2595
Abstract 2556
Antibiotic management programme in a tertiary intensive care unit: investigation of the effects of a carbapenem-restricted period
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Rahmet GÜNER
Poster P2596
Abstract 2591
Appropriateness of antibiotic use: an antimicrobial stewardship implementation project in a regional hospital in north Denmark
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Shakil A. SHAKAR
Poster P2597
Abstract 2595
National surveillance of antibiotic use among dentists in Japan from 2015 to 2021 using the national database of health insurance claims and specific health checkups of Japan
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Masahiro ISHIKANE
Poster P2598
Abstract 2762
The evolution of a beta-lactam resistance: a holistic narrative
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Tom ASHFIELD
Poster P2599
Abstract 2905
Study of prescribing patterns and effectiveness of ceftolozane/tazobactam (C/T) real-world analysis (SPECTRA): clinical outcomes and treatment patterns from Italy
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emre YUCEL
Poster P2600
Abstract 2911
Pharmacist-led optimisation of discharge antibiotic therapy duration in the emergency department
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Joel ZAPATA
Poster P2601
Abstract 2919
Study of prescribing patterns and effectiveness of ceftolozane/tazobactam (C/T) real-world analysis (SPECTRA): clinical outcomes and treatment patterns from Spain
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emre YUCEL
Poster P2602
Abstract 3007
Promoting real-world evidence use in antimicrobial stewardship in Latin America
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Maria Virginia VILLEGAS
Poster P2603
Abstract 3025
Effect of an antibiotic stewardship intervention on provider prescribing behavior for acute respiratory infections
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Larissa MAY
Poster P2604
Abstract 3080
Study of prescribing patterns and effectiveness of ceftolozane/tazobactam (C/T) real-world analysis (SPECTRA): clinical outcomes and treatment patterns from UK
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emre YUCEL
Poster P2605
Abstract 3088
Study of prescribing patterns and effectiveness of ceftolozane/tazobactam (C/T) real-world analysis (SPECTRA): clinical outcomes and treatment patterns from Austria and Germany
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emre YUCEL
Poster P2606
Abstract 3145
Impact of enhanced antimicrobial stewardship and environmental cleaning on carbapenem-resistant Enterobacterales incidence in a hospital setting
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Toshibumi TANIGUCHI
Poster P2607
Abstract 3147
Data for action: results of the 2022 Australian hospital national antimicrobial prescribing survey
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Zohal RASHIDZADA
Poster P2608
Abstract 3193
Community antibiotic consumption in Cyprus 2015-2022
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Eirini MITSOURA
Poster P2609
Abstract 3202
Outcomes of antimicrobial de-escalation with emphasis on antimicrobial utilisation in a tertiary care hospital at south India
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jasper Victoria Leelarani MARTINRAJ
Poster P2610
Abstract 3262
The GraNBASS (Gram-negative bacteraemia antimicrobial spectrum score): a new score to evaluate antibiotic treatment spectrum in uncomplicated Gram-negative bacteraemia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Marco BONGIOVANNI
Poster P2611
Abstract 3329
Improving antibiotic prescribing quality: impact of AMS measures and infectious diseases specialist services in non-university hospitals in Germany
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Gesche FÖRST
Poster P2612
Abstract 3364
Surveillance of antibiotic prescriptions in primary care in the Netherlands: indication-linked antibiotic prescribing quality indicator outcomes collected from routine care data
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Lieke WIELDERS
Poster P2613
Abstract 3366
Reduction in piperacillin/tazobactam empiric use by antimicrobial stewardship implementation
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jon HOLLER GITZ
Poster P2614
Abstract 3376
Clinical outcomes of hospitalised patients with chronic pulmonary diseases treated with ceftolozane/tazobactam: results from SPECTRA
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Emre YUCEL
Poster P2615
Abstract 3395
Identifying excessive length of antibiotic treatment duration for hospital-acquired infections: a semi-automated approach to enhance antimicrobial stewardship
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Suzanne KUIJPERS
Poster P2616
Abstract 3429
Driving antimicrobial stewardship practice change: analysis of ten years of data from a national antimicrobial prescribing auditing platform in Australian hospitals
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Zohal RASHIDZADA
Poster P2617
Abstract 3448
Impact of new EUCAST criteria on the treatment of Pseudomonas aeruginosa respiratory tract infections
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Anna MURGADELLA-SANCHO
Poster P2618
Abstract 3449
The first audit of antifungal prescribing quality in Australia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Anna KHANINA
Poster P2619
Abstract 3452
Improving patient outcomes by addressing access disparities to develop quality antimicrobial stewardship programmes
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Mark GILCHRIST
Poster P2620
Abstract 3497
Carbapenem or new β-lactam-β-lactamase inhibitors for empiric therapy? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Marta COLANERI
Poster P2621
Abstract 3510
Is shortened surgical antimicrobial prophylaxis the new norm? Surgeons' perspective
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Saied ALI
Poster P2622
Abstract 3544
Antibiotic utilisation for residents with suspected infections in nursing homes
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Carl LLOR
Poster P2623
Abstract 3556
Antimicrobial prescribing in emergency wards in Belgium, Brazil, Canada, Georgia and the United Kingdom: first results from the outpatient Global Point Prevalence Survey of Antimicrobial Consumption and Resistance
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Annelies BOVEN
Poster P2624
Abstract 3594
A scoping review of implementation of infection prevention and control programmes & antimicrobial stewardship in Sub-Saharan African hospitals: Facilitators and barriers
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Natasha BERTULIS
Poster P2625
Abstract 3600
Antibiotic prescription appropriateness in directing stewardship interventions and benchmarking
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Liliana DIAS
Poster P2626
Abstract 3739
A quality improvement initiative to improve compliance with timely antimicrobial review
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sabina BASHIR
Poster P2627
Abstract 3800
Implementation of a regional antibiotic stewardship program (ASP) in a high-income, low multidrug-resistant organisms setting
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Susanna DEUTCH
Poster P2628
Abstract 3813
Antimicrobial stewardship program value driven outcomes
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Geraldine FOO
Poster P2629
Abstract 3902
Measuring the impact of improved diagnostics on antimicrobial stewardship in respiratory tract infection (MIDAS-RTI Study)
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Alexandria CHUNG
Poster P2630
Abstract 3903
Improved usage of standard treatment packages for community-acquired pneumonia in the emergency department
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Susanna DEUTCH
Poster P2631
Abstract 3915
Improving inpatient antimicrobial stewardship through single dose oral amoxicillin challenge among penicillin allergic veterans
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Poster P2632
Abstract 3922
How much can we SAVE? A cost-effectiveness analysis of an antibiotic stewardship intervention in the intensive care setting
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Anna ERBOGASTO
Poster P2633
Abstract 3957
Preliminary findings on antimicrobial stewardship in Brazilian primary care
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Marcelo CARNEIRO
Poster P2634
Abstract 4023
A comparison of antimicrobial prescription between a Belgian and Rwandan tertiary care hospital using the Global Point Prevalence Survey (Global-PPS) tool
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Caroline THEUNISSEN
Poster P2635
Abstract 4046
Antimicrobial stewardship in Brazilian intensive care units: second round
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Marcelo CARNEIRO
Poster P2636
Abstract 4136
Long term benefits of an AMS intervention to improve blood culture diagnostics in the emergency department
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jette JUNG
Poster P2637
Abstract 4296
Mapping and characterisation of antimicrobial stewardship tools for nursing homes in France
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Nicolas JACQUET
Poster P2638
Abstract 4329
Clinical impact of extended spectrum β-lactamases (ESBL)-producing Escherichia coli and antimicrobial stewardship in a cohort study of bacteremic urinary tract infections
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Silvia GÓMEZ-ZORRILLA
Poster P2639
Abstract 4407
Switzerland on its way to the WHO target of 60% access group antibiotics: a two decades analysis of outpatient antibiotic consumption
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Catherine PLUESS-SUARD
Poster P2640
Abstract 4439
EU targets for 2030 from the European action plan to combat antimicrobial resistance: where does Germany stand in the outpatient sector? Prescriptions of antibiotics for systemic use vary by patient age, prescribing specialty and geographical region, Germany 2019-2022
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Susanne Barbara SCHINK
Poster P2641
Abstract 4483
Knowledge gap in urine diagnostics
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Anna SCHWABE
Poster P2642
Abstract 4521
A need for better communication between clinicians and microbiology laboratories in human and animal health care
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Oana JOEAN
Poster P2643
Abstract 4567
Impact of changes in antibiotic susceptibility reporting on meropenem prescriptions for Pseudomonas aeruginosa bacteraemia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Yvon RUCH
Poster P2644
Abstract 4776
Geriatric ward perspectives on antibiotic use in palliative care: need for specific antibiotic policies
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Matteo MORRA
Poster P2645
Abstract 4823
Trends in antibiotics prescription during the implementation of antibiotic stewardship in high antimicrobial resistance settings
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Konstantinos THOMAS
Poster P2646
Abstract 4886
Lack of agreement of 80 national standard treatment guidelines with WHO AWaRe antibiotic book recommendations
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Giovanni AUTORE
Poster P2647
Abstract 4914
Mycology stewardship tool (MyST): reviewing antifungal prescribing practice to improve patient care
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Bee NG
Poster P2648
Abstract 4923
Implementation of antimicrobial stewardship (AMS) ward round at University Hospital of Birmingham, Queen Elizabeth Hospital (QE), United Kingdom
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Nirlep AGRAVEDI
Poster P2649
Abstract 4973
Leveraging partnerships to strengthen antimicrobial stewardship in Zambian public hospitals using a hub-and-spoke model
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
David BANDA
Poster P2650
Abstract 4988
Switching the script: nurses perceptions of IV-to-oral switch in acute care
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Shahzad RAZAQ
Poster P2651
Abstract 5020
Real-life use of recently introduced antibiotics against multidrug-resistant Gram-negative bacteria at Swedish university hospitals
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Lisa FAXÉN
Poster P2652
Abstract 5027
Mapping methods and metrics for assessing antibiotic use in primary care
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Martina ESCHER
Poster P2653
Abstract 5078
Piperacillin-tazobactam and carbapenem use for ESBL-producing Enterobacteriaceae in urinary tract infections
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Catarina MELITA
Poster P2654
Abstract 5111
Antibiotic consumption in inpatient CF medicine
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Johannes Till OTHMER
Poster P2655
Abstract 5154
Are cephalosporins without beta-lactamase inhibitors an option for treating OXA-48 carbapenemase-producing Enterobacterales bloodstream infections?
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Alejandro BLANCO ARÉVALO
Poster P2656
Abstract 5187
Reduction of antimicrobial resistance after the implementation of an antimicrobial stewardship program in a Mexican reference hospital
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Aaron MOLINA JAIMES
Poster P2657
Abstract 5208
Nationwide assessment of hospital antibiotic stewardship programme implementation in Indonesia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Robert SINTO
Poster P2659
Abstract 5311
Long-term and sustained effect of a multifaceted intervention to improve antibiotic management in patients with penicillin allergy at a university hospital in Florida, USA
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jose Guillermo CASTRO DANOS
Poster P2660
Abstract 5501
Retrospective multicentre cohort of critically ill burn patients treated with cefiderocol for infections caused by multidrug-resistant non-fermenting Gram-negative bacteria
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sarah SOUEGES
Poster P2661
Abstract 5613
WHO reserved antibiotic utilisation patterns: audit from a tertiary care hospital in India
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Ratheesh RAJAKUMAR
Poster P2662
Abstract 5695
Pharmacist-led stewardship of echinocandins at a private hospital in South Africa
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Cahlia NAESTED
Poster P2663
Abstract 5896
Antimicrobial stewardship (AMS) practices in intensive care units (ICU): which elements should be implemented?
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Roberta BUSSOLINO
Poster P2664
Abstract 6051
Development and evaluation of a novel antibiotic point prevalence survey method in primary care (APC-PPS)
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Aislinn COOK
Poster P2665
Abstract 6053
Implementation of a national workshop on antimicrobial resistance in Lao PDR
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Christelle ELIAS
Poster P2666
Abstract 6121
Determinants and opportunities of antimicrobial stewardship implementation in hospitals in low- and middle- income countries: a qualitative study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Ines PAUWELS
Poster P2667
Abstract 6145
Utilising pharmacist-led antimicrobial stewardship (AMS) rounds as a means to stop and reduce antibacterial use: a quality improvement approach
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Priti KUKADIA
Poster P2668
Abstract 6183
Point prevalence survey on antibiotic use in a tertiary care hospital in Lao PDR
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Christelle ELIAS
Poster P2669
Abstract 6304
Optimising vancomycin management in paediatric ICU: impact of a dosing package on severe AKI
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Michael STOKES
Poster P2670
Abstract 6371
Co-design of a visual ICU nurse handover tool to optimise infection care in a low-resource setting: a nurse led collaboration
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Candice BONACONSA
Poster P2671
Abstract 6420
Global Antimicrobial Consumption System (GLASS-AMC): 2023 highlights
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Martina ESCHER
Poster P2672
Abstract 6424
Exploring antibiotic prescription patterns in a low-income country: the TSARA project in Madagascar
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Christelle ELIAS
Poster P2673
Abstract 6473
Implementing antimicrobial stewardship in a Philippine tertiary care hospital: a five-year analysis of repeated point prevalence surveys for monitoring and quality improvement
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Mari Rose DELOS REYES
Poster P2674
Abstract 6474
Impact of an antimicrobial stewardship intervention in patients with negative blood cultures in days of treatment: the NO-BACT clinical trial
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
José Antonio GIRÓN ORTEGA
Poster P2675
Abstract 6523
Process evaluation of an effective antibiotic stewardship intervention in hospitalised patients with community-acquired pneumonia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sharon VAN DEN EIJNDE
Poster P2676
Abstract 6555
The global point prevalence survey of antimicrobial consumption and resistance (Global-PPS): October 2023 results of antimicrobial prescribing in Calabar, Nigeria
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Akaninyene OTU
Poster P2677
Abstract 6562
Impact of a bundle of interventions on quality-of-care indicators for Staphylococcus aures bacteraemia: preliminary results of a quasi-experimental study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Giacomo CASALINI
Poster P2678
Abstract 6598
Antimicrobial susceptibility and time of hospitalisation: when is the empiric initiation of broad-spectrum antibiotics necessary?
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Andrea MORENO ARAYA
Poster P2679
Abstract 6653
Audit of penicillin-allergy incidence in BMT patients and its effect on meropenem usage
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Philip BAKER
Poster P2680
Abstract 6709
Consumption of reserve-antibiotics in German acute care hospitals: before, during and after the COVID-19 pandemic
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Birgitta SCHWEICKERT
Poster P2681
Abstract 6718
Antimicrobial prescribing in three public hospitals of rural South-Africa in 2023: results from the global point prevalence survey
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Joanna GALLAY
Poster P2682
Abstract 6768
Multidisciplinary perspectives on training for non-allergy specialists new to penicillin allergy de-labelling
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Bee Yean NG
Poster P2683
Abstract 6778
Implementation of clinical decision rules in Dutch hospitals to improve the quality of antibiotic prescribing
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
P.D. VAN DER LINDEN
Poster P2684
Abstract 6817
Trends in antibacterial consumption in Belgian hospitals 2017-2021: assessing the impact of the COVID-19 pandemic
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Lucy CATTEAU
Poster P2685
Abstract 6917
A systematic review of patient and public knowledge and understanding of antimicrobial resistance and antimicrobial stewardship
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Benson JACOB
Poster P2686
Abstract 6939
Assessing the differences in outpatient antibiotic consumption between reimbursement and sales data in Belgium, 2012-2022
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Lucy CATTEAU
Poster P2687
Abstract 6943
Evaluation and expansion of a pharmacy-led therapeutic drug monitoring advisory service as part of an antimicrobial stewardship programme
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Pieter DE COCK
Poster P2688
Abstract 7089
Patient-focused training in outpatient parenteral antimicrobial therapy (OPAT) results in significant increases in self-administration
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Imogen KEMP
Poster P2689
Abstract 7122
Structuring and implementation of an antimicrobial stewardship program in a public oncological hospital: challenges and achievements
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Odeli Nicole ENCINAS SEJAS
Poster P2690
Abstract 7160
Improving primary care antibiotic prescribing to reduce antibiotic-resistant urine infections (IPAP-UTI): methods for selecting integrated care boards
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Susan HOPKINS
Poster P2691
Abstract 7203
Transforming prescribing culture: the impact of a restrictive intervention on empirical antimicrobial prescribing at a third-level hospital in Costa Rica
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Luis David GARRO ZAMORA
Poster P2692
Abstract 7263
A multifaceted antimicrobial stewardship intervention in the urology department
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Giacomo STROFFOLINI
Poster P2693
Abstract 7371
Impact of the EUCAST rapid antimicrobial susceptibility testing (RAST) in patients with bacteremia on outcomes and antimicrobial stewardship: a real-life study
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Antonella SANTORO
Poster P2694
Abstract 7383
Check of appropriateness of antimicrobial therapy in nursing homes (CAPTAIN) study: a point prevalence study in Belgium
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Charlotte QUINTENS
Poster P2695
Abstract 7404
Impact on the pharmacoeconomics of a public oncological hospital through the implementation of an antimicrobial stewardship program
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Odeli Nicole ENCINAS SEJAS
Poster P2696
Abstract 7468
Stealth prescribing of antibiotics after the implementation of a urinary tract infection e-prescribing protocol
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Elpida MASTROGIANNI
Poster P2697
Abstract 7539
Engaging the patients and prescribers of tomorrow to address antimicrobial resistance
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Christopher LITTLE
Poster P2698
Abstract 7556
Reducing empirical ceftriaxone use for CAP: a behavioral intervention tutored within the 2022-2024 ESCMID AMS Certificate
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Francisco ALMEIDA
Poster P2699
Abstract 7672
Antibiotic consumption and prescription patterns over seven years in a tertiary care hospital in Karachi, Pakistan
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Nosheen NASIR
Poster P2700
Abstract 7674
Point-of-care tests for acute respiratory infections need comprehensive implementation packages to support use in primary care
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sibyl ANTHIERENS
Poster P2701
Abstract 7677
The global point revalence survey (Global-PPS): surgical antimicrobial prophylaxis in the Philippines from 2017-2022
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jemelyn GARCIA
Poster P2702
Abstract 7788
Impact of respiratory PCR testing on antimicrobial prescription in a infectious diseases department
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Lotfi DAHMANE
Poster P2703
Abstract 7798
Adherence of quality indicators for appropriate antibiotic use in the emergency department (ED)
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Garreta Fontelles GEMMA
Poster P2704
Abstract 7889
The clinimetric profile of 11 generic quality indicators for appropriate antibiotic use in Hospitalised patients in Indonesia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Rahajeng N. TUNJUNGPUTRI
Poster P2705
Abstract 7919
Mortality predictors in patients with negative blood cultures after a specific antimicrobial stewardship intervention: a post hoc analysis of NO-BACT clinical trial
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Pilar RETAMAR GENTIL
Poster P2706
Abstract 7962
Implementation of a pharmacist driven nasal MRSA PCR screening protocol and evaluation on impact of vancomycin utilisation and antibiotic susceptibility at a community hospital in Miami
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Renata BOATWRIGHT
Poster P2707
Abstract 8029
Antibiotic usage shifts in a northeast Mexico COVID-19 care facility: a retrospective analysis
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Gloria Mayela AGUIRRE-GARCÍA
Poster P2708
Abstract 8080
A carbapenem focussed stewardship ward round (CSW), reduces duration of carbapenem prescribing in a tertiary hospital
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Jacob BROLLY
Poster P2709
Abstract 8097
Uptake of OpenWHO massive open online courses on antimicrobial stewardship
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Deborah TONG
Poster P2710
Abstract 8218
Point prevalence vs period prevalence: the best timing to collect antibiotic prescription data in a hospital setting using AWARE classification
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Giulia BRIGADOI
Poster P2711
Abstract 8230
Surveillance non-directed bronchial lavage allows early targeted antibiotic therapy in ventilator associated pneumonia
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Joseph THOMPSON
Poster P2712
Abstract 8524
Intervention programme for optimisation of antimicrobials in an haematology service
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Maria Del Mar ARENAS MIRAS
Poster P2713
Abstract 8541
When the solution becomes the problem: particulate formation in piperacillin/tazobactam continuous infusion
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Charlotte QUINTENS
Poster P2714
Abstract 8556
The experience of an antimicrobial stewardship programme and resistance trends during the COVID-19 pandemic at a tertiary care center in a low- and middle-income country
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Remie EL HELOU
Poster P2715
Abstract 8591
Age and sex-specific differences in inpatient antibiotic utilisation at a tertiary care centre in a low-middle-income country
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Nosheen NASIR
Poster P2716
Abstract 8635
Facilitating safer fluoroquinolone prescribing using formalised risk-assessment
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Sandra LAUHOFF
Poster P2717
Abstract 8657
Role of clinical pharmacists (CP)in the conduct of auditing antibiotic IP prescriptions in resource-limited countries
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Anusha ROHIT
Poster P2718
Abstract 8659
Multidisciplinary visit of the antimicrobial stewardship programme as a strategy for optimising antimicrobial use in the intensive care units of a private hospital with an open medical staff
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Odeli Nicole ENCINAS SEJAS
Poster P2719
Abstract 8661
Point prevalence survey in community pharmacies identifies targets for quality improvement in antimicrobial stewardship in community pharmacies in Lagos Nigeria
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Philip OSHUN
Poster P2720
Abstract 8723
Antibiotic dispensing per type of healthcare provider in rural Burkina Faso: a healthcare visit exit survey
28/04 12:00
5d. Antimicrobial stewardship and prescribing (incl interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects)
Daniel VALIA
Poster P2721
Abstract 668
Risk factors for the development of acute kidney injury in patients treated with polymyxin B in a tertiary medical centre: a prospective cohort study
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Joseph Louie VICENCIO
Poster P2722
Abstract 976
Outpatient parenteral antibiotic therapy (OPAT) through elastomeric continuous infusion pumps in a real-life observational study: characteristics, safety, and efficacy analysis
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Gabriele GIULIANO
Poster P2723
Abstract 1590
RETRACE: a retrospective chart review to evaluate the safety profile of ceftobiprole in patients with impaired hepatic, renal or immune function
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Emanuele DURANTE-MANGONI
Poster P2724
Abstract 1633
Safety profile of oral zoliflodacin for uncomplicated gonorrhoea in a Phase 3 trial
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Gabrielle KORNMANN
Poster P2725
Abstract 1732
Five years of quality control of therapeutic phage APIs in Belgium: lessons learned
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Pieter-Jan CEYSSENS
Poster P2726
Abstract 1818
Penicillin allergy delabeling in Germany: current challenges and novel clinical pathways
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Till KOCH
Poster P2727
Abstract 3127
Search for nephroprotectants to eliminate polymyxin nephrotoxicity
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Ilya KLEYN
Poster P2728
Abstract 3740
Implementation of UK regulator advice on risk of deafness with aminoglycosides
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Philip HOWARD
Poster P2729
Abstract 3962
Evaluating the safety of a novel bacterial protease for the treatment of Clostridioides difficile infection in a murine model
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Hannah M WOOD
Poster P2730
Abstract 4201
Investigation of polypharmacy, antimicrobial related potential drug-drug interactions in patients with hematological malignities
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Rahmet GÜNER
Poster P2731
Abstract 4835
Incidence of serotonin syndrome caused by tedizolid and concomitant serotonergic agents
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Sunish SHAH
Poster P2732
Abstract 5014
Intravenous push vs intermittent infusion beta-lactams in paediatrics: safety and time to administration
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Kassandra MARSH
Poster P2733
Abstract 5068
Spatially resolved transcriptomic analysis of polymyxin-induced nephrotoxicity in mice
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Jinxin ZHAO
Poster P2734
Abstract 5279
The strategy of preventing colistin induced nephrotoxicity on murine thigh model
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Kook MINSOO
Poster P2735
Abstract 6153
How should we start implementing aminoglycoside pharmacogenetic testing to prevent ototoxicity? Considerations for future practice
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Veronica CHORRO-MARI
Poster P2736
Abstract 8586
Allergy to liposomal amphotericin B: how does it compare with other antimicrobials and what are the risks associated with use?
28/04 12:00
5e. Safety, hypersensitivity and adverse effects of treatment
Sophie ROBERTS
Poster P2737
Abstract 1262
Budget impact evaluation of fidaxomicin vs vancomycin in treating Clostridioides difficile infections: a retrospective analysis of reimbursement data of a German tertiary hospital
28/04 12:00
5f. Pharmacoepidemiology / pharmacoeconomics (incl cost-effectiveness, modelling, data tools)
Ann-Cathrine SIEFEN
Poster P2738
Abstract 1998
Essential antibiotics experience an 87% price variation, impacting affordability in India: a study over a decade
28/04 12:00
5f. Pharmacoepidemiology / pharmacoeconomics (incl cost-effectiveness, modelling, data tools)
Sriram RADHAKRISHNAN
Poster P2739
Abstract 3743
Antibiotic prescribing for common infections and association with patient outcomes: analysis using electronic prescription data in Vietnam primary care centres
28/04 12:00
5f. Pharmacoepidemiology / pharmacoeconomics (incl cost-effectiveness, modelling, data tools)
Vinh Nam NGUYEN
Poster P2740
Abstract 4099
Antimicrobial subscription pilot model: thirteen months experience in England
28/04 12:00
5f. Pharmacoepidemiology / pharmacoeconomics (incl cost-effectiveness, modelling, data tools)
Philip HOWARD
Poster P1250
Abstract 152
Resistome diversity in coagulase-negative staphylococci from nostrils of healthy humans in La Rioja (Spain): genomic analysis of MDR-S. epidermidis and S. haemolyticus strains
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Idris Nasir ABDULLAHI
Poster P1251
Abstract 281
Unveiling the potency of combined fosfomycin and meropenem against methicillin-resistant Staphylococcus aureus (MRSA) using the hollow-fiber infection model
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Tetsuo YAMAGUCHI
Poster P1252
Abstract 777
Molecular characterisation of vanA genotype-VanB phenotype vancomycin- resistant Enterococcus faecium isolates from Taiwan
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Tzu-Ching HUNG
Poster P1253
Abstract 909
Disease pattern, serotype distribution and risk factors of antimicrobial resistance in patients with pneumococcal infection in Hong Kong – a population-based study
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Sze Ling Celine CHUI
Poster P1254
Abstract 1074
Characteristics of Staphylococcus aureus sterilisation with various aminoglycoside antibiotics used by the continuous local antibiotic perfusion (CLAP) therapy
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Takumi SATO
Poster P1255
Abstract 1326
Shedding light on the population structure of vancomycin-susceptible and -resistant Enterococcus faecium (VSE/VRE) from German hospital patients, 2010-2019
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jennifer BENDER
Poster P1256
Abstract 1340
Emergence of multidrug-resistant penicillin non-susceptible Streptococcus agalactiae via community and nosocomial transmission in Korea
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Bosung PARK
Poster P1257
Abstract 1358
Changes in Staphylococcus aureus antimicrobial susceptibility during the COVID-19 pandemic
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Tomonori TAKANO
Poster P1258
Abstract 1482
Insights into S. pneumoniae serotypes dynamics and antimicrobial resistance in Argentine adults: 2018-2022 perspective
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jonathan ZINTGRAFF
Poster P1259
Abstract 1486
Dynamic trends in serotypes and antimicrobial resistance of S. pneumoniae in Argentine paediatrics: insights from 2018 to 2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jonathan ZINTGRAFF
Poster P1260
Abstract 1562
Whole-genome sequencing analysis of Listeria monocytogenes case clusters in maternity hospital, Kuwait
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ola MOGHNIA
Poster P1261
Abstract 1760
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae clinical isolates in Greek adults between 2017 and 2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Dimitra STAFYLAKI
Poster P1262
Abstract 1775
Population structure of Czech vancomycin-resistant and susceptible enterococci, a multicentric surveillance study, 2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Marie BRAJEROVÁ
Poster P1263
Abstract 1962
Emergence of linezolid resistance in Staphylococcus epidermidis in Occitania (France): a growing concern in healthcare settings
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Matthieu BERNIER
Poster P1264
Abstract 2129
Antibiotic resistance and clonal composition of methicillin-susceptible Staphylococcus aureus in Kuwait hospitals
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Edet Ekpenyong UDO
Poster P1265
Abstract 2157
Resistome and phylogenetic characterization of Streptococcus pyogenes clinical isolates from adult patients in Riga East University Hospital
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Girts SKENDERS
Poster P1266
Abstract 2211
Streptococcus pyogenes infections, clinical presentation and trends in resistance across the COVID-19 pandemic?
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
José CANELA GOMÀ
Poster P1267
Abstract 2264
MRSA from bloodstream and skin and soft tissue infections in Polish hospitals, 2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Monika ORCZYKOWSKA-KOTYNA
Poster P1268
Abstract 2334
Molecular epidemiology of methicillin resistant Staphylococcus aureus: emerging trends from the United Arab Emirates
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Syrine Nouara BOUCHERABINE
Poster P1269
Abstract 2337
Streptococcus pneumoniae surveillance in the United Arab Emirates: a comparative analysis of trends before and during the COVID-19 pandemic
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Abiola SENOK
Poster P1270
Abstract 2396
Incidence of Staphylococcus argenteus and methicillin-resistant S. argenteus based on the Dutch national surveillance system of antimicrobial resistance (ISIS-AR)
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Feline VELTHUIS
Poster P1271
Abstract 2552
Unveiling the status of antiseptic resistance in Staphylococcus aureus from South America
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jesús Eduardo VIELMA VALLENILLA
Poster P1272
Abstract 2560
In vitro effectiveness of ceftobiprole alone and in combination on methicillin-resistant Staphylococcus aureus isolates isolated from clinical samples
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Lutfiye OKSUZ
Poster P1273
Abstract 2572
In vitro efficacy of ceftaroline alone and in combinations against methicillin-resistant Staphylococcus aureus isolates
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Lutfiye OKSUZ
Poster P1274
Abstract 2748
Surveillance of vancomycin-resistant enterococci in Denmark between 2015 and 2022 reveals a shift in dominating resistance genes and core genome clusters from vanA Enterococcus faecium to vanB E. faecium clusters
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Kasper THYSTRUP KARSTENSEN
Poster P1275
Abstract 2767
Trends in the prevalence of virulence and antimicrobial resistant genes among USA300 MRSA from 2004-2020 in Chicago, IL
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Timileyin ADEDIRAN
Poster P1276
Abstract 2775
Dynamics of antibiotic resistance in Staphylococcus aureus during persistent airway infection in people with cystic fibrosis
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Barbara C. KAHL
Poster P1277
Abstract 2951
Emergence of optrA/cfr(D)-positive Enterococcus spp. resistant to linezolid and vancomycin in tertiary hospital
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Vyacheslav PLESHKOV
Poster P1278
Abstract 3213
Prevalence of methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci in nasal cavity of healthy individuals in Japan
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Sayaka ANDO
Poster P1279
Abstract 3399
Prevalence and time of infection with vancomycin-resistant or -susceptible Enterococcus faecium following a rectal swab positive for vancomycin-resistant E. faecium
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Julia NILSSON GRAM
Poster P1280
Abstract 3480
Study on Streptococcus pyogenes strains isolated from university hospital in Sofia, Bulgaria during pharyngitis/scarlet fever outbreak 2023
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Georgi TODOROV
Poster P1281
Abstract 3488
Eravacycline susceptibility against Gram-positive pathogens, collected in Europe during 2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Stephen HAWSER
Poster P1282
Abstract 3494
Antimicrobial susceptibilities of toxin producing Corynebacterium diphtheriae and Corynebacterium ulcerans in Belgium
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Zan JANSSEN
Poster P1283
Abstract 3552
Increasing trend of community-associated methicillin-resistant Staphylococcus aureus infections among patients of a tertiary care hospital
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jan TKADLEC
Poster P1284
Abstract 3569
The increased occurrence and virulence of Streptococcus pyogenes in the Czech Republic: genomic futures of epidemic lineages
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Marek STEFAN
Poster P1285
Abstract 3597
S. epidermidis from blood cultures of newborn infants in Sweden: a four-decade genome-based retrospective study
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Mia Aarris NIELSEN
Poster P1286
Abstract 3601
The true burden of group A streptococcus in South East Ireland
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Meadhbh COLLISON
Poster P1287
Abstract 3686
Split k-mer analysis of the vancomycin-resistant Enterococcus faecium CT71 endemic clone from Germany
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Kyriaki XANTHOPOULOU
Poster P1288
Abstract 3753
Increasing macrolide resistance among pharyngeal Streptococcus pyogenes in a Portuguese hospital due to emm2-ST55 lineage carrying mef(A)-msr(D)
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ana FRIÃES
Poster P1289
Abstract 3776
Antibiotics' synergistic activity in a Granulicatella adiacens strain: could double beta-lactam be an option for treatment?
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Francesca PRATAVIERA
Poster P1290
Abstract 3822
Antimicrobial selective pressure and the expression of oxacillin resistance in Staphylococcus aureus
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Helvécio CARDOSO CORRÊA PÓVOA
Poster P1291
Abstract 3884
Antimicrobial resistant Corynebacterium diphtheriae: what, when, where, how and why?
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Sylvain BRISSE
Poster P1292
Abstract 3928
Genomic epidemiology of vancomycin-resistant Enterococcus faecium in Stockholm, Sweden 2018-2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Hong FANG
Poster P1293
Abstract 3988
Beyond Antimicrobial Resistance: Competitive interactions and bacteriocin diversity in Enterococcus faecium and E. lactis
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ana ALMEIDA SANTOS
Poster P1294
Abstract 4210
Population snapshot of vancomycin-resistant enterococci in central Europe.
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Wulf SCHNEIDER
Poster P1295
Abstract 4238
Impact of conjugate vaccines in penicillin and cefotaxime resistance of Streptococcus pneumoniae causing meningitis in Gipuzkoa, Spain, 1993-2023.
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ayla MANZANAL PEREZ
Poster P1296
Abstract 4242
Vancomycin-variable Enterococcus faecium (VVE) in human clinical and commensal samples: a challenge in antibiotic stewardship
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ana ALMEIDA SANTOS
Poster P1297
Abstract 4244
Macrolide-resistant Mycoplasma pneumoniae in paediatric population in a low income setting - an emerging threat
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Sajitha VENKATESAN
Poster P1298
Abstract 4331
Streptococcus pneumoniae antibiotic susceptibility among isolates from hospitalised adults with invasive pneumococcal disease in Portugal - the SPHERE study
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Filipe FROES
Poster P1299
Abstract 4469
Antimicrobial resistance and multiple resistance in Listeria monocytogenes human strains isolated from invasive listeriosis cases
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Maria GORI
Poster P1300
Abstract 4518
Post-pandemic acquisition of vanA gene cluster into vanB harbouring vancomycin-resistant Enterococcus faecium isolates from invasive infections in Chile
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jose R. W. MARTINEZ
Poster P1301
Abstract 4526
South american CC398: primary clone associated with erythromycin and clindamycin resistance in MSSA bacteremia, featuring the genetic element carrying ermT
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Jesús Eduardo VIELMA VALLENILLA
Poster P1302
Abstract 4566
Nasal carriage of (mecA-carrying) Staphylococcus aureus among health sciences students: intermittent colonisation and lifestyle factors
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ana Raquel FREITAS
Poster P1303
Abstract 4624
Emergence of invasive isolates of vancomycin- and penicillin-resistant Enterococcus faecalis exhibiting unusually high MICs to ß-lactam antibiotics in Chile
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Lorena DIAZ
Poster P1304
Abstract 4822
Correlation between resistance pheno- and genotypes of Enterococcus spp. collected in a tertiary hospital in Denmark
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Karen Leth NIELSEN
Poster P1305
Abstract 4977
Risk factors of vancomycin reduced susceptibility in clinical Clostridioides difficile isolates
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Taryn EUBANK
Poster P1306
Abstract 5125
Prevalence of Streptococcus pneumoniae resistance to antibiotics in Brazilian patients with bacteremic pneumococcal pneumonia in Rio de Janeiro
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Paulo Vieira DAMASCO
Poster P1307
Abstract 5314
Molecular nature of Staphylococcus aureus causing infections in hospitals in Lagos, Nigeria
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Adesola OLALEKAN
Poster P1308
Abstract 5361
Genomic characterisation of linezolid-resistant Enterococcus faecalis isolated in Western Australia, 2016-2021
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Shakeel MOWLABOCCUS
Poster P1309
Abstract 5417
Antimicrobial resistance genomics of Enterococcus faecium causing bloodstream infections across Australia in 2022
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Shakeel MOWLABOCCUS
Poster P1310
Abstract 5454
Linezolid-resistant Enterococcus clinical isolates from Pakistan: a genomic analysis
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Syed Mohammad ZEESHAN
Poster P1311
Abstract 5576
Genomic surveillance of invasive Staphylococcus isolates in Germany, 2021-2023
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Franziska LAYER-NICOLAOU
Poster P1312
Abstract 5610
AMR trends in Streptococcus pyogenes in the Netherlands
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Rony Elisabeth ZOETIGHEID
Poster P1313
Abstract 5660
Proportion of vancomycin MIC other than 1 mg/L in MRSA and its potential implication in therapeutic drug monitoring
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Beom Joon KIM
Poster P1314
Abstract 5758
Correlation of GAS emm-types and invasiveness: a retrospective cohort study, Germany, 2023
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Joerg STEINMANN
Poster P1315
Abstract 5776
Virulome of vancomycin-resistant enterococci in bloodstream infection and carriage
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Christian Wilhelm BÖING
Poster P1316
Abstract 5917
Assessing the molecular bases of fusidic acid resistance Staphylococcus aureus methicillin susceptible clinical strains
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Emanuele NICITRA
Poster P1317
Abstract 5969
Performance of chromogenic selective agar for identifying linezolid resistant enterococci and staphylococci using a genetically defined set of challenge isolates
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Sarah BUUR BENDIXEN
Poster P1318
Abstract 6012
Linezolid-resistant Enterococcus faecium and Enterococcus faecalis from Polish hospitals: diversity of resistance determinants and clonal types
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Dorota ZABICKA
Poster P1319
Abstract 6052
Antibiotic resistance and epidemiological evolution of Streptococcus pneumoniae in 2020-2022 at Hospital Universitari de Bellvitge, Barcelona
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Rocío ESPAÑA BONILLA
Poster P1320
Abstract 6107
Linezolid-resistant Enterococcus faecium bloodstream isolates from Germany: molecular epidemiology and resistance mechanisms
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
David TOBYS
Poster P1321
Abstract 6189
VanB Enterococcus faecium and Enterococcus faecalis isolated from blood in 2022 in Poland
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Malgorzata GRZEGORCZYK
Poster P1322
Abstract 6301
Frequency of MRSA-CC398 among tetracycline resistant MRSA isolates. A multicentre study in 2023
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Allelen CAMPAÑA-BURGUET
Poster P1323
Abstract 6332
Detection of MRSA and MSSA CC398 isolates in osteoarticular infections in a multicenter study, Spain.
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Paula EGUIZÁBAL
Poster P1324
Abstract 6602
Livestock-associated methicillin-resistant S. aureus causing bacteremia in a region with high pig-farming-density
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Saray MORMENEO
Poster P1325
Abstract 6722
Temporal trends of Enterococcal and vancomycin-resistant E. faecium Bloodstream infections in the Northern Dutch-German cross-border region: a ten-year multi-centre analysis (2013-2022)
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Cansu CIMEN VAN DIJCK
Poster P1326
Abstract 7015
Increasing macrolide and lincosamide resistance among Streptococcus dysgalactiae subsp. equisimilis invasive isolates (Portugal, 2019-2022)
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Marcos Daniel PINHO
Poster P1327
Abstract 7019
An increase of the emerging methicillin-resistant Staphylococcus aureus t4549 lineage in Denmark: an investigation of demographics and risk factors
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Johanna YOUNG
Poster P1328
Abstract 7231
Evaluation of oritavancin susceptibility in vancomycin-resistant Enterococcus faecium isolates
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Carcione DAVIDE
Poster P1329
Abstract 7357
A multicentre study: penicillin is still susceptible, macrolide resistance and biofilm production is low in Streptococccus pyogenes isolates
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Özgen ESER
Poster P1330
Abstract 7717
Detection of poxtA- and optrA-positive enterococci and lactobacilli from rectal swabs from hospitalized patients in Tuscany, Italy
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Nicla GIOVACCHINI
Poster P1331
Abstract 7763
Increase in methicillin-resistant Staphylococcus spp. colonisation among pregnant women in Brazil, during the COVID-19 pandemic
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Tatiana PINTO
Poster P1332
Abstract 8071
Genomic insights into community-associated methicillin resistant Staphylococcus aureus: an Egyptian perspective
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Nehal Aasem SAIF
Poster P1333
Abstract 8089
Increase of invasive group A streptococcal (GAS) disease in adult patients in Barcelona 2018-2023
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Dàmaris BERBEL PALAU
Poster P1334
Abstract 8142
Unveiling pediatric challenges: Serotype dynamics, sequence types and multidrug resistance of Streptococcus pneumoniae isolates – insights from a comprehensive Indian study???
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Gk HARSHITHA
Poster P1335
Abstract 8614
Decoding diversity of Streptococcus pneumoniae isolated from Indian adults: genomic insights into lineages, population dynamics, and resistance patterns
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Varun SHAMANNA
Poster P1336
Abstract 8907
Epidemiology of bacterial resistance at the Grand Magal of Touba in Senegal.
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Ouaddane IHSSANE
Poster P1337
Abstract 8910
Correlation between the incidence of invasive Streptococcus pyogenes and influenza virus infection in the paediatric age: a retrospective population-based study in Catalonia
29/04 12:00
3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives
Victoria RELLO
Poster P1338
Abstract 29
In vitro and in vivo activity of cefiderocol against Elizabethkingia spp. and its resistance mechanisms
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Shu-Chen KUO
Poster P1339
Abstract 58
In vitro activity of cefiderocol against clinical Gram-negative bacteria in Taiwan
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Shu-Chen KUO
Poster P1340
Abstract 173
A retrospective single centre study to access risk factors for colistin-resistant Acinetobacter baumannii (CoR-AB) infection among patients in tertiary care hospital in Thailand
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sureerat WATCHARASUWANSEREE
Poster P1341
Abstract 216
The molecular epidemiology and characterisation carbapenem-resistant Klebsiella pneumoniae among hospitalised patients in Cape Town, South Africa
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Clinton MOODLEY
Poster P1342
Abstract 260
Elucidating the underlying genetic mechanism of amoxicillin-clavulanate resistance in Escherichia coli isolated from a highly anthropogenic urban river
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Nambram SOMENDRO SINGH
Poster P1343
Abstract 265
In vitro activity of ceftazidime-avibactam against ceftazidime-non-susceptible Gram-negative pathogens recovered from hospitalised patients from Germany, Austria and Switzerland, 2019-2020
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Esther WOHLFARTH
Poster P1344
Abstract 289
Diversity of carbapenemase gene localised across different plasmid incompatibility groups among Gram-negative clinical bacteria and antibiotic combinations to combat them
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sangram Singh PATEL
Poster P1345
Abstract 298
Multidrug-resistant invasive nontypeable Haemophilus influenzae in Taiwan: molecular epidemiology, antimicrobial resistance mechanisms
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Tsai-Wen WAN
Poster P1346
Abstract 312
Distribution of ß-lactamase genes among multidrug-resistant and extended-spectrum ß-lactamase-producing diarrheagenic Escherichia coli from under-five children in Ethiopia
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Tizazu ZELELIE
Poster P1347
Abstract 380
Superinfection with carbapenemase-producing organisms in a patient who received treatment in Indonesia
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Satoshi NISHIDA
Poster P1348
Abstract 395
Frequency of carbapenem resistant Providencia stuartii isolation from clinical samples in relation to colistin consumption in the ICU of a tertiary hospital before and during the pandemic (2019-2022)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Charalampos ZARRAS
Poster P1349
Abstract 406
Clonal diversity and antimicrobial resistance of Escherichia coli from a tertiary care hospital in Nepal
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Suchitra THAPA
Poster P1350
Abstract 682
Longitudinal analysis of in vitro activities of aztreonam-avibactam and comparator agents against metallo-β-lactamase-producing Enterobacterales: ATLAS global surveillance program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark ESTABROOK
Poster P1351
Abstract 689
In vitro activity of aztreonam-avibactam and comparator agents against clinical Enterobacterales isolates collected worldwide, stratified by global region as a part of ATLAS global surveillance program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark ESTABROOK
Poster P1352
Abstract 694
In vitro activity of aztreonam-avibactam and comparator agents against Enterobacterales isolates collected from patients in ICU compared to other wards, ATLAS global surveillance program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark ESTABROOK
Poster P1353
Abstract 696
In vitro activity of aztreonam-avibactam and comparator agents against carbapenemase-producing Enterobacterales collected as part of the ATLAS surveillance program: 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1354
Abstract 697
Longitudinal analysis of the in vitro activity of aztreonam-avibactam and comparator agents against Enterobacterales collected globally for the ATLAS surveillance program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark ESTABROOK
Poster P1355
Abstract 801
Activity of the novel combination therapies aztreonam/nacubactam and cefepime/nacubactam against 3,694 clinical isolates of Enterobacterales collected worldwide during 2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Stephen HAWSER
Poster P1356
Abstract 941
Characteristics of E. coli and K. pneumoniae infections in international travellers: a GeoSentinel analysis
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Giacomo STROFFOLINI
Poster P1357
Abstract 942
Antimicrobial activity of aztreonam-avibactam and comparator agents against a large collection of Stenotrophomonas maltophilia isolates collected in Europe, Asia and Latin America (2018-2023)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Helio SADER
Poster P1358
Abstract 964
Clonal diversity and mechanisms of antimicrobial resistance in clinical Pseudomonas aeruginosa strains from northern-western Nigeria
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Yahaya USMAN
Poster P1359
Abstract 966
Characteristics of patients with carbapenem-resistant Enterobacterales infections demonstrating heteroresistance to novel antibiotic combinations
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Christina LIN
Poster P1360
Abstract 1066
Activity of cefiderocol and comparator agents against Difficult-to-Treat Resistant (DTR) Pseudomonas aeruginosa collected during 2020-2022 as part of the SENTRY antimicrobial surveillance program
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Boudewijn DEJONGE
Poster P1361
Abstract 1068
Activity of cefiderocol and comparator agents against difficult-to-treat resistant (DTR) Acinetobacter baumannii-calcoaceticus species complex isolates collected during 2020-2022 as part of the SENTRY antimicrobial surveillance programme
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Boudewijn DEJONGE
Poster P1362
Abstract 1077
Results of nationwide enhanced surveillance on antimicrobial resistance (AMR) in Ukraine: data for July–September of 2023
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Arkadii VODIANYK
Poster P1363
Abstract 1091
High prevalence of faecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales among patients with urinary tract infections in rural Tanzania: preliminary findings
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Magreth MACHA
Poster P1364
Abstract 1164
In vitro activity of aztreonam-avibactam (ATM-AVI) and comparators against Enterobacterales collected worldwide stratified by infection source: ATLAS global surveillance program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1365
Abstract 1165
In vitro activity of ceftazidime-avibactam and comparator agents against KPC-producing Enterobacterales collected globally as a part of the ATLAS global surveillance program from 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark ESTABROOK
Poster P1366
Abstract 1169
In vitro activity of ceftaroline and comparator agents against bacterial pathogens frequently isolated from patients with respiratory tract, skin and soft tissue, and bloodstream infections collected during the ATLAS global surveillance program in 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Meredith HACKEL
Poster P1367
Abstract 1254
In vitro activity of cefiderocol in bloodstream infection isolates from North American and European hospitals: SENTRY 2020-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sean NGUYEN
Poster P1368
Abstract 1315
Occurrence and molecular characterisation of ceftazidime-avibactam resistant Pseudomonas aeruginosa in a hospital in Lisbon, Portugal
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Samanta FREIRE
Poster P1369
Abstract 1320
Genomics of a surge in VIM-carbapenemase-producing Enterobacterales in a London hospital network
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Elita JAUNEIKAITE
Poster P1370
Abstract 1348
Surveillance of cefiderocol activity against carbapenem-resistant Gram-negative clinical isolates in a tertiary care hospital
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sreekanthreddy BASIREDDY
Poster P1371
Abstract 1384
Genomic study of high-risk clones of Enterobacter hormaechei collected from tertiary hospitals in United Arab Emirates
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Akela Ahmed GHAZAWI
Poster P1372
Abstract 1410
Activity of a combination of ceftolozane and tazobactam in vitro against ESBL-producing Enterobacterales in China: SMART 2016 – 2019
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Qiwen YANG
Poster P1373
Abstract 1461
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care centre in a developing country
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Banan AIESH
Poster P1374
Abstract 1600
The activity of cefiderocol and comparator agents against uncommon Gram-negative isolates collected during 2020-2022 as part of the SENTRY antimicrobial surveillance programme
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Christopher LONGSHAW
Poster P1375
Abstract 1607
Spontaneous frequency of resistance to meropenem/ANT3310 in carbapenem-resistant Enterobacterales and Acinetobacter baumannii
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Agustina LLANOS
Poster P1376
Abstract 1659
Epidemiologic and trend changes in antimicrobial resistance in Pseudomonas aeruginosa: a regional five-year time-lapse study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Lucía HENRÍQUEZ MEDEROS
Poster P1377
Abstract 1670
Molecular features of carbapenem-producing Enterobacteriaceae strains: a regional multicenter genomic surveillance study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Lucía HENRÍQUEZ MEDEROS
Poster P1378
Abstract 1737
In vitro activity of aztreonam-avibactam against MBL-producing Enterobacterales isolates across Germany
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Esther WOHLFARTH
Poster P1379
Abstract 1782
E. coli-ST131-blaCTX-M-15 and K. pneumoniae-ST1- blaNDM-1 strains in Tunisia: a report of genetic surveillance of Enterobacteriaceae from diabetic foot infections
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Klibi NAOUEL
Poster P1380
Abstract 1822
Carbapenem and colistin resistant Acinetobacter spp. cultured from hospital sanitary ware
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Shannon CARTER
Poster P1381
Abstract 1843
Epidemiology of Citrobacter infections among hospitalised patients: a systematic review and meta-analysis
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Pérince FONTON
Poster P1382
Abstract 1884
Gut Escherichia coli of healthy humans and animals are reservoirs of critical antimicrobial resistance genes: a meta-analysis
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Islem TRABELSI
Poster P1383
Abstract 1910
Heteroresistance to piperacillin-tazobactam in Klebsiella pneumoniae is mediated by amplification of multiple beta-lactamase genes
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ahmed BABIKER
Poster P1384
Abstract 2058
Genomic features of carbapenem-resistant Klebsiella pneumoniae isolated in French Polynesia and novel transposon responsible for blaNDM-1 dissemination
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Huynh Ngoc Tram VO
Poster P1385
Abstract 2072
Culture positivity and antimicrobial susceptibility profile of Helicobacter pylori isolates from 2009-2023 in Vancouver, Canada.
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Hasan HAMZE
Poster P1386
Abstract 2112
Epidemiology of carbapenemases in carbapenemase producing Klebsiella spp., and Pseudomonas spp. strains isolated from a tertiary hospital in Athens, Greece during 2020-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Eleni VOUDANTA
Poster P1387
Abstract 2305
The impact of peri-COVID-19 antibiotic prescribing on downstream antimicrobial resistance: a population-based cohort study ?
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Derek MACFADDEN
Poster P1388
Abstract 2335
Prevalence and characteristics of carbapenem-resistant Enterobacterales in 23 hospitals in Nara City, Japan from 2018 to 2020: predominance of IMP-6 carbapenemase
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ryuichi NAKANO
Poster P1389
Abstract 2339
Surveillance report (ATLAS) on antimicrobial activity of aztreonam-avibactam and comparator agents tested against metallo-β-lactamase (MBL)-positive carbapenem-resistant E. coli and Klebsiella spp. isolated from India (2020-2021)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Akshata MANE
Poster P1390
Abstract 2347
Epidemiology of carbapenem-resistant Klebsiella pneumoniae reveals a crisis of the resistance and virulence convergence in China
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Qiucheng SHI
Poster P1391
Abstract 2354
Coexistence of seven different carbapenemase producers in one patient upon hospital admission confirmed by whole-genome sequencing
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Frieder FUCHS
Poster P1392
Abstract 2384
Antimicrobial resistance profile of Helicobacter pylori in a large tertiary hospital in Singapore from 2004 to 2023
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Azhar HAMDAN
Poster P1393
Abstract 2405
Unlocking the iron gate: cefiderocol's efficacy against Acinetobacter baumannii biofilms
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ilaria CAVALLO
Poster P1394
Abstract 2445
Antimicrobial susceptibility trends of multidrug-resistant Pseudomonas aeruginosa in Africa
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Yogandree RAMSAMY
Poster P1395
Abstract 2500
Impacts and management of carbapenem-resistant and hypervirulent Klebsiella pneumoniae infection on gut health
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Hongyuhang NI
Poster P1396
Abstract 2523
Clinical relevance, mechanisms and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: a genomic, retrospective cohort study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Qixia LUO
Poster P1397
Abstract 2587
Trends in Klebsiella pneumoniae antimicrobial susceptibility in Africa: phenotypic and genotypic regional analyses, 2005-2021
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Trusha NANA
Poster P1398
Abstract 2619
In vitro activity of aztreonam-avibactam and cefiderocol against metallo-β-lactamase-producing Enterobacterales
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Anna DUDAKOVA
Poster P1399
Abstract 2647
In vitro activity of ceftibuten/avibactam and comparator agents against Enterobacterales collected globally as part of the ATLAS surveillance programme, 2022 by β-lactamase carriage
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark ESTABROOK
Poster P1400
Abstract 2671
In vitro activity of ceftibuten-avibactam and comparator agents against Enterobacterales collected globally as part of the ATLAS Surveillance Program, 2022 by length of stay
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Meredith HACKEL
Poster P1401
Abstract 2724
In vitro activity of aztreonam/avibactam and comparator agents against multidrug-resistant Enterobacterales collected globally as part of the ATLAS Surveillance Program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Meredith HACKEL
Poster P1402
Abstract 2735
Molecular epidemiology and genomic comparison of ST191/195/208 and other types of Acinetobacter baumannii in eastern China
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Yonghong XIAO
Poster P1403
Abstract 2776
Activity of aztreonam/avibactam against a panel of multi-drug resistant Klebsiella pneumoniae
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Jamie MURPHY
Poster P1404
Abstract 2860
Screening sites for detection of carbapenemase-producers: a retrospective cohort study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Isabelle VOCK
Poster P1405
Abstract 2901
Co-existence of extended-spectrum β-lactamases and carbapenemases in neonatal Klebsiella pneumoniae isolates from a children's specialized hospital in Cairo, Egypt
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Marwa ABOU-GALIEL
Poster P1406
Abstract 2902
Activity of cefiderocol against carbapenem non-susceptible Enterobacterales, including molecularly characterised clinical isolates causing infection in hospitals in European and adjacent regions (2020–2022)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Rodrigo E. MENDES
Poster P1407
Abstract 2937
Molecular characterisation of carbapenem-resistant Enterobacteriaceae isolated from military Ukrainian patients in a tertiary hospital in Zaragoza, Spain
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Miriam LATORRE-MILLÁN
Poster P1408
Abstract 3001
Surveillance of carbapenemase-producing Enterobacterales in six medical centres in Germany between 2015 and 2021: results from the DIOGENES study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Janko SATTLER
Poster P1409
Abstract 3050
Double beta-lactam therapy in ESBL+CPE+E. Coli isolates - what is the relationship between synergy, penicillin-binding protein activity, and in vitro susceptibility?
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Joseph SUICH
Poster P1410
Abstract 3085
Prevalence and characteristics of third-generation cephalosporin-resistant Escherichia coli isolated from deer at a tourist area in Japan
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Akiyo NAKANO
Poster P1411
Abstract 3101
Molecular epidemiology of carbapenem-resistant Gram-negative isolates obtained from clinical samples at Jimma Medical Center, Ethiopia
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mulatu Gashaw ADBARU
Poster P1412
Abstract 3205
Characterisation of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli isolates from bloodstream infections in a tertiary care hospital in south India and their susceptibility to ceftazidime-avibactam
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Anna KURIAN
Poster P1413
Abstract 3314
Genomic analysis of blaOXA-48 plasmids in a single hospital in Singapore over ten years
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Dennis LOY
Poster P1414
Abstract 3377
Decoding genetics of AMR genes in human pathogens for rapid diagnostic test development
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Tanshi MEHROTRA
Poster P1415
Abstract 3421
60 years of evolution in Bacteroides fragilis antimicrobial resistance
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Flemming Damgaard NIELSEN
Poster P1416
Abstract 3427
Emerging resistance against new antibiotics in carbapenem resistant Pseudomonas aeruginosa infections
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Fatihan PINARLIK
Poster P1417
Abstract 3447
Clinical profile and outcome of nosocomial Stenotrophomonas maltophilia infection among adult patients in a tertiary hospital: a five-year retrospective study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ralph Bryan HERNANDEZ
Poster P1418
Abstract 3464
Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022-2023
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Jacqueline FINDLAY
Poster P1419
Abstract 3477
Use of antipseudomonal antibiotics and prevalence of multiple drug resistance (MDR) in Pseudomonas aeruginosa (PA): a time series analysis in hospitalised patients
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
José Antonio MARTÍNEZ
Poster P1420
Abstract 3489
In vitro activity of cefiderocol against carbapenem-resistant Pseudomonas aeruginosa (CRPA) clinical isolates from countries with high CRPA incidence, 2019-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Renata DA COSTA
Poster P1421
Abstract 3538
In vitro activity of eravacycline against Enterobacterales and non-fermenter clinical isolates, including resistant isolates, collected in Europe during 2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Stephen HAWSER
Poster P1422
Abstract 3545
Fosfomycin resistance in E. coli ST131: an emerging Italian threat
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Vittoria MATTIONI MARCHETTI
Poster P1423
Abstract 3658
In-depth genomic analysis of two Acinetobacter baumannii isolates from the same patient
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Linda Alexandra CASSELMANN
Poster P1424
Abstract 3683
Characterising a cluster of NDM-5-positive Escherichia coli clinical isolates
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Rocío ARAZO DEL PINO
Poster P1425
Abstract 3698
Carbapenem-resistant Pseudomonas aeruginosa prevailing among the hospitals in Czech Republic: the evolution of a regional menace
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Tsolaire SOURENIAN
Poster P1426
Abstract 3702
Genotypes of ESBL-producing Escherichia coli isolated from lower respiratory tract samples before and during the COVID-19 pandemic (2017–2022)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Katja HROVAT
Poster P1427
Abstract 3708
In vitro activity of cefiderocol against carbapenemases-OXA-type producing Acinetobacter baumannii clinical strains: a report of six Italian laboratories
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mariagrazia PERILLI
Poster P1428
Abstract 3724
Frequent high-level rifaximin resistance in Escherichia coli associated with long-term treatment of patients with hepatic cirrhosis – a prospective, controlled study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Johannes CAMP
Poster P1429
Abstract 3729
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against a Spanish nationwide collection of double carbapenemase-producing Enterobacterales
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Tania BLANCO MARTÍN
Poster P1430
Abstract 3772
Acquisition and loss of carriage of antimicrobial resistant Enterobacterales among vulnerable children Africa and Asia
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Caroline TIGOI
Poster P1431
Abstract 3799
Effect of glyphosate and antibiotic combinations on ESKAPEE Gram-negative bacteria
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Hanane ZERROUKI
Poster P1432
Abstract 3845
Antimicrobial resistance and genomic insights into Campylobacter spp. isolated from Australian meat chickens
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sam ABRAHAM
Poster P1433
Abstract 3868
Emergence of Klebsiella pneumoniae ST307 colistin resistant and co-producing NDM-5 and CTX-M-15 in Uruguay
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Carmen MAGALLANES
Poster P1434
Abstract 4103
In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates from countries with high CRAB incidence, 2019-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Renata DA COSTA
Poster P1435
Abstract 4111
Emerging cefiderocol resistance in carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Jale BORAL
Poster P1436
Abstract 4158
TROJAN-BMR: in vitro activity of cefiderocol and its comparators on multidrug-resistant Enterobacterales and Pseudomonas aeruginosa strains in South of France, performance of available testing methods
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Massinissa BENYAHIA
Poster P1437
Abstract 4171
Exploring multidrug resistance patterns in community acquired E. coli urinary tract infections with machine learning
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Elise HODBERT
Poster P1438
Abstract 4178
Activity of new β-lactamases inhibitors/antibiotic combination and cefiderocol against carbapenems resistant Pseudomonas aeruginosa strains
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Elena ADDIS
Poster P1439
Abstract 4216
Activity of aztreonam-avibactam and comparator agents against a global collection of MBL-producing Enterobacterales
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mariana CASTANHEIRA
Poster P1440
Abstract 4247
High frequency of CTX-M-115 and OXA-72 in ST78 Acinetobacter baumannii
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Paul G HIGGINS
Poster P1441
Abstract 4262
Activity of gepotidacin against Klebsiella pneumoniae, including molecularly characterised fluoroquinolone not susceptible subsets causing urinary tract infections in Europe and adjacent regions (2019-2022)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Rodrigo E. MENDES
Poster P1442
Abstract 4264
Activity of aztreonam-avibactam and comparator agents against Enterobacterales collected from patients with presumed hospital- and community-acquired infections: ATLAS Global Surveillance Program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1443
Abstract 4300
In vitro activity of ceftazidime-avibactam and comparator agents against Enterobacterales and Pseudomonas aeruginosa stratified by infection source and patient age: ATLAS Global Surveillance Program, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1444
Abstract 4302
Prevalence and genetic background of trimethoprim-sulfamethoxazole and levofloxacin resistance in Stenotrophomonas maltophilia
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Céline SAKR
Poster P1445
Abstract 4304
Activity of sulbactam/durlobactam against a panel of multi-drug resistant Acinetobacter baumannii
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Zhayne HACKETT
Poster P1446
Abstract 4348
In vitro activity of cefiderocol against carbapenem-resistant Enterobacterales (CREs) clinical isolates from countries with high CRE incidence, 2019-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Renata DA COSTA
Poster P1447
Abstract 4369
Antimicrobial resistance in Helicobacter pylori: a ten-year perspective from the national gastrointestinal bacteria reference unit, UK Health Security Agency, United Kingdom
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Vanessa WONG
Poster P1448
Abstract 4387
Activity of cefiderocol and comparator agents against isolates from paediatric patients collected during 2020-2022 as part of the SENTRY antimicrobial surveillance program
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sean NGUYEN
Poster P1449
Abstract 4392
Aztreonam-avibactam resistance is lower than cefiderocol resistance in recent carbapenemase-positive Enterobacterales from the German National Reference Centre (NRC) for multidrug-resistant Gram-negative bacteria
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Agnes ANDERS
Poster P1450
Abstract 4400
Antimicrobial activity of cefepime in combination with taniborbactam against resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Europe, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Meredith HACKEL
Poster P1451
Abstract 4453
Activity of cefepime-taniborbactam and comparators against Enterobacterales and Pseudomonas aeruginosa with defined β-lactamase carriage collected in Europe, 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1452
Abstract 4473
Is imipenem a good option for treatment of erythromycin-resistant Campylobacter coli infections?
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Laura PÉREZ FERNÁNDEZ
Poster P1453
Abstract 4500
Rising prevalence of ST15-KL19 carbapenemase-producing Klebsiella pneumoniae in post-COVID-19 in Portugal
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Poster P1454
Abstract 4637
Genomics of a global collection of Klebsiella pneumoniae reveals multiple routes for the emergence of convergent lineages
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Anjali SAPRE
Poster P1455
Abstract 4705
Susceptibility of ESBL-producing, carbapenemase-negative clinical Enterobacterales isolates from eastern Europe to ceftolozane/tazobactam and comparator antibiotics: SMART 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1456
Abstract 4731
Activity of ceftolozane/tazobactam and comparators against ESBL-producing, carbapenemase-negative clinical Enterobacterales isolates from the Middle East/Africa region: SMART 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1457
Abstract 4736
A new problem for the Romanian healthcare system: the emergence of Stenotrophomonas maltophilia
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Alin-Stefan VIZITIU
Poster P1458
Abstract 4758
Rising of ArmA and OXA-23 co-occurrence in Acinetobacter baumannii ST2: an increasingly challenging scenario for antibiotic resistance management in Europe
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Paula GUIJARRO
Poster P1459
Abstract 4769
Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from hospitalised patients in South Africa: SMART 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1460
Abstract 4796
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Pseudomonas aeruginosa from hospitalised patients in Israel: SMART 2018-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1461
Abstract 4815
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Pseudomonas aeruginosa from latin America: SMART 2020-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mark WISE
Poster P1462
Abstract 4892
Unraveling cefiderocol resistance in Acinetobacter baumannii: a genomic perspective on in vivo adaptations
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sara CARLONI
Poster P1463
Abstract 4895
Extensively drug-resistant Acinetobacter baumannii in an intensive care burn center unit in Uruguay: molecular epidemiology and synergy in colistin resistant strains.
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Matilde OUTEDA
Poster P1464
Abstract 4919
Antibiotic susceptibility and molecular resistance mechanisms in Escherichia coli and Klebsiella pneumoniae isolates from Peruvian hospitals: a focus on cefiderocol
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Joaquin RUIZ BLAZQUEZ
Poster P1465
Abstract 4934
Relebactam enhances the activity of imipenem against Burkholderia cepacia complex isolates SMART 2020-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Katherine YOUNG
Poster P1466
Abstract 4956
Antimicrobial susceptibility of Stenotrophomonas maltophilia clinical isolates and genotypic analysis of cotrimoxazole resistance
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Patricia Luisa GÓMEZ SASTRE
Poster P1467
Abstract 4991
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Laura DABOS
Poster P1468
Abstract 5046
Multidrug-resistant, extensively drug-resistant and pan drug resistance Gram-negative orthopedic implant-associated infections: role of carbapenemase production
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mariana NERI LUCAS KURIHARA
Poster P1469
Abstract 5180
Phenotypic and genotypic characterization of ertapenem-mono-resistant carbapenem-resistant Enterobacterales
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Yinping WANG
Poster P1470
Abstract 5218
Epidemiologic, clinical profile and antibiotic sensitivity and resistance pattern of melioidosis at Southern Isabela Medical Centre, Santiago City, Philippines
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Maria Jonelyn MENDOZA-COLOBONG
Poster P1471
Abstract 5271
Multi-institute analysis of carbapenem-resistant Enterobacterales reveals rapid changes in resistance mechanisms over time
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Nicoletta COMMINS
Poster P1472
Abstract 5278
Molecular genetic analysis of extended-spectrum β-lactamase(ESBL)-producing Escherichia coli isolated from outpatients at a tertiary care emergency centre
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Yasumitsu NOMURA
Poster P1473
Abstract 5285
Epidemiology of Klebsiella pneumoniae and their plasmids through the last decade in the United States
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ting LUO
Poster P1474
Abstract 5316
Susceptibility levels to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB) from Peruvian hospitals
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Rosario Del Pilar HUERTO HUÁNUCO
Poster P1475
Abstract 5431
In vitro evaluation of antibiotic combinations against Acinetobacter baumannii isolated from bloodstream infections in Indian intensive care units
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Manasa Chandrashekar TANTRY
Poster P1476
Abstract 5434
Antibiotic resistance patterns of Pseudomonas aeruginosa in a community-based hospital in Korea: the role of ceftazidime-avibactam
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Hyo-Jin LEE
Poster P1477
Abstract 5508
Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Yumiko HOSAKA
Poster P1478
Abstract 5519
Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol in carbapenem-resistant Pseudomonas aeruginosa
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ecem BUYUKYANBOLU
Poster P1479
Abstract 5572
High prevalence of hypervirulence-associated genes in carbapenemase-producing Klebsiella pneumoniae isolates in Hungary
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Akos TOTH
Poster P1480
Abstract 5677
Unnoticeable resistant pathogen Stenotrophomonas maltophilia: antimicrobial resistance, virulence and biofilm production
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Seyma Aybüke ÖZYAR KURTÇU
Poster P1481
Abstract 5703
Phenotypic characteristics of multidrug-resistant bacteria from five Ukrainian war-trauma patients
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Diana Isabela STRACHINARU
Poster P1482
Abstract 5713
In vitro activity of cefepime-enmetazobactam against OXA-48-like carbapenemase producing Enterobacterales collected in France
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Laurent DORTET
Poster P1483
Abstract 5720
Antimicrobial resistance of Shigella spp. in south Australia and its detection using whole genome sequencing
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Helena TORPY
Poster P1484
Abstract 5731
Distribution of resistance determinants among the most prevalent clones of Campylobacter jejuni according to cgMLST scheme
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Pablo FERNÁNDEZ PALACIOS
Poster P1485
Abstract 5796
Epidemiology of IMI-type-carbapenemase-producing E. cloacae complex in France from 2012 to 2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Cécile EMERAUD
Poster P1486
Abstract 5858
High levels of antimicrobial resistance among common bacterial pathogens in Indonesia: a systematic review
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Raph HAMERS
Poster P1487
Abstract 5890
Characterisation of carbapenemase-producing Klebsiella pneumoniae isolates in a hospital in Madrid (Spain) before and during COVID-19 pandemic
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Marta NIETO TORRES
Poster P1488
Abstract 5908
Plasmid-driven epidemiology: unravelling carbapenem resistance transmission in hospital setting
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Dominique S. BLANC
Poster P1489
Abstract 6010
A five-year trend analysis of epidemiology and susceptibility of Salmonella species in a tertiary care centre, South India
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Jaya PRASANTHI
Poster P1490
Abstract 6018
Russian-Ukraine war raised antibiotic resistance and Gram-negative infections of wounds in Ukraine
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Kateryna RUDNIEVA
Poster P1491
Abstract 6024
The global burden of infections caused by metallo-β-lactamase- producing carbapenem-resistant Enterobacterales: results of a targeted literature review
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Maria GHEORGHE
Poster P1492
Abstract 6082
Identification of regional, interregional, and international dissemination events of Klebsiella pneumoniae clones from Portugal
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Rita ELIAS
Poster P1493
Abstract 6084
Clonal dissemination of a trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia harbouring the carbapenemase gene blaIMP in a clinical setting
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Esther ALMAZÁN GÁRATE
Poster P1494
Abstract 6093
A melanin-producing Acinetobacter baumannii outbreak: the first report in EU area
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Alessandro LEONILDI
Poster P1495
Abstract 6111
Clinical characteristics of patients with reported acquired carbapenemase-producing Gram-negative bacteria in England, October 2020 – April 2023
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Emily MASON
Poster P1496
Abstract 6122
Phenotypic and genotypic characterisation of colistin-resistant Escherichia coli isolates from poultry farms in Uganda
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ulrike BINSKER
Poster P1497
Abstract 6131
Within-host chromosomal diversity of extended-spectrum beta-lactamase-producing Escherichia coli during long-term carriage
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Karlijn HOUKES
Poster P1498
Abstract 6218
Colonisation rates of hospitalised patients with carbapenem resistant pathogens in a Greek hospital: a single centre, point prevalence study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Nikolaos SIPSAS
Poster P1499
Abstract 6222
Azithromycin mitigates PDR phenotype and improves sensitivity to meropenem in PDR Klebsiella pneumoniae biofilms
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Olena MOSHYNETS
Poster P1500
Abstract 6263
Emergence of extensively drug-resistant hypervirulent Acinetobacter baumannii ST2 in Taiwan, a 16-year study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Pek Kee CHEN
Poster P1501
Abstract 6414
Epidemiological profile and antimicrobial resistance of non typhoidal Salmonella isolates in children in Tunis 2000-2022
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Eya ANANE
Poster P1502
Abstract 6428
Evolution of betalactam susceptibility and penA polymorphism in invasive meningococcal disease in a Tunisian pediatric population (2009-2019)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Dhouha KARRAY
Poster P1503
Abstract 6436
Bacteriological profile of carbapenem-resistant organism colonisation and infections among inpatients at a national spinal injuries unit: a five-year retrospective study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Melanie ETTI
Poster P1504
Abstract 6442
Carbapenem-resistant Acinetobacter baumannii causing healthcare-associated bloodstream infections in Hungary in 2018-2019 and in 2020-2021: epidemiological and genomic epidemiological aspects
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Adrienn HANCZVIKKEL
Poster P1505
Abstract 6458
Road to success in a quality improvement activity for the detection of carbapenemase producing Enterobacterales in a tertiary care hospital in the United Kingdom
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Gammanpila I. ATHUKORALA
Poster P1506
Abstract 6500
Characterisation of beta-lactam resistance among H. influenzae in Switzerland
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Dominique HILTI
Poster P1507
Abstract 6505
National surveillance of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii circulating in Belgian hospitals, 2023
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Denis OLIVIER
Poster P1508
Abstract 6546
In vitro antibiotic susceptibility of Vibrio parahaemolyticus strains isolated in Southern Spain
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sandra TAPIA-POZA
Poster P1509
Abstract 6578
Prevalence of carbapenem-resistant Enterobacteriaceae (CRE) among various specimen received at Kwazulu-Natal Academic Hospital, South Africa: a retrospective study
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Afsana KAJEE
Poster P1510
Abstract 6656
Carbapenemases in Germany in 2023: report of the German national reference centre for multidrug-resistant Gram-negative bacteria
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Niels PFENNIGWERTH
Poster P1511
Abstract 6738
Carbapenem-resistant Escherichia coli: the results of 1-year WGS surveillance in a northern Italy hospital
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Aurora PIAZZA
Poster P1512
Abstract 6779
In vitro activity of newly-developed ß-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-ß-lactamase producing Escherichia coli clinical isolates
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Clement VIGUIER
Poster P1513
Abstract 6781
In vitro evaluation of incremental avibactam concentrations on ceftazidime activity against ceftazidime/avibactam susceptible and resistant KPC-producing Klebsiella pneumoniae clinical isolates
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Paolo GAIBANI
Poster P1514
Abstract 6898
Efficacy in the use of beta-lactamase inhibitors compared to other antimicrobials in carbapenem-resistant Acinetobacter baumannii infections
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Maria LIMA
Poster P1515
Abstract 6947
Genomic epidemiology of Klebsiella pneumoniae in the Comunitat Valenciana, Spain (2017-2019)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Fernando GONZALEZ-CANDELAS
Poster P1516
Abstract 7115
Unraveling the impact of COVID-19: a comprehensive study on Pseudomonas aeruginosa and carbapenem-resistant strains in Italian ICUs
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Giovanni SCAGLIONE
Poster P1517
Abstract 7172
Comparison of resistance profiles of extended-spectrum β-lactamase-producing Escherichia coli from two poultry production systems in Uganda
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ulrike BINSKER
Poster P1518
Abstract 7319
Clinical and microbiological characterisation of infections by Stenotrophomonas maltophilia in a university hospital in Chile in 2021
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Patricio ROSS
Poster P1519
Abstract 7355
Polymyxin and meropenem resistance in clinical Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii isolates and respective outcomes in patients treated at a tertiary hospital
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Carlos KIFFER
Poster P1520
Abstract 7406
In vitro activity of funobactam (XNW4107) combined with imipenem against Gram-negative isolates collected in 2021
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Jianguo LI
Poster P1521
Abstract 7445
Epidemiological and clinical characteristics of infected and colonised patients with carbapenem-resistant Enterobacterales in a university hospital of Colombia: are coproductions relevant?
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sandra Milena GUALTERO TRUJILLO
Poster P1522
Abstract 1718
In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany, 2022/23
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Esther WOHLFARTH
Poster P1523
Abstract 7592
Antimicrobial resistance surveillance of Pseudomonas aeruginosa invasive isolates in Catalonia (Spain) in the 2016-2022 period
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Pilar CIRUELA
Poster P1524
Abstract 7703
Molecular epidemiology and genomic insights into cefiderocol-resistant carbapenemase-producing Citrobacter spp. isolates obtained in Barcelona
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Guillem PUIGSECH BOIXEDA
Poster P1525
Abstract 7911
Epidemiology and antimicrobial susceptibility pattern of Klebsiella pneumoniae isolated from clinical samples in Poland
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Elzbieta LITERACKA
Poster P1526
Abstract 7924
Prevalence of carbapenemase-producing enterobacteriaceae in kidney transplant patients
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ariane BAPTISTA MONTEIRO
Poster P1527
Abstract 7997
Presence of multidrug-resistant Acinetobacter kanungonis with blaIMP-16, blaGES-1 and blaOXA-143 in the Aurá river, Amazon, Brazil
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Poster P1528
Abstract 8018
Faecal carriage of carbapenemase-producing Enterobacteriaceae among patients admitted to tertiary hospital in Havana, Cuba
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Dianelys QUINONES PEREZ
Poster P1529
Abstract 8022
CORE-MDR study: contact isolation removal evaluation on multidrug-resistant bacterial infections in India
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Sureshkumar DORAIRAJAN
Poster P1530
Abstract 8061
Integrating genetic and epidemiological data supported the investigation of spatiotemporally dispersed genetic clusters and a local outbreak of NDM-1 producing Klebsiella pneumoniae in Germany, 2022-2023
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mirco SANDFORT
Poster P1531
Abstract 8068
Emerging metallo-β-lactamase producing Klebsiella oxytoca complex in Taiwan: a decade-long analysis
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Chou CHIAHUA
Poster P1532
Abstract 8081
Comparison of gene-by-gene and SNPs analysis for typing of K. pneumoniae ST512/KPC-3 genomes from southern Spain
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Mercedes DELGADO VALVERDE
Poster P1533
Abstract 8167
Recurrence rate carbapenemase-producing Enterobacterales (CPE) after clearance
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ji Hye PARK
Poster P1534
Abstract 8244
Are ceftolozane/tazobactam and imipenem/relebactam potential options to overcome the threat of Gram-negative bacterial infections in Portugal? SMART 2018-21
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Hugo CRUZ
Poster P1535
Abstract 8252
Colonisation by multidrug-resistant Gram-negative bacteria in acute graft-versus-host disease
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Aleksandr SINIAEV
Poster P1536
Abstract 8261
AMRnet: unlocking pathogen genomics data for AMR surveillance
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Megan Elizabeth CAREY
Poster P1537
Abstract 8339
Antimicrobial susceptibility rates and carbapenemase types of carbapenem-resistant Klebsiella pneumoniae isolated over a six-year period
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Selin Gamze KILIC SINCI
Poster P1538
Abstract 8385
Genetic analysis of carbapenem resistant Acinetobacter baumannii isolates associated with the war in Ukraine
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Jessica EISFELD
Poster P1539
Abstract 8386
Multidrug-resistance Enterobacteriaceae isolated from meats marketed in El Tarf, Algeria
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Zineb BELBEL
Poster P1540
Abstract 8394
Genomics of clinical extensively drug-resistant Enterobacteriaceae strains isolated in Dakar, Senegal
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Komla Mawunyo DOSSOUVI
Poster P1541
Abstract 8472
Prevalence of plasmid-mediated AmpC in Enterobacterales clinical isolates
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Patricia Luisa GÓMEZ SASTRE
Poster P1542
Abstract 8477
Co-existence of two blaNDM-5 and blaOXA-181 on distinct plasmids in carbapenem-resistant Klebsiella pneumoniae isolates a tertiary hospital, Tanzania
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Joel MANYAHI
Poster P1543
Abstract 8480
The changing epidemiology of carbapenem-resistant Klebsiella pneumoniae in Serbia: the expansion of the high-risk clone ST147/blaNDM-1
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Ina GAJIC
Poster P1544
Abstract 8567
One year surveillance of carbapenem-resistant Enterobacterales: the impact of WGS
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Cristina MERLA
Poster P1545
Abstract 8601
Comparative analysis of the multidrug-resistant Acinetobacter baumannii ST492 Romanian isolates in a global context
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Marius SURLEAC
Poster P1546
Abstract 8726
Evaluation of new and old drugs for the management of complicated urinary tract infection in the era of MDR and XDR Gram-negative Bacilli in Oman
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Nawal AL SHIZAWI
Poster P1547
Abstract 8824
Multidrug-resistant carbapenemase-producing Acinetobacter species in hospitals from Brazilian Amazon region during the COVID-19 pandemic
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Danielle BRASILIENSE SELIGMANN
Poster P1548
Abstract 8908
Genomic characterisation of colistin-resistant clinical isolates of Klebsiella pneumoniae from Tahiti (French Polynesia)
29/04 12:00
3b. Resistance surveillance & epidemiology: Gram-negatives
Nadia AMRAOUI
Poster P1549
Abstract 67
Multivariable evaluation of in vitro erformance of ceftolozane/tazobactam, ceftazidime/avibactam, imipenem/relebactam & cefiderocol on difficult-to-treat Pseudomonas aeruginosa isolated from clinical samples
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jose ALEXANDER
Poster P1550
Abstract 186
Dual E-test overlay method to screen multi-drug resistant Gram-negative bacteria for synergy with meropenem-vaborbactam and aztreonam
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Oliver FLETCHER
Poster P1551
Abstract 269
Multicentre interlaboratory study of routine systems for the susceptibility testing of temocillin using a challenge panel of multidrug-resistant strains
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Corentin DECKERS
Poster P1552
Abstract 436
Sub-MIC antibiotic pre-exposure increased the single-cell MIC and promoted hetero-resistance in bacteria
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Shakeel AHMAD
Poster P1553
Abstract 535
Rapid antimicrobial susceptibility testing using automated broth microdilution: performance evaluation of a four-hours bacterial cultivation from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Barbara KÖRBER-IRRGANG
Poster P1554
Abstract 753
Comparison of two commercial broth microdilution panels for AST of multidrug-resistant Gram-negative bacteria
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Antoine AUPAIX
Poster P1555
Abstract 763
Performance of a commercial assay for the detection and classification of OXA-48 producing-Escherichia coli isolates that do not co-produce ESBL/pAmpC
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Fátima GALÁN-SÁNCHEZ
Poster P1556
Abstract 805
Evaluation of gradient strip diffusion for measuring the minimum inhibitory concentration of aztreonam/avibactam in metallo-beta-lactamase producing Enterobacterales
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jamie LEMON
Poster P1557
Abstract 893
Development and evaluation of gradient strip-based synergy testing methods to determine susceptibility of carbapenem-resistant Gram-negative organisms to the aztreonam (ATM) and ceftazidime-avibactam (CZA) combination
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Carmila MANUEL
Poster P1558
Abstract 1103
Rapid antimicrobial susceptibility testing by SdFFF directly from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Linda TLILI
Poster P1559
Abstract 1183
Identification of in vitro susceptibility test interpretive criteria (STIC) for sulfamethoxazole (SMX)-trimethoprim (TMP) against Escherichia coli and Klebsiella pneumoniae
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Brian VANSCOY
Poster P1560
Abstract 1318
Evaluation of a new gradient MIC test for aztreonam/avibactam (AZA) susceptibility testing of Enterobacterales
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Maxime BOUVIER
Poster P1561
Abstract 1476
Adaptation of the updated CA-SFM 2022 algorithm for screening of carbapenemase-producing Enterobacterales on automated antibiotic susceptibility test instrument
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Charles GIBERT
Poster P1562
Abstract 1487
Rapid antimicrobial susceptibility testing of urinary tract infection bacteria using an innovative technology: scattered light integrated collector
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Hellen ONYANGO
Poster P1563
Abstract 1492
Minimal inhibitory concentrations (MICs) of tigecycline correlate strongly with those of omadacycline
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Vinicius CALADO
Poster P1564
Abstract 1495
Validation of aztreonam-avibactam MIC antimicrobial susceptibility test for MicroScan dried Gram-negative MIC panels from a multicenter assessment of Enterobacterales, Pseudomonas species, and Stenotrophomonas maltophilia
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Christine HASTEY
Poster P1565
Abstract 1551
Evaluation of a rapid antibiotic susceptibility testing system on multidrug-resistant Gram-negative bacteria responsible for non-bloodstream infections: preliminary data
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Paolo BOTTINO
Poster P1566
Abstract 1575
A comparative study of the specific REVEAL vs the VITEK2 system in susceptibility testing of NDM-producing Enterobacterales directly from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Amos ADLER
Poster P1567
Abstract 1610
Evaluation of the equivalency of the oxoid aztreonam/avibactam (30/20 μg) antimicrobial susceptibility testing disc to the CLSI M07 broth microdilution frozen reference method
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
James BOVILL
Poster P1568
Abstract 1664
Performance of a novel holographic imaging system for rapid susceptibility testing directly from Gram-negative positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Dulini GAMAGE
Poster P1569
Abstract 1806
VITEK reveal, a new fast, phenotypical antimicrobial susceptibility testing from positive blood culture: a real-life experience in a tertiary care hospital from Spain
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Josué PENDONES ULERIO
Poster P1570
Abstract 1810
Comparison of three MIC gradient tests with the disk diffusion method for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Andrea ZAPPAVIGNA
Poster P1571
Abstract 1826
Rapid AST directly from blood culture bottles is now possible on lab automation: a performance study
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Matteo LUCCHINI
Poster P1572
Abstract 1858
Disc diffusion test is reliable in detecting penicillin susceptibility in Staphylococcus aureus bacteraemia
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Pernilla KIHLBERG
Poster P1573
Abstract 2018
Can EUCAST rapid antibiotic susceptibility testing be considered for Salmonella enterica? A pilot study
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Gunnar KAHLMETER
Poster P1574
Abstract 2258
New insights in therapeutic options against difficult-to-threat Pseudomonas aeruginosa (DTR-PA): in vitro activity of aztreonam in combination with avibactam, relebactam and in double β-lactams combinations with ceftazidime/avibactam and imipenem/relebactam
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Fernando PASTERAN
Poster P1575
Abstract 2349
Multicentre evaluation of a newly developed rapid antibiotic susceptibility testing automated system with three-hours MIC results using commonly encountered Gram-negative organisms in Chinese clinical microbiology laboratories
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Ming YANG
Poster P1576
Abstract 2372
Susceptibility testing for Enterococcus species other than E. faecalis and E. faecium using EUCAST methodology and breakpoints
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jenny AHMAN
Poster P1577
Abstract 2391
Multicentre evaluation of a newly developed rapid antibiotic susceptibility testing automated system with 3-hours MIC results using commonly encountered gram-negative organisms in Chinese clinical microbiology laboratories
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Enhua SUN
Poster P1578
Abstract 2394
Increasing pH of the test medium suppresses trailing phenomenon in cefiderocol MIC determinations for Acinetobacter baumannii
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Naoki ISHIBASHI
Poster P1579
Abstract 2524
Comparison of different disk diffusion and MIC test strips brands with reference broth microdilution for imipenem/relebactam susceptibility testing of Pseudomonas aeruginosa
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Ana CANDELA
Poster P1580
Abstract 2545
Performance of the EUCAST disk diffusion method for linezolid susceptibility testing in enterococci: a nordic multicentre study
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Björg C. HALDORSEN
Poster P1581
Abstract 2549
How accurate is direct antibiotic sensitivity testing of Enterobacterales from positive blood cultures? Don't get caught out!
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Gemma VANSTONE
Poster P1582
Abstract 2570
Detection by automated antimicrobial susceptibility testing method of trimethoprim/sulfamethoxazole heteroresistance in Staphylococcus aureus not detected by reference methods
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Geraldine DURAND
Poster P1583
Abstract 2597
In vitro assessment of the novel antibiotic combination meropenem/ANT3310 against Gram-negative bacteria: CLSI Tier 1 study examining effects of varying MIC parameters and equivalency between agar dilution and broth microdilution methodologies
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Stephen HAWSER
Poster P1584
Abstract 2637
Effect of miniaturisation of EUCAST broth microdilution
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Sarah NEEDS
Poster P1585
Abstract 2754
A comparison of cefiderocol broth microdilution and disk diffusion against a panel of carbapenem-resistant Pseudomonas aeruginosa
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Katherine LANE
Poster P1586
Abstract 2763
Diagnostic pathways for a rapid, culture based antibiotic susceptibility testing for urinary tract infections
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Stephen KIDD
Poster P1587
Abstract 2855
Environmental context influences antimicrobial susceptibility testing
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Caroline BLACK
Poster P1588
Abstract 2934
Evaluation of in vitro antibiotic susceptibility of Haemophilus influenzae strains isolated from clinical samples according to the EUCAST and CLSI criteria and molecular analysis of beta-lactam resistance
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Aylin Irem OCAKLI
Poster P1589
Abstract 3148
Measuring reactive oxygen species (ROS) to determine minimal inhibitory concentrations (MIC) for Enterobacterales using flow cytometry (FCM)
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Andrea Lay Hoon KWA
Poster P1590
Abstract 3201
Third generation cephalosporin antimicrobial susceptibility testing assay using scanning electron microscopy: a pilot investigation
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Omar ZMERLI
Poster P1591
Abstract 3203
Comparative analysis of a commercially avaialble antibiotic susceptibility testing with microbial suspensions prepared with an automated specimen workup instrument
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Nicole SCHEPIS
Poster P1592
Abstract 3250
Performance evaluation of meropenem-vaborbactam on clinical isolates in a fully automated rapid AST system
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jenny GÖRANSSON
Poster P1593
Abstract 3264
Interim results of a clinical and economic evaluation of a rapid AST system – the LIFETIMES study
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Gian Maria ROSSOLINI
Poster P1594
Abstract 3496
Comparison of testing methods assessing the in vitro efficacy of the combination of aztreonam with avibactam on multidrug-resistant Gram-negative bacilli
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Te-Din Daniel HUANG
Poster P1595
Abstract 3520
Deduction of dalbavancin susceptibility from vancomycin susceptibility in staphylococci
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Céline DUPIEUX-CHABERT
Poster P1596
Abstract 3529
Analytical and clinical performance of a rapid AST system directly from positive blood cultures: results of a real-life diagnostic clinical trial in Madrid, Spain
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Ana Verónica HALPERIN
Poster P1597
Abstract 3583
Phenotypic antibiotic susceptibility testing for last-resort antibiotics based on bacterial nanomotions provides results in two hours
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Alexander STURM
Poster P1598
Abstract 3636
Multicentre comparison of different commercial antimicrobial susceptibility testing methods compared to broth microdilution for beta-lactam susceptibility testing of Streptococcus pneumoniae
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Steven MARTENS
Poster P1599
Abstract 3647
Assessment of aztreonam-avibactam (ATM-AVI) CLSI 30/20 μg disk content against carbapenemase-producing Enterobacterales (CPEs)
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Paulina MARCHETTI
Poster P1600
Abstract 3657
Detection of colistin susceptibility in multidrug resistant Acinetobacter baumannii isolates by different methods, determination of colistin resistance by molecular and rapid methods
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Fatih Mehmet AKILLI
Poster P1601
Abstract 3673
How to properly determine fosfomycin susceptibility: comparison of three susceptibility methods
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Gabriela KRONEISLOVÁ
Poster P1602
Abstract 3730
Performance of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections in low and high resistance settings
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Christer MALMBERG
Poster P1603
Abstract 3803
Developing a microfluidic-platform to support in vitro assessment of dynamic exposure-response relationships: towards individualised susceptibility testing
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jennifer LAWRENCE
Poster P1604
Abstract 3880
A cost-effective AST directly from positive blood culture bottles: preliminary data for Enterobacterales and staphylococci using two automatized methods
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Marco PERADOTTO
Poster P1605
Abstract 3894
Preliminary performance of a new gradient MIC test strip for aztreonam/avibactam susceptibility testing of Enterobacterales
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Edwige PILLON
Poster P1606
Abstract 4083
Ability of two rapid phenotypic AST methods to detect carbapenem-resistance in Gram-negative bacteria directly from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Nicole DEGEL-BROßMANN
Poster P1607
Abstract 4206
Automated screening of carbapenemase classes by an antimicrobial susceptibility testing system
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Gilles ZAMBARDI
Poster P1608
Abstract 4341
CLSI M23 tier 2 study to establish broth microdilution quality control ranges for meropenem-ANT3310
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Dana DRESSEL
Poster P1609
Abstract 4378
Evaluation of the QuickMIC rapid antibiotic susceptibility testing assay with carbapenem resistant Escherichia coli and Klebsiella pneumoniae isolates
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Meszéna RÉKA
Poster P1610
Abstract 4717
Comparison of Enterococcus faecalis penicillin susceptibility via commercial direct MIC test vs broth microdilution
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Olivia FUNK
Poster P1612
Abstract 4965
AST comparison for Pseudomonas aeruginosa and other nonfermenting Gram-negative bacilli: disk diffusion and automated microdilution vs broth microdilution
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Samy MZOUGUI
Poster P1613
Abstract 4992
Testing efficacy of a novel diagnostic antimicrobial susceptibility testing platform on patient bacterial isolates from a large Scottish teaching hospital
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Stuart REID
Poster P1614
Abstract 5155
Evaluation of disk diffusion breakpoints for Aerococcus spp. using CLSI methods
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Richard MAYNARD
Poster P1615
Abstract 5241
Fine tuning polymyxin B combinations: tackling the growing threat of pan-drug resistant Klebsiella pneumoniae
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jan Naseer KAUR
Poster P1616
Abstract 5444
mATM/CZA: a new rapid and inexpensive methodology for evaluating the combination in vitro of ceftazidime-avibactam plus aztreonam among Enterobacterales
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Juliana CAIERÃO
Poster P1617
Abstract 5453
Validation of commercial automated bacterial suspension preparation and plate streaking for antibiotic disk diffusion susceptibility testing
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Robin VANSTOKSTRAETEN
Poster P1618
Abstract 5542
Evaluation of EUCAST breakpoints and methods for antimicrobial susceptibility testing of cefiderocol
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Erika MATUSCHEK
Poster P1619
Abstract 5549
Quality assessment of antimicrobial susceptibility testing among Level 2 and 3 medical laboratories in Zambia
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Lungowe Inonge MUKUBUTA
Poster P1620
Abstract 5767
Prospects for using MICs assessed under clinically relevant conditions to predict the development of antibiotic resistance: a study with meropenem and Klebsiella pneumoniae
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Stephen H. ZINNER
Poster P1621
Abstract 5783
Direct identification and antibiotic susceptibility testing in Bacteroides fragilis isolates from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Mervenur DEMIR
Poster P1622
Abstract 5814
Cefiderocol MIC against cefiderocol-resistant Acinetobacter baumannii can be affected by starting inoculum size
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Hidenori YAMASHIRO
Poster P1623
Abstract 5816
New approach to evaluate the bactericidal activity of different antiseptic ophthalmic preparations used as surgical prophylaxis
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Sara CALDRER
Poster P1624
Abstract 5830
Evaluation of methods for aztreonam-avibactam MIC determination
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Laurent DORTET
Poster P1625
Abstract 5954
Evaluation of antibiogram and microbial identification in terms of accuracy and time when applied with the RAST technique
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Huseyin GUDUCUOGLU
Poster P1626
Abstract 6037
Evaluation of the oxoid imipenem/relebactam (10/25 µg) antimicrobial susceptibility testing (AST) disc against the predicate AST disc
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
James BOVILL
Poster P1627
Abstract 6105
A novel fast and easy test for determination of tigecycline and colistin susceptibility
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Seyma Aybüke ÖZYAR KURTÇU
Poster P1628
Abstract 6159
Two-dimensional checkerboard screening of ceftazidime-avibactam and fosfomycin against carbapenemase-producing E. coli, K. oxytoca, E. cloacae and K. pneumoniae clinical isolates
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Miklas MARTENS
Poster P1629
Abstract 6203
FASTinov ultrarapid AST directly from positive blood cultures: performance validation study in 6 Portuguese hospitals
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Luís ROSETA
Poster P1630
Abstract 6230
Inoculum effect of meropenem and meropenem/avibactam with Klebsiella pneumoniae: can MIC at high inoculum predict MPC?
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Stephen H. ZINNER
Poster P1631
Abstract 6239
Comparison of commercial methods for evaluating susceptibility to cefiderocol
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Edoardo CARRETTO
Poster P1632
Abstract 6270
QMAC dRAST for rapid AST on colonies yielded from respiratory specimens in ICU
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Emmanuelle GALLOIS
Poster P1633
Abstract 6416
Investigation of carbapenem heteroresistance in Acinetobacter baumannii and Pseudomonas aeruginosa blood isolates
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Ekin KIRBAS
Poster P1634
Abstract 6455
Is counting of Colony-Forming Units a reliable method to evaluate antibiotic activity against intracellular bacteria?
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Audrey COMEIN
Poster P1635
Abstract 6480
Rapid antibiotic susceptibility testing in patients with bloodstream infection in a low resistance environment
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Jan Egil AFSET
Poster P1636
Abstract 6541
Evaluation of a novel system for rapid antimicrobial susceptibility testing of Gram-negative pathogens from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Fabio MORECCHIATO
Poster P1637
Abstract 6549
Evaluation of a new system for rapid antimicrobial susceptibility of Gram-negative bacteria directly from positive blood cultures
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Livia TARTAGLIONE
Poster P1638
Abstract 6799
Evaluation of an automated antimicrobial susceptibility testing system performance for colistin susceptibility in multi drug resistant Acinetobacter baumannii isolates
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Arzu ILKI
Poster P1639
Abstract 6811
Optimising ESBL confirmation: evaluating routine EUCAST cephalosporin disks in double disk synergy test
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Eysan ÖZGÜR YARKICI
Poster P1640
Abstract 6825
Reducing turn around time by rapid identification and antimicrobial susceptibility testing directly from urine combining conventional with automated technology advancing integrated stewardship
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Maitrayee NARAYAN
Poster P1641
Abstract 6973
In vitro susceptibility test to cefiderocol of NDM-producing K. pneumoniae from bloodstream isolates: a comparison of commercial methods and the reference method
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Alessandro LEONILDI
Poster P1642
Abstract 6987
Optimising access to ceftazidime-avibactam-aztreonam combination therapy and in-house susceptibility testing
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Emily WOODHOUSE
Poster P1643
Abstract 7025
Evaluation of pH-dependent effect on finafloxacin activity against Pseudomonas aeruginosa isolates
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Alba RUIZ-GAITÁN
Poster P1644
Abstract 7027
Evaluation of media for MIC susceptibility testing of N. gonorrhoeae.
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Leanne DAVIES
Poster P1645
Abstract 7113
Metronidazole MIC testing and anaerobic bacteria: comparison of the two agar dilution reference method EUCAST and CLSI. Impact on a commercial device
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Martelin ROLAND
Poster P1646
Abstract 7281
Study of two susceptibility testing methods with gradient strips for aztreonam and ceftazidime/avibactam combination in bacteria producing metallo-β-lactamases
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Violeta ARTAL
Poster P1647
Abstract 7416
A new rapid antimicrobial susceptibility testing assay evaluated with positive blood cultures for antimicrobial-resistant bacterial pathogens
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Giulia MENCHINELLI
Poster P1648
Abstract 7531
Susceptibility testing of carbapenemase-producing bacteria: comparison of two MIC panels
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Petra HILKENS
Poster P1649
Abstract 7535
Determination of aztreonam/avibactam MIC and two simple methods for detection of combined in-vitro activity of aztreonam and ceftazidim/avibactam against metallobetalactamase-producing Enterobacterales
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Julija GERM
Poster P1650
Abstract 8184
First hospital trials of a new antimicrobial susceptibility test (AST) demonstrate accurate, cost-effective results from positive blood cultures in three hours
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Toby KING
Poster P1651
Abstract 8324
Investigation of the synergistic effect of ceftazidime-avibactam and aztreonam combination in multidrug-resistant Stenotrophomonas maltophilia clinical isolates using checkerboard and double disk synergy methods
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Ekin KIRBAS
Poster P1652
Abstract 8486
Performance of two different colistin susceptibility tests on carbapenemase producing Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Stenotrophomonas maltophilia
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Doga ILKI
Poster P1653
Abstract 8549
Utilisation of the breakpoints from the clinical and laboratory standards institute and the European committee on antimicrobial susceptibility testing at the quality control programme of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Enrique RUIZ DE GOPEGUI BORDES
Poster P1654
Abstract 8933
Rapid antimicrobial susceptibility testing directly from urine
29/04 12:00
3c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)
Emelie JANSSON
Poster P1655
Abstract 8
Lipid remodelling in Gram-negative bacteria does not affect octenidine's activity
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Nermina MALANOVIC
Poster P1656
Abstract 114
Divergent genetic landscapes drive lower levels of AmpC induction and stable de-repression in Serratia marcescens compared to Enterobacter cloacae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Lazarus JACOB
Poster P1658
Abstract 602
Changing trend of Enterobacterales carrying blaNDM and the emergence of multidrug-resistant E. coli ST8346 with multiple carbapenemases in southern Taiwan, 2016-2022
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Tu-Hsuan CHANG
Poster P1659
Abstract 672
Integrative and conjugative elements in invasive Haemophilus influenzae in Scandinavia
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Helene Johannessen WEFRING
Poster P1660
Abstract 674
Association between MLST and the PmrCAB operon with colistin resistance and biofilm-related gene expression in Acinetobacter nosocomialis strains
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Jun-Ren SUN
Poster P1661
Abstract 933
Emergence of a transferrable daptomycin resistance mechanism in Gram-positive bacteria: a novel membrane-associated ABC transporter confers high-level daptomycin resistance in Staphylococci
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Tessa MARCINIAK
Poster P1662
Abstract 1241
Highly active blaDHA-1 harbouring transposon in E. coli from German food production chain
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Alexandra IRRGANG
Poster P1663
Abstract 1286
NDM-1-mediated resistance to cefiderocol (FDC): mechanistic insights
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Alejandro Jose VILA
Poster P1664
Abstract 1294
Evolutionary advantage of taniborbactam-resistant NDM-9
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Alejandro Jose VILA
Poster P1665
Abstract 1378
Mobile integrons carry phage defence cassettes
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Nicolas KIEFFER
Poster P1666
Abstract 1430
Genomic and metabolic characteristics in laboratory-induced colistin-resistance Acinetobacter baumannii
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Huang XIAOLAN
Poster P1667
Abstract 1533
Phenotypic and genotypic characterization of a carbapenem-resistant Acinetobacter baumannii clinical isolate harboring the carbapenemase IMP-8
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Xu QINGYE
Poster P1668
Abstract 1682
Carvacrol: a natural defense against Staphylococcus aureus and its aminoglycoside resistance
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Cristina GAN ORIA
Poster P1669
Abstract 1992
Clonal lineage profiling of colistin resistance gene mcr-1 in clinical, veterinary and environmental bacterial isolates and antibiotics effective in them
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Chinmoy SAHU
Poster P1670
Abstract 2053
Mechanisms of acquisition of vanA operon among vancomycin-resistant Staphylococcus aureus genomes: the tip of the iceberg?
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Huynh Ngoc Tram VO
Poster P1671
Abstract 2346
In vivo evolution of a novel KPC-144 variant conferring ceftazidime/avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Ping YANG
Poster P1672
Abstract 2348
Two-component sensor factor envZ influence antibiotic resistance and virulence in the evolutionary dynamics of multidrug-resistant Salmonella enteritidis causing multisite invasive infections
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Lifei YU
Poster P1673
Abstract 2357
Chromosomal integration and plasmid fusion induce the transmission, resistance, fitness differences in carbapenem-resistant Klebsiella pneumoniae isolates co-harboring blaNDM-1 and blaIMP-4
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Qiucheng SHI
Poster P1674
Abstract 2522
Antimicrobial treatment failure: persistence and toxin/antitoxin systems in carbapenem-resistant Acinetobacter baumannii evolving in colistin-resistant strains
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Eleonora CHINES
Poster P1675
Abstract 2702
The transcriptional regulator SpoVG strongly impacts the zinc tolerance of Staphylococcus aureus via regulation of multiple cellular pathways
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Jacqueline SCHÜRMANN
Poster P1676
Abstract 2729
Spontaneous resistance against novel β-lactamase inhibitors
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Ling ZHUOREN
Poster P1677
Abstract 2741
Suppression of fumarases and adaptive response in combination with the SOS response enhances antimicrobial susceptibility in Escherichia coli
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Marina MURILLO TORRES
Poster P1678
Abstract 2782
Host-specific evolution of NDM carbapenemases
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Lisandro Javier GONZÁLEZ
Poster P1679
Abstract 2789
Phenotypic and genetic characteristics of blaIMP-6 harbouring Enterobacteriaceae: emergence of novel plasmid variants coding blaIMP-6
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Koichi YAMAGUCHI
Poster P1680
Abstract 2904
Dynamics of antimicrobial resistance plasmids in OXA-48-producing K. pneumoniae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Fátima GALÁN-SÁNCHEZ
Poster P1681
Abstract 3023
Conditional evolution and novel mechanism of biocide tolerance in two nosocomial Gram-positive pathogens
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Maria SOLSONA GAYA
Poster P1682
Abstract 3134
Genomic variability and resistance mechanisms of Salmonella isolates recovered at hospitals in Peru
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Fiorella KRAPP LOPEZ
Poster P1683
Abstract 3172
Identification of the novel fosfomycin resistance gene fosSC in Staphylococcus capitis
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Yueqin HONG
Poster P1684
Abstract 3251
Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake deficient mutants of Pseudomonas aeruginosa
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Gonzalez LUCIA
Poster P1685
Abstract 3252
Interplay between DNA repair systems and antimicrobial heteroresistance in Escherichia coli
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Sara DIAZ-DIAZ
Poster P1686
Abstract 3278
Prevalence and distribution of mobile genetic elements in ESBL and/or carbapenemase-producing Klebsiella pneumoniae isolates belonging or not to high-risk clones
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Manuel ALCALDE-RICO
Poster P1687
Abstract 3337
Triclosan-selected de novo mutations in carbapenemase-producing Klebsiella pneumoniae clinical isolates
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Patricia PEREZ PALACIOS
Poster P1688
Abstract 3509
Characterisation of a high-risk Klebsiella pneumoniae clone with normal and small colony variant phenotypes in the form of a phenotypic “hyper-splitting” phenomenon
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Eyüp DOGAN
Poster P1689
Abstract 3537
FosA gene is not responsible of the different in vitro response to fosfomycin in carbapenem-resistant K. pneumoniae clinical strains
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Stefano STRACQUADANIO
Poster P1690
Abstract 3540
ATP-binding cassette transporter mediates and regulates metronidazole resistance in Clostridioides difficile
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Xu TENG
Poster P1691
Abstract 3553
Cefepime/enmetazobactam is an innovative ?-lactam/?-lactam-derived ?-lactamase inhibitor combination with increased in vitro potency against KPC Ω-loop variants involved in ceftazidime/avibactam resistance
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Martín PAMPÍN GARCÍA
Poster P1692
Abstract 3669
Chromosomally encoded OXA-23 transferred by recombination in Acinetobacter baumannii
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Kyriaki XANTHOPOULOU
Poster P1693
Abstract 3709
Evaluation of cefiderocol stability against clinically relevant serine- and metallo-β-lactamases
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Alessandra PICCIRILLI
Poster P1694
Abstract 3774
High-level plazomicin exposure selects for mutations in fusA, ratA, and a novel two-component system in Morganella morganii
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Mariana CASTANHEIRA
Poster P1695
Abstract 3775
Investigation of the β-lactam/β-lactamase combination resistance mechanisms of Bacteroides species
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Danhui HEO
Poster P1696
Abstract 3885
Heteroresistance to piperacillin-tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple beta-lactamase genes
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Ahmed BABIKER
Poster P1697
Abstract 3980
Co-selection of IncC plasmids carrying blaVIM-1 and IncFII plasmids carrying the mercury resistance operon (merRTPCADE) in Escherichia coli in presence of mercury.
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Patricia PEREZ PALACIOS
Poster P1698
Abstract 4370
Impact of two missense mutations (p.I515M and p.A606D) in the pbp2 gene of an MRSA strain on the development of resistance to dalbavancin and cell wall thickness
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Heimo LAGLER
Poster P1699
Abstract 4514
First report of resistance to aztreonam/avibactam and to cefiderocol in NDM-5 producers E.coli in Algeria
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Mohamed Azzedine BACHTARZI
Poster P1700
Abstract 4539
Changes in resistance phenotype in consecutive isolates of KPC-8-producing Klebsiella pneumoniae from a long-term colonised patient
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Fátima GALÁN-SÁNCHEZ
Poster P1701
Abstract 4591
Presence of OXA-1 gene not predictive of Piperacillin-Tazobactam resistance among ESBL Enterobacteriales
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Melissa GITMAN
Poster P1702
Abstract 4618
Differences in oxazolidinone resistance mechanisms and small colony variants emergence of Staphylococcus aureus induced in an in vitro resistance development model
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Heimo LAGLER
Poster P1703
Abstract 4794
Molecular mechanisms of cefiderocol resistance in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa isolates from Peru
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Luciano Augusto PALOMINO KOBAYASHI
Poster P1704
Abstract 4901
Environmental reservoir of carbapenemase-producing Klebsiella pneumoniae ST35 and molecular characterisation of incF plasmids
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Liliana Marcela PESARESI
Poster P1705
Abstract 4993
Presence of diverse metal resistance determinants amongst antibiotic-resistant bacteria from Peru
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Luciano Augusto PALOMINO KOBAYASHI
Poster P1706
Abstract 5003
Increased efficiency or periplasm stability? That is the question, in the evolution of KPC-2
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Laura DABOS
Poster P1707
Abstract 5099
Conformational changes in Acinetobacter-derived cephalosporinase (ADC) variants lead to enhanced cephalosporinase activity in Acinetobacter baumannii; two mechanisms of deacylation
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Brad WALLAR
Poster P1708
Abstract 5118
Assessing genetic diversity and similarity of carbapenemases-encoding plasmids in Gram-negative bacteria isolated from cases of bacteremia of Ecuador
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Gabriela SEVILLANO
Poster P1709
Abstract 5649
Trade-off between beta-lactam resistance and stability in Gram-positive class B1 penicillin binding proteins
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Mélanie ROCH
Poster P1710
Abstract 5745
Delaying the emergence of cefiderocol resistance in NDM-producing Enterobacter cloacae complex using the combination cefiderocol-aztreonam in vitro
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Dennis NURJADI
Poster P1711
Abstract 5759
Cross regulation of IMI carbapenemase and intrinsic cephalosporinase AmpC in Enterobacter cloacae complex
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Cécile EMERAUD
Poster P1712
Abstract 5829
Mutations of surA and pcoS increase carbapenem resistance in Klebsiella pneumoniae with blaOXA-48
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Martina CREMANNS
Poster P1713
Abstract 5854
In-human reversion from methicillin-resistant to methicillin-susceptible Staphylococcus aureus leads to potential fitness benefit at the site of infection
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Aya IIZUKA
Poster P1714
Abstract 5960
The analysis of cell wall morphological changes induced by betalactams in Haemophilus influenzae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Lucia MALISOVA
Poster P1715
Abstract 6113
Three major plasmid groups mobilize the most frequent third-generation cephalosporin resistance genes among E. coli isolated from poultry and human clinical samples in Switzerland
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Javier Eduardo FERNANDEZ
Poster P1716
Abstract 6267
Comparative genomic analysis reveals the emergence of ST-2096 Klebsiella pneumoniae strains associated with the high transmissibility of blaOXA-232 in Oman
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Alrujaibi ARWA
Poster P1717
Abstract 6285
In vitro development of aztreonam-avibactam resistance in clinical isolates of NDM-1-producing Klebsiella pneumoniae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Stephanie WILSON
Poster P1718
Abstract 6769
A delayed resistance evolution under combination treatment strategy in carbapenem-resistant Klebsiella pneumoniae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Ruobing WANG
Poster P1719
Abstract 6838
A single point mutation in the promoter region of the mgrB gene induces colistin resistance in Salmonella enterica
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Judith GUITART-MATAS
Poster P1720
Abstract 6963
Purification and enzyme kinetics of newly discovered metallo-beta-lactamase NWM-1
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Lisa-Marie HÖFKEN
Poster P1721
Abstract 6970
Molecular characterisation of resistance mechanisms in cefiderocol-resistant Enterobacterales
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Pia TUROWSKI
Poster P1722
Abstract 7005
Molecular and biochemical characterization of a putative Pseudomonas prolyl-4-hydroxylase involved in the resistance to siderophore conjugated antibiotics
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Faisal ALSHREF
Poster P1723
Abstract 7021
Mutation in mepM confers salt tolerance in Escherichia coli
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Priya NAGPAL
Poster P1724
Abstract 7375
Absence of LiaF increases daptomycin activity against E. faecalis in a rat model of infective endocarditis
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Cesar ARIAS
Poster P1725
Abstract 7384
ACM-like enzymes, new subclass B3 metallo-ß-lactamases identified in Acinetobacter spp.
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Clement VIGUIER
Poster P1726
Abstract 7399
Transmission of mcr-3-carrying IncHI2 plasmids at high temperature through formation a hybrid plasmid
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Mei LI
Poster P1727
Abstract 7558
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Jacqueline FINDLAY
Poster P1728
Abstract 7565
Molecular characterisation of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Emilia CERCENADO
Poster P1729
Abstract 7741
A strain of Serratia marcescens exhibiting high-level tolerance to meropenem
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Xiaobing CHU
Poster P1730
Abstract 7961
Mutation in piuA promoter mediated reduced cefiderocol susceptibility in Acinetobacter baomannii
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Xiaochen LIU
Poster P1731
Abstract 8084
Analysis of two class A β-lactamases from Nocardia brasiliensis (BRA-1 and BRA-2) and associated β-lactam resistance
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Hervé JACQUIER
Poster P1732
Abstract 8186
Tolerance detection among Enterococcus gallinarum bloodstream isolates
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Jacob STRAHILEVITZ
Poster P1733
Abstract 8283
The cooperative interaction of penicillin-binding proteins (PBPs) in Enterococcus faecalis promotes resistance to beta-lactams
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Paola CONTI
Poster P1734
Abstract 8344
Genomic framework of Klebsiella pneumoniae high-risk clone sequence type 101 and the CZA resistance evolution by the novel KPC-111 variant
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Riccardo POLANI
Poster P1735
Abstract 8361
Carbapenem resistance determinants in integrons and related mobilisable elements in KAPEc isolates from Peru
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Luciano Augusto PALOMINO KOBAYASHI
Poster P1736
Abstract 8366
In vitro selected V562L substitution outside the PBP3 transpeptidase region in Haemophilus influenzae results in increased MIC of cefuroxime
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Vladislav JAKUBU
Poster P1737
Abstract 8376
Fosfomycin resistance associated with chromosomic fosA gene overexpression in Klebsiella pneumoniae clinical isolates
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Ághata RIBEIRO
Poster P1738
Abstract 8618
Evolution of viscosity due to the wzc mutation in Klebsiella pneumoniae isolates producing KPC-31 carbapenemase variant from a single patient
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Valerio CAPITANI
Poster P1739
Abstract 8700
Population analysis, mutant prevention concentrations and characterisation of resistance mutations to novel β-lactams in wild-type, mutator, and high-risk clones of Pseudomonas aeruginosa
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Miquel Àngel SASTRE FEMENIA
Poster P1740
Abstract 8780
The role of tpiA: a key metabolic enzyme in regulating drug-resistance and virulence in Klebsiella pneumoniae
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Anru ZHANG
Poster P1741
Abstract 8784
LiaF has an activator role in the LiaR-mediated response against daptomycin (DAP) in Enterococcus faecalis (Efs)
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Cesar ARIAS
Poster P1742
Abstract 8863
ST39 K. pneumoniae harboring an IncM1-plasmid promotes clonal and plasmid-mediated OXA-48 transmission in a Swiss institution
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Diego ANDREY
Poster P1743
Abstract 8875
Molecular analysis of the carbapenem resistance mechanism of a Phocaeicola vulgatus strain
29/04 12:00
3d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)
Bakhtiyar MAHMOOD
Poster P1744
Abstract 759
Adaptation of an antibiotic disc-based assay for improved detection of carbapenemases in Enterobacterales
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Meg JAGO
Poster P1745
Abstract 794
Comparative analysis of prediction values for antimicrobial resistance of Staphylococcus aureus using MALDI-TOF mass spectra and various machine learning programs
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Wei-Yao WANG
Poster P1746
Abstract 831
High accuracy and prediction values for mecA+ methicillin-resistant (MRSA) and phenotypic oxacillin-resistant Staphylococcus aureus (ORSA) on the basis of MALDI-TOF MS by using machine learning approach
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Wei-Yao WANG
Poster P1747
Abstract 899
Evaluation of blood culture identification and antimicrobial resistance instrumentation for detection of antimicrobial resistance markers
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Richard MAYNARD
Poster P1748
Abstract 1046
Evaluation of an immunochromatographic test for rapid detection of patients colonised with carbapenemase-producing organisms from broth-enriched rectal swabs
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Maristela P FREIRE
Poster P1749
Abstract 1270
Evaluation of an immunochromatographic method (NG-TEST CARBA-5) for detection of different allelic variants of KPC, NDM, IMP and VIM carbapenemases in Enterobacterales (ETB) and Pseudomonas aeruginosa (PAE) isolates
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Fernando PASTERAN
Poster P1750
Abstract 1524
Epidemiology of carbapenemase-producing Enterobacterales (CPE) and a proposed adequate phenotypic methods for carbapenemase detection
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Yiel-Hea SEO
Poster P1751
Abstract 1635
MultiRapid NP test for detecting concomitantly susceptibility and resistance of last resort novel antibiotics available to treat multidrug-resistant Enterobacterales infections
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Otavio RARO
Poster P1752
Abstract 1836
Evaluation of the ability of the Gene Xpert Carba-R system to detect KPC and IMP carbapenemases variants
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Alejandra CORSO
Poster P1753
Abstract 1860
Detection of lipid A by MALDI-TOF for colistin heteroresistant strains
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Nadine PERROT
Poster P1754
Abstract 1869
Cefiderocol resistance genes identified using functional metagenomics
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Rémi GSCHWIND
Poster P1755
Abstract 1870
Genetic determinants against therapeutically relevant antibiotics in 26,557 publicly available genome sequences from Clostridioides difficile isolates
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Baban Sanjay KOLTE
Poster P1756
Abstract 2082
Rapid detection of third-generation cephalosporin resistance in Enterobacterales directly from positive blood cultures by an electrochemical test
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Philipp THELEN
Poster P1757
Abstract 2478
CRISPR-Cas12a-based GES carbapenemase detection assay: a pilot study
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Samuel GARCÍA GARCÍA
Poster P1758
Abstract 2531
Rapid detection of aztreonam/avibactam susceptibility by MALDI-TOF MS in a collection of β-lactamase producing Enterobacterales
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Ana CANDELA
Poster P1759
Abstract 2614
Tracking clonal and plasmid transmissions in colistin and carbapenem resistant Klebsiella pneumoniae
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Sandra REUTER
Poster P1760
Abstract 2684
Standardisation of an agglutination test for detection of clinical isolates producing carbapenemases
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Valêncio Siqueira ANDRÉ
Poster P1761
Abstract 2870
Carbapenemases screening of high-risk patients with a commercial test: a 4-year follow-up study
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Frederic JANVIER
Poster P1762
Abstract 2881
A pooling strategy for detecting carbapenem resistance genes by a commercial test in rectal swab specimens
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Frederic JANVIER
Poster P1763
Abstract 2947
Uncovering genetic markers of antimicrobial resistance in Bacillus anthracis using comparative genomic analysis
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Tucker MAXSON
Poster P1764
Abstract 2994
Lateral flow assay phenotypically detects bacterial growth for antibiotic susceptibility testing
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Emily MELZER
Poster P1765
Abstract 2995
XDR nosocomial Pseudomonas putida driving a plasmid-blaVIM-1 gene
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Lidia RUIZ-ROLDÁN
Poster P1766
Abstract 3308
Occurrence of β-lactone synthesis among OXA-48-like carbapenemase-producing bacteria collected in the Czech Republic and the implication for MALDI-TOF MS-based carbapenemase detection
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Vendula HERINGOVÁ
Poster P1767
Abstract 3353
Evaluation of a modified carbapenem inactivation method for detection of carbapenemases in Enterobacterales: results of a multi-centre surveillance study in Turkey
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Elif Seren TANRIVERDI
Poster P1768
Abstract 3580
Iridium oxide-based biosensors towards the quantification of ESBL production
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Jennifer LAWRENCE
Poster P1769
Abstract 3865
Chip-based molecular detection of beta-lactam resistance in pathogen-positive blood cultures
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Vittorio IVAGNES
Poster P1770
Abstract 3960
Including structural information complements antibiotic susceptibility prediction methods in M. tuberculosis and E. coli
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Viktoria BRUNNER
Poster P1771
Abstract 4005
From phenotype to genotype: mapping the epidemiology of carbapenemase-producing Enterobacteriaceae using whole genome sequencing
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Pedro SUAREZ URQUIZA
Poster P1772
Abstract 4115
Polymerase chain reaction blood sample genotype results accurately predict blood culture resistance phenotypes and aid in optimal antimicrobial selection
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Jill ARGOTSINGER
Poster P1773
Abstract 4267
Refined algorithm for detection of OXA-48-like carbapenemase producing Enterobacterales
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Peter Michael KELLER
Poster P1774
Abstract 4558
Indeterminate CPE testing – what are the chances?
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Julie-Anne HOULIHAN
Poster P1775
Abstract 4654
Carbapenemase detection by flow cytometry: a rapid and promising technology
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Blanca PÉREZ VISO
Poster P1776
Abstract 4733
Resistome description of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa isolated from Ukrainian military patients
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Miriam LATORRE-MILLÁN
Poster P1777
Abstract 4983
The rapid detection of carbapenem resistance by using fluorescence flow cytometry analyser
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Seyma Aybüke ÖZYAR KURTÇU
Poster P1778
Abstract 5012
Evaluation of the DNA microarray, sepsis flow chip assay for the rapid detection of microorganisms and resistance genes directly from positive blood cultures
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Prakaithip THONGKOOM
Poster P1779
Abstract 5040
Genomic analysis of Klebsiella pneumoniae clinical isolates from greek hospitals resistant to β-lactams/β-lactamase inhibitor combinations
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Olga KOUTSOPETRA
Poster P1780
Abstract 5105
Reducing rectal carriage of carbapenemase-producing bacteria in general wards: the impact of implementing a modified Blue-Carba test to guide infection control
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Fernando PASTERAN
Poster P1781
Abstract 5506
Evaluation of a molecular test for H. pylori & Clarithromycin resistance from stool reveals a highly efficient non-invasive diagnostic tool
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Yael MALI
Poster P1782
Abstract 5546
Early life factors influencing the gut resistome and mobilome: meta-analysis
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Ahmed BARGHEET
Poster P1783
Abstract 5584
Investigation of the presence of tolerance in Esherichia coli isolates isolated from urine cultures
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Ecem BUYUKYANBOLU
Poster P1784
Abstract 5598
Comparison of modified hodge test and carbapenem inactivation method in carbapenemase producing Klebsiella pneumoniae isolates
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Fatih Mehmet AKILLI
Poster P1785
Abstract 5641
Effect of rapid carbapenemases detection-guided antibiotic therapy on clinical response in patients with intra-abdominal infections (RAPID): protocol for a randomised controlled trial
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Jiajie WANG
Poster P1786
Abstract 5710
Mycoplasma genitalium, drug resistance, nucleic acid detection; introducing a new external quality assessment scheme
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Kati LUIRO
Poster P1787
Abstract 5724
Analytic and clinical validation of a lab-developed multiplex-PCR assay for fully-automated high-throughput detection of seven carbapenemase genes for isolate characterization and primary patient screening.
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Dominik Sebastian NOERZ
Poster P1788
Abstract 5772
Evaluation of the novel French disc diffusion-based algorithm for the phenotypic screening of carbapenemase-producing Enterobacterales
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Laurent DORTET
Poster P1789
Abstract 5778
Deciphering the molecular basis of colistin-resistant Escherichia marmotae
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Ulrike BINSKER
Poster P1790
Abstract 6324
Resistome and plasmid content of ceftazidime/avibactam Resistant Klebsiella pneumoniae strains isolated in a transplant and highly specialised therapies centre
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Alessia MIRABILE
Poster P1791
Abstract 6477
Comprehensive whole exome sequencing correlates with antimicrobial resistance genes acquired by two Indian clinical isolates of Klebsiella pneumoniae: first report
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Deepali DESAI
Poster P1792
Abstract 6717
Rapid Combo ESBL/Carba NP test for rapid detection of expanded-spectrum ß-lactamase and carbapenemase producers in Enterobacterales
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Clement VIGUIER
Poster P1793
Abstract 6765
Indirect detection of blaKPC in Klebsiella pneumoniae and Escherichia coli by MALDI-TOF mass spectrometry: a single centre experience
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Marines DALLA VALLE MARTINO
Poster P1794
Abstract 7007
Performance of an automated method for screening carbapenem-resistant Enterobacterales (CRE) compared to a reference method
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Marines DALLA VALLE MARTINO
Poster P1795
Abstract 7070
KPC enzymes with new mutations: the new challenge of clinical microbiology laboratory
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Annarita MAZZARIOL
Poster P1796
Abstract 7266
Evaluation of the comercial test for the rapid detection of third-generation cephalosporins resistance in Enterobacterales on early culture of positive blood cultures
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Mehdi BONNET
Poster P1797
Abstract 7347
Decipherin the evolution of the infant intestinal resistome
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Poster P1798
Abstract 7420
Deciphering the genome of a Acinetobacter seifertii (Asf) strain showing co-resistance to carbapenems and polymyxin B in Brazil
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Alessandro RODRIGUES
Poster P1799
Abstract 7716
Performance of MBT Lipid Kit for rapid screening of colistin resistance in Klebsiella pneumoniae
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Sam LOCKWOOD
Poster P1800
Abstract 7785
Rapid temocillin resistance detection by a colorimetric test
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
José Luis RODRÍGUEZ OCHOA
Poster P1801
Abstract 7834
Economic impact of rapid molecular diagnostic testing in management of carbapenem-resistant Enterobacteriaceae in high risk patients in the UK
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Isaac ODEYEMI
Poster P1802
Abstract 8260
Evaluation of whole genome sequencing to predict quinolones susceptibilityphenotypes in non-typhoidal Salmonella enterica.????
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Manuel A. RODRÍGUEZ-IGLESIAS
Poster P1803
Abstract 8267
Landscape of open-access antimicrobial resistance gene catalogues
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Chad CENTNER
Poster P1804
Abstract 8397
Genomic diversity and resistome of Acinetobacter baumannii from a hospital in Paraguay
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Elena BELLO-LOPEZ
Poster P1805
Abstract 8800
New protocol for rapid detection and differentiation of carbapenemases in rectal swabs by laser nephelometry, mass spectrometry and lateral flow assay
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Diego JOSA
Poster P1806
Abstract 8819
Rapid characterisation of antimicrobial resistance genes by PCR and reverse hybridisation in rectal swab samples from colonised patients
29/04 12:00
3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)
Diego JOSA
Poster P1807
Abstract 197
Comparison of the clinical outcomes of patients with carbapenem-resistant and susceptible Pseudomonas aeruginosa in Japan
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Sho SAITO
Poster P1808
Abstract 457
Comparison of clinical outcomes and molecular epidemiology between fluoroquinolone-susceptible and resistant carbapenem-resistant Enterobacterales: a multicentre study from multi-drug resistant organisms clinical research network (MDRnet)
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Kubo TAKETO
Poster P1809
Abstract 642
Blaz betalactamase impacts treatment outcomes in infective endocarditis due to methicillin-sensitive Staphylococcus aureus
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Baptiste JEAN
Poster P1810
Abstract 680
Carbapenem-based antibiotic regimen in the treatment of carbapenemase-producing Enterobacterales infections: a retrospective cohort study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Baptiste HOELLINGER
Poster P1811
Abstract 952
Risk factors and outcomes of linezolid- and vancomycin-resistant E. faecium infections: a case-control study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Flavio SANGIORGI
Poster P1812
Abstract 1488
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas (POP) study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Lee GOTTESDIENER
Poster P1813
Abstract 2161
Mortality and morbidity attributable to infections caused by carbapenem-resistant Enterobacterales – initial results from a matched cohort study in Vietnam
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Hoa NGUYEN THI
Poster P1814
Abstract 2183
Effect of antimicrobial stewardship actions on broad-spectrum antibiotic usage and resistance patterns of Gram-negative isolates at a district general hospital
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Eleanor SENIOR
Poster P1815
Abstract 2275
The changing epidemiology and long-term outcomes of patients with CRE infections
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Ryan SHIELDS
Poster P1816
Abstract 2715
In vitro activity of sulbactam/durlobactam in combination with cefepime against Gram-negative bacterial isolates from a recent Phase 3 clinical trial
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Sarah MCLEOD
Poster P1817
Abstract 2876
Cefiderocol for the treatment of infections by VIM-type-producing Gram-negative bacteria
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Cristina KIRKEGAARD BIOSCA
Poster P1818
Abstract 2886
The emergence of difficult to treat Klebsiella pneumoniae in COVID-19 patients in a Vietnamese tertiary hospital
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Thi Quynh Ngan LE
Poster P1819
Abstract 3047
Reappraisal of mortality risk associated with cefiderocol based therapy for treatment of carbapenem resistant Acinetobacter baumannii infections: a real-world comparative effectiveness study from 201 US hospitals
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Morgan WALKER
Poster P1820
Abstract 3078
Use of novel ß-lactam-ß-lactamase-inhibitors in adult cystic fibrosis medicine: a 5-year monocentric retrospective analysis
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Johannes Till OTHMER
Poster P1821
Abstract 3218
A real-world study on efficacy, safety, and cost-effectiveness of ceftazidime-avibactam and polymyxin B for the treatment of CRE infections
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Chen DAYU
Poster P1822
Abstract 3333
Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Alice LIU
Poster P1823
Abstract 3613
A recursive partitioning approach to identify prognostic factors associated with mortality at time of infection in patients with carbapenem-resistant Enterobacterales infection
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Yiying CAI
Poster P1824
Abstract 3906
β-lactam resistance mechanisms in baseline Enterobacterales from the REVIST and ASSEMBLE aztreonam-avibactam Phase 3 clinical trials
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Rodrigo E. MENDES
Poster P1825
Abstract 3917
Resistance Optimised Antibiotic Dosing (The ROAD Study): is beta-lactam dosing optimised to prevent the emergence of antibiotic resistance safe and feasible in the ICU?
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Jason ROBERTS
Poster P1826
Abstract 3947
Impact of colistin MIC on outcomes: results from the OVERCOME trial comparing colistin monotherapy and colistin + meropenem combination therapy
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Jason POGUE
Poster P1827
Abstract 4188
Ceftazidime/avibactam alone or in combination to treat infections caused by Pseudomonas aeruginosa: preliminary reports from a retrospective observational multi-centre cohort study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Pietro VALSECCHI
Poster P1828
Abstract 4499
The production of OXA-2/10 ß-lactamases is a risk factor for resistance development to ceftolozane/tazobactam and ceftazidime/avibactam during the treatment of Pseudomonas aeruginosa infections
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Inmaculada LÓPEZ MONTESINOS
Poster P1829
Abstract 4625
Black females hospitalised in the United States have worse outcomes after carbapenem-resistant Enterobacterales (CRE) bloodstream infection (BSI)
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Felicia RUFFIN
Poster P1830
Abstract 4680
Resistance to third generation cephalosporins is associated with increased all-cause mortality at 1 year among patients with Enterobacterales clinical isolates
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Heather HENDERSON
Poster P1831
Abstract 5063
Comparison of piperacillin-tazobactam and carbapenem strategies in ESBL-producing Enterobacteriaceae urinary tract infections
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Leonor NEVES
Poster P1832
Abstract 5156
Outcomes of adult patients with multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) treated with monotherapy versus combination therapy in a tertiary hospital
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Leisa Jeanne Kaye YEE
Poster P1833
Abstract 5174
Characteristics and outcomes of resistant Gram-negative infections treated with cefiderocol in a multi-centre institution
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Olivia FUNK
Poster P1834
Abstract 5229
Outcomes of intermittent versus extended infusion of common beta-lactams in Pseudomonas aeruginosa infections where minimum inhibitory concentration is at the susceptibility breakpoint
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Megan KLATT
Poster P1835
Abstract 5373
Analysis of clearance and infection rates according to the genotype in patients with carbapenemase-producing Enterobacterales co-colonization
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Lee JIYOUNG
Poster P1836
Abstract 5846
Excess mortality due to antimicrobial resistance in bacteraemias among cancer patients in Oxford and Oslo, 2008-2018
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Anders SKYRUD DANIELSEN
Poster P1837
Abstract 6294
Use of cefiderocol to treat carbapenem resistant Acinetobacter baumanii NDM-producing strains
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Giovanna TRAVI
Poster P1838
Abstract 6445
Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) ventilator-associated pneumonia (VAP) in critically ill patients with respiratory CRAB colonisation
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Sara COVINO
Poster P1839
Abstract 6518
MIC increase in Clostridioides difficile isolates from patients with recurrence: results from a retrospective single-centre cohort study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Pietro VALSECCHI
Poster P1840
Abstract 6776
HAI mortality in acute hospitals in Spain 2022-2023
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Lina Marcela PARRA
Poster P1841
Abstract 7207
Risk factors and clinical outcomes associated with the acquisition of New Delhi metallo-beta-lactamase (NDM) in Enterobacterales: a single-center study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Raissa ARONICA
Poster P1842
Abstract 7359
A single hospital-based study on the profile and outcomes of patients treated with Polymyxin B: the difficulties for controlled clinical trials
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Carlos KIFFER
Poster P1843
Abstract 7382
Prevalence of antimicrobial resistance in patients with cancer in the outpatient setting: a multicentre analysis
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Diane FLAYHART
Poster P1844
Abstract 7738
Use of ceftaroline for treatment of bacteremia in Colombian paediatric patients: a descriptive study of 34 patients
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Natalia GONZÁLEZ-LEAL
Poster P1845
Abstract 7774
Real world data for novel β-lactam/β-lactamase inhibitors: a prospective single-institution study
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Pantazis-Michael VOUTSINAS
Poster P1846
Abstract 7875
Management of febrile neutropenia in hematologic patients colonized by OXA-48-producing Enterobacter cloacae: experience from a tertiary-level hospital
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Miguel RODRÍGUEZ FERNÁNDEZ
Poster P1847
Abstract 8402
Is cefepime safe to treat infections caused by Escherichia coli or Klebsiella pneumoniae that display an ESBL phenotype? Results from a systematic review and meta-analysis of clinical studies
29/04 12:00
3f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs)
Giulia MENCHINELLI
Poster P1848
Abstract 467
Characterising the loss and acquisition of Tn2-like transposon in Klebsiella pneumoniae: implications for carbapemase gene dissemination
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Xiao YU
Poster P1849
Abstract 944
Antimicrobial resistance prevalence varies by age and sex in bloodstream infection in European hospitals
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Gwen KNIGHT
Poster P1850
Abstract 1549
First report of colistin-resistant Escherichia coli carrying mcr-1 IncI2(delta) and IncX4 plasmids from camels (Camelus dromedarius) in the Gulf region
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Akela Ahmed GHAZAWI
Poster P1851
Abstract 1787
Antibiotic resistance profiles of Escherichia coli from wastewater treatment plants in the full water cycle in Barcelona, Spain
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Laura MONDÉJAR TRAVERIA
Poster P1852
Abstract 2128
Exploring the dynamics of Staphylococcus spp. in wild bat populations: insights into antibiotic resistance and microbial adaptation
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Vanessa SILVA
Poster P1853
Abstract 2204
Profile of bacterial infections in COVID-19 time in a health area
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Maria Jesús GUTIÉRREZ FERNÁNDEZ
Poster P1854
Abstract 2307
Comparison of antibiotic resistance in Aeromonas spp. between clinical isolates and food animals in Hong Kong
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Christopher Koon Chi LAI
Poster P1855
Abstract 2377
Spread of plasmidic blaOXA-58, blaNDM-1 and blaIMP-14 among three different Acinetobacter spp.
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Pierre BOGAERTS
Poster P1856
Abstract 2392
The potential for antimicrobial resistance in highly transferable strains of Haemophilus influenzae
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Takeaki WAJIMA
Poster P1857
Abstract 2468
Pseudomonas aeruginosa carriage and associated risk factors in patients and healthy individuals
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Anneloes VAN VEEN
Poster P1858
Abstract 2631
How to measure bacterial genome plasticity? New insights and implications for pathogens
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Stefano GAIARSA
Poster P1859
Abstract 2653
Global colistin-resistance mcr-1 plasmid epidemiology: mystooking the part for the whole, or how Asia does not mean the whole world
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Biel GARCIAS
Poster P1860
Abstract 2666
Characterisation of bacterial isolates throughout the entire water cycle in Barcelona, Spain.
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Victoria Del Pilar BALLÉN TORRES
Poster P1861
Abstract 2772
Increased abundance of ESBL producing Enterobacterales in municipal wastewater receiving hospital effluent during and after the COVID-19 pandemic
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Lisandra AGUILAR BULTET
Poster P1862
Abstract 2958
AVIAR, arthropods as vectors of infection and antimicrobial resistance: a global study update
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Edward A R PORTAL
Poster P1863
Abstract 3029
Identifying risk factors for carbapenem-resistant Acinetobacter baumannii carriage upon admission: a case-case control study
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Debby BEN-DAVID
Poster P1864
Abstract 3039
The overlooked pandemic in the shadow of COVID-19: antimicrobial use and resistance data, a Romanian single-centre study
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Agnes CSISZER
Poster P1865
Abstract 3254
Black-headed gulls as a reservoir for multidrug-resistant high-risk clonal Enterobacterales
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Jana BRENDECKE
Poster P1866
Abstract 3469
Extended co-colonisation of IncX3-type plasmid harbouring blaNDM-5 among non-clonal Escherichia coli in a dog
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Juliana MENEZES
Poster P1867
Abstract 3482
Nasopharyngeal bacterial carriage and antibiotic resistance in children with sickle cell disease: DREPANOBACT a French multicentric prospective study
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Luu-Ly PHAM
Poster P1868
Abstract 3542
Paws and pathogens: co-carriage of ESBL-producing Enterobacterales strains between companion animals and owners
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Juliana MENEZES
Poster P1869
Abstract 3626
Spreading colistin resistant Klebsiella pneumoniaein Rabta Tunisian hospital
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Meriam ZRIBI
Poster P1870
Abstract 3871
Potential for widespread dissemination of blaOXA-370 in a new genetic context within IncN2 Plasmids of Klebsiella pneumoniae ST6326 – KL151
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Ághata RIBEIRO
Poster P1871
Abstract 3890
Penicillin allergy is associated with increased resistance in Streptococcus pneumoniae
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Shadia AHMED
Poster P1873
Abstract 4301
Impact of sub-inhibitory concentrations of chlorhexidine on in vitro horizontal transfer of vancomycin and linezolid resistance genes in Enterococcus faecium
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Carla NOVAIS
Poster P1874
Abstract 4513
Local circulation of ESBL genes: what is behind the scenes?
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Bálint TIMMER
Poster P1875
Abstract 4531
Analysis of plasmid-mediated ESBL production and colistin resistance in Escherichia coli from pig nostrils: a new reservoir of concern?
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Sandra A MARTÍNEZ ÁLVAREZ
Poster P1876
Abstract 4939
Inter-species transmission of a blaVIM-2 carrying plasmid during an hospital outbreak of VIM-producing Pseudomonas spp.
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Laurence ARMAND-LEFEVRE
Poster P1877
Abstract 5100
Recurring import of an endemic pstS-null ST-1421 vancomycin-resistant Enterococcus faecium from Australia to the United States
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Brendan JONES
Poster P1878
Abstract 5106
Genomics analysis of methicillin-resistant Staphylococcus aureus: detection of the clonal lineage ST398 in wild birds from Brazil
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Jussara Kasuko PALMEIRO
Poster P1879
Abstract 5126
Monitoring clinically important antimicrobial-resistant bacteria in wastewater and clinical samples from children's hospital
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Hiroaki BABA
Poster P1880
Abstract 5130
Antibiotics and the gut microbiome: potential roles in persistent gut colonization with ESBL-producing Enterobacterales among Peruvian children
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Maya NADIMPALLI
Poster P1881
Abstract 5158
Presence of pharmaceutical contaminants and antibiotic-resistant bacteria across diverse environmental matrices within a Brazilian lagoon ecosystem
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Jussara Kasuko PALMEIRO
Poster P1882
Abstract 5587
Microcosmic matters: assessing micropollutants and evaluating removal efficiency in urban wastewater treatment plants
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Poonam SHARMA
Poster P1883
Abstract 5637
Sinks as a reservoir of ceftazidime-avibactam resistant ST307 K. pneumoniae high-risk clone harbouring novel blaKPC variants in a hospital in Spain
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Marta HERNÁNDEZ-GARCÍA
Poster P1884
Abstract 5779
Variability of multidrug-resistant Enterobacterales prevalence carriage and interfacilities connections across a large nursing homes network
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Cécile FERRIOT
Poster P1885
Abstract 5909
e-DNA approach to assess the antimicrobial resistance genes in the coastal sediments of India
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Pradip GAWANDE
Poster P1886
Abstract 5970
Bacterial diversity in choanal swabs from free-living pelicans in Greece. High frequency of methicillin-susceptible S. aureus
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Teresa CARDONA-CABRERA
Poster P1887
Abstract 6116
Plasmid sharing between cephalosporin-resistant commensal bacteria and enteropathogens in Vietnamese community
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Phuong PHAM
Poster P1888
Abstract 6259
Antibiotic resistance in Italian urban wastewater: exploring of antibiotic-resistant bacteria (ARBs), antibiotic resistance genes (ARGs), and microbial communities
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Giusy BONANNO FERRARO
Poster P1889
Abstract 6391
Diversity and dynamics of Pseudomonas spp. in ICU sinks with long-term persistent clones carrying blaGES and blaVIM far beyond outbreaks
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Bárbara CATALÁ-SÁNCHEZ
Poster P1890
Abstract 6606
NDM-producing clone of Klebsiella pneumoniae ST6668 (CC147) keeps spreading in the Pavia area, Italy
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Irene MILETO
Poster P1891
Abstract 6691
High household co-carriage of extended-spectrum beta-lactamases in Hong Kong
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Kin On KWOK
Poster P1892
Abstract 7047
That sinking feeling: destructive u-bend sampling reveals common OXA-48 plasmids among Enterobacterales in an environmental reservoir
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Aoife KEARNEY
Poster P1893
Abstract 7253
Effect of various strategies of antibiotic de-escalation and continuous ciprofloxacin on the intestinal microbiota and its colonization by multidrug resistant E. coli in a murine experimental model
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Quentin LE BASTARD
Poster P1894
Abstract 7284
Unexpected cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic background
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Céline SAKR
Poster P1895
Abstract 7436
Inter- and intraspecies spread of mcr-1 between twenty-nine distinct Enterobacteriaceae isolates from one patient
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Beiwen ZHENG
Poster P1896
Abstract 7452
The veterinary hospital as a cross-infection hub of multidrug resistant bacteria
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Tal ZILBERMAN DANIELS
Poster P1897
Abstract 7568
Large DNA fragment transposition during natural transformation allows interspecies dissemination of antimicrobial resistance genes
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Tiago LIMA
Poster P1898
Abstract 7575
Urban and rural free-ranging hedgehogs as sentinels of environmental extended-spectrum beta-lactamase producing enterobacterales
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Tal ZILBERMAN DANIELS
Poster P1899
Abstract 7692
Long persistence of Citrobacter freundii carrying blaVIM-1 encoding plasmids in water systems in an intensive care unit
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Natalia GUERRA PINTO
Poster P1900
Abstract 7701
Klebsiella pneumoniae ST307 and its multidrug-resistant plasmids in the environmental water reservoir of an intensive care unit.
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Natalia GUERRA PINTO
Poster P1901
Abstract 8221
Host distribution, dissemination and mobile genetic context of the NpmA gene in Clostridioides difficile populations
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Carlos SERNA
Poster P1902
Abstract 8516
Resistance to critically important antibiotics in meat sold for consumption
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Jordan SEALEY
Poster P1903
Abstract 2220
Plasmid location of carbapenemase encoding genes in Enterobacterales co-harbouring two carbapenemases
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Marta HERNÁNDEZ-GARCÍA
Poster P1904
Abstract 8674
Antimicrobial resistance of Mammaliicoccus species and staphylococci other than Staphylococcus aureus isolated from retail beef in KwaZulu Natal, South Africa
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Thembeka THWALA
Poster P1905
Abstract 8840
A few days of parenteral colistin therapy markedly selects colistin-resistant Enterobacteriaceae in the gut flora of critically ill Indian patients
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Jayeeta BHOWMICK
Poster P1906
Abstract 8850
Vancomycin-resistant Enterococcus faecium in black-headed Gulls (Chroicocephalus ridibundus): nosocomial clonal complex 17 detected in wild birds
29/04 12:00
3g. Spread of resistance (incl carriage, reservoirs, ecology, models, excl nosocomial transmission)
Balázs KOLESZÁR
Poster P1907
Abstract 1412
Expert consensus on antimicrobial resistance research priorities to guide antibacterial vaccines and monoclonal antibodies development and implementation
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Nasreen HASSOUN-KHEIR
Poster P1908
Abstract 1845
Evidence-based policy for mitigating AMR in Lao PDR: an intervention-implementation research approach
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Somphou SAYASONE
Poster P1909
Abstract 2479
Global costing of key AWaRe antibiotics
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Filip DJUKIC
Poster P1910
Abstract 2760
Meri-no or meri-yes: that is the question! Healthcare professional preferences in managing piperacillin/tazobactam-susceptible ESBL-producing Gram-negative bacilli bacteremia at an university hospital in Spain
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Patricio FAVIER
Poster P1911
Abstract 2885
Local antimicrobial resistance surveillance in nursing homes using lot quality assurance sampling
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Sacha KUIL
Poster P1912
Abstract 3690
Globally antimicrobial stewardship programs are lagging behind: an example of the need for a people-centred comprehensive approach to address antimicrobial resistance
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Zlatina DOBREVA
Poster P1913
Abstract 5072
Current global total and AWaRe global antibiotic use are inversely related to infectious disease burden and not equitable.
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Aislinn COOK
Poster P1914
Abstract 5889
Estimation of the annual burden of infections caused by multidrug-resistant bacteria in hospitalised patients in Spain: the SEIMC_BMR-2023 study
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
José Miguel CISNEROS
Poster P1915
Abstract 5940
Economic costs associated to antimicrobial resistance among newborns with bloodstream infection in a maternity hospital in Peru
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Maria J. PONS
Poster P1916
Abstract 6187
Antibiotic resistance watch: Gaza's post-war preparedness
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Anna FARRA
Poster P1917
Abstract 6329
Minimum inhibitory concentration distributions of worldwide clinical bacterial isolates vary by patient age and other key variables
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Jacob WILDFIRE
Poster P1918
Abstract 7002
Evidence on the intersection of the social determinants of health and antibiotic resistant (ABR) infections: a systematic review
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Alison SHUTT
Poster P1919
Abstract 7249
Globally there has been a fragmented approach to AMR national action plan implementation – results of trend analysis of the one health and human health indicators in the tracking AMR country self-assessment survey (TrACSS)
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Ponnu PADIYARA
Poster P1920
Abstract 7878
Cost impact of implementing carbapenemase-producing Enterobacterales (CPE) screening guidelines in France
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Isaac ODEYEMI
Poster P1921
Abstract 8727
High levels of antibiotic resistance: latest insights from WHO's GLASS surveillance system
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Olga TOSAS AUGUET
Poster P1922
Abstract 8867
Practices and drivers for antibiotic use in cattle production systems in Kenya
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Lydiah KISOO
Poster P1923
Abstract 8870
Differences in patient access to antimicrobial medicines in Europe
29/04 12:00
3h. Policy aspects of AMR (incl societal impact, economics, mitigation)
Elina BACHEVA
Poster P2741
Abstract 184
Manifestations and risk of cryptococcosis in liver transplant candidiates
29/04 12:00
6a. Fungal disease epidemiology
Wan-Ting TSAI
Poster P2742
Abstract 540
The Cologne ECMM Excellence Center: a comprehensive evaluation of its external consultation service for invasive fungal infections over two years
29/04 12:00
6a. Fungal disease epidemiology
Jon SALMANTON-GARCIA
Poster P2743
Abstract 546
Assessing diagnostic capabilities and treatment accessibility for invasive fungal infections in the Balkan Region
29/04 12:00
6a. Fungal disease epidemiology
Jon SALMANTON-GARCIA
Poster P2744
Abstract 548
Exploring invasive fungal infection diagnosis and treatment: a cross-continental comparison between Brazil and Europe
29/04 12:00
6a. Fungal disease epidemiology
Jon SALMANTON-GARCIA
Poster P2745
Abstract 566
A review of coccidioidomycosis occurrence in Europe
29/04 12:00
6a. Fungal disease epidemiology
Priya SHASTRI
Poster P2746
Abstract 817
Otomycosis: the foremost etiological agent causing otitis externa and the antifungal susceptibility pattern in Iran
29/04 12:00
6a. Fungal disease epidemiology
Mahmoud KHANSARI
Poster P2747
Abstract 877
The tale of two seas: the Black and the Mediterranean regarding clinically relevant fungi
29/04 12:00
6a. Fungal disease epidemiology
Mihai MARES
Poster P2748
Abstract 1071
Whole genome sequencing of Candida glabrata isolates in Korea: unveiling nosocomial transmission and antifungal resistance mechanisms
29/04 12:00
6a. Fungal disease epidemiology
Jong Hee SHIN
Poster P2749
Abstract 1126
Clinical outcomes of Candida auris fungemia at an academic medical centre
29/04 12:00
6a. Fungal disease epidemiology
Yifan WANG
Poster P2750
Abstract 1377
Attributable mortality of candidaemia: results from the ECMM Candida III multinational European observational cohort study
29/04 12:00
6a. Fungal disease epidemiology
Jon SALMANTON-GARCIA
Poster P2751
Abstract 1473
Higher Blastomyces dermatitidis initial antigen levels associated with disseminated disease, use of amphotericin B, and mortality
29/04 12:00
6a. Fungal disease epidemiology
Caroline EWING
Poster P2752
Abstract 1511
High rates of azole resistant Aspergillus fumigatus in Asia: results from a systematic review
29/04 12:00
6a. Fungal disease epidemiology
Souradeep CHOWDHURY
Poster P2753
Abstract 1557
Clinical characteristics of hospitalised adults with invasive pulmonary aspergillosis: a single-institution retrospective study (2013-2022)
29/04 12:00
6a. Fungal disease epidemiology
Sara ARAÚJO
Poster P2754
Abstract 1580
Invasive fungal infections in solid organ transplant recipients
29/04 12:00
6a. Fungal disease epidemiology
Caglayan Merve AYAZ
Poster P2755
Abstract 1594
Risk of Candida auris infection following positive surveillance screening
29/04 12:00
6a. Fungal disease epidemiology
Emily DRWIEGA
Poster P2756
Abstract 1672
Mandatory notification of human cases of cat-transmitted sporotrichosis (CTS) caused by Sporothrix brasiliensis in Southern Brazil indicates expressive raising of zoonosis in the State
29/04 12:00
6a. Fungal disease epidemiology
Francelise BRIDI CAVASSIN
Poster P2757
Abstract 1676
Epidemiology, clinical manifestations, and outcome of mucormycosis in solid organ transplant recipients: a systematic review of reported cases
29/04 12:00
6a. Fungal disease epidemiology
Emanuele PALOMBA
Poster P2758
Abstract 2012
Epidemiology and clinical outcomes of histoplasmosis among kidney transplant recipients
29/04 12:00
6a. Fungal disease epidemiology
Caroline AGNELLI
Poster P2759
Abstract 2019
Culture-positive sporotrichosis: the ten-year Mayo Clinic experience
29/04 12:00
6a. Fungal disease epidemiology
Rita IGWILO-ALANEME
Poster P2760
Abstract 2022
Mycological trends (1999-2019) in patients treated for postoperative peritonitis
29/04 12:00
6a. Fungal disease epidemiology
Philippe MONTRAVERS
Poster P2761
Abstract 2237
Impact of lactate dehydrogenase, bacterial and cytomegalovirus co-infections on mortality in non-HIV-infected patients with Pneumocystis jirovecii pneumonia
29/04 12:00
6a. Fungal disease epidemiology
Berk MIZRAK
Poster P2762
Abstract 2409
Point prevalence study of Candida auris in a tertiary hospital in Crete, Greece
29/04 12:00
6a. Fungal disease epidemiology
Petros IOANNOU
Poster P2763
Abstract 2457
Incidence of invasive pulmonary aspergillosis according to basal thoracic computed tomography findings in patients with newly diagnosed acute myeloid leukaemia
29/04 12:00
6a. Fungal disease epidemiology
Buket ERTURK SENGEL
Poster P2764
Abstract 2529
A retrospective study on profile of Pneumocystis jirovecii pneumonia among cancer patients of a tertiary care cancer centre in eastern India
29/04 12:00
6a. Fungal disease epidemiology
Soumyadip CHATTERJI
Poster P2765
Abstract 2540
Emergence of fluconazole-resistant Candida parapsilosis in a population of burn patients
29/04 12:00
6a. Fungal disease epidemiology
Gianpiero TEBANO
Poster P2766
Abstract 2873
Aspergillosis in patients with lymphoproliferative malignancies: new population at risk?
29/04 12:00
6a. Fungal disease epidemiology
Anna FALCÓ ROGET
Poster P2767
Abstract 2884
The state of laboratory mycology in France in 2023: a survey from the European Confederation of Medical Mycology (ECMM), International Society for Human and Animal Mycology (ISHAM) and French Society of Medical Mycology (SFMM)
29/04 12:00
6a. Fungal disease epidemiology
Francoise BOTTEREL
Poster P2768
Abstract 2964
Positivity of galactomannan and fungal culture in bronchoalveolar lavage early after lung transplantation as risk factors for invasive aspergillosis and chronic lung allograft dysfunction
29/04 12:00
6a. Fungal disease epidemiology
Roni BITTERMAN
Poster P2769
Abstract 3018
Audit of paediatric candidaemia using the European Confederation of Medical Mycology (ECMM) Quality (EQUAL) of clinical candidaemia management score
29/04 12:00
6a. Fungal disease epidemiology
Collette MCCARRON
Poster P2770
Abstract 3120
Mucormycosis in Colombia: the relevance of Cunninghamella spp. in the epidemological landscape
29/04 12:00
6a. Fungal disease epidemiology
Isabel RAMIREZ
Poster P2771
Abstract 3125
Invasive fusariosis in patients with haematological malignancies: a single-centre experience in Colombia
29/04 12:00
6a. Fungal disease epidemiology
Isabel RAMIREZ
Poster P2772
Abstract 3128
Epidemiologic investigation of a potential Candida auris hospital outbreak in Rio de Janeiro, Brazil
29/04 12:00
6a. Fungal disease epidemiology
Matheus OLIVEIRA BASTOS
Poster P2773
Abstract 3277
Clinical characteristics of endemic mycoses in HIV and non-HIV individuals: a 23-year retrospective study in a university hospital in Thailand
29/04 12:00
6a. Fungal disease epidemiology
Yanapat TAECHASANSIRI
Poster P2774
Abstract 3283
Skin colonisation by Candida auris and the associated risk of bloodstream infection
29/04 12:00
6a. Fungal disease epidemiology
Spyros POURNARAS
Poster P2775
Abstract 3410
Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: a cohort study
29/04 12:00
6a. Fungal disease epidemiology
Ying-Kui JIANG
Poster P2776
Abstract 3568
Invasive fungal infections (IFIs) and survival of acute myeloid leukemia (AML) patients at 12 months after AML diagnosis
29/04 12:00
6a. Fungal disease epidemiology
Alessandra MICOZZI
Poster P2777
Abstract 3579
The virulence potential of Prototheca microalgae as assessed by histopathological and microbiological studies in a murine model
29/04 12:00
6a. Fungal disease epidemiology
Angelika PROSKURNICKA
Poster P2778
Abstract 3632
Epidemiology of candidaemia in Czech Republic in 2023
29/04 12:00
6a. Fungal disease epidemiology
Pavlina LYSKOVA
Poster P2779
Abstract 3831
Real-world epidemiology and risk factors of invasive fungal infections in haematologic patients in the era of new oncologic therapies and antifungal prophylaxis
29/04 12:00
6a. Fungal disease epidemiology
Patricia MONZO GALLO
Poster P2780
Abstract 3856
Clavispora lusitaniae invasive infection in two immunocompromised patients
29/04 12:00
6a. Fungal disease epidemiology
Francesca PRATAVIERA
Poster P2781
Abstract 3940
Clinical characteristics and outcomes of invasive mucormycosis following allogeneic haematopoietic stem cell transplantation
29/04 12:00
6a. Fungal disease epidemiology
Yuqian SUN
Poster P2782
Abstract 3978
A laboratory experience on infection control after Candida auris isolation in neurology ICU
29/04 12:00
6a. Fungal disease epidemiology
Baran IRMAK
Poster P2783
Abstract 4134
A retrospective study of candidaemia and Candida auris colonisation in a tertiary hospital
29/04 12:00
6a. Fungal disease epidemiology
Spyridon KAMARIOTIS
Poster P2784
Abstract 4181
Epidemiology of candiduria in hospitalised patients: evolution and predictive value for candidaemia
29/04 12:00
6a. Fungal disease epidemiology
Pedro SUAREZ URQUIZA
Poster P2785
Abstract 4233
Impact of breakthrough status on mortality in patients with haematological malignancies (HM) and invasive pulmonary aspergillosis (IPA): a propensity score-matched analysis
29/04 12:00
6a. Fungal disease epidemiology
Sung-Yeon CHO
Poster P2786
Abstract 4263
Preliminary results of the epidemiology of invasive fungal infections in patients with haematological malignancies in the greater Paris area between 2017 and 2022
29/04 12:00
6a. Fungal disease epidemiology
Emmanuelle GRAS
Poster P2787
Abstract 4294
CANDINEG Registry: is it worth performing a fundoscopy examination in all patients affected by candidaemia?
29/04 12:00
6a. Fungal disease epidemiology
Melody PÉREZ LÓPEZ
Poster P2788
Abstract 4354
Fusariosis in patients with acute leukaemia: a 26-case series
29/04 12:00
6a. Fungal disease epidemiology
Raquel Keiko DE LUCA ITO
Poster P2789
Abstract 4419
Baseline IgG Aspergillus and SGRQ at 3 months can predict the occurrence of chronic pulmonary aspergillosis at end-of-therapy in newly diagnosed pulmonary tuberculosis patients
29/04 12:00
6a. Fungal disease epidemiology
Animesh RAY
Poster P2790
Abstract 4486
Association between allergic bronchopulmonary aspergillosis and tuberculosis: a systematic review of 397 cases in literature
29/04 12:00
6a. Fungal disease epidemiology
Anuj AJAYABABU
Poster P2791
Abstract 4593
Contribution of Aspergillus fumigatus and A. flavus to invasive aspergillosis and azole resistance: results from a national surveillance programme in Israel
29/04 12:00
6a. Fungal disease epidemiology
Ronen BEN-AMI
Poster P2792
Abstract 4615
Changes in species distribution, antifungal resistance, and outcomes of candidemia at two south korean tertiary hospitals: a 9-year retrospective study
29/04 12:00
6a. Fungal disease epidemiology
Ahrang LEE
Poster P2793
Abstract 4667
Epidemiology of Candida auris asymptomatic colonisation in a Greek intensive care unit
29/04 12:00
6a. Fungal disease epidemiology
Spyros POURNARAS
Poster P2794
Abstract 4679
How paediatric epidemiology and outcome of yeast fungemia differ from adults
29/04 12:00
6a. Fungal disease epidemiology
Fanny ALBY-LAURENT
Poster P2795
Abstract 4689
Update on the antifungal susceptibility pattern of Trichophyton isolates in Greece: alarming rise in terbinafine-resistant T. indotineae
29/04 12:00
6a. Fungal disease epidemiology
Maria SIOPI
Poster P2796
Abstract 4724
Association between allergic bronchopulmonary aspergillosis, aspergillus sensitisation and chronic obstructive pulmonary disease: a systematic review of 369 cases in literature
29/04 12:00
6a. Fungal disease epidemiology
Anuj AJAYABABU
Poster P2797
Abstract 4791
Underdiagnosis of invasive fungal infections amongst inpatients in Ireland: a national retrospective study of discharge diagnoses
29/04 12:00
6a. Fungal disease epidemiology
Josephine HEBERT
Poster P2798
Abstract 4828
Update on the Iranian Candida auris isolates, a retrospective analysis
29/04 12:00
6a. Fungal disease epidemiology
Hamid BADALI
Poster P2799
Abstract 4926
Candida osteoarticular infections: a case series of cancer patients from an oncological tertiary centre since 2018
29/04 12:00
6a. Fungal disease epidemiology
Adriana MAGRI
Poster P2800
Abstract 4941
Risk factors, complications and mortality associated to intravascular Candida infection: CANDINEG database results
29/04 12:00
6a. Fungal disease epidemiology
Cristobal RAMÍREZ
Poster P2801
Abstract 4952
Invasive pulmonary aspergillosis in heart transplant recipients: contemporary incidence, characteristics and outcomes
29/04 12:00
6a. Fungal disease epidemiology
Marina MACHADO
Poster P2802
Abstract 4962
Epidemiology of superficial mycoses in Tenerife Island
29/04 12:00
6a. Fungal disease epidemiology
Ana MARTÍN
Poster P2803
Abstract 5075
Invasive aspergillosis in patients with liver disease: a comprehensive analysis of characteristics, risk factors, and outcomes
29/04 12:00
6a. Fungal disease epidemiology
Alessandro GIACINTA
Poster P2804
Abstract 5151
Infection prevention, antimicrobial stewardship and genome sequencing interventions to control an outbreak of Candida auris in adult and paediatric intensive care units
29/04 12:00
6a. Fungal disease epidemiology
Rossana ROSA
Poster P2805
Abstract 5191
Changing trends in the sources and volumes of clinical cultures with Candida auris at an integrated health system in Miami, Florida, 2019-2023
29/04 12:00
6a. Fungal disease epidemiology
Rossana ROSA
Poster P2806
Abstract 5212
Development of a diagnostic score for disseminated histoplasmosis in a cohort of HIV patients
29/04 12:00
6a. Fungal disease epidemiology
Julián Andres HOYOS PULGARIN
Poster P2807
Abstract 5443
Evaluation of pulmonary aspergillosis in COVID-19 patients admitted to intensive care unit
29/04 12:00
6a. Fungal disease epidemiology
Afsane VAEZI
Poster P2808
Abstract 5456
Characteristics and outcomes of Pneumocystis pneumonia in different immunocompromised populations
29/04 12:00
6a. Fungal disease epidemiology
Javier Tomás SOLERA RALLO
Poster P2809
Abstract 5521
Prospective evaluation of septic shock patients with culture-proven Candida spp in a tertiary care educational university hospital: a series of 103 cases
29/04 12:00
6a. Fungal disease epidemiology
Gamze SANLIDAG ISBILEN
Poster P2810
Abstract 5568
Exploring the dynamics of the epidemic C. parapsilosis bloodstream infections in a tertiary university hospital in Greece
29/04 12:00
6a. Fungal disease epidemiology
Joseph MELETIADIS
Poster P2811
Abstract 5622
Colonising Candida in the ICU: the impact of antifungal exposure on epidemiology and resistance
29/04 12:00
6a. Fungal disease epidemiology
Phoebe ALLEBONE-SALT
Poster P2812
Abstract 5843
Risk factors and outcome associated with fungal infections in patients with severe burn injury: 10-year retrospective IFI-BURN study
29/04 12:00
6a. Fungal disease epidemiology
Sarah DELLIERE
Poster P2813
Abstract 5928
Mycophenolic acid selects specific strains responsible for Pneumocystis pneumonia (PCP) in organ transplant recipients: probable implication in PCP outbreaks
29/04 12:00
6a. Fungal disease epidemiology
Gilles NEVEZ
Poster P2814
Abstract 6008
Epidemiology and risk factors for mortality in a large cohort of patients diagnosed with proven/probable invasive aspergillosis
29/04 12:00
6a. Fungal disease epidemiology
Matteo RINALDI
Poster P2815
Abstract 6021
The prevalence of Cryptococcus positive samples from hospitals in KwaZulu-Natal (KZN), South Africa
29/04 12:00
6a. Fungal disease epidemiology
Brilliant ZANDILE
Poster P2816
Abstract 6062
Distribution and antifungal susceptibility pattern of Candida spp. in a Belgian Walloon university hospital between January 2017 and October 2023
29/04 12:00
6a. Fungal disease epidemiology
Sarah CUGNATA
Poster P2817
Abstract 6179
CNS sporotrichosis (clinical features, diagnosis, and treatment): a systematic review and meta-analysis
29/04 12:00
6a. Fungal disease epidemiology
Vítor FALCÃO DE OLIVEIRA
Poster P2818
Abstract 6232
Non-Aspergillus mould infections in adult liver transplant recipients, a French national retrospective cohort from 2007 to 2021
29/04 12:00
6a. Fungal disease epidemiology
Cléa MELENOTTE
Poster P2819
Abstract 6651
Candida spp. workload: the burden and cost of a yeast in a microbiology department
29/04 12:00
6a. Fungal disease epidemiology
Ana SORIANO-MARTÍN
Poster P2820
Abstract 6652
Sporothrix brasiliensis spread is largely driven by single clonal clade
29/04 12:00
6a. Fungal disease epidemiology
Eelco F.J. MEIJER
Poster P2821
Abstract 6887
Candida auris candidemia in colonised patients: antifungal susceptibility and outcome
29/04 12:00
6a. Fungal disease epidemiology
Aikaterini MICHELAKI
Poster P2822
Abstract 6915
Emergence of invasive infections due to the rare yeast Trichosporon austroamericanum sp. nov. (formerly T. inkin sensu lato) in patients undergoing cardio-vascular surgery in three European countries
29/04 12:00
6a. Fungal disease epidemiology
Arnaud FEKKAR
Poster P2823
Abstract 7016
Characteristics and prognosis factors of Pneumocystis jirovecii pneumonia according to underlying disease: a retrospective multicentre study
29/04 12:00
6a. Fungal disease epidemiology
Romain LECUYER
Poster P2824
Abstract 7131
Should we reconsider Pneumocystis pneumonia presentation and treatment according to its underlying disease? An unsupervised cluster analysis of a retrospective multicentre study
29/04 12:00
6a. Fungal disease epidemiology
Benjamin GABORIT
Poster P2825
Abstract 7306
Prevalence and clinic-radiological features of allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis in patients with post tubercular lung disease
29/04 12:00
6a. Fungal disease epidemiology
Anuj AJAYABABU
Poster P2826
Abstract 7380
Investigation of breakthrough invasive fungal infection risk factors in patients with haematological malignancy
29/04 12:00
6a. Fungal disease epidemiology
Dondu CELIK
Poster P2827
Abstract 7576
Epidemiological trends and genotypic analysis of Candida parapsilosis candidaemia: a 13-year retrospective study in a tertiary care hospital in Madrid, Spain
29/04 12:00
6a. Fungal disease epidemiology
Ana SORIANO-MARTÍN
Poster P2828
Abstract 7615
Clinical significance of mucor in airway culture of immunocompetent patients with chronic lung disease
29/04 12:00
6a. Fungal disease epidemiology
Michal MEIR
Poster P2829
Abstract 7740
Distribution of fluconazole-resistant Candida parapsilosis in a university hospital: the transformation of an epidemic event?
29/04 12:00
6a. Fungal disease epidemiology
Luigi RONGA
Poster P2830
Abstract 7743
Prevalence of vaginal Candida infections among females under screening to high risk human papillomavirus infection
29/04 12:00
6a. Fungal disease epidemiology
Elahe NASRI
Poster P2831
Abstract 7836
Immune profile in Covid-19 associated pulmonary aspergillosis: The CYTOCAPA Study
29/04 12:00
6a. Fungal disease epidemiology
Olivier MASCLE
Poster P2832
Abstract 7846
The alarming prevalence of Trichophyton indotineae as the causal agent of skin dermatophytosis in Iran
29/04 12:00
6a. Fungal disease epidemiology
Hossein MIRHENDI
Poster P2833
Abstract 7892
Pneumonia by Pneumocystis jirovecii in elderly patients: new clinical and microbiological data
29/04 12:00
6a. Fungal disease epidemiology
Sara FUEYO
Poster P2834
Abstract 7894
Invasive aspergillosis in non-haematological patients
29/04 12:00
6a. Fungal disease epidemiology
Vasilyeva NATALYA
Poster P2835
Abstract 8047
Pulmonary mucormycosis is a complex infection: ten-year experience in Mexico
29/04 12:00
6a. Fungal disease epidemiology
Paulina CARREÑO PÉREZ
Poster P2836
Abstract 8083
Four-year retrospective case-control study on the bacteremia concomitant with candidemia: clinical, risk factors and impact on the survival at an Italian tertiary-care hospital.
29/04 12:00
6a. Fungal disease epidemiology
Andrea BEDINI
Poster P2837
Abstract 8155
Global emergence of Candida auris: first outbreaks in Germany
29/04 12:00
6a. Fungal disease epidemiology
Alexander Maxmilian ALDEJOHANN
Poster P2838
Abstract 8305
Clinical and mycological implications of cryptococcal meningitis in Iran with emphasis on immunocompetent patients
29/04 12:00
6a. Fungal disease epidemiology
Sadegh KHODAVAISY
Poster P2839
Abstract 8336
Prevalence assessment of Candida auris colonisation in hospitalised patients: implications for transmission control
29/04 12:00
6a. Fungal disease epidemiology
Shivaprakash SHASHIKALA
Poster P2840
Abstract 8407
Gastrointestinal mucormycosis: an analysis of 339 adults from the FungiScope registry and literature
29/04 12:00
6a. Fungal disease epidemiology
Ertan SAL
Poster P2841
Abstract 8571
Population genomic analyses reveal high diversity, recombination, and nosocomial transmission among Candida glabrata isolates causing invasive infections
29/04 12:00
6a. Fungal disease epidemiology
Clement TSUI
Poster P2842
Abstract 8632
Outcomes associated with mucor infections at a tertiary care hospital over a ten year period
29/04 12:00
6a. Fungal disease epidemiology
Gautam KALYATANDA
Poster P2843
Abstract 8664
Epidemiologic surveillance of Candida auris: a comparative study of pre and post-COVID periods in the ICU at IRCCS Ospedale Policlinico San Martino, Liguria, Italy
29/04 12:00
6a. Fungal disease epidemiology
Elisa GIRIBALDI
Poster P2844
Abstract 8673
Changing epidemiology of candidaemia: data from a referral tertiar university hospital
29/04 12:00
6a. Fungal disease epidemiology
Michela PAGNUCCO
Poster P2845
Abstract 8742
Epidemiological trends of human aspergillosis in the region of Sousse, Tunisia, from 1982-2021
29/04 12:00
6a. Fungal disease epidemiology
Rania MRASSI
Poster P2846
Abstract 8900
Candida auris: data from the national surveillance system for mandatory notification (SURVNET) 2021-2023
29/04 12:00
6a. Fungal disease epidemiology
Jane HECHT
Poster P2847
Abstract 213
Rapid identification of Candia auris from screen samples
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Merav STRAUSS
Poster P2848
Abstract 326
Clinical evaluation of commercial candida panel for the rapid diagnosis of candidemia
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Kuenyoul PARK
Poster P2849
Abstract 451
Comparison of 1,3 β-D-glucan values for Candida auris to other Candida species
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Trusha NANA
Poster P2850
Abstract 577
Comparative analysis of abnormalities detected in chest radiography vs chest computed tomography for pulmonary coccidioidomycosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Sandhya NAGARAKANTI
Poster P2851
Abstract 584
Usefulness of the fungus (1-3)-β-D-glucan assay (chemiluminescence) as a diagnostic tool of invasive fungal disease
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Zhou ZEQI
Poster P2852
Abstract 809
Pneumocystis jirovecii pneumonia: quantitative PCR clinical impact and differences with qualitative PCR
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Riccardo PAGGI
Poster P2853
Abstract 903
Prospective evaluation of Aspergillus-specific IgG assay using a new chemiluminescence method for diagnosis of chronic pulmonary aspergillosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Zhou ZEQI
Poster P2854
Abstract 1040
Diagnosis of invasive fungal infection using a cell-free DNA assay coupled with giant magnetoresistance lab-on-a-chip technology
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Paschalis VERGIDIS
Poster P2855
Abstract 1069
Point-of-care testing for peritoneal and serum 1.3 beta-D-glucan to rule out intra-abdominal candidiasis in critically ill patients
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Emmanuel NOVY
Poster P2856
Abstract 1120
Comparative evaluation between two real-time PCR for the detection of Pneumocystis jirovecii and the ability to differentiate colonisation and clinical infection
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Tsz Yung HUI
Poster P2857
Abstract 1156
Digital diagnostics in medical mycology
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Volkan ÖZENCI
Poster P2858
Abstract 1188
Assessing new approaches for establishing the fast identification process of filamentous fungi
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Chou CHIAHUA
Poster P2859
Abstract 1261
Evaluation of the Aspergillus Galactomannan enzyme immunoassay for the diagnosis of invasive pulmonary aspergillosis in bronchoalveolar lavage fluid
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Sarah SEDIK
Poster P2860
Abstract 1263
Validation and implementation of a real-time PCR assay for the direct detection of Candida auris from surveillance samples in the context of a C. auris outbreak
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Esther FRANCO
Poster P2861
Abstract 1268
Rapid identification and antifungal susceptibility testing of Candida spp. from blood culture bottles
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Volkan ÖZENCI
Poster P2862
Abstract 1310
A novel T cell assay for monitoring scedosporiosis treatment
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Rosanne SPRUTE
Poster P2863
Abstract 1512
The combination of multiplex Aspergillus PCR assay and Aspergillus galactomannan lateral flow assay for the rapid diagnosis of invasive aspergillosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
He WANG
Poster P2864
Abstract 1523
A novel chemiluminescent immunoassay detection of Aspergillus galactomannan antigen
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Zhou ZEQI
Poster P2865
Abstract 1906
MALDI biotyping of fungal siderophores: how far we are?
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Vladimir HAVLICEK
Poster P2866
Abstract 2232
PCR on respiratory tract specimens of immunocompromised patients to diagnose Pneumocystis Pneumonia (PcP): a systematic review and meta-analysis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Lottie BROWN
Poster P2867
Abstract 2279
Evaluation of a rapid and high throughput automated Candida auris PCR assay for screening samples
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Terrence KUNG
Poster P2868
Abstract 2437
Chronic respiratory diseases: bacterial or fungal?
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Mohit CHOWDHURY
Poster P2869
Abstract 2530
Enhancing fungal DNA detection in liquid biopsies of paediatric cancer patients at risk of invasive pulmonary aspergillosis: a comprehensive computational and sequencing approach
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Emmy WESDORP
Poster P2870
Abstract 2799
Opening the DOOR to candidaemia diagnostics: a desirability of outcomes ranking analysis of a commerical assay vs blood culture in critically ill patients
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Kaylee CANIFF
Poster P2871
Abstract 2816
Enhancing mycological investigations: insights from a pilot study on inter-laboratory consistency and molecular identification
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Sara ALHOSANI
Poster P2872
Abstract 2836
Does the highly migratory Trichophyton indotineae finally knock the UAE?: “does the buck stop here?”
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Hari VANAM
Poster P2873
Abstract 2986
Advancing mold identification in the routine laboratory: performance of smartphone-based imaging and a newly developed convolutional neural network
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Lukas WEBER
Poster P2874
Abstract 2998
Verification, analytical sensitivity, cost-effectiveness, and comparison of four Candida auris screening methods
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Xena LI
Poster P2875
Abstract 3124
Multicentre prospective clinical validation of the novel Mp1p enzyme immunoassay as a screening tool for talaromycosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Khanh DANG HOANG
Poster P2876
Abstract 3209
Aspergillus IgG antibodies in diagnosing pulmonary aspergillosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Tingting WANG
Poster P2877
Abstract 3225
Fungal species identification: a comparative analysis of nanopore-based 18S sequencing and Sanger sequencing of the large subunit (LSU)
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Silje HOEGH
Poster P2878
Abstract 3797
Enhancing dermatomycosis sample collection and transport performance for molecular detection approaches
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Chiara SENTI
Poster P2879
Abstract 3905
In-vitro performance of a novel broth media for selection and enrichment of Candida auris strain
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Chiara SENTI
Poster P2880
Abstract 4128
Current microbiological testing and diagnostic yield for fungal infections in hospitalised haematological patients: a call for diagnostic stewardship
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Patricia MONZO GALLO
Poster P2881
Abstract 4209
Sensitivity of urine antigen for diagnosis of blastomycosis in solid organ transplant recipients
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Vaisak NAIR
Poster P2882
Abstract 4211
Evaluation of a commercial real-time PCR assay on pulmonary and extra-pulmonary aamples for mucormycosis diagnosis: assessing diagnostic performance
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Kruthi MALUR
Poster P2883
Abstract 4412
Candida PCR optimise the diagnosis of intra-abdominal candidiasis?
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Cristian CASTELLÓ-ABIETAR
Poster P2884
Abstract 4417
Microbial cell-free DNA sequencing from plasma and BAL in patients with a suspected invasive fungal infection: a retrospective multicentre study
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Sammy HUYGENS
Poster P2885
Abstract 5090
How can a Candida real-time PCR complement culture-based diagnostics of invasive candidiasis?
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Elizabeth Nagy Roshdy ISKANDAR
Poster P2886
Abstract 5222
Accuracy of galactomannan in tracheal aspirate for diagnosing invasive pulmonary aspergillosis in non-neutropaenic patients
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Graciela HERNANDEZ SILVA
Poster P2887
Abstract 5293
Laboratory diagnosis of invasive aspergillosis among haematological patients with use of 1,3-β-D glucan in combination with galactomannan and molecular detection of Aspergillus DNA: routine laboratory data collection 2019-2023
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Georgia VRIONI
Poster P2888
Abstract 5326
Development of multiplex real-time PCR assay for the simultaneous detection of two pathogens causing fungal pneumonia
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Younghyun BAEK
Poster P2889
Abstract 5479
Screening for Candida auris in critically ill patients: a two-year analysis from a Greek tertiary-care hospital, during COVID-19 waves
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Vasiliki MAMALI
Poster P2890
Abstract 5894
Comparison of culture and molecular detection of infections in nails and skin samples
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Radovan BRIGITA
Poster P2891
Abstract 6432
Single enrichment approach: evaluating thiol broth for comprehensive detection of bacteria and fungi in human bone fragments
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Livia TARTAGLIONE
Poster P2892
Abstract 6574
Diagnostic performance of different Candida antigens and anti-Candida antibody assays for the diagnosis of invasive candidiasis in ICU patients: an analysis of the CandiSep randomized clinical trial
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Jürgen HELD
Poster P2893
Abstract 6886
Longitudinal study reviewing the performance of Candida molecular diagnostic workflows from 2019 to 2023
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Dorothy MONTGOMERY
Poster P2894
Abstract 6977
MALDI-TOF MS in the identification of filamentous fungi, directly from the colony
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Eva MOLNAR
Poster P2895
Abstract 7041
Suboptimal sensitivity of a commercial panel for candidaemia: a Bayesian latent class meta-analysis of diagnostic test accuracy
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Alberto Enrico MARAOLO
Poster P2896
Abstract 7168
Infection vs colonisation: low-level detection of Pneumocystis jirovecii by PCR is uncommon in asymptomatic community patients
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Vicki FLEMING
Poster P2897
Abstract 7185
Development and performance of a new commercial urine diagnostic test for aspergillosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Kieren MARR
Poster P2898
Abstract 7296
Pentraxin 3 in onco-haematological patients: a potential biomarker for invasive fusariosis and aspergillosis
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Elaine Cristina FRANCISCO
Poster P2899
Abstract 7582
Analytical and clinical performance of a Candida auris IVD real-time PCR kit
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Julie GREEN
Poster P2900
Abstract 7723
Acute infection or colonisation? A comparative analysis of four molecular assays for the detection of Pneumocystis jirovecii
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Rosalind TUCKER
Poster P2901
Abstract 7750
Identification of fungi from histopathology positive formalin fixed paraffin embedded tissue by panfungal PCR
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Rija ZEHRA
Poster P2902
Abstract 7805
Can bronchoalveolar lavage galactomannan levels predict patient outcomes
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Elif ATES
Poster P2903
Abstract 7972
Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: A multicenter study
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Guo JIAN
Poster P2904
Abstract 8117
Development and validation of a molecular assay for the rapid diagnosis of fungal pneumonia
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Margherita CACACI
Poster P2905
Abstract 8145
Real-time assessment of dermatomycosis using a PCR/microarray-based diagnostic system
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Vittorio IVAGNES
Poster P2906
Abstract 8294
Optimisation of two commercial real-time PCR assays for rapid diagnosis of mucormycosis; analysis of 120 clinical specimens from COVID-19 patients
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Sajedeh SOLTANI
Poster P2907
Abstract 8317
Study of Candida spp. colonisation in patients admitted to an ICU
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Konstantinia KONTOPOULOU
Poster P2908
Abstract 8457
Mucor germinans, a novel dimorphic species mimicking Paracoccidioides in a pulmonary sample
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Seyed Mojtaba SEYED MOUSAVI TASIEH
Poster P2909
Abstract 8491
Label-free surface-enhanced Raman scattering (SERS) spectroscopy as a diagnostic tool for invasive aspergillosis: a pilot study
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Maria SIOPI
Poster P2910
Abstract 8648
Real-world applicability of EUROArray DNA systems for molecular diagnosis of dermatophytoses
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Claudelle TACUGUE
Poster P2911
Abstract 8786
Detection Mucorales DNA in sera specimens of both COVID-19 and non-COVID-19 associated mucormycosis using probe-based Mucorales-specific real-time PCR
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Kazem AHMADIKIA
Poster P2912
Abstract 3756
Evaluation of the metabolomic changes of fluconazole-resistant C.parapsilosis under fluconazole exposure
29/04 12:00
6b. Diagnostic mycology (incl traditional, molecular and other methods)
Ozlem DOGAN
Poster P2912
Abstract 804
A novel mechanism drives amphotericin B resistance in Candida auris
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Phan-Canh TRINH
Poster P2913
Abstract 1146
Antifungal susceptibility profile and local epidemiological cut-off values of Yarrowia (Candida) lipolytica: an emergent and rare opportunistic yeast
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Jinhan YU
Poster P2914
Abstract 1451
The seven year itch: how T. indotineae is driving the dermatophytosis epidemic in India
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Vaishnavi VERMA
Poster P2916
Abstract 1536
Whole genome sequencing of fluconazole non-susceptible bloodstream Candida parapsilosis isolates in South Korea
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Jong Hee SHIN
Poster P2917
Abstract 1783
Nationwide surveillance of azole resistance in clinical Aspergillus fumigatus (ARAf) 2018-2022
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Karen ASTVAD
Poster P2918
Abstract 1811
Molecular identification and antifungal susceptibility of clinical isolates of Fusarium spp: a single centre study
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Aleksandra GÓRZYNSKA
Poster P2919
Abstract 2583
Analysis of resistance in antifungals (ARIA): surveillance of Aspergillus isolates collected globally from 2020-2022
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Stephen HAWSER
Poster P2920
Abstract 2895
SCY-247, a novel second-generation IV/oral triterpenoid antifungal, demonstrates in vitro activity against fungal pathogens, including azole-resistant strains of Candida and Aspergillus
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Nathan WIEDERHOLD
Poster P2921
Abstract 3306
Aneuploidy is associated with azole cross-resistance in Trichosporon asahii evolved to voriconazole
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Lina GUO
Poster P2922
Abstract 3694
A service evaluation of the management of candidaemia in a UK tertiary healthcare centre
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Vanessa WONG
Poster P2923
Abstract 3771
In vitro activity of olorofim against the agents of the endemic mycoses
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Corinne PINDER
Poster P2924
Abstract 3786
In vitro activity of olorofim against Scedosporium species, Lomentospora prolificans and Scopulariopsis species
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Corinne PINDER
Poster P2925
Abstract 3934
Life in plastic is (not so) fantastic: a single-centre study on antifungal susceptibility of Candida parapsilosis
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Denise D'ELIA
Poster P2926
Abstract 3944
Survey on azole resistance in clinical Aspergillus spp collected in 2023 in hospitals located in central Iberian Peninsula (ASPEIN III)
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Jesus GUINEA
Poster P2927
Abstract 4085
Olorofim showed potent in vitro activity against Aspergillus spp clinical isolates collected in a national survey on azole resistance conducted in Spain in 2022 (ASPEIN II)
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Julia SERRANO-LOBO
Poster P2928
Abstract 4174
Biocide and antifungal susceptibility of Candida auris isolates
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Bedia DINC
Poster P2929
Abstract 4232
Synergistic interaction of milbemycin oxime with fluconazole against Candida auris
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Lola AUBRY
Poster P2930
Abstract 4243
Use of voriconazole to predict susceptibility and resistance to isavuconazole for Aspergillus fumigatus by using the CLSI methods and interpretive criteria
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Mariana CASTANHEIRA
Poster P2931
Abstract 4346
Unveiling azole-resistant Aspergillus fumigatus in ambient air: genotypic relationship between clinical and environmental isolates
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Laura ALGUACIL CUÉLLAR
Poster P2932
Abstract 4386
Characterisation of fluconazole non susceptible (FNS) Candida parapsilosis strains isolated from Hospitals from Spain
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Oscar ZARAGOZA
Poster P2933
Abstract 4454
Clinical impact of azole-resistant A. fumigatus (AFAR) complex isolates in a tertiary centre
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Anna FALCÓ ROGET
Poster P2934
Abstract 4657
Gradient diffusion plastic strip for detection of azole resistance in Aspergillus fumigatus sensu stricto: inoculum preparation might not require prior filtration and adjustment
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Julia SERRANO-LOBO
Poster P2935
Abstract 4746
Effect of SCY-247, a second-generation triterpenoid antifungal, on growth kinetics and ultrastructure of Candida auris
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Mahmoud A. GHANNOUM
Poster P2936
Abstract 4773
Comparative evaluation of gradient concentration strip and reference CLSI methods for antifungal susceptibility testing of Candida auris using a representative international panel of isolates
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Maria SIOPI
Poster P2937
Abstract 4789
Azole-resistant aspergillus species in poultry feed in Kabale, South West, Uganda
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Adeyinka ODEBODE
Poster P2938
Abstract 4888
Species-specific mortality and antifungal susceptibilityof the Candida spp. isolated in a north-eastern italian region between 2018 and 2022
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Fabiana DELLAI
Poster P2939
Abstract 4889
Inoculum density has an impact on SF001 fungicidal activity against Candida albicans
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
David HUFNAGEL
Poster P2940
Abstract 5329
In vitro activities of polyene, azole, and echinocandins against Candida auris isolates under both planktonic and biofilm-growing conditions
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Hamid BADALI
Poster P2941
Abstract 5336
Surveillance study of triazole-resistant Aspergillus fumigatus isolates in Iran
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Hamid BADALI
Poster P2942
Abstract 5368
Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: antimicrobial testing leadership and surveillance programme, 2010–2020
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Po-Ren HSUEH
Poster P2943
Abstract 5380
Candida guilliermondii fungemia: 10-year retrospective clinical analysis and antimicrobial susceptibility profiles from a reference laboratory
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Jack MCHUGH
Poster P2944
Abstract 5462
Distribution and antifungal susceptibility of yeast species causing invasive fungal diseases in China: a 12.5 years' review from the CHIF-NET study
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Meng XIAO
Poster P2945
Abstract 5525
Multicentre evaluation of a EUCAST-based agar-screening method for terbinafine and itraconazole susceptibility of Trichophyton spp.
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Joseph MELETIADIS
Poster P2946
Abstract 5705
Mechanistic investigations to understand the complex metabolism of voriconazole by cross-linking in silico and in vitro methods
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Amrei-Pauline KONRAD
Poster P2947
Abstract 6015
Current antifungal resistance in invasive aspergillosis
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Andrea GUTIÉRREZ VILLANUEVA
Poster P2948
Abstract 6030
Status of surveillance of antifungal resistance in candidaemia to inform antifungal stewardship in European countries
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Liliana GALIA
Poster P2949
Abstract 6139
Q-PHAST: simple, large-scale quantitative phenotyping and antimicrobial susceptibility testing
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Poster P2950
Abstract 6225
In vitro antifungal susceptibility testing of Cladophialophora bantiana clinical isolates in France
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Dea GARCIA-HERMOSO
Poster P2951
Abstract 6227
Copy number variants of ERG11 gene: an uncharacterised mechanism of azole resistance in Candida parapsilosis
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Ning YATING
Poster P2952
Abstract 6528
Worldwide genomic convergent evolution in clinical fungi: an emerging azole-resistance mechanism
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Rong-Chen DAI
Poster P2953
Abstract 7069
Amino-acid substitutions in CYP51A protein from Purpureocillium lilacinum likely to be associated with itraconazole resistance
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Lorra MONPIERRE
Poster P2954
Abstract 7107
Whole genome sequence analysis of terbinafine resistant and susceptible Trichophyton isolates from human and animal origin
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Sheetal THAKUR
Poster P2955
Abstract 7128
Mutations of the ERG11 gene in fluconazole-resistant Candida albicans isolates in Ivory Coast
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Kouassi Francis KOUADJO
Poster P2956
Abstract 7297
Delineation of the direct contribution of clinically observed FKS1 mutations to echinocandin resistance in Candida auris
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Katherine BARKER
Poster P2957
Abstract 7442
Antifungal resistance and breakthrough candidaemia among paediatric cancer patients: an emerging threat
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Youssef MADNEY
Poster P2958
Abstract 7545
In vitro antifungal susceptibility profile and genotypic characterisation of clinical Aspergillus isolates in eastern China on behalf of eastern China invasive fungi infection group
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Wenjuan WU
Poster P2959
Abstract 7781
Antifungal susceptibility profiles of dermatophyte isolates in Iran
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Shima ABOUTALEBIAN
Poster P2960
Abstract 7829
In vitro long-term exposure to chlorhexidine or triclosan is associated with cross-resistance against azoles in Nakaseomyces glabratus
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Kathrin SPETTEL
Poster P2961
Abstract 8063
Antifungal susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections: a multicentre observational study of the Turkish fungal infections study group
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Suda TEKIN
Poster P2962
Abstract 8335
Comparing the in vitro activity of seven antifungal drug with chlorhexidine against the most important causative agents of fungal keratitis
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Sadegh KHODAVAISY
Poster P2963
Abstract 8430
Unraveling the genotypic diversity and molecular mechanisms of fluconazole resistance in Candida parapsilosis clinical isolates in a tertiary care hospital from North India
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Vrinda SHARMA
Poster P2964
Abstract 8481
Synergistic interaction between amphotericin B and azoles against Candida guilliermondii using pharmacodynamics-modelling approach.
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Adrien BAILLOD
Poster P2965
Abstract 8860
ERG11 copy number variations in the human fungal pathogen Yarrowia lipolytica
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Jinhan YU
Poster P2966
Abstract 8898
In vitro activity of the novel antifungal olorofim against multiresistant Fusarium in China
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Yinggai SONG
Poster P2967
Abstract 8909
Categorisation of Candida auris isolates for second generation triazoles based on fluconazole susceptibility
29/04 12:00
6c. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)
Paschalis PARANOS
Poster P2968
Abstract 360
Post-infectious inflammatory response syndrome (PIIRS) in HIV-negative patients with cryptococcal meningitis in Vietnam
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Dang Trung Nghia HO
Poster P2969
Abstract 589
Real-world evaluation of isavuconazole as prophylaxis and therapy for invasive fungal infections in paediatric patients with cancer
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Janine NIJHUIS
Poster P2970
Abstract 593
Inadequate isavuconazole plasma concentrations in haemato-oncological non-ICU patients: need for routine therapeutic drug monitoring?
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Till KLEIN
Poster P2971
Abstract 911
Evaluation of posaconazole serum concentrations achieved with delayed-release tablets and oral suspension in patients undergoing intensive chemotherapy for acute myeloid leukemia and myelodysplastic syndrome
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Cédric HIRZEL
Poster P2972
Abstract 1060
Efficacy and safety of ibrexafungerp in the treatment of vulvovaginal candidiasis: a systematic review and meta–analysis
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Thiago NETTO
Poster P2973
Abstract 1285
Front-loaded exposures increase the fungicidal effect of SF001: a basis for infrequent dosing regimens
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Brian VANSCOY
Poster P2974
Abstract 1334
Opening the DOOR for clinical mycology: preliminary results of a Delphi process
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Jose PORTUGAL GONZALES
Poster P2975
Abstract 1546
In vitro interactions between 1,3,4-thiadiazole derivative and selected antifungal drugs
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Dominika KUBERA
Poster P2976
Abstract 1571
The evaluation of risk factors and prognostic impact of glucocorticoid therapy among non-HIV patients with Pneumocystis jirovecii pneumonia (PCP)
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Jun LI
Poster P2977
Abstract 1777
Treatment outcomes with rezafungin and caspofungin in adults with invasive candidiasis and/or candidaemia who had received no prior antifungal therapy: ReSTORE trial subgroup analysis
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
George R THOMPSON
Poster P2978
Abstract 1828
Personalised antifungal therapy through model-informed precision dosing of posaconazole
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Anouk JANSEN
Poster P2979
Abstract 1875
Daily intravenous liposomal Amphotericin B as antifungal prophylaxis in haematological patients: a clinical experience
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Ana María BADÍA-TEJERO
Poster P2980
Abstract 2102
Breakthrough invasive mould infections among high-risk haematologic patients
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Jorge BOÁN
Poster P2981
Abstract 2218
Timing of antifungal therapy for candida bloodstream infection
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Alaa ATAMNA
Poster P2982
Abstract 2341
Fluconazole target attainment during mechanical circulatory support device insertion
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Kelly CAIRNS
Poster P2983
Abstract 2438
Toward individualised antifungal therapy: mechanism-based pharmacokinetic/pharmacodynamic model of voriconazole to predict the clinical outcomes of adult patients with invasive aspergillosis
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Vasin VASIKASIN
Poster P2984
Abstract 2615
Efficacy and safety of L-AmB-containing treatment on paediatric IFD patients previously exposed to broad spectrum antifungal agents
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Beiqun CHEN
Poster P2985
Abstract 2623
An analysis of the use of posaconazole alone or in combination with any form of amphotericin B during a pandemic disaster in a low resource setting for COVID-19 associated mucormycosis (CAM)
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Pugazhenthan THANGARAJU
Poster P2986
Abstract 2925
Olorofim demonstrates potent in vitro activity against Coccidioides species including against isolates with reduced fluconazole susceptibility
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Nathan WIEDERHOLD
Poster P2987
Abstract 3048
Novel liposomal formulations of amphotericin B (LFAMB) were effective in murine models of experimental mycotic keratitis caused by Candida albicans (CA), Aspergillus fumigatus (AF), and Fusarium solani complex (FS)
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Ruta PETRAITIENE
Poster P2988
Abstract 3560
Voriconazole as secondary invasive fungal infection prophyalxis during allogeneic haematopoietic stem cell transplantation
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Yuwen WANG
Poster P2989
Abstract 3936
Revisiting amphotericin B prophylaxis in patients with haematology malignancies
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Gajaani KUGANARUL
Poster P2990
Abstract 4864
SF001, a novel micellar polyene, demonstrates a prolonged post-antifungal effect in vitro against yeast
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
David HUFNAGEL
Poster P2991
Abstract 5035
Using real-world data: can CYP2C19 genotype predict poor response to voriconazole?
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Sophie STOCKER
Poster P2992
Abstract 5129
PK/PD target attainment with contemporary dosing of antifungal drugs. Outcomes from an international, multicentre pharmacokinetic study for screening antifungal exposure in intensive care units: The SAFE-ICU study
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Jason ROBERTS
Poster P2993
Abstract 5719
Role of isavuconazole therapeutic drug monitor (TDM) in real life: is it possible and sure to reduce isavuconazole dosage in patients with overdose?
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Elena GHIDONI
Poster P2994
Abstract 5866
The echipof study: predictors of treatment failure to echinocandins for Candida bloodstream infection: a multicentre retrospective cohort study
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Lucia DIELLA
Poster P2995
Abstract 6197
Retrospective cost analysis model of treating candidaemia with rezafungin based on real-world data from a German tertiary hospital
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Melina Sophie KURTE
Poster P2996
Abstract 6392
Efficacy of extended-interval micafungin dosing against Candida albicans and Candida parapsilosis isolates using an in vitro pharmacokinetic/pharmacodynamic model
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Maria-Ioanna BEREDAKI
Poster P2997
Abstract 6465
Posaconazole TDM and pharmacogenetic as a tool for antifungal stewardship in haematological patients with acute myeloid leukaemia
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Silvia CORCIONE
Poster P2998
Abstract 6511
Evaluation of real-world isavuconazole therapeutic drug monitoring: where to go from here?
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Beatrijs MERTENS
Poster P2999
Abstract 3638
Model-informed identification of a weight-based fluconazole dosing strategy aiming for improved target attainment in critically ill patients
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Luong VUONG
Poster P2999
Abstract 7818
Evaluation of clinical outcomes for anidulafungin standard dosing in hospitalised critically ill obese patients with candidaemia: a retrospective cohort study
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Yazed ALSOWAIDA
Poster P3000
Abstract 7974
Isavuconazole therapeutic drug monitoring may be advocated in Asian patients with invasive mould infections based on their pharmacogenomic profiling
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Fu Zi Yvonne CHAN
Poster P3001
Abstract 8220
Voriconazole or isavuconazole in the treatment of aspergillosis in elderly patients?
29/04 12:00
6d. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)
Julieth CABALLERO
Poster P3002
Abstract 684
A multidrug delivery platform based on azole-loaded mucosomes as promising strategy to counteract infections caused by Candida albicans
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Giuliana BANCHE
Poster P3003
Abstract 1178
In vivo effectiveness of fluconazole and posaconazole in a murine model of Coccidioides meningitis caused by fluconazole-resistant isolates
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Laura NAJVAR
Poster P3004
Abstract 1277
Anti-fungal and anti-biofilm activities of polycaprolactone blended with calcium phosphates and silver against Candida albicans and C. auris for bone tissue regeneration applications
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Valeria ALLIZOND
Poster P3005
Abstract 1561
IL-15 secretion enhances the potential of Af-CAR-NK92 cells for off-the-shelf treatment of invasive pulmonary aspergillosis
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Beeke TAPPE
Poster P3006
Abstract 1713
The impact of melanisation on hyphal formation in pathogenic fungi
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Hamide ZOQI
Poster P3007
Abstract 1871
Development of a combat-relevant murine model of wound mucormycosis as a platform for rapid screening and validation of novel treatments
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Alexander BOBROV
Poster P3008
Abstract 2417
The intravenous challenge mouse model for experimental infections with Yarrowia lipolytica
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Jinhan YU
Poster P3009
Abstract 2441
Detection and prevalence of moulds and aflatoxins in food and feed for animal and human consumption
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Emina IDRIZOVIC
Poster P3010
Abstract 3577
Bacterial-mucorales interactions and antimicrobial resistance during mucormycosis: literature search and in vitro observations
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Dora Edith CORZO LEON
Poster P3011
Abstract 3886
Isavuconazole and micafungin elicit synergistic antifungal activity against azole-resistant Aspergillus fumigatus and stimulate hyphal inactivation by mononuclear phagocytes
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Sebastian WURSTER
Poster P3012
Abstract 6988
N-chlorotaurine is effective in Aspergillus fumigatus pneumonia in the mouse model
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Markus NAGL
Poster P3013
Abstract 7636
Whole genome sequencing endorses microsatellite-defined Candida parapsilosis genotypes even though they involve isolates from unrelated patients
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Aina Catalina MESQUIDA MARCOS
Poster P3014
Abstract 8751
Fungal pathogens exposed – genomic and phenotypic insights into Candida auris and its relatives of the Candida haemulonii species complex
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Auke DE JONG
Poster P3015
Abstract 8775
Fungal BET protein Bdf1 shows promise as a potential antifungal drug target in Candida spp.
29/04 12:00
6e. Basic mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)
Carlo PETOSA
Poster P3016
Abstract 33
Rodent-adapted Cryptosporidium infections in humans: seven new cases and review of the literature
29/04 12:00
7a. Parasitic disease epidemiology
Christen Rune STENSVOLD
Poster P3017
Abstract 472
Canine and sand fly aspects to the Leishmania donovani transmission in endemic villages of Bihar, India
29/04 12:00
7a. Parasitic disease epidemiology
Anurag KUSHWAHA
Poster P3018
Abstract 1085
Investigation of the Visceral Leishmaniasis outbreak in the endemic region of India
29/04 12:00
7a. Parasitic disease epidemiology
Aziza NEYAZ
Poster P3019
Abstract 1443
Can the use of larviciding with biological compounds contribute in increasing Anopheles gambiae s.l. susceptibility to pyrethroid in a population expressing high resistance intensity?
29/04 12:00
7a. Parasitic disease epidemiology
Diane Leslie NKAHE
Poster P3020
Abstract 1807
Toxoplasmosis surveillance in a tertiary hospital in Barcelona, Spain
29/04 12:00
7a. Parasitic disease epidemiology
Celso BATISTA
Poster P3021
Abstract 2057
Oxyuriasis is a risk factor for Dientamoeba fragilis infection: a case-control study
29/04 12:00
7a. Parasitic disease epidemiology
Felipe PÉREZ-GARCÍA
Poster P3022
Abstract 2516
Leishmaniasis: looking back to face the future. A retrospective study of an endemic area in the south of Madrid
29/04 12:00
7a. Parasitic disease epidemiology
Víctor ANTÓN BERENGUER
Poster P3023
Abstract 2518
Odyssean malaria outbreak investigations in South Africa, 2014-2022
29/04 12:00
7a. Parasitic disease epidemiology
Lucille BLUMBERG
Poster P3024
Abstract 2794
Factors associated with severe Plasmodium vivax infection in Thailand was different from the WHO criteria
29/04 12:00
7a. Parasitic disease epidemiology
Pattaratida SINGHASENEE
Poster P3025
Abstract 2838
TB-TROPIcare: Prevalence study of schistosomiasis and strongyloidiasis in a multicultural TB clinic
29/04 12:00
7a. Parasitic disease epidemiology
Camilla GENOVESE
Poster P3026
Abstract 3187
Zoonotic Echinococcus granulosus sensu lato genotypes circulating in small ruminants of north India: a comprehensive appraisal based on mtDNA signatures
29/04 12:00
7a. Parasitic disease epidemiology
Pallavi MOUDGIL
Poster P3027
Abstract 3677
Toxoplasmosis in the Netherlands: seroprevalence and risk factors
29/04 12:00
7a. Parasitic disease epidemiology
Titia M. KORTBEEK
Poster P3028
Abstract 4574
Prevalence and associated factors of pediculosis capitis (Phthiraptera: Pediculidae) among primary schoolchildren in rural and urban areas in Monastir, Tunisia
29/04 12:00
7a. Parasitic disease epidemiology
Dhekra FARJALLAH
Poster P3029
Abstract 5134
Declining seroprevalence of toxoplasmosis in the female population and changing ethnic distributions in Singapore over the last 2 decades
29/04 12:00
7a. Parasitic disease epidemiology
Cecilia Cheng Lai NGAN
Poster P3030
Abstract 5223
Chagas disease causing heart failure in Central America: burden and trend analysis between 1990 and 2019.
29/04 12:00
7a. Parasitic disease epidemiology
Rafael CORTORREAL JAVIER
Poster P3031
Abstract 5276
First report of seroprevalence and risk factors of human fascioliasis in communities in North Vietnam
29/04 12:00
7a. Parasitic disease epidemiology
Thi Bich Thao NGUYEN
Poster P3032
Abstract 5986
Unusual increase of Cryptosporidium spp. cases in Madrid, Spain
29/04 12:00
7a. Parasitic disease epidemiology
Claudia SANZ-GONZÁLEZ
Poster P3033
Abstract 6014
Visceral leishmaniasis resurgence after COVID-19 pandemic. Data from Regional Surveillance System of the Lazio Region (Italy)
29/04 12:00
7a. Parasitic disease epidemiology
Martina SPAZIANTE
Poster P3034
Abstract 6219
Shifting sands: Exploring the clinical and genomic dynamics of leishmaniasis in Turkey's changing landscape
29/04 12:00
7a. Parasitic disease epidemiology
Varol TUNALI
Poster P3035
Abstract 6363
Sequencing and Phylogenetic Analysis of Enterobius Vermicularis Isolates from Bulgaria - First Genetic Study
29/04 12:00
7a. Parasitic disease epidemiology
Reneta DIMITROVA
Poster P3036
Abstract 6427
Overview of clinical, microbiological and epidemiological characteristics of patients with malaria in Slovenia
29/04 12:00
7a. Parasitic disease epidemiology
Jasna CERNOSA
Poster P3037
Abstract 6972
DNA sequencing of Plasmodium falciparum apical membrane antigen-1 identified genetic sub-structure and novel nsSNPs modulating functional motifs
29/04 12:00
7a. Parasitic disease epidemiology
Sahib GUL
Poster P3038
Abstract 7557
Reactivation of Trypanosoma cruzi infection in immunosuppressed patients: a systematic review and meta-analysis
29/04 12:00
7a. Parasitic disease epidemiology
Alba ANTEQUERA MARTIN
Poster P3039
Abstract 8542
Cystic echinococcosis among adults in Tunisia: a burden of a disease
29/04 12:00
7a. Parasitic disease epidemiology
Sana ROUIS
Poster P3040
Abstract 210
Confirmation of Ancylostoma and Strongyloides nematodes through molecular analysis in human and canine populations of Bangladesh
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Tilak Chandra NATH
Poster P3041
Abstract 242
Congenital malaria in a non-endemic setting: a literature review and update on diagnosis and management
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Charlotte PATTERSON
Poster P3042
Abstract 628
Increased detection of strongyloidiasis in Gipuzkoa, northern Spain, after a change in diagnostics algorithm and introduction of a multiplex PCR
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Inigo ANSA ISASA
Poster P3043
Abstract 1094
Comparative evaluation of microscopy, conventional PCR and real-time PCR for detection of soil-transmitted helminths
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Sumeeta KHURANA
Poster P3044
Abstract 1619
Comparison between a molecular and a standard staining technique to detect Cryptosporidium sp in stool samples: evaluation in an outbreak situtation
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Jordi IGLESIES TORRENT
Poster P3045
Abstract 1681
Evaluation of Lb6H recombinant protein produced in Brazil to diagnose American tegumentary leishmaniasis
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Ruth Tamara VALENCIA PORTILLO
Poster P3046
Abstract 1954
Utilizing a real-time PCR platform to identify Strongyloides stercoralis infection.
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Chao-Chi CHEN
Poster P3047
Abstract 2259
High proportion of sexually transmitted infections in Trichomonas vaginalis positive patients using syndromic PCR: a French monocentric study on 199 patients
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Jean-Pierre GANGNEUX
Poster P3048
Abstract 3028
Comparison of prototype ELISAs for serodiagnosis of visceral leishmaniasis
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Babett MENGE
Poster P3049
Abstract 3343
Diagnostic performance of qPCR for detecting cell-free DNA (cf DNA) in urine and serum of amoebic liver abscess patients before & after treatment
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Priya DATTA
Poster P3050
Abstract 3650
Performance and impact of introducing real-time PCR for detection of Acanthamoeba spp in corneal scrapings
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Stefanie VAN KLEEF VAN KOEVERINGE
Poster P3051
Abstract 4139
Usefulness of real-time PCR for malaria diagnosis and identification of Plasmodium species in febrile patients in Cubal, Angola
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Alejandro MEDIAVILLA PÉREZ
Poster P3052
Abstract 4275
Taenia asiatica: mitochondrial signatures based analysis of an emerging global health threat
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Aman Dev MOUDGIL
Poster P3053
Abstract 4317
A novel syndromic approach for the diagnosis of gastrointestinal parasites
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Maria Sofia MONTANARI
Poster P3054
Abstract 4598
Genetic variation of metabolic enzymes of Leishmania spp. parasites isolated from different clinical types of cutaneous leishmaniasis patients
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Mansoure HOSSEINI
Poster P3055
Abstract 5643
Accuracy of the new immunocromatography black version as a novel sensitive tool for both screening and diagnosis of schistosomiasis among Sub-Saharan immigrants in health care settings in non endemic countries
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Alaa H. A. HEGAZY
Poster P3056
Abstract 5748
Detection of new genotype of Echinococcus multilocularis raising health concerns in Canada
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Kinga KOWALEWSKA-GROCHOWSKA
Poster P3057
Abstract 5923
Evaluation of a western blot associated with a line blot assay for the serodiagnosis of alveolar and cystic echinococcosis
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Sabrina EGREK
Poster P3058
Abstract 6309
Molecular screening of Malaria and other neglected parasitic diseases in the Peruvian Amazon by Multiplex qPCR
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Víctor ANTÓN BERENGUER
Poster P3059
Abstract 6385
Behind the veil: Exploring the hidden dynamics of asymptomatic cutaneous leishmaniasis
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Varol TUNALI
Poster P3060
Abstract 6576
Intestinal protozoa diagnosis in a low prevalence setting: evaluation of the impact of formalin-free fixative and the number of specimens/episode using a commercial single-vial in a referral laboratory
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Lidia GOTERRIS BONET
Poster P3061
Abstract 6633
The emergence of a hypertransmissible Cryptosporidium hominis subtype in Spain
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
María DUCÓNS
Poster P3062
Abstract 7229
Investigation of Leishmania RNA viruses (LRV 1, LRV 2) in L.tropica isolated from CL patients in Sanliurfa, Turkiye where CL is highly endemic
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Fadile YILDIZ ZEYREK
Poster P3063
Abstract 7251
The correlation between procalcitonin levels and the possibility of bacteremia in the setting of malaria infection
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Shahad ABASAEED ELHAG
Poster P3064
Abstract 7356
Heterogeneity primer spacers (staggering) improve the performance of amplicon sequencing of V3-V4 region of 16S rDNA as well as 18S region for Blastocystis subtyping
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Ondrej CINEK
Poster P3065
Abstract 7670
Molecular detection of cell-free DNA in human plasma with cystic echinococcosis as a diagnosis method
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Mahboubeh HADIPOUR
Poster P3066
Abstract 8171
Detection of Treponema pallidum in non-lesional specimens
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Roberto ALONSO
Poster P3067
Abstract 8456
Evaluation of a commercial kit for detection of T. cruzi-specific antibodies
29/04 12:00
7b. Diagnostic parasitology (incl traditional, molecular and other methods)
Aroa SILGADO
Poster P3068
Abstract 1889
Evolving trends of molecular subtyping and macrolide resistance of Treponema pallidum in British Columbia, Canada: a ten years review
29/04 12:00
7c. Antiparasitic susceptibility & drug resistance (incl surveillance, mechasnism)
Muhammad MORSHED
Poster P3069
Abstract 2089
In silico analysis of tryparedoxin peroxidase in Leishmania major
29/04 12:00
7c. Antiparasitic susceptibility & drug resistance (incl surveillance, mechasnism)
Sahel HAMZEHPOUR
Poster P3070
Abstract 8915
Frequencies of molecular markers of plasmodium falciparum antimalarial drug resistance in a context of seasonal malaria chemoprevention (smc) with two different treatment regimens in koulikoro health district, mali
29/04 12:00
7c. Antiparasitic susceptibility & drug resistance (incl surveillance, mechasnism)
Kane FOUSSEYNI
Poster P3071
Abstract 27
Pyocyanin displays amoebicidal activity against Naegleria fowleri, a brain-eating amoeba, through inducing reactive oxygen species accumulation
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Pichet RUENCHIT
Poster P3072
Abstract 718
Targeting sterol 14α-demethylase (CYP51) in Leishmania major: towards effective broad-spectrum treatment and overcoming drug resistance
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Chandra Kanta BHUSAL
Poster P3073
Abstract 782
Acanthamoeba castellanii prefers lipids as food, offering new possibilities for treatment
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Maarten SARINK
Poster P3074
Abstract 2132
Visceral leishmaniasis by L. infantum in immunosupressed patients
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Juan Victor SAN MARTIN
Poster P3075
Abstract 2160
Analysis of clinical characteristics and results of patients with Plasmodium vivax infection in South Korean military hospital, 2012-2021
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Hong Sang OH
Poster P3076
Abstract 2365
Novel artemisinin hunt: investigation of the in vivo antimalarial efficacy of Cotinus coggygria
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Ahmet YILDIRIM
Poster P3077
Abstract 2375
Antileishmanial activity of thymol on Leishmania tropica isolated from Turkey: in vitro and ex vivo study
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Tülay AKSOY
Poster P3078
Abstract 2672
Efficacy of adjunctive topical liposomal clarithromycin on systemic glucantime in old world cutaneous leishmaniasis: a pilot clinical study
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Atousa HAKAMIFARD
Poster P3079
Abstract 3367
Longitudinal changes in iron homeostasis in human experimental and clinical malaria
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Stephen WOOLLEY
Poster P3080
Abstract 3462
Recurrence of pleural echinococcosis: a surgical challenge
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Raffaella LISSANDRIN
Poster P3081
Abstract 3662
Evaluation of BCG training effects on lesion size and parasite load caused by Leishmania major in BALB/c mice
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Askarypour ZOHREH
Poster P3082
Abstract 4477
A national multidisciplinary team meeting for leishmaniasis in the United Kingdom: experience at two years
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Owain DONNELLY
Poster P3083
Abstract 7342
Use of extracellular vesicles of Giardia lamblia as a promising vaccine candidate
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Bárbara FERREIRA
Poster P3084
Abstract 7951
Tolerance and safety of benznidazol in adults patients with chagas disease: experience in four public medical center of Buenos Aires, Argentina
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Alvaro OTRERAS
Poster P3085
Abstract 8405
Biodiversity study of endophytes fungi from Alstonia boonei De Wild and assessment of the antiplasmodial effects of their ethyl acetate extracts against Plasmodium falciparum strains
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Paola Cynthia DEMENI EMOH
Poster P3086
Abstract 8415
Cellular effects of fosfomycin on Wolbachia spp.
29/04 12:00
7d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)
Lara BEHRMANN
Poster P3088
Abstract 256
Documentation of initial health assessments for people seeking asylum presenting to an infectious disease clinic in a tertiary infectious diseases centre
29/04 12:00
7e. Travel medicine, migrant and refugee health
Ioan Dafydd WARDHAUGH
Poster P3089
Abstract 468
Seroprevalence of Schistosoma and Strongyloides in migrants from sub-Saharan Africa screened in Sweden
29/04 12:00
7e. Travel medicine, migrant and refugee health
Caroline RÖNNBERG
Poster P3090
Abstract 2042
Imported Plasmodium vivax cases among newly arrived migrants in New York City
29/04 12:00
7e. Travel medicine, migrant and refugee health
Maria Alyssa POLICARPIO
Poster P3091
Abstract 2155
Risk factors for Strongyloides stercoralis infection in immigrant populations: case-control study
29/04 12:00
7e. Travel medicine, migrant and refugee health
Azucena RODRIGUEZ-GUARDADO
Poster P3092
Abstract 2207
Burden of infectious diseases in pregnant and postpartum migrant women and newborn babies and barriers to health services: a systematic review in MENA region and qualitative study in Tunisia
29/04 12:00
7e. Travel medicine, migrant and refugee health
Anissa OUAHCHI
Poster P3093
Abstract 2228
Results of a screening programme for schistosomiasis in an immigrant population
29/04 12:00
7e. Travel medicine, migrant and refugee health
Azucena RODRIGUEZ-GUARDADO
Poster P3094
Abstract 2390
Epidemiological characteristics of respiratory illnesses among Thai repatriates from armed conflict areas in Myanmar, November 2023
29/04 12:00
7e. Travel medicine, migrant and refugee health
Bhanasut HUNSAJARUPAN
Poster P3095
Abstract 2945
Improving malaria care in a non-endemic setting with high malaria caseloads but without a specialist infection unit: a targeted approach
29/04 12:00
7e. Travel medicine, migrant and refugee health
Marc WOODMAN
Poster P3096
Abstract 3348
Diagnostic landscape of eosinophilia in immigrants
29/04 12:00
7e. Travel medicine, migrant and refugee health
Laura Noelly NIÑO PUERTO
Poster P3097
Abstract 4000
Imported schistosomiasis in travelers: experience from a referral tropical medicine unit in Barcelona, Spain
29/04 12:00
7e. Travel medicine, migrant and refugee health
Fernando SALVADOR
Poster P3098
Abstract 4836
Asymptomatic malaria infection can affect the lipid profile of patients: cause or consequence?
29/04 12:00
7e. Travel medicine, migrant and refugee health
Diego GAYOSO CANTERO
Poster P3099
Abstract 4884
S. stercoralis infections in a Tropical Medicine Clinic - a 5 year retrospective review
29/04 12:00
7e. Travel medicine, migrant and refugee health
Maria Alyssa POLICARPIO
Poster P3100
Abstract 5831
Sexual and reproductive health of female asylum seekers seen by RESPOND, a UK integrated refugee health screening programme
29/04 12:00
7e. Travel medicine, migrant and refugee health
Rebecca RYAN
Poster P3101
Abstract 5844
Traveller's adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
29/04 12:00
7e. Travel medicine, migrant and refugee health
Jenny Lea SCHNYDER
Poster P3102
Abstract 6127
Missed opportunities for Chagas screening in in a UK tertiary-level hospital
29/04 12:00
7e. Travel medicine, migrant and refugee health
Harriet DAVIDSON
Poster P3103
Abstract 6198
Clinical findings in sub-Saharan migrants with asymptomatic Plasmodium infections screened in Sweden
29/04 12:00
7e. Travel medicine, migrant and refugee health
Isabelle ELIASSON
Poster P3104
Abstract 6679
Severe Plasmodium falciparum Malaria: Epidemiological Shifts and Clinical Challenges in the Czech Republic
29/04 12:00
7e. Travel medicine, migrant and refugee health
Vyacheslav GREBENYUK
Poster P3105
Abstract 7394
The malaria mantra mislaid: new insights from a retrospective analysis of malaria cases at a UK south coast centre
29/04 12:00
7e. Travel medicine, migrant and refugee health
Daisy WOOLHAM
Poster P3106
Abstract 7458
Health screening for returning Hajj pilgrims across international airports in Thailand, July 2023
29/04 12:00
7e. Travel medicine, migrant and refugee health
Suttiporn PRAPASO
Poster P3107
Abstract 8124
Views and experiences of catch-up vaccination among adult migrants in the UK: an in-depth interview study
29/04 12:00
7e. Travel medicine, migrant and refugee health
Anna DEAL
Poster P3108
Abstract 8285
Experience from a diagnosis approach algorithm for travelers diarrhoea in a specialised international health unit, Barcelona, Spain
29/04 12:00
7e. Travel medicine, migrant and refugee health
Saul LEVY BLITCHTEIN
Poster P3109
Abstract 8773
A closer look into imported malaria diagnosis delay: medical skills need a push forward
29/04 12:00
7e. Travel medicine, migrant and refugee health
Joaquín SALAS-CORONAS
Poster P3110
Abstract 121
Insecticide susceptibility of the sand fly leishmaniasis vector Phlebotomus argentipes in Bihar, India
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Ashish SHUKLA
Poster P3111
Abstract 1423
Salmonella enterica in farm environments in the Ashanti region of Ghana
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Dennis FOSU
Poster P3112
Abstract 1654
Tick-borne encephalitis seroprevalence in Northern Italy: a cross-sectional study on a randomly selected population
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Silvia NOZZA
Poster P3113
Abstract 1711
Genomic characteristics of carbapenemase-producing non-Enterobacterale Gram-negative isolates from wastewater in Japan
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Hiroaki BABA
Poster P3114
Abstract 2894
Assessment of antimicrobial resistance in Gram-negative bacteria from rivers supplying drinking water: insights for water quality management
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Patricia ANTUNES
Poster P3115
Abstract 3635
Persistence of viable but nonculturable Legionella pneumophila state in hospital water systems
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Laura GAVALDÀ-MESTRE
Poster P3116
Abstract 3759
Nationwide surveillance, antibiogram, and genotypic characteristic of pathogenic Escherichia coli isolated from pork production chain in Korea
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Hyeonwoo CHO
Poster P3118
Abstract 4669
Vulnerability to infectious diseases among people exposed to climate disasters in Mozambique: a cross-sectional study
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Elda DE VITA
Poster P3119
Abstract 5461
Epidemiological study on prevalence of Toxoplasma gondii from pigs, cats, water, soil and vegetables in North India: One health integrative research
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Divya RATTAN
Poster P3120
Abstract 6160
Predicting the age of field Anopheles mosquitoes using mass spectrometry and deep learning
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Pauline NAUDION
Poster P3121
Abstract 6452
Antimicrobial resistant enterococci in semi-intensive and free-range broiler farms in Uganda
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Linnet ATIENO OCHIENG
Poster P3122
Abstract 6674
Application of Culturomics and Whole Genome Sequencing for the detection of antibiotic resistance genes in novel bacteria isolated from Wastewater Treatment sites.
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Eleni OURANOU
Poster P3123
Abstract 6794
Occurrence and persistence of multi-drug resistant Enterobacterales isolated from urban, industrial and surface water in Monastir, Tunisia
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Wejdene MANSOUR
Poster P3124
Abstract 6830
Carbapenem-resistant P. aeruginosa from environmental origin: spread of GES-5 producing ST235 strains.
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Klibi NAOUEL
Poster P3125
Abstract 6831
Detection of Salmonella in stream environment and its association with clinical strains
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Jeong Hwan SHIN
Poster P3126
Abstract 6872
Therapeutic alternative to the use of antibiotics in chicken farming: about detection of ESBL Escherichia coli?
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Wejdene MANSOUR
Poster P3127
Abstract 6937
Ticks on French Riviera (France): Diversity, seasonality and associated bacteria
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Christelle POMARES
Poster P3128
Abstract 7282
Resistant-Enterococcus species in wild boar (Sus scrofa) from Portugal
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Josman PALMEIRA
Poster P3129
Abstract 8210
Seeking the molecular identity of blood meals in mosquitoes of medical importance, collected within a five-year period (2017-2022) in urban and rural areas of Greece
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Nikolaos TEGOS
Poster P3130
Abstract 8239
Metagenomic approach to aquatic matrices in the South American metropolitan region: pathways for maintenance and dissemination of antimicrobial resistance genes (ARGs)
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Fernanda FERNANDES SANTOS
Poster P3131
Abstract 8565
BIM-1 (Belém-Imipenemase) in multidrug-resistant Pseudomonas spp in rivers and hospital sewage in the Brazilian Amazon
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Marcia NAZARE MIRANDA BAHIA
Poster P3132
Abstract 8699
Residual Bacillus cereus contamination of processed laundry supplied to health and social care providers: more questions than answers
29/04 12:00
7f. Food & water safety, environmental health, vector epidemiology
Christopher JONES
Poster P3133
Abstract 550
Assessing pandemic risks: expert ranking of infectious diseases in WHO's blueprint for action to prevent epidemics
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Jon SALMANTON-GARCIA
Poster P3134
Abstract 932
Increase of Legionella positive environmental sources and its correlation with climate change
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Elisenda ARQUÉ PÉREZ
Poster P3135
Abstract 3414
Lessons to be learned: challenges and solutions to implementation of clinical research responses to high priority diseases of epidemic/pandemic potential: a scoping review
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Shanthi LEVANITA
Poster P3136
Abstract 5193
Knowledge about sexually transmitted infections according to the biopsychosocial characteristics of Brazilian undergraduates
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Felipe Santos De CARVALHO
Poster P3137
Abstract 5949
A rapid evaluation of the New Variant Assessment Platform: promoting programme sustainability
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Koren JONES
Poster P3138
Abstract 6355
Modelling the interplay between patients' socioeconomic characteristics, health insurance, contextual factors and antibiotic misuse behaviour in Tanzania: a Bayesian Belief Network approach
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Madeleine CLARKSON
Poster P3139
Abstract 6537
Charting the landscape: understanding the full scope of the burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Tomislav MESTROVIC
Poster P3140
Abstract 6903
A cutaneous anthrax outbreak in the rural region of Kars, Turkey
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Hazal ERDEM
Poster P3141
Abstract 7756
Climate change negatively impacts AMR
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Srishti GOEL
Poster P3142
Abstract 7931
The Italian registry of fever of unknown origin
29/04 12:00
7g. Global and public health &health security (incl policy-making, climate change, biosafety/biosecurity)
Verena ZERBATO
Poster P3143
Abstract 611
Factors that affect the timely diagnosis and treatment of neutropenic fever in Ugandan patients with cancer and HIV: A process mapping study
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Elizabeth GULLEEN
Poster P3144
Abstract 647
Expansion of cytotoxic immune cells in the lesion border skin of PKDL and Leprosy
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Shashi KUMAR
Poster P3145
Abstract 960
The experience of genital ulcer disease, barriers to treatment and acceptability of sexually transmitted infection diagnostics in Harare, Zimbabwe
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Catrin THOMAS
Poster P3147
Abstract 1820
Findings of a low-cost nurse-led mental health screening approach: underdiagnosis and undertreatment of mental health disorders among people living with HIV in Rwanda
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Laura OMANN
Poster P3148
Abstract 2071
High rates of ciproflaxicin and doxycline resistance in Neisseria gonorrhoeae infection in Lesotho
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Liteboho MADUNA
Poster P3149
Abstract 2404
The burden and clinical outcomes for neglected tropical diseases in migrant populations in the Middle East and North Africa: a systematic review
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Eman ELAFEF
Poster P3150
Abstract 2707
Assessment on the rational use of antimalaria drugs in health facilities of Ethiopia: cross sectional study
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Natnael Solomon HASSEN
Poster P3151
Abstract 3718
Systemic engineering initiative for patient safety model helped categorize barriers and facilitators for surgical site infection prevention at King Faisal Hospital Rwanda
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Buddhi HATHARALIYADDA
Poster P3152
Abstract 3819
Human African trypanosomiasis: preliminary retrospective analysis of cases treated in Lui Hospital, Western Equatoria, South Sudan
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Francesca MARIOTTI
Poster P3153
Abstract 4075
Anal self-sampling is suitable for anal cancer screening among men who have sex with men in Togo
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Valentine Marie FERRÉ
Poster P3154
Abstract 4738
Infectious disease profile in the Embera Dóbida, indigenous tribe of Colombian Pacific Coast: descriptive cross-sectional study
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Santiago RAMIREZ
Poster P3155
Abstract 4850
Impact of diabetes and metabolic syndrome on malaria severity in two hospital settings in Cameroon
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Katja WYSS
Poster P3156
Abstract 5559
High prevalence of antimicrobial resistance in bacterial isolates from clinical specimens in Timor-Leste
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Tessa OAKLEY
Poster P3157
Abstract 5571
Serotype distribution of invasive pneumococcal disease in Vietnam in the pre-vaccination era: a retrospective study 2011-2023
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Thomas KESTEMAN
Poster P3158
Abstract 7164
Malaria in the indigenous peoples of the Colombian Pacific coast: ancestral knowledge and practices
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Maria Jose GARCIA TIRADO
Poster P3159
Abstract 7257
Achieving threshold coverage in mass drug administration campaigns; mixed methods approach Bijagos Archipelago, Guinea-Bissau
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Ellen SUGRUE
Poster P3160
Abstract 7304
Carrier Mediated Delivery of Amphotericin-B Through Mannosylated Liposomes for Effective Management of Leishmaniasis
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Mani BHARGAVA
Poster P3161
Abstract 7485
Chagas disease: treatments with nifurtimox and benznidazole in indigenous communities in Colombia
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Simone KANN
Poster P3162
Abstract 7825
Developing a clinical prediction model to modify empirical antibiotics for non-typhoidal Salmonella bloodstream infection in children under-five in DR Congo
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Bieke TACK
Poster P3163
Abstract 7847
World Health Organization's clinical criteria orienting hospital referral and diagnosis of serious bacterial infections in children under-five perform poorly
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Bieke TACK
Poster P3164
Abstract 8580
A multi-component pragmatic intervention to improve diagnosis and early hospital management of patients with suspected acute brain infections in Brazil, India and Malawi: the Brain Infections Global Intervention Study
29/04 12:00
7h. Infections in low-resource settings (incl epidemiology, burden, health infrastructure, health disparities and vulnerable populations)
Bhagteshwar SINGH
Poster LB001
Abstract 9660
Immune response to MPXV wanes rapidly after intradermal vaccination with MVA-BN (Jynneos)
30/04 12:00
21. New drugs and vaccines
Klara SONDÉN
Poster LB002
Abstract 9625
In vitro activity of two aztreonam-based combinations, aztreonam/avibactam and aztreonam/nacubactam against molecularly characterised carbapenemase expressing Enterobacterales collected in India
30/04 12:00
21. New drugs and vaccines
Yamuna Devi BAKTHAVATCHALAM
Poster LB003
Abstract 9614
SLAMF1 weaken colonization resistance of gut microbiome against carbapenem-resistant Klebsiella pneumoniae
30/04 12:00
21. New drugs and vaccines
Tian GUO-BAO
Poster LB004
Abstract 9317
Toll-like receptor ligand as a potent adjuvant for extracellular vesicle-based vaccines
30/04 12:00
21. New drugs and vaccines
Young Rong KIM
Poster LB005
Abstract 9596
Targeted-Antibacterial-Plasmid (TAPs) delivered by RP4 conjugation system specifically kill E.coli ST131 resistant strains carrying blaCTX-M-15 in vitro
30/04 12:00
21. New drugs and vaccines
Elisabeth DEROLLEZ
Poster LB006
Abstract 9580
Flavone acetic acid can inhibit SARSCoV2 variants and mimicry of human respiratory pacemaker proteins
30/04 12:00
21. New drugs and vaccines
Manish KUMAR
Poster LB007
Abstract 9517
A novel compound library screen identifies antibiotics that can be combined with LpxC inhibitors for treatment of Acinetobacter baumannii
30/04 12:00
21. New drugs and vaccines
Beatriz CANO CASTAÑO
Poster LB008
Abstract 9450
A cocktail of two heavy chain-only antibodies targeting three epitopes spread across the spike protein S1 and S2 subunits that neutralises all SARS-CoV-2 variants tested so far with exceptional potency
30/04 12:00
21. New drugs and vaccines
Viki BOCKSTAL
Poster LB010
Abstract 9539
High specificity of bacteriophages and cocktails against methicillin sensitive and resistant S. aureus (MSSA-MRSA) belonging to clonal complex 8 (CC8)
30/04 12:00
21. New drugs and vaccines
Lorena SALAZAR OSPINA
Poster LB011
Abstract 9519
An in vitro approach for anti-microbial peptide library screening on a high-throughput droplet-based microfluidic platform
30/04 12:00
21. New drugs and vaccines
Eunhee CHO
Poster LB012
Abstract 9473
Drug repurposing for treatment of Prototheca infections
30/04 12:00
21. New drugs and vaccines
Amir ALIRAMEZANI
Poster LB013
Abstract 9123
Serotype coverage of invasive pneumococcal disease with V116 and other vaccines among adults in Canada
30/04 12:00
21. New drugs and vaccines
Marie Claude MEILLEUR
Poster LB014
Abstract 9380
Triple synergistic action of a novel small molecule adjuvant with gentamicin and daptomycin against MRSA persisters
30/04 12:00
21. New drugs and vaccines
Wooseong KIM
Poster LB015
Abstract 9337
Preclinical efficacy and safety of AIC468: a first-in class antiviral antisense oligonucleotide for the treatment of BKV infection in kidney transplant recipients
30/04 12:00
21. New drugs and vaccines
Peter LISCHKA
Poster LB016
Abstract 9331
Preclinical development and proteomic and immunogenic analysis of a cytomegalovirus vaccine based on dense bodies produced by epithelial cells
30/04 12:00
21. New drugs and vaccines
Clara MARTÍN MARTÍN
Poster LB017
Abstract 9329
Characterisation of immune response to recombinant varicella-zoster vaccine in people with multiple sclerosis under disease-modifying therapies
30/04 12:00
21. New drugs and vaccines
Federica DOMINELLI
Poster LB018
Abstract 9316
Inhibition of the outer membrane protein OprF: a novel target to counteract carbapenem resistance in Pseudomonas aeruginosa
30/04 12:00
21. New drugs and vaccines
Nicolas HELSENS
Poster LB019
Abstract 9278
Novel antibiotics: the promise of small molecule iron-inhibitors against multidrug-resistant Gram-negative superbugs
30/04 12:00
21. New drugs and vaccines
Emmanuel Chima EZE
Poster LB020
Abstract 9226
Unveiling the mechanism of action and resistance of novel quaternary phosphonium compound effective against highly drug-resistant Pseudomonas aeruginosa isolates
30/04 12:00
21. New drugs and vaccines
German VARGAS-CUEBAS
Poster LB021
Abstract 9249
Superior immunogenicity of self-amplifying mRNA vs standard mRNA COVID-19 vaccine
30/04 12:00
21. New drugs and vaccines
Yukihiro YAGI
Poster LB022
Abstract 9015
COSAN boosts colistin's bactericidal power against Gram-negative nosocomial pathogens
30/04 12:00
21. New drugs and vaccines
Andromeda Celeste GOMEZ CAMACHO
Poster LB023
Abstract 9666
B cell depletion therapy in people with multiple sclerosis impacts on antibody response to COVID-19 mRNA vaccines
30/04 12:00
22. Clinical trials
Marianne SHAWE-TAYLOR
Poster LB024
Abstract 9612
Exploring the efficacy of plasma exchange therapy in post-COVID-19 condition: a pilot randomised double-blind trial
30/04 12:00
22. Clinical trials
Sergio ESPAÑA-CUETO
Poster LB026
Abstract 9323
Pharmacokinetics and safety of the SARS-CoV-2 monoclonal antibody AZD3152 are consistent with those of tixagevimab/cilgavimab
30/04 12:00
22. Clinical trials
Taylor S. COHEN
Poster LB027
Abstract 9303
Tocilizumab in COVID-19 with significant hypoxia and inflammation does not improve clinical outcomes
30/04 12:00
22. Clinical trials
Eoin FEENEY
Poster LB028
Abstract 9649
Impact of ceftriaxone+ sulbactam+ EDTA combination in treatment of metallo beta-lactamase producing Enterobacterales causing complicated urinary tract infections: an open label randomised controlled trial
30/04 12:00
22. Clinical trials
Subhashree SAMANTARAY
Poster LB029
Abstract 9645
Divergent performance of bivalent BA.5 and monovalent XBB.1.5 COVID-19 vaccines given as annual booster
30/04 12:00
22. Clinical trials
Marianne SHAWE-TAYLOR
Poster LB030
Abstract 9428
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea: results of a randomised, multicentre Phase 3 trial (EAGLE-1)
30/04 12:00
22. Clinical trials
Jonathan ROSS
Poster LB031
Abstract 9245
Early treatment with pyronaridine-artesunate reduced time to sustained symptom resolution in patients with mild-to-moderate COVID-19 not requiring supplemental oxygen
30/04 12:00
22. Clinical trials
Joon Young SONG
Poster LB032
Abstract 9500
Oral sulopenem/probenecid for uncomplicated urinary tract infections (uUTI): results from the REASSURE trial
30/04 12:00
22. Clinical trials
Kalpana GUPTA
Poster LB033
Abstract 9569
Repurposing Clofazimine as a part of first line anti-TB regimen in order to shorten the overall duration of treatment in patients with drug susceptible pulmonary TB - CORTAIL Study
30/04 12:00
22. Clinical trials
Nusrat SHAFIQ
Poster LB034
Abstract 9513
A nationwide randomised trial to confirm effectiveness of electronically delivered nudges in increasing influenza vaccination uptake among older adults: the NUDGE-FLU-2 trial
30/04 12:00
22. Clinical trials
Niklas Dyrby JOHANSEN
Poster LB035
Abstract 9521
Electronic nudges to increase influenza vaccination uptake: a prespecified participant-level pooled analysis of NUDGE-FLU, NUDGE-FLU-2, and NUDGE-FLU-CHRONIC
30/04 12:00
22. Clinical trials
Niklas Dyrby JOHANSEN
Poster LB036
Abstract 9220
Open-label study to evaluate the safety and immunogenicity of an XBB.1.5 (Omicron subvariant) CoV-2 rS vaccine booster in previously mRNA COVID-19 vaccinated participants
30/04 12:00
22. Clinical trials
Vivek SHINDE
Poster LB037
Abstract 9431
Cytomegalovirus (CMV) immunoguided prevention clinical trial in CMV-seropositive lung transplant recipients
30/04 12:00
22. Clinical trials
Elisa RUIZ ARABÍ
Poster LB038
Abstract 9439
Effectiveness of one dose of MVA-BN vaccine against mpox: a multicountry target trial emulation study
30/04 12:00
22. Clinical trials
Clara SUÑER
Poster LB039
Abstract 9426
A novel human co-infection model of Streptococcus pneumoniae and respiratory syncytial virus: initial safety results of the RESPECCT study
30/04 12:00
22. Clinical trials
Sanjita BRITO MUTUNAYAGAM
Poster LB040
Abstract 9423
Mid-season 2023-2024 influenza vaccine effectiveness in children and elderly: a register-based cohort analysis, Finland
30/04 12:00
22. Clinical trials
Hanna M. NOHYNEK
Poster LB041
Abstract 9410
Short-course aminoglycosides as adjunctive treatment in adults with sepsis: a cluster randomised trial
30/04 12:00
22. Clinical trials
Eva KOEKENBIER
Poster LB042
Abstract 9379
Intravenous brincidofovir rapidly clears adenoviremia in immunocompromised patients: interim results from Phase 2a ATHENA study
30/04 12:00
22. Clinical trials
Genovefa PAPANICOLAOU
Poster LB043
Abstract 9194
Clinical impact of laboratory stewardship intervention for plasma metagenomic next-generation sequencing infectious disease testing in a multi-centre paediatric hospital system
30/04 12:00
22. Clinical trials
Denver NILES
Poster LB044
Abstract 9269
Self-replicating RNA vaccine: significantly improved de novo immune protection, safety against rabies in healthy volunteers
30/04 12:00
22. Clinical trials
Zelanna GOLDBERG
Poster LB045
Abstract 9236
Effect of a community-based behavioural intervention bundle to improve antibiotic use, quality of primary care, and household infection prevention/control in rural Burkina Faso and DR Congo: preliminary analysis of a cluster controlled trial
30/04 12:00
22. Clinical trials
Brecht INGELBEEN
Poster LB046
Abstract 9121
Immunogenicity and reactogenicity of fractional vs full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, Phase 4 clinical trial in Brazil
30/04 12:00
22. Clinical trials
Julio CRODA
Poster LB047
Abstract 9105
Continuation vs temporary interruption of immunomodulatory agents during infections: preliminary results of a randomised controlled trial in patients with inflammatory rheumatic diseases
30/04 12:00
22. Clinical trials
Merel Antoinette Aloisius OPDAM
Poster LB048
Abstract 9183
ADVANCED trial: a clinical trial on dried blood spot samples and venepuncture plasma samples for monitoring vancomycin and creatinine simultaneously in trauma and orthopedic adult patients
30/04 12:00
22. Clinical trials
Moska HASSANZAI
Poster LB049
Abstract 9029
Olgotrelvir as a standalone treatment for non-hospitalised COVID-19 patients: a Phase 3, double-blind, randomised, placebo-controlled trial
30/04 12:00
22. Clinical trials
Xiao XU
Poster LB050
Abstract 9154
Adjuvanted recombinant zoster vaccine (RZV) is the first vaccine to provide durable protection against herpes zoster (HZ) in all age ranges ≥50 years: final analysis of efficacy and safety after 11 years (Y) of follow-up
30/04 12:00
22. Clinical trials
Ana STREZOVA
Poster LB051
Abstract 9076
Boosted antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy: a prospective trail
30/04 12:00
22. Clinical trials
Lukas VAN DE SAND
Poster LB052
Abstract 9072
Prolonged awake prone positioning vs usual care for non-intubated patients with COVID-19-related acute respiratory failure: a multicentre, randomised controlled trial
30/04 12:00
22. Clinical trials
Ling LIU
Poster LB053
Abstract 9055
Modelling the impact of the Autumn 2022 and Spring 2023 COVID-19 booster vaccine campaigns in the UK
30/04 12:00
22. Clinical trials
Cale HARRISON
Poster LB054
Abstract 9034
Ivermectin therapy for young children aged <5 years with scabies infection
30/04 12:00
22. Clinical trials
Amanda GWEE
Poster LB055
Abstract 9027
IgG subclass switch in volunteers repeatedly immunised with the full-length Plasmodium falciparum merozoite surface protein 1 (MSP1)
30/04 12:00
22. Clinical trials
Veronika RATHAY
Poster LB056
Abstract 9440
Identification of two new species of the family Silvanigrellaceae and study of virulence characteristics of clinical isolates
30/04 12:00
23. New and emerging pathogens
Peijuan TANG
Poster LB057
Abstract 9694
Genomic characterisation of a blaOXA-244-producing Escherichia coli ST648 outbreak in Irish hospitals 2023-2024
30/04 12:00
24. Outbreaks and public health emergencies
Liam BURKE
Poster LB058
Abstract 9689
Contribution of laboratories during a measles epidemic among vaccinated adolescents
30/04 12:00
24. Outbreaks and public health emergencies
Julia DINA
Poster LB059
Abstract 9673
The prevalence of antimicrobial resistance among the wounded in Ukraine makes it impossible to prescribe effective empiric antibiotic therapy
30/04 12:00
24. Outbreaks and public health emergencies
Mariia PANASIUK
Poster LB060
Abstract 9657
Ongoing low-intensity outbreak of hepatitis A virus among men who have sex with men in Italy with molecular links to sub-genotype 1B epidemic strain in 2022 in Hungary
30/04 12:00
24. Outbreaks and public health emergencies
Sara CAUCCI
Poster LB061
Abstract 9532
Emergence of a Klebsiella pneumoniae ST307 clone carrying an IncFBI plasmid with blaCTX-M-15 and blaOXA-1: a One Health concern
30/04 12:00
24. Outbreaks and public health emergencies
Ana GALES
Poster LB062
Abstract 9139
Protective effect of influenza vaccination among children in Hong Kong, 2022-23 season
30/04 12:00
24. Outbreaks and public health emergencies
Chun Wai Jerome LEUNG
Poster LB063
Abstract 9529
Genomic surveillance of an outbreak of Legionella pneumophila in Galicia, 2023
30/04 12:00
24. Outbreaks and public health emergencies
Sonia PEREZ-CASTRO
Poster LB064
Abstract 9639
First Austrian mpox breakthrough infection after full vaccination course
30/04 12:00
24. Outbreaks and public health emergencies
Julia PONGRACZ
Poster LB065
Abstract 9621
Wastewater surveillance detects echovirus 11 lineage 1 introduction in Sicily
30/04 12:00
24. Outbreaks and public health emergencies
Chiara FILIZZOLO
Poster LB066
Abstract 9405
Clonal dissemination of methicillin-resistant Staphylococcus saprophyticus and Staphylococcus haemolyticus among different sheep farms: an emerging threat to animal and public health
30/04 12:00
24. Outbreaks and public health emergencies
Chahrazed BELHOUT
Poster LB067
Abstract 9590
Measles strikes back: up-to-the-minute updates from surveillance activities
30/04 12:00
24. Outbreaks and public health emergencies
Silvia BIANCHI
Poster LB068
Abstract 9567
Multi-country outbreak of multi-drug resistant Campylobacter coli ST-10042 strain (2018-2023)
30/04 12:00
24. Outbreaks and public health emergencies
Mónica OLEASTRO
Poster LB069
Abstract 9566
First genomic description of pig-to-pig transmission of an emerging and extensively drug-resistant Staphylococcus borealis in Spain
30/04 12:00
24. Outbreaks and public health emergencies
Idris Nasir ABDULLAHI
Poster LB070
Abstract 9552
Indirect interhuman transmission of Mycobacterium abscessus subsp. massiliense among non-cystic fibrosis patients at a pediatric hospital in Japan
30/04 12:00
24. Outbreaks and public health emergencies
Shiomi YOSHIDA
Poster LB071
Abstract 9436
Pertussis epidemic in 2023-2024, region of Vallès (Catalonia, Spain)
30/04 12:00
24. Outbreaks and public health emergencies
Eva BORRÀS LOPEZ
Poster LB072
Abstract 9546
Feasibility of point-of-care multiplex RT-PCR testing at airport for acute respiratory tract infection among Thai repatriate workers from Israel, Thailand, October – December 2023
30/04 12:00
24. Outbreaks and public health emergencies
Anongnat MANOPIROM
Poster LB073
Abstract 9482
Epidemiological aspects of current measles outbreak in Romania
30/04 12:00
24. Outbreaks and public health emergencies
David MANGALOIU
Poster LB074
Abstract 9395
Point of entry screening for cutaneous leishmaniasis among Thai repatriate workers from Israel, Thailand, October – December 2023
30/04 12:00
24. Outbreaks and public health emergencies
Ladda WONGKAEW
Poster LB075
Abstract 9392
Tracking two-way human-mink transmission during an outbreak of severe acute respiratory syndrome coronavirus 2 on a farm in Bulgaria
30/04 12:00
24. Outbreaks and public health emergencies
Ivelina TRIFONOVA
Poster LB076
Abstract 9357
Aircraft lavatory wastewater surveillance for SARS-CoV-2 and other coronaviruses by using family-wide PCR, Thailand, October – November 2023
30/04 12:00
24. Outbreaks and public health emergencies
Rome BUATHONG
Poster LB077
Abstract 9075
A large outbreak of acute hemorrhagic conjunctivitis in Hainan, China in 2023
30/04 12:00
24. Outbreaks and public health emergencies
Dongmei YAN
Poster LB078
Abstract 9020
Development of a small animal model for aerosolised Ebola virus
30/04 12:00
24. Outbreaks and public health emergencies
Aysegul NALCA
Poster P3165
Abstract 700
Antibiotic lock therapy versus catheter removal: evaluating the optimal approach for management of central vascular catheter infection
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Nischal RANGANATH
Poster P3166
Abstract 2149
The impact of early infectious disease consultation for central line associated bloodstream infection: a retrospective cohort study
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Jeong-Han KIM
Poster P3167
Abstract 2385
Touch the zero in central line-associated bloodstream infection in the medical intensive care unit at Rambam medical campus, Israel
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Jalal TARABEIA
Poster P3168
Abstract 2971
Tackling rising numbers of hospital acquired Staphylococcus aureus blood stream infections (HASABSI): failures in peripheral venous access device (PVAD) care in Tallaght University Hospital (TUH)
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Zachary RAMSAMAROO
Poster P3169
Abstract 3154
Hospital outcomes of hemodialysis patients with central line associated bloodstream infection admitted in a tertiary government hospital
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Edson FUENTES
Poster P3170
Abstract 3598
The risk of bloodstream infections in patients with central venous access port in non-ICUs in Germany
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Beate WEIKERT
Poster P3171
Abstract 4824
Central venous catheter fungal infection: incidence and predictive factors
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Aida ZAGHDOUDI
Poster P3172
Abstract 4999
Utility of tip cultures in the diagnosis of catheter-related bloodstream infections
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Vaisak NAIR
Poster P3173
Abstract 6312
Impact of the COVID-19 pandemic on incidence and epidemiology of catheter-related bloodstream infection two years later
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Maria Jesus PEREZ-GRANDA
Poster P3174
Abstract 6426
Impact of sterile gloving during proximal manipulation of a central venous catheter: the multicentre study CleanHandPROX
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Anne-Sophie VALENTIN
Poster P3175
Abstract 6637
Central line-associated bloodstream infection incidence in Belgium's general hospitals: comparison between before and after the start of the COVID-19 pandemic (2013-2019 vs 2020-2022)
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Nathalie SHODU
Poster P3176
Abstract 7209
The potential role of Presepsin(sCD14) in device-associated ventriculitis/meningitis
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Veena Kumari HARADARA BAHUBALI
Poster P3177
Abstract 8778
The impact of a newly established intravenous care team on peripheral venous catheter bloodstream infections in an acute hospital in Ireland
30/04 12:00
8a. Intravascular catheter-related infections (incl epidemiology, prevention)
Margaret CARROLL
Poster P3178
Abstract 442
Worrying rates of MDR organisms causing PJI; A retrospective study from India
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Souradeep CHOWDHURY
Poster P3179
Abstract 621
Fungal periprosthetic joint infection: uncommon but complex condition
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Helmi ERNANDES
Poster P3180
Abstract 1133
Dalbavancin as suppressive treatment in a tertiary hospital
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Loeches Yague MARÍA BELEN
Poster P3181
Abstract 1279
Highly tunable release of antimicrobial peptide SAAP-148 to prevent implant-associated-infections using drop-on-demand printing technology
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Clara GUARCH PÉREZ
Poster P3182
Abstract 1795
Quantification of sonicated implants from patients with osteoarticular implant infections
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Llanos SALAR VIDAL
Poster P3183
Abstract 2133
Bioinspired antibacterial nanostructured surfaces based on oriented calcium phosphate nanocrystals arrays against carbapenems-resistant P.aeruginosa and methicillin-resistant S.aureus
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Damiano SQUITIERI
Poster P3184
Abstract 2250
Sonication fluid culture shows little benefit compared with optimised periprosthetic tissue sample culture for diagnosis of periprosthetic hip infections
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Reinhard HOFFMANN
Poster P3185
Abstract 2360
Real-world experience of cefiderocol in bone and joint infections from the PROVE (retrospective cefiderocol chart review) study
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Anne SANTERRE HENRIKSEN
Poster P3186
Abstract 3099
Suppressive antimicrobial therapy for prosthetic joint infection
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Craig ABOLTINS
Poster P3187
Abstract 3539
Using the WHO multimodal strategy in an improvement project to minimize surgical site infections in total knee and hip prosthesis
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Ellen VAN GEERTSOM
Poster P3188
Abstract 3666
Suppressive antibiotic treatment for orthopaedic implant infections: how to dose and when to stop?
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Jaap Leonardus Jacobus HANSSEN
Poster P3189
Abstract 4492
Activity of standard surgical antimicrobial prophylaxis regimens against pathogens causing postoperative prosthetic joint infections: a multinational study
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Natividad BENITO
Poster P3190
Abstract 4697
What's the fate of prosthetic joint infection-associated Cutibacterium acnes after the interaction with neutrophils?
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Fany REFFUVEILLE
Poster P3191
Abstract 4953
Clinical experience with intravenous (IV) fosfomycin for treatment of complex bone and implant-associated infections: prospective cohort
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Svetlana KARBYSHEVA
Poster P3192
Abstract 5786
High rates of polymicrobial and multidrug-resistant bacterial infections of modular megaprostheses: a retrospective cohort study
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Giulia MICHELI
Poster P3193
Abstract 6231
A retrospective study of sonicate fluid cultures for the diagnosis of orthopedic implant infections
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Spyridon KAMARIOTIS
Poster P3194
Abstract 7812
Proof-of-concept for intraoperative electric field application as prophylaxis against prosthetic joint infections: in vivo validation
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Francisco CARMONA-TORRE
Poster P3195
Abstract 8264
Cutibacterium species in orthopaedic patients: pathogenic or contaminating role? A five-year retrospective study in a tertiary-care hospital
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Andrea BEDINI
Poster P3196
Abstract 8622
Panton-valentine leucocidin-producing Staphylococcus aureus strains are associated with treatment failure of implant-associated infections
30/04 12:00
8b. Other foreign-body and implant-associated infections (incl PJI)
Martina MARITATI
Poster P3197
Abstract 73
Surgical antibiotic prophylaxis: acompliance improving practices
30/04 12:00
8c. Surgical site infections
Tugba YANIK YALÇIN
Poster P3198
Abstract 470
Semiautomated surveillance of deep surgical site infections: algorithms for colon surgery, vascular surgery and orthopaedics
30/04 12:00
8c. Surgical site infections
Jannie ROMME
Poster P3199
Abstract 726
Administration of cephalosporine surgical antimicrobial prophylaxis in low-risk cholecystectomy and its association with surgical site infections
30/04 12:00
8c. Surgical site infections
Rami SOMMERSTEIN
Poster P3200
Abstract 740
Automated trend monitoring of surgical site infection incidence
30/04 12:00
8c. Surgical site infections
Mark TINGA
Poster P3201
Abstract 871
Post operative spinal infection; a review of epidemiology, microbiology, management and outcomes over a 15 month period at a tertiary UK hospital
30/04 12:00
8c. Surgical site infections
Peter DAVIS
Poster P3202
Abstract 1513
Optimising prophylactic antibiotic use among surgery patients in Ethiopian hospitals
30/04 12:00
8c. Surgical site infections
Niranjan KONDURI
Poster P3203
Abstract 1696
Adherence to antimicrobial prophylaxis guidelines for elective surgeries in a tertiary hospital: ADEQUAP study
30/04 12:00
8c. Surgical site infections
Marco PISCAGLIA
Poster P3204
Abstract 2049
Complications of cesarean sections in Brazil: a population-based study
30/04 12:00
8c. Surgical site infections
Jonas MARSCHALL
Poster P3205
Abstract 2194
Surgical site infection surveillance in knee and hip arthroplasty: an algorithm to detect high risk patients based on electronic health records
30/04 12:00
8c. Surgical site infections
Mariana GUEDES
Poster P3206
Abstract 2294
To what extent can colorectal surgical site infections be prevented? An individual-based modelling study
30/04 12:00
8c. Surgical site infections
Jonas MARSCHALL
Poster P3207
Abstract 2872
Antimicrobial resistance in post transrectal ultrasound-guided biopsy infections – the case for transperineal biopsies
30/04 12:00
8c. Surgical site infections
James DONNELLY
Poster P3208
Abstract 3052
Performance of an algorithm for semi-automated surveillance of surgical site infections after cardiac valve replacement: preliminary results
30/04 12:00
8c. Surgical site infections
Mireia PUIG-ASENSIO
Poster P3209
Abstract 4725
Impact of VRE active perioperative prophylaxis in liver transplant patients colonised by Vancomycin-resistant Enterococci
30/04 12:00
8c. Surgical site infections
Giulia Jole BURASTERO
Poster P3210
Abstract 5606
Surgical antibiotic prophylaxis adherence in cardiothoracic and vascular surgeries: a four-year report from the developing world
30/04 12:00
8c. Surgical site infections
G PAVITHRA
Poster P3211
Abstract 5919
Optimising antibiotic selection in Fournier's gangrene: a rationalised approach in the South East of Scotland
30/04 12:00
8c. Surgical site infections
Simon DEWAR
Poster P3212
Abstract 6961
Surveillance of surgical site infections: a prospective study in a tertiary care hospital in Bangladesh
30/04 12:00
8c. Surgical site infections
Saifur RAHMAN
Poster P3213
Abstract 7143
Origin of pathogens: surgery-dependent S. epidermidis strains in endophthalmitis
30/04 12:00
8c. Surgical site infections
Leandro Andrés ESCOBAR-HERRERA
Poster P3214
Abstract 7465
A prospective study on implementing the ideal time to administer pre - operative antibiotics for cesarean delivery in a south indian secondary care hospital
30/04 12:00
8c. Surgical site infections
Sanju Menaka SIVAKUMAR
Poster P3215
Abstract 7506
Postsurgical mediastinis after major heart surgery: a retrospective study of the last 11 years at a tertiary care institution
30/04 12:00
8c. Surgical site infections
Maria Jesus PEREZ-GRANDA
Poster P3216
Abstract 7578
A multi-faceted, surgically led quality improvement initiative produces positive change in surgical antibiotic prophylaxis practices
30/04 12:00
8c. Surgical site infections
Katie GIBLIN
Poster P3217
Abstract 70
Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicentre cohort study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
François BARBIER
Poster P3218
Abstract 492
Protocol for the Hospital Acquired Pneumonia PrEveNtion (The HAPPEN study): a multi-centre randomised control trial exploring the effectiveness of improving the frequency and quality of oral care, in reducing the incidence of pneumonia
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Brett MITCHELL
Poster P3219
Abstract 683
Combined therapy with phages and ceftolozane/tazobactam against P. aeruginosa endotracheal tube biofilms
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Laia FERNÁNDEZ-BARAT
Poster P3220
Abstract 815
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalised with bacterial pneumonia in western and eastern Europe (SENTRY Program; 2021-2022)
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Helio SADER
Poster P3221
Abstract 915
Prognosis and etiology of hospital-acquired pneumonia and ventilator-associated pneumonia in patients with active lung or lower neck cancer: the PEPP-C study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Sebastian WINGEN-HEIMANN
Poster P3222
Abstract 955
Hospital acquired Burkholderia cepacia complex carrying blaNDM-1 and blaNDM-5 in ventilator-associated pneumonia patients and contaminated ventilator tubing
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Muhammad SAEED
Poster P3223
Abstract 1076
Risk factors on multiple drug-resistant organisms infection in patients with nosocomial pneumonia and their prognosis assessment: a nationwide multi-centre, large population, retrospective nested case-control study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Zhenchao WU
Poster P3224
Abstract 1291
Piperacillin is an effective de-escalation treatment for ventilator associated pneumonia caused by Pseudomonas aeruginosa
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Sirine SMAOUI
Poster P3225
Abstract 1564
The Ecraid perpetual observational study on ventilator-associated pneumonia: a solid operational backbone ready for embedding clinical studies
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Holly JACKSON
Poster P3226
Abstract 1827
Ventilator-associated lower respiratory tract infections in intensive care unit patients at a tertiary care centre after implementation of a multifaceted intervention: a before-after study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Nando BLOCH
Poster P3227
Abstract 1863
Identifying patients at risk for S. aureus ICU pneumonia: the added predictive value of immunological biomarkers
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Claudia RECANATINI
Poster P3228
Abstract 2376
Real-world experience of cefiderocol in France from the PROVE (retrospective cefiderocol chart Rreview) study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Anne SANTERRE HENRIKSEN
Poster P3229
Abstract 3301
Clinical epidemiology of ventilator-associated pneumonia caused by Acinetobacter baumannii in Vietnam
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Hidetoshi NOMOTO
Poster P3230
Abstract 3783
Survival impact of initial adequate antimicrobial therapy in critically ill patients with nosocomial pneumonia due to Gram-negative pathogens: a multicenter cohort study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
François BARBIER
Poster P3231
Abstract 3942
Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Atousa HAKAMIFARD
Poster P3232
Abstract 4364
Role of microbiological confirmation in ventilator-associated pneumonia diagnosis: data from PULMIVAP, an Italian prospective multicentre study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Anna TONIZZO
Poster P3233
Abstract 5426
The clinical characteristics and bacterial genomics of HAP caused by Acinetobacter baumannii
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Zhenchao WU
Poster P3234
Abstract 5782
Incidence and lethality of hospitalised pneumonia among people over 50 years in Catalonia in the pre-COVID-19 era: a population-based study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Cinta DE DIEGO-CABANES
Poster P3235
Abstract 5849
Hospital acquired pneumonia has a significant attributable mortality and triples hospital length of stay
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Dan WOOTTON
Poster P3236
Abstract 5990
Wide variations in the incidence risk of hospital acquired pneumonia in England
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Dan WOOTTON
Poster P3237
Abstract 6071
A multistate model for clinical outcomes in nosocomial pneumonia patients
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Diego VERA-YUNCA
Poster P3238
Abstract 6501
Post-antibiotic risk for recurrent lower respiratory tract infection during prolonged hospitalisation
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Brendan KELLY
Poster P3239
Abstract 7225
Persistent higher antimicrobial resistance in mechanically ventilated ICU patients: a before-and-after analysis of the COVID-19 surge
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Fernando BOZZA
Poster P3240
Abstract 8229
Adjunctive nebulised colistin along with intravenous polymyxin B versus intravenous polymyxin B alone for the treatment of nosocomial pneumonia caused by multi-drug resistant gram-negative (MDR) bacteria: A retrospective study
30/04 12:00
8d. Healthcare-associated pneumonia (incl VAP)
Viplov VAIDYA
Poster P3241
Abstract 555
Rapid detection of carbapenem non-susceptible bacteria isolated from patients for public policy strategies to control hospital-acquired infections
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Maria NOVELLA
Poster P3242
Abstract 571
How long do nosocomial pathogens persist on inanimate surfaces: a scoping review
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Philip RUSSO
Poster P3243
Abstract 583
Nosocomial and household transmission of carbapenemase-producing organisms (CPO) through direct patient contact: interim analysis of a multicentre prospective cohort study
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Stephanie SUTJIPTO
Poster P3245
Abstract 1053
Loaned endoscopes: how safe are they?
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Taeyang CHIN
Poster P3246
Abstract 1260
Whole genome sequencing reveals a cluster of Enterobacter cloacae ST198, blaVIM-1 positive in pediatric haematologic ward
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Sergio Maria Ivano MALANDRIN
Poster P3247
Abstract 1343
Pathogenic microbial contamination of handwashing sinks changes over time following installation
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Itaru NAKAMURA
Poster P3248
Abstract 1350
A comparison of an algorithm and coding data to traditional surveillance to identify surgical site infections: an Australian retrospective multicentred cohort study
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Philip RUSSO
Poster P3249
Abstract 1530
Factors impacting hospital-associated microbial communities composition and stability
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Iván LINARES AMBOHADES
Poster P3251
Abstract 1614
Predictors of vancomycin-resistant Enterococcus acquisition among acute care roommate exposures
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Victoria WILLIAMS
Poster P3252
Abstract 1651
Impact of the COVID-19 pandemic on antibiotic resistance spread among hospitalised patients in France
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Maylis LAYAN
Poster P3253
Abstract 1855
Epidemiology of multi-resistant S. haemolyticus in French neonatal intense care units: spread of two multidrug-resistant lineages
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Camille KOLENDA
Poster P3254
Abstract 1868
Community-onset impetigo: emergence of a multi-resistant clone in France
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Anne TRISTAN
Poster P3255
Abstract 2421
Carbapenem-resistant non-aeruginosa Pseudomonas species in the wet hospital environment
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Anneloes VAN VEEN
Poster P3256
Abstract 2491
Simplified hospital acquired infection prevalence method with high sensitivity
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Anna Maria KAISER
Poster P3257
Abstract 2508
Rapid MRSA/MSSA surveillance: insights from a six-years dual molecular-cultural approach
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Valeria CENTO
Poster P3258
Abstract 2561
Screening of haematology patients on admission for P. aeruginosa (PA) showed acquisition from the hospital environment, particularly drains, is more likely than from endogenous flora
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Özge YETIS
Poster P3259
Abstract 2576
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated in intensive care unit
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Tingting XIAO
Poster P3260
Abstract 2585
Investigating linezolid resistant Staphylococcus epidermidis (LRSE) at a tertiary hospital
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Katrine Snorradottir GUDMUNDSSON
Poster P3261
Abstract 3115
Comparison of sink sites carbapenemase-producing organisms (CPOs) colonisation in a tertiary hospital in Singapore
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Xiaowei HUAN
Poster P3262
Abstract 3166
Genomic characterisation of ST23 K1 Serotype ESBL Klebsiella pneumoniae ST23 strains in University Hospital Brno, Czech Republic
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Matej BEZDÍCEK
Poster P3263
Abstract 3255
Impact of medical waste bin on contamination of patient's environment
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Minkyeong LEE
Poster P3264
Abstract 3291
Transmission patterns of ESBL-producing Enterobacterales in a non-critical care setting
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Minh NGUYEN NGOC
Poster P3265
Abstract 3312
Decreasing Staphylococcus aureus colonisation rates in a Greek neonatal intensive care unit during the COVID-19 pandemic
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Spyros POURNARAS
Poster P3266
Abstract 3391
Trends in healthcare associated infections and medical device use in hospitals, based on point prevalence studies in the Netherlands from 2014-2023
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Sarah Juanita VALK
Poster P3268
Abstract 3426
Epidemiology of intestinal colonisation with carbapenem-resistant organisms (MDROs) in a Greek Intensive care Unit
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
George BAZIOTIS
Poster P3269
Abstract 3582
Investigation of a cluster of carbapenemase-producing Klebsiella pneumoniae identifies a persistent two-year cluster with multiple routes of transmission among patients attending hospital ward X in England
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Kate WILSON
Poster P3270
Abstract 3612
Implementation of semi-automated surveillance of surgical site infections after hip or knee replacement: a pilot study
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Manon BREKELMANS
Poster P3271
Abstract 3699
Conception of a score to predict the result of extensively drug-resistant bacteria screening in known carriers
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Florence STORDEUR
Poster P3272
Abstract 3727
Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent PCR test for carbapenemase-producing Enterobacterales
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Hyeonji SEO
Poster P3273
Abstract 3785
An active follow-up strategy for carbapenemase-producing Enterobacterales carriers: do carbapenemase genes and patient characteristics matter?
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Jade Leigh VAN RHEENEN
Poster P3274
Abstract 3867
Genetic insights into carbapenem-resistant and carbapenemase-producing Enterobacterales
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Suhanya Veronica PRASAD
Poster P3275
Abstract 4007
Risk factors in endoscopes reprocessing: microbiological surveillance to support the device engineering
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Luna GIROLAMINI
Poster P3276
Abstract 4057
One year of genomic surveillance of healthcare-associated bloodstream infections at a university hospital
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Thomas VOGNBJERG SYDENHAM
Poster P3277
Abstract 4086
Implementation of a system for early detection of bacterial clusters in a tertiary care university hospital using laboratory routine data
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Mélanie COLOMB-COTINAT
Poster P3278
Abstract 4208
Deciphering the temporal short-term dynamics of Acinetobacter baumannii: impact of colonisation pressure on infection in an endemic Indian intensive care unit
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Poster P3279
Abstract 4218
NDM dissemination within ICU patients associated with an epidemic clone and putative horizontal transfer to other Enterobacterales
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Cristina PITART FERRE
Poster P3280
Abstract 4399
Implementation of cohorting to reduce transmission of carbapenemase-producing Klebsiella pneumoniae in a Greek ICU
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Elisavet KOUSOULI
Poster P3281
Abstract 4413
Transmission of multidrug-resistant organisms during physical and occupational therapy appointments at three VA CLCs
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Kristen PANSON (GIBSON)
Poster P3282
Abstract 4479
Follow-up of digestive Klebsiella pneumoniae species complex in ICUs patients
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Bénédicte LANGLOIS
Poster P3283
Abstract 4504
Multidrug-resistant organism transmission during out-of-room visits in post-acute care: a multicentre study
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Lona MODY
Poster P3284
Abstract 4589
No evidence for transmission of carbapenem-resistant pathogens from war injured Ukrainian patients (2014-2019) to other inpatients: a retrospective molecular study from a Military hospital
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Frieder FUCHS
Poster P3285
Abstract 4787
A machine learning approach to predict healthcare-associated infections in an intensive care unit patients in Tunisia
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Asma MHIRI
Poster P3286
Abstract 4832
Routine genomic surveillance of third generation cephalosporins resistant Enterobacterales in a Neonatology Unit
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
François GRAVEY
Poster P3287
Abstract 5005
Investigation of the environmental presence of Pseudomonas aeruginosa to facilitate sequence analysis and determine a possible cause of bloodstream infection
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Katherine DEVER
Poster P3289
Abstract 5287
Prevalence of Stenotrophomonas maltophilia colonization among patients receiving mechanical ventilation in long-term care facilities in the state of Maryland, United States
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Green ALEXIS
Poster P3290
Abstract 5476
The use of whole genome and metagenomic sequencing for environmental surveillance of blaOXA48 antimicrobial resistance transmission in a hospital setting
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Linzy ELTON
Poster P3291
Abstract 5492
Study of hospital-acquired infections, a multidrug-resistant organism in tertiary hospital, Malaysia
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Noor Zaitulakma MD ZAIN
Poster P3292
Abstract 5661
Unit-level antibiotic resistant bacterial colonisation pressure in 14 neonatal units across Europe
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Aislinn COOK
Poster P3293
Abstract 5741
AMR surveillance in wastewater and clinical isolates from a tertiary hospital: preliminary results
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Carlos FRANCÉS CUESTA
Poster P3294
Abstract 5780
Nanopore long-reads sequencing is suitable for epidemiological surveillance of Klebsiella pneumoniae using cgMLST
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Dominique S. BLANC
Poster P3295
Abstract 5822
Unveiling microbial dynamics in neonatal intensive care: applications from long-read sequencing
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Stefany AYALA MONTAÑO
Poster P3296
Abstract 5996
Exploring the environment's role in hospitals as a reservoir for carbapenemase-producing Enterobacteriaceae
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Lena SLEIMAN
Poster P3297
Abstract 6003
Recall of 5,000 patients related to no-conformity sterilization practices of dental instrumentation.
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Juliette DESSEMON
Poster P3298
Abstract 6234
Genomic surveillance and computational modeling of the transmission of multi-drug resistant isolates in hospital settings during the SARS-CoV-2 pandemic
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Judit BURGAYA
Poster P3299
Abstract 6384
Assessment of using linked electronic surveillance data to replace mandatory reporting of healthcare-associated infections in England
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Ann Sarah WALKER
Poster P3300
Abstract 6395
E.coli bacteraemia surveillance: bridging the data and clinical gap to improve outcomes
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Harin NAVALAN
Poster P3301
Abstract 6411
Nosocomial transmission of NDM-producing Klebsiella pneumoniae ST147 in a Dutch paediatric cancer centre associated with patients from Ukraine
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Wouter SMIT
Poster P3302
Abstract 6517
Seek and you shall find: the practical infection control implications of culture-negative results when introducing molecular-based screening for Carbapenemase-producing Enterobacterales (CPE)
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Mairead SKALLY
Poster P3303
Abstract 6587
Longitudinal carriage of antimicrobial resistant microorganisms in preterm neonates gastrointestinal tract
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Anna MCCORMICK
Poster P3304
Abstract 6683
Prevalence of healthcare-associated infections and antimicrobial use in Spanish long-term care hospitals (2022-2023)
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Lina Marcela PARRA
Poster P3305
Abstract 6726
Molecular epidemiology of bacteria infecting war wounds at tertiary care hospitals in Ukraine
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Patrick MC GANN
Poster P3306
Abstract 6870
Unnecessary contact precaution for MRSA in a low-endemicity area
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Euclimeire NEVES
Poster P3307
Abstract 6885
Time-saving water monitoring -qPCR-based detection of up to 15 Legionella cells per mL within 4 hours
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Peter Michael KELLER
Poster P3308
Abstract 6995
Environmental air and surface sampling for mpox virus in contaminated settings
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Ginny MOORE
Poster P3309
Abstract 7044
The data when tortured, speaks: the FUO's whispering
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Alessandra SCAGLIARINI
Poster P3310
Abstract 7106
Hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase-producing Enterobacterales: 20 years of surveillance in a French tertiary hospital
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Antoine VILLA
Poster P3311
Abstract 7126
Longitudinal genomic analysis of clinical and environmental Pseudomonas aeruginosa links sink drains to nosocomial transmission in intensive care units
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Katelyn BARTLETT
Poster P3312
Abstract 7224
Can hospitals derive clinically useful surveillance data from their wastewater using currently available collection methods and next-generation sequencing data?
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Aoife KEARNEY
Poster P3313
Abstract 7245
The environmental microbiome of hospital areas with and without patient areas reveals the influence of human activity in the dynamics of multidrug-resistant organisms
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Natalia GUERRA PINTO
Poster P3314
Abstract 7345
Antimicrobial resistance in clinically important anaerobes at a tertiary university hospital in Greece
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Eleni KALOGEROPOULOU
Poster P3315
Abstract 7501
Nine-year epidemiology of group A streptococci and whole-genome sequencing of invasive strains isolated in an Italian hospital
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Angela KUKA
Poster P3316
Abstract 7507
Impact of whole genome sequencing to investigate transmission of Serratia marcescens in a neonatal intensive care unit
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Marina RAMUS
Poster P3317
Abstract 7734
CPE screening in a tertiary care hospital in Portugal: burden of colonisation and impact on subsequent infection
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Margarida TORRES
Poster P3318
Abstract 8096
Vancomycin resistant enterococci (VRE) surveillance using hospital wastewater during an outbreak with VRE
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Djamayl ENGELEN
Poster P3319
Abstract 8149
Pseudomonas aeruginosa as relevant cause of healthcare-associated infections in neonatal intensive care: a molecular epidemiology investigation
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Giancarlo RIPABELLI
Poster P3320
Abstract 8298
Genomic Epidemiology insights reveals pivotal role of plasmids in blaNDM mediated antimicrobial resistance - Need for urgent global action
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Nagaraj GEETHA
Poster P3321
Abstract 8530
Transmission dynamics of carbapenemase-producing microorganisms in a high endemicity critical care unit from a public hospital in Bogota, Colombia
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Gerardo Antonio MUÑETON LOPEZ
Poster P3322
Abstract 8596
Long-read sequencing characterises multi-modal transmission of ESBL genes amongst Klebsiella pneumoniae and Escherichia coli in a neonatal unit
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Melody PARKER
Poster P3323
Abstract 8645
Excess length of stay due to healthcare-associated infections in acute care hospitals in Spain
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Lina Marcela PARRA
Poster P3324
Abstract 8719
Years of life lost atributables to healthcare-associated infections in Spain
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Lina Marcela PARRA
Poster P3325
Abstract 8808
Recent emergence of the multidrug-resistant epidemic variant in Acinetobacter baumannii revealed by hierarchical genotype
30/04 12:00
8e. Hospital epidemiology, transmission, surveillance & screening (incl. hospital environment)
Shengkai LI
Poster P3326
Abstract 69
Secondary prophylaxis for Clostridioides difficile infection for patients on non-Clostridioides difficile antibiotics: a retrospective cohort study
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Ronza NAJJAR-DEBBINY
Poster P3327
Abstract 125
The first established microsatellite markers to distinguish Candida orthopsilosis isolates and detection of a nosocomial outbreak in China
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Luo ZHENGYU
Poster P3328
Abstract 218
Selective, isosteric growth inhibitors of Clostridioides difficile
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
William FRASER
Poster P3329
Abstract 443
Electric floor scrubbers, centralised kitchens and an outbreak of carbapenemase producing Enterobacterales
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Aled BENBOW
Poster P3330
Abstract 532
Melioidosis outbreak traced to a single hospital ward in Singapore
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Hwang Ching CHAN
Poster P3331
Abstract 570
Quinolone-resistant Acinetobacter baumannii international clone II outbreak with shower trolleys as reservoir
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Hideki KAWAMURA
Poster P3332
Abstract 761
Significant and sustained decline in catheter-associated urinary tract infections rate following implementation of a multifaceted interdisciplinary infection prevention programme
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Avish NAGPAL
Poster P3333
Abstract 847
Phenotypic characterisation of Clostridioides difficile PCR ribotype 046, involved in an outbreak, presents high toxin production and multidrug-resistance
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Cecilia MAGNUSSON
Poster P3334
Abstract 916
Clinical and pharmacoeconomic evaluation of fidaxomicin in risk patients with recurrent or refractory Clostridioides difficile infection
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Sina Marie HOPFF
Poster P3335
Abstract 1102
Interrogation of Clostridioides difficile (CD) Ribotype 078 genomes from Irish pigs and human cases of CD Infection (CDI) to determine epidemiological relationships.
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Aoife DOYLE
Poster P3336
Abstract 1417
Antimicrobial susceptibility pattern of Clostridioides difficile in a Spanish university hospital
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Luciana URBINA
Poster P3337
Abstract 1504
Identification of the first nosocomial outbreak of clade ? Candida auris in Korea: a nationwide surveillance study
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Yong Jun KWON
Poster P3338
Abstract 1698
Core genome multi-locus sequence typing (cgMLST) reveals a long-term silent outbreak with the rare MRSA ST4110 in outpatient wound care
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Danielle VUICHARD-GYSIN
Poster P3339
Abstract 1742
Whole-genome sequencing revealed multiple undetected SARS-CoV-2 outbreaks in a university hospital in Norway
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Kirsten GRAVNINGEN
Poster P3340
Abstract 1803
Multicentre outbreak of blaOXA-72 Acinetobacter baumannii: a comprehensive whole genome sequencing analysis
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Tomasz KASPERSKI
Poster P3341
Abstract 1838
Effectiveness and safety of bezlotoxumab in combination with standard-of-care therapy in patients with Clostridioides difficile infection: a single-centre real-life experience
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Judith POBLET
Poster P3342
Abstract 1848
First report of outbreaks of Clostridioides difficile caused by ribotype 955: a highly transmissible and pathogenic strain
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Eftihia YIANNAKIS
Poster P3343
Abstract 1912
Risk factors and outcomes of bloodstream infections following Clostridioides difficile infection in the time of increased use of fidaxomicin
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Vera MAURO
Poster P3344
Abstract 2062
Characteristics of dual carbapenemase-producing Klebsiella pneumoniae ST147 strains from an outbreak in Tenerife
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Cristian MATEO LEÓN
Poster P3345
Abstract 2117
The burden of Clostridioides difficile infection in the COVID-19 era in the second largest Slovak hospital
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Daniela JAVORSKÁ
Poster P3346
Abstract 2188
Increasing incidence of Clostridium difficile (CDI) infection in admitted patients in the post covid era: epidemiological data
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Dimitrios KOUROUPIS
Poster P3347
Abstract 2190
PopPIPE accurately clusters vancomycin resistant Enterococcus faecium in nosocomial outbreaks
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Martin MCHUGH
Poster P3348
Abstract 2201
Outcome of Clostridium difficile infection (CDI) in admitted patients; association with epidemiological and clinical parameters
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Dimitrios KOUROUPIS
Poster P3349
Abstract 2309
Real-world data on epidemiology and tests of Clostridioides difficile infection in Korea: the need for nationwide diagnostic stewardship
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Jae Hyeon PARK
Poster P3350
Abstract 2431
Plasmid content and composition in vancomycin-resistant Enterococci from suspected hospital outbreaks in Berlin, Germany
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Friederike MAECHLER
Poster P3351
Abstract 2448
Outbreak of carbapenem-resistant Enterobacteriaceae in a kidney transplant unit, how to manage?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Charlotte MOREAU
Poster P3352
Abstract 2512
Successful control of an outbreak of vancomycin-resistant Enterococcus faecium in a low-prevalence setting
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Jordi CÀMARA
Poster P3353
Abstract 2514
A linezolid resistant coagulase-negative Staphylococci outbreak in an intensive care unit in Gipuzkoa, northern Spain
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Inigo ANSA ISASA
Poster P3354
Abstract 2837
Current perspectives on ventriculitis: clinical insights, microbial trends, and the impact of the COVID-19 pandemic
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Alejandro DÍEZ VIDAL
Poster P3356
Abstract 2932
Efficacy of polyclonal intravenous immunoglobulin for refractory Clostridioides difficile infection: time for a re-think?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Shanika Anne-Marie CRUSZ
Poster P3357
Abstract 3004
Clostrioides difficile infection at County Durham and Darlington NHS Foundation Trust (CDDFT) 2022/23: review of antimicrobial stewardship and treatment outcomes
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Matthew CHRISTIE
Poster P3358
Abstract 3012
Clostridioides difficile infection epidemiology during COVID-19 pandemic in Greece
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Anna NIKOPOULOU
Poster P3359
Abstract 3152
Exploring the mode of transmission of community-acquired C.difficile from the concept of One Health
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Sadako YOSHIZAWA
Poster P3360
Abstract 3409
Prospective surveillance of health-care associated infections in long-term care facilities in Graz, Austria from 2018 to 2022
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Ines ZOLLNER-SCHWETZ
Poster P3361
Abstract 3417
Accumulation of antimicrobial resistance in Czech and Slovak Clostridioides difficile isolates
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Jaroslava ZÍKOVÁ
Poster P3362
Abstract 3592
Long lasting outbreak of VIM-producing Pseudomonas aeruginosa in a surgical intensive care unit
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Sarah JOLIVET
Poster P3363
Abstract 3639
Cost-effectiveness analysis in the treatment of Clostridioides difficile infection in the Brazilian healthcare system and faecal transplant microbiote
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Leticia DANTAS
Poster P3364
Abstract 3664
Identification of the first large French Candida auris outbreak using qPCR
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Sarah JOLIVET
Poster P3365
Abstract 3700
Berberine alleviates the severity of recurrent Clostridioides difficile infection by enhancing intestinal epithelial barrier and modulating gut microbiota
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Haihui HUANG
Poster P3366
Abstract 3747
Healthcare-associated infections following kidney or kidney-pancreas transplantations
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Elodie MARION
Poster P3367
Abstract 3965
Whole genome sequencing is superior to high molecular weight typing by MALDI-ToF in clarifying Clostridioides difficile transmission
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Sara MERNELIUS
Poster P3368
Abstract 4040
A hospital outbreak with methicillin-resistant Staphylococcus argenteus in the Netherlands, June 2023
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Serena SLAVENBURG
Poster P3369
Abstract 4080
Is older age a risk factor for recurrent Clostridioides difficile infection (r-CDI) in the era of new C. difficile treatments?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Cecilia SUÁREZ CARANTOÑA
Poster P3370
Abstract 4314
A real-world analysis of Clostridioides difficile infection epidemiology using the TriNetX global health research network
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Kelsey STREY
Poster P3371
Abstract 4336
Outbreak of a linezolid resistant clone of ST18 Enterococcus faecium bearing the G2576T 23S rDNA mutation and its control
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Aleksandra MAREK
Poster P3372
Abstract 4435
Study of antibacterial susceptibility and the hypervirulent strains of Clostridioides difficile in a Spanish hospital
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Carlos RESCALVO CASAS
Poster P3373
Abstract 4443
Outbreak caused by NDM-producing Pseudomonas aeruginosa in a Greek hospital: just visiting or here to stay?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Christina LOUKA
Poster P3374
Abstract 4444
Prolonged regional outbreak of clinically virulent, highly resistant Klebsiella pneumoniae NDM-14 (ST-147) in Corsica, France, 2022-2023
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Arthur MAKA
Poster P3375
Abstract 4452
Empiric treatment of healthcare-associated central nervous system infections in Denmark: do we need carbapenems?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Christian KRAEF
Poster P3376
Abstract 4827
Prolonged VIM-producing Pseudomonas aeruginosa outbreak at a Belgian intensive care department, an outbreak investigation report 2019-2023
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Marco MORETTI
Poster P3377
Abstract 4869
Use of bezlotoxumab for the prevention of Clostridioides difficile infections within the German health care system: an observational post-authorization study (BODEGA Study)
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Katharina GIESBRECHT
Poster P3378
Abstract 4937
From the shadows to the spotlight: emergence of vancomycin-resistant Enterococcus faecium ST1299-vanA in upper Austria
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Adriana CABAL ROSEL
Poster P3379
Abstract 4951
Basis of fidaxomicin resistance in Clostridioides difficile: a systematic review and meta-analysis
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Thanh LE
Poster P3380
Abstract 5131
A study on the microbiological differences of Clostridioides difficile strains isolated from community onset Clostridioides difficile infection (CDI) patients and healthcare-associated CDI patients in South Korea
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Jieun KIM
Poster P3381
Abstract 5203
Clostridium difficile contamination of Australian retail vegetables and households
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Deirdre COLLINS
Poster P3382
Abstract 5294
The use of whole genome sequence to uncover undetected healthcare outbreak and transmission of extensively drug-resistant Pseudomonas aeruginosa across four hospitals
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Edwin KAMAU
Poster P3383
Abstract 5432
Relationship between high-risk antibiotic consumption and incidence of nosocomial Clostridiodes difficile infection in tertiary care hospitals in Costa Rica during COVID-19 pandemic
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Cristina FERNANDEZ-BARRANTES
Poster P3384
Abstract 5564
High risk of recurrent Clostridioides difficile infection after previous episodes, regardless of treatment or number of recurrences
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Måns STEFANSSON
Poster P3385
Abstract 5699
Recurrent outbreak of carbapenemase-producing Pseudomonas aeruginosa (IMIP) in kidney transplant recipients: the role of prolonged carriers
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Maristela P FREIRE
Poster P3386
Abstract 5717
Successful control of a cluster of OXA-48 producing Klebsiella pneumoniae sequence type 147 in a tertiary care spinal unit
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Abhijit BAL
Poster P3387
Abstract 5756
Uncovering the alarming spike of VRE CC17 at a Belgian hospital in 2022: a comprehensive genome sequencing investigation
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Katrien VAN DEN PLAS
Poster P3388
Abstract 5972
Genomically-supported redefinition of an outbreak in a paediatric unit caused by blaVIM-harboring Klebsiella michiganensis
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Elena LÓPEZ CAMACHO
Poster P3389
Abstract 6006
Genomic analysis of a nosocomial outbreak of Candida auris in the Comunitat Valenciana (Spain)
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Fernando GONZALEZ-CANDELAS
Poster P3390
Abstract 6207
Toilet drain water as a potential reservoir for NDM1-producing Klebsiella pneumoniae: an outbreak report from a German university hospital including an effective eradication strategy
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Giovanni-Battista FUCINI
Poster P3391
Abstract 6327
Are cycle threshold (CT) values useful for predicting specific attributes of Clostridioides difficile infection?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Mairead SKALLY
Poster P3392
Abstract 6383
The added value of a regional, prospective whole genome sequencing (WGS) based surveillance for methicillin-resistant Staphylococcus aureus (MRSA) outbreak detection in five hospitals in the Netherlands
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Veronica WETERINGS
Poster P3393
Abstract 6434
Increase in antimicrobial consumption and C. difficile infection after the SARS-CoV-2 pandemic
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Michail SAMARKOS
Poster P3394
Abstract 6522
Prevalence of healthcare-associated infections in Greek long-term care facilities, HALT-4 2023: a fleeting glance for a promising future
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Lida POLITI
Poster P3395
Abstract 6646
Correlation between toxin-producing Clostridiodes difficile infection and multidrug-resistant bacteria in pre- and COVID-19 periods
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Luisa TORRINI
Poster P3396
Abstract 6707
Implementing nanopore whole-genome sequencing in C. difficile surveillance and outbreak investigation
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Anita BLOMFELDT
Poster P3397
Abstract 6890
WGS confirmed the non-inferiority of the rapid and simple McRAPD typing in comparison with MLST in a Klebsiella pneumoniae outbreak
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Rakesh Rao GERGAL NAGABHUSHANA RAO
Poster P3398
Abstract 7004
Tip of the iceberg: how severe is ‘severe' C. difficile?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Niamh REIDY
Poster P3399
Abstract 7026
Outbreak of gastrointestinal symptoms in professionals related to water consumption in hospital
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Euclimeire NEVES
Poster P3400
Abstract 7178
Clostridioides difficile-associated infections: a gap in the Swiss surveillance of hospital-acquired infections
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Andreas F. WIDMER
Poster P3401
Abstract 7204
Acquisition of blaCTX-M-15 throughout a Pseudomonas aeruginosa nosocomial outbreak
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Katelyn BARTLETT
Poster P3402
Abstract 7235
Two years of an active carbapenem-resistant Acinetobacter baumannii outbreak in a burn intensive care unit
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Nagham Léa KHANAFER
Poster P3403
Abstract 7244
Early developability assessment of a single-domain antibody construct for gastrointestinal neutralisation of Clostridium difficile toxins
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Everardo RODRIGUEZ RODRIGUEZ
Poster P3404
Abstract 7484
Efficient outbreak investigation of post-surgical intraocular Staphylococcus epidermidis infections by rapid whole genome sequencing and sharing data between hospitals.
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Michael KEMP
Poster P3405
Abstract 7537
Genomic insight into suspected outbreak of methicillin-susceptible Staphylococcus aureus surgical site infections in orthopaedic surgery
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Chloé MAGNAN
Poster P3406
Abstract 7540
Outbreak of Burkholderia contaminans in Intensive Care Units of a Tertiary Hospital
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Marcos BELSOL
Poster P3407
Abstract 7544
Chlorhexadine linked Burkholderia-like outbreak in a tertiary care hospital: unique challenges in LMICs
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Syed Faisal MAHMOOD
Poster P3408
Abstract 7571
Investigation of an outbreak due to Achromobacter xylosoxidans
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Konstantinia KONTOPOULOU
Poster P3410
Abstract 7767
Adjunctive eravacycline as treatment in severe and fulminant Clostridioides difficile infections?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Christen ARENA
Poster P3411
Abstract 7794
Outbreak of NDM-1, OXA-48 and CTXM co-producing Klebsiella pneumoniae in a tertiary hospital in Spain
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Patricia Luisa GÓMEZ SASTRE
Poster P3412
Abstract 7909
Outbreak of Burkholderia cepacia in a hospital in southern Spain
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Ana LÓPEZ GONZÁLEZ-SALIDO
Poster P3413
Abstract 7952
Assessment of institutional management and control of Clostridioides difficile in public and private hospitals in Brazil
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Silvia FIGUEIREDO COSTA
Poster P3414
Abstract 7958
Impact of the COVID-19 pandemic on Clostridioides difficile infection in Brazilian hospitals
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Luiza ARCAS GONÇALVES
Poster P3415
Abstract 8258
Increased incidence of CDI over time as an indirect consequence of COVID-19 pandemic?
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Evdoxia DOUMOULIAKA
Poster P3416
Abstract 8354
Epidemiology and antimicrobial resistance pattern of Clostridioides difficile at a tertiary university hospital in Greece
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Eleni KALOGEROPOULOU
Poster P3417
Abstract 8370
Healthcare-associated spondilodiscitis: worse outcome in patients on hemodialysis
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Özlem AZAP
Poster P3418
Abstract 8517
Clostridioides difficile Infections in England: switch to sustained increasing trends
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Rimsha QURESHI
Poster P3419
Abstract 8570
Core genome predictors of CDI severity
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
S GABER
Poster P3420
Abstract 8654
A novel sequence-based typing scheme for Candida parapsilosis can be used to track outbreaks
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Phillip BRASSINGTON
Poster P3421
Abstract 8923
Practices to reduce the risk of transmission of Clostridioides difficile in France: national survey
30/04 12:00
8f. Other healthcare associated infections (incl CDI, hospital outbreaks)
Nagham Léa KHANAFER
Poster P3422
Abstract 1150
Direct molecular detection of pathogens in stool sample donors for fecal microbiota transplantation: five years experience
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Gianluca QUARANTA
Poster P3423
Abstract 1589
Contaminated duodenoscopes in endoscopic retrograde cholangiopancreatopgraphy: assessing risk and culture sensitivity
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Koen VAN DER PLOEG
Poster P3425
Abstract 1729
The impact of universal contact precautions and chlorhexidine bathing on the acquisition of carbapenem resistant Enterobacterales in the intensive care unit
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Jung JONGTAK
Poster P3426
Abstract 1990
Faecal microbiota transplantation with lyophilized oral capsules in patients with Clostridioides difficile infection: a five-year experience in a university hospital
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Sofia DE LA VILLA MARTINEZ
Poster P3427
Abstract 2415
Prolonged use of breathing systems used in anaesthesia for up to seven days instead of 24 hours
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Cynthia Paola HAANAPPEL
Poster P3428
Abstract 2711
Efficacy and safety of antiseptic cleansing in reducing bacterial vertical transmission: NeoVTAMR
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Emily BEALES
Poster P3429
Abstract 2869
Faecal microbiota transplantation excluding C. difficile French experience from 2019 to 2022, indication and efficacy analysis
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Alexandre BLEIBTREU
Poster P3430
Abstract 3169
Decolonization: the beginning of the end of carbapenemases?
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Ana ALBEROLA ROMANO
Poster P3431
Abstract 5205
Nanoparticle-impregnated textiles as a promising tool to reduce incidence of healthcare-associated infections in the intensive care unit: an interrupted time-series study
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Diego Rodrigues FALCI
Poster P3432
Abstract 5967
Safe and effective administration of subcutaneous antimicrobials: an observational retrospective cohort-study in 136 patients
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Marie JUMPERTZ
Poster P3433
Abstract 8039
Results of an antibiotic stewardship programme in an oncologic institution from Bogota, Colombia
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Maria Jose LOPEZ
Poster P3434
Abstract 8106
Semi-continuous disinfection of sinks with UVC on a haematology-oncology department for prevention of nosocomial infection
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Wil VAN DER ZWET
Poster P3435
Abstract 8265
Faecal microbiota transplantation: bacterial viability throughout the procedure of capsule preparation
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Lucía SAIZ ESCOBEDO
Poster P3436
Abstract 8333
Whole genome sequencing in clinical microbiology laboratory as a tool for infection control
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Maria RIESGO MAGAÑA
Poster P3437
Abstract 8411
Impact of in loco training to reduce cases of Clostridioides difficile infection in onco-hematology patients and hematopoietic stem cell transplantation
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Odeli Nicole ENCINAS SEJAS
Poster P3438
Abstract 8628
Intestinal microbiota transplantation for patients colonised with multidrug-resistant organisms have an improvement in clinical outcomes associated with a significant increase in alpha-diversity metrics of the gastrointestinal microbiota
30/04 12:00
8g. Infection control interventions and trials (incl. microbiota transplantation)
Rohma GHANI
Poster P3439
Abstract 799
Unraveling the complex interplay of biocide resistance, efflux pump mechanisms, and sequence typing in carbapenem-resistant Acinetobacter baumannii: a comprehensive multicentre investigation
30/04 12:00
8h. Disinfection & biocides
Muhammd Usman QAMAR
Poster P3441
Abstract 2469
Antiseptics, biocides, disinfectants: a common practice under the aegis of complex regulations
30/04 12:00
8h. Disinfection & biocides
Charlotte MOREAU
Poster P3442
Abstract 2858
Exploring tolerance to quaternary ammonium compounds in Klebsiella pneumoniae with a focus on the food chain: phenotypic and genomic insights
30/04 12:00
8h. Disinfection & biocides
Patricia ANTUNES
Poster P3443
Abstract 3072
Portable UV-C device decontaminator: an in vitro microbiological analysis
30/04 12:00
8h. Disinfection & biocides
Natalia IORIO
Poster P3444
Abstract 3216
Persistence and bactericidal effect of various disinfectants for clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii
30/04 12:00
8h. Disinfection & biocides
Masato KAWAMURA
Poster P3445
Abstract 3418
Alcohol-based hand rubs meet EN 1500 requirements in 15 seconds
30/04 12:00
8h. Disinfection & biocides
Christoph SENGES
Poster P3446
Abstract 3536
Biocide resistance among Enterobacteriaceae from fecal samples of children living in urban polluted areas
30/04 12:00
8h. Disinfection & biocides
Carolina LÓPEZ LÓPEZ
Poster P3447
Abstract 4608
Bactericidal activities of ceragenins and N-chlorotaurine against Staphylococcus aureus and Pseudomonas aeruginosa clinical strains
30/04 12:00
8h. Disinfection & biocides
Mayram HACIOGLU
Poster P3448
Abstract 6176
Biocides susceptibility among high-risk clones of multidrug-resistant Pseudomonas aeruginosa in Southern France
30/04 12:00
8h. Disinfection & biocides
Maëliss CONSTANT
Poster P3449
Abstract 6456
Fading solutions: are 2-in-1 oxidising disinfectants too good to be true?
30/04 12:00
8h. Disinfection & biocides
Lauren BROWN
Poster P3450
Abstract 8433
Label-free flow cytometry for fast evaluation of surface disinfectants bactericidal efficacy
30/04 12:00
8h. Disinfection & biocides
Andreea Maria PÎNDARU
Poster P3451
Abstract 178
Hand hygiene practice compliance among health care workers and associated factors during and after COVID-19 pandemic
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Haythem AYACHI
Poster P3452
Abstract 245
Frequency and distribution of carriers of pathogenic bacteria during regular sanitary examinations in throat and nose swabs of employees in the surgical departments of the University Clinical Center Tuzla, Bosnia and Herzegovina: overview of the period 2020-2022
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Dijana HASIC
Poster P3453
Abstract 1134
Reliability of healthcare worker self-reported COVID-19 vaccination status
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Liam TOWNSEND
Poster P3454
Abstract 1283
Employing Delphi survey methods to identify indicators and targets for the World Health Organization (WHO) infection prevention and control (IPC) global action plan
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Giovanni SATTA
Poster P3455
Abstract 1629
Does gel nail polish really have a negative impact on the quality of hand hygiene (HH) with alcohol rub?
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Paula ARREBA
Poster P3456
Abstract 1747
Enhancing feedback and implementation of infection risk scan (IRIS) findings among healthcare workers in nursing homes
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Yvonne HENDRIKS
Poster P3457
Abstract 2179
Radiant protection: confidence in appropriate use of personal protective equipment improved following ultraviolet dye simulation training in a pilot study
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Alexander RICHARDS
Poster P3458
Abstract 2214
Assessment of a novel isolation care tent in Uganda during the 2022 Sudan ebolavirus outbreak showed potential impact and feasibility
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Mara Jana BROADHURST
Poster P3459
Abstract 2308
Hand hygiene compliance rates and the interventions to increase hand hygiene compliance among healthcare workers in a tertiary care educational hemato-oncology hospital
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Oguz Resat SIPAHI
Poster P3460
Abstract 2317
Isolation precautions compliance rates among healthcare workers in a tertiary care educational hemato-oncology hospital
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Oguz Resat SIPAHI
Poster P3461
Abstract 2420
Proper glove use: a multicentre before-after regional de-implementation study
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Anne VOOR IN T HOLT
Poster P3462
Abstract 2481
Immune status of healthcare workers to the measles virus in an infectious disease tertiary medical center in Croatia
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Oktavija DAKOVIC RODE
Poster P3463
Abstract 2487
Preliminary insights into the applicability of a gamification strategy to improve hand hygiene and IPC
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Nicolas REINOSO SCHILLER
Poster P3464
Abstract 3077
Factors influencing healthcare workers' compliance with infection prevention and control measures in acute care settings during the COVID-19 pandemic in Canada
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Nicole ROBERTSON
Poster P3465
Abstract 3515
Healthcare workers known to be colonised with livestock-associated methicillin-resistant Staphylococcus aureus did not cause nosocomial transmission
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Thera HABBEN JANSEN
Poster P3466
Abstract 3581
Electronic hand hygiene monitoring tools for implementation of optimal hand sanitising adherence in neonatal intensive care
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Chiara MINOTTI
Poster P3467
Abstract 3769
A multimodal approach to high consequence infectious disease training
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Cecilia TUUDAH
Poster P3468
Abstract 4175
Results of electronic monitoring of hand hygiene performance in Dutch primary care
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Nataliya HILT
Poster P3469
Abstract 4503
Assessing the Hawthorne effect: implications and solutions
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Syed Faisal MAHMOOD
Poster P3470
Abstract 5164
Adherence to hand hygiene in the five moments in an intensive care unit of a reference hospital for infectious diseases in the state of San Paulo, Brazil
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Raquel Keiko DE LUCA ITO
Poster P3471
Abstract 5429
Occupational HIV exposures and post-exposure prophylaxis practices in Indian healthcare organisations: a survey
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Jasper Victoria Leelarani MARTINRAJ
Poster P3472
Abstract 6244
Evaluation of the infection prevention and control education program for all medical master students at Radboud university medical centre, the Netherlands
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Olga COENEN
Poster P3474
Abstract 6745
Preparing first-line health care workers in the Flemish health care system for 'Virus X' (FiLi-Vi-X)
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Annelies MONDELAERS
Poster P3475
Abstract 6876
A decade of high-level isolation unit activities at Antwerp university hospital: lessons learned and future challenges (2014-2023)
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Annelies MONDELAERS
Poster P3476
Abstract 6880
Infection prevention and control and water, sanitation and hygiene training for strengthening national outbreak capacity in the eastern mediterranean region
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
April BALLER
Poster P3477
Abstract 7554
Assessing infection control readiness in LMIC hospitals through mystery patient drills
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Syed Faisal MAHMOOD
Poster P3478
Abstract 8308
Evaluation of the knowledge of doctors in training at the Mohamed VI university hospital of Marrakech regarding blood exposure accidents
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Fatima IHBIBANE
Poster P3479
Abstract 8853
Evaluation of infection prevention and control practices at a tertiary care hospital in southwest Ethiopia
30/04 12:00
8i. Healthcare workers and infection prevention (incl vaccination, protective equipment, behavioural aspects, training and practices)
Mulualem Tadesse JANO
Poster P3480
Abstract 772
Clostridioides difficile toxin B suppresses the migration ability in human neutrophils
30/04 12:00
9a. Microbial pathogenesis & virulence
Yoshitaka KIMURA
Poster P3481
Abstract 1005
Decoding Acinetobacter pittii: unveiling phenotypic and genotypic traits in seven isolates
30/04 12:00
9a. Microbial pathogenesis & virulence
Nadya RAKOVITSKY
Poster P3482
Abstract 1143
Testosterone alters the virulence traits of uropathogenic Escherichia coli
30/04 12:00
9a. Microbial pathogenesis & virulence
Rongrong WU
Poster P3483
Abstract 1191
ST218 Klebsiella pneumoniae became a high-risk clone for multidrug resistance and hypervirulence
30/04 12:00
9a. Microbial pathogenesis & virulence
Ping YANG
Poster P3484
Abstract 1645
Alpha-1-antitrypsin as novel target of Staphylococcus aureus' Spl proteases
30/04 12:00
9a. Microbial pathogenesis & virulence
Franziska SCHERR
Poster P3485
Abstract 1872
Polymicrobial interactions: implications for virulence in chronic lung disease
30/04 12:00
9a. Microbial pathogenesis & virulence
Natasha SARWAR
Poster P3487
Abstract 2584
Virulence factors among carbapenem-resistant Klebsiella pneumoniae in Portugal: a multicentre study
30/04 12:00
9a. Microbial pathogenesis & virulence
Gabriel MENDES
Poster P3488
Abstract 2662
Molecular and phenotypic approaches to characterise virulence determinants among clinical Staphylococcus lugdunensis isolates
30/04 12:00
9a. Microbial pathogenesis & virulence
Christophe ISNARD
Poster P3489
Abstract 2695
Virulence Factor Profiles of carbapenem-resistant Acinetobacter baumannii harbouring blaOXA-24/40 involved in two outbreaks in a Tertiary Hospital in northern Spain
30/04 12:00
9a. Microbial pathogenesis & virulence
Maitane ARANZAMENDI
Poster P3490
Abstract 2840
Roles of mltB1-rlpA-dacC operon in bacterial morphology and β-lactam susceptibility in Stenotrophomonas maltophilia
30/04 12:00
9a. Microbial pathogenesis & virulence
Cheng-Mu WU
Poster P3491
Abstract 2850
Virulence mechanism changes in colistin tolerant K.pneumoniae, A.baumannii, and P.aeruginosa cells at the transcriptomic level
30/04 12:00
9a. Microbial pathogenesis & virulence
Cansel VATANSEVER
Poster P3492
Abstract 2962
Microbiological features and clinical impact of the T6SS in Pseudomonas aeruginosa isolates
30/04 12:00
9a. Microbial pathogenesis & virulence
Telma Susana LOPES DE SOUSA
Poster P3493
Abstract 3170
Testing physiologically relevant oxygen concentrations on antibiotic susceptibility and virulence of classical multidrug-resistant, hypervirulent and convergent Klebsiella pneumoniae lineages
30/04 12:00
9a. Microbial pathogenesis & virulence
Amal AL-BAKRI
Poster P3494
Abstract 3722
Disappearance and recovery of ompW protein in cellular membrane of Acinetobacter baumannii in relation with colistin resistance
30/04 12:00
9a. Microbial pathogenesis & virulence
Jale BORAL
Poster P3495
Abstract 3777
The roles of Wzc variants on hypermucoviscosity (HMV) and capsular polysaccharide (CPS) production in Klebsiella pneumoniae
30/04 12:00
9a. Microbial pathogenesis & virulence
Wenxing ZHAO
Poster P3496
Abstract 3790
Cyclophilin AIL09810.1 from Stenotrophomonas maltophilia has a PPIase activity and could potentially be inhibited by non-peptide small-molecule cyclophilin inhibitors
30/04 12:00
9a. Microbial pathogenesis & virulence
Francoise BOTTEREL
Poster P3497
Abstract 3851
Evolution of triclosan resistance modulates bacterial permissiveness to multidrug resistance plasmids and phages
30/04 12:00
9a. Microbial pathogenesis & virulence
Qiu YANG
Poster P3498
Abstract 3910
Inter-species interactions alter antimicrobial susceptibility in polymicrobial infection scenarios
30/04 12:00
9a. Microbial pathogenesis & virulence
Eva BENYEI
Poster P3499
Abstract 3919
Impact of genomic adaptation on stress response and virulence of sequential urinary isolates of Pseudomonas aeruginosa
30/04 12:00
9a. Microbial pathogenesis & virulence
Caroline MARTIN-DUVAL
Poster P3500
Abstract 4199
Characterisation of the outer membrane vesicles of Pseudomonas aeruginosa exhibiting growth inhibition against Acinetobacter baumannii
30/04 12:00
9a. Microbial pathogenesis & virulence
Jinwoong SUH
Poster P3501
Abstract 4743
Comparative genomic markers of Staphylococcus epidermidis strains causing bone and joint infection with skin colonisers
30/04 12:00
9a. Microbial pathogenesis & virulence
Mauro SALLES
Poster P3502
Abstract 5002
Pig farms in crisis: Reveals imminent threats of antibiotic resistance, biofilm formation and high-risk clonal lineages
30/04 12:00
9a. Microbial pathogenesis & virulence
Adriana SILVA
Poster P3503
Abstract 5958
Hypervirulent Klebsiella pneumoniae isolates from the Western Cape of South Africa
30/04 12:00
9a. Microbial pathogenesis & virulence
Amike DE VILLIERS
Poster P3504
Abstract 6095
The FhaB/C two partner secretion system plays an important role in the pathogenesis of Klebsiella pneumoniae ST15
30/04 12:00
9a. Microbial pathogenesis & virulence
Ana TAJUELO MORENO-PALANCAS
Poster P3505
Abstract 6192
Altered virulence patterns in the ST235 high-risk clone of carbapenem-resistant Pseudomonas aeruginosa
30/04 12:00
9a. Microbial pathogenesis & virulence
Cansel VATANSEVER
Poster P3506
Abstract 6345
Implication of colanic acid in the pathogenicity of adherent-invasive Escherichia coli
30/04 12:00
9a. Microbial pathogenesis & virulence
Queralt BONET-ROSSINYOL
Poster P3507
Abstract 6557
Phylogenic and genomic comparative studies of Pseudomonas aeruginosa strains without the type III secretion system
30/04 12:00
9a. Microbial pathogenesis & virulence
Yolanda SAENZ
Poster P3508
Abstract 6833
Pilus expression and gene copy number dynamics in Neisseria meningitidis causing invasive disease vs carriage
30/04 12:00
9a. Microbial pathogenesis & virulence
Sara THULIN HEDBERG
Poster P3509
Abstract 7731
Streptococcus sanguinis strains isolated from patients with infective endocarditis show immune system evasion mechanisms
30/04 12:00
9a. Microbial pathogenesis & virulence
Livia ARAUJO ALVES
Poster P3510
Abstract 7746
Clinical GBS strains display membrane damaging activity which is glucose dependent
30/04 12:00
9a. Microbial pathogenesis & virulence
Emelie ALSHEIM
Poster P3511
Abstract 7893
Exploring microbial interaction in polymicrobial biofilms: impact on biomass and antibiotic susceptibility
30/04 12:00
9a. Microbial pathogenesis & virulence
Tiago LIMA
Poster P3512
Abstract 8255
Corema album activity against biofilm formation and adhesion in Streptococcus pyogenes
30/04 12:00
9a. Microbial pathogenesis & virulence
Nádia OSÓRIO
Poster P3513
Abstract 8883
Unusual hypermucoid KPC-producing Klebsiella pneumoniae Sequence Type 101
30/04 12:00
9a. Microbial pathogenesis & virulence
Alice DE FRANCESCO
Poster P3514
Abstract 220
The impacts of the crosstalk between bacterial vaginosis associated bacteria and Trichomonas vaginalis on the pathogenesis and host immune responses
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Shu-Fang CHIU
Poster P3514
Abstract 1764
Gut microbiome characterisation of inflammatory bowel disease, Clostridioides difficille infection and co-infection
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Silvia Noemi VAZQUEZ CUESTA
Poster P3515
Abstract 320
In vivo mapping of key bacterial species reveals Enterococcus faecalis and Escherichia coli as promising biomarkers of postmortem interval estimation
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Ana Raquel FREITAS
Poster P3516
Abstract 403
Ex vivo modeling of pneumonia-associated bacterial infections using hamster precision-cut lung tissue slices
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Hsung-Yu CHEN
Poster P3517
Abstract 517
Impact of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Benjamin DAVIDO
Poster P3518
Abstract 520
Synchrony or divergence? Exploring the vaginal and endometrial microbiome
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Courtney POVEY
Poster P3519
Abstract 929
Ciprofloxacin residues in food can induce resistance to ciprofloxacin in Klebsiella pneumoniae in Galleria mellonella
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Chris KENYON
Poster P3520
Abstract 1011
Establishing Zophobas morio larvae as a model for the study of Klebsiella pneumoniae virulence and therapeutics
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Nadya RAKOVITSKY
Poster P3521
Abstract 1096
Impact of gestation, maternal diet and low body mass index (BMI) on breastmilk microbiome of Indian mothers delivering preterm
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Anwesha CHAKRABORTY
Poster P3522
Abstract 1139
Associations between the gut microbiome, inflammation and cardiovascular profiles in People with HIV (PWH)
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Rachel MAC CANN
Poster P3523
Abstract 1544
Analgesia with buprenorphine influences clinical relevant outcome parameters in experimental pneumococcal meningitis
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Denis GRANDGIRARD
Poster P3524
Abstract 1626
High-frequency apoptosis upon human splenic macrophages after phagocytosis of blood borne pathogens
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Marco Rinaldo OGGIONI
Poster P3525
Abstract 1900
THP-1 infection model for characterization of clinical Mycobacterium abscessus strains from Cystic Fibrosis patients: a multicenter study.
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Alba RUEDAS LÓPEZ
Poster P3526
Abstract 1952
Alterations in gut microbiome-immune interface in multiple sclerosis
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Simeon NTHUKU
Poster P3527
Abstract 2087
Urinary tract microbiological diversity of healthy young men in Poland
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Filip BIELEC
Poster P3528
Abstract 2116
Cefiderocol and inoculum effect: discordant results between in vitro and murine model of peritonitis
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Agnès LEFORT
Poster P3529
Abstract 2229
Delving into the oral-gut axis: within-host evolution and dynamics of oral and intestinal streptococci
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Mohamed M. H. ABDELBARY
Poster P3530
Abstract 2241
A four-member defined microbial community and its soluble products protect mice from Clostridioides difficile infection
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Katya DOUCHANT
Poster P3531
Abstract 2381
Deepness of dormancy of intracellular persisters of Escherichia coli selected by ciprofloxacin depends on host cell oxidative stress
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Gang WANG
Poster P3532
Abstract 2397
Staphylococcus epidermidis has low internalization capacity in periprosthetic nonprofessional phagocytic cells
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Anne-Lise MAUCOTEL
Poster P3533
Abstract 2484
Salmonella type 1 fimbriae induce interferon-β expression via Toll-like receptor in macrophages
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Uchiya KEI-ICHI
Poster P3534
Abstract 2510
Ultraviolet A light, a novel approach to combat ventilator-associated pneumonia caused by Pseudomonas aeruginosa: an animal study
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Blanca LLONCH BERTRAND
Poster P3535
Abstract 2525
Clinical isolates of P. aeruginosa cause different virulence biomarker signatures in the course of a chronic lung infection model
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Katharina ROX
Poster P3536
Abstract 2703
Nasal microbiota influence clinical response in chronic rhinosinusitis with nasal polyps in surgery and monoclonal treatments
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Gaia VERTILLO ALUISIO
Poster P3537
Abstract 2852
Urinary tract microbiome of asymptomatic individuals with spinal cord injury
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Ezra VALIDO
Poster P3538
Abstract 2897
HOCl-producing electrochemical bandages for treating MRSA and polymicrobial murine wound infections
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Derek FLEMING
Poster P3539
Abstract 2914
The immune modulator role of the peg344 gene among Hypervirulent Klebsiella pneumoniae (hvKp)
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Güz EKINCI
Poster P3540
Abstract 3466
Multi-kingdom oral microbiome analysis identifies biomarkers of early-onset cryptogenic ischemic stroke
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Muhammed MANZOOR
Poster P3541
Abstract 3474
Glatiramer acetate used for the treatment of multiple sclerosis stimulates phagocytosis and intracellular killing of Escherichia coli by peritoneal macrophages and microglia
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Roland NAU
Poster P3542
Abstract 4240
A pilot study to investigate the competence of the eye-seeking fly Musca sorbens as a vector for ocular strains of Chlamydia trachomatis
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Eyob Addise WORKNEH
Poster P3543
Abstract 4251
Different phylotypes of Cutibacterium acnes strains were able to infect an in vivo model of Galleria mellonella
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Mariana NERI LUCAS KURIHARA
Poster P3544
Abstract 4468
Duration of cefazolin prophylaxis did not impact periprosthetic joint infection (PJI) risk in a murine model of total joint arthroplasty
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Melissa KARAU
Poster P3545
Abstract 4478
Characterising the synovial microbiome: a role for nanopore sequencing?
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Chuo CHER BING
Poster P3546
Abstract 4765
Humanised serum concentrations of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam against carbapenem-resistant Enterobacter cloacae
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Thomas LAVOIE
Poster P3547
Abstract 4883
In vivo evolution of antimicrobial resistance in a biofilm model of Pseudomonas aeruginosa chronic lung infection
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Doaa HIGAZY
Poster P3548
Abstract 4950
Neutrophil-mediated molecular immune response to bacterial CNS infection
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Dominika LUPTÁKOVÁ
Poster P3549
Abstract 5065
Impact of antibiotic substance class and duration on intestinal microbiome alterations and presence of fungi
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Lena BIEHL
Poster P3550
Abstract 5178
Quantitative assessment of pneumococcal urinary antigen reflects the severity of pneumonia and the effect of antibiotics treatment in pneumococcal pneumonia mouse model
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Shota KIKUCHI
Poster P3551
Abstract 5267
Inhibition of high-priority respiratory pathogens is a general feature of the fastidious nasal commensal Dolosigranulum pigrum
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Nathan WEBER
Poster P3552
Abstract 5418
Melatonin induces antiviral effect in human intestinal organoids via type III IFN pathway
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Milda SESKUTE
Poster P3553
Abstract 5504
Gut Muribaculaceae determines susceptibility to sepsis by modulating the systemic immune response
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Hwi Won SEO
Poster P3554
Abstract 6060
Characterization of Escherichia coli present in maternal-infant environment
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Manuel BERNABEU
Poster P3555
Abstract 6152
Giardia infection is associated with altered Commensal Microbial Diversity of the Murine Gut
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Sucheta GULERIA
Poster P3556
Abstract 6166
Human papillomavirus infection and cervico-vaginal microbiome in women in the sub-Himalayan population of India
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Shailesh Kumar GUPTA
Poster P3557
Abstract 6279
Probing the Antimicrobial Arsenal: Characterization and Evaluation of a Proteus Phage isolated from Human Pus against Predefined Multidrug-Resistant Host-Range
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Sreska SHRESTHA
Poster P3558
Abstract 6298
Interaction between IgA and Methanobrevibacter smithii in early onset of Multiple Sclerosis
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Tea SONICKI
Poster P3559
Abstract 6328
Differential phagocytosis and cytokine response to Mycobacterium massiliense and Mycobacterium abscessus in human keratinocytes
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Un In WU
Poster P3560
Abstract 6389
Microbiome analysis of non-healing diabetic foot ulcers reveal distinct patient specific microbiomes containing fungi that are minimally impacted by antibiotic therapy
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Craig WILLIAMS
Poster P3561
Abstract 6531
Dietary consumption of antibiotics can favour the colonization of antibiotic resistant Gram-negative pathogens (ARGNs) in an ex-vivo model of the human gut microbiome
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Didier HOCQUET
Poster P3562
Abstract 6976
Characterization of Enterococcus faecalis-platelet interactions: insights into infective endocarditis mechanisms
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Mustapha Abdeljalil BRAI
Poster P3563
Abstract 6989
Effect of metabolites produced by pathogenic microbes on wound healing
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Chandni SACHDEVA
Poster P3564
Abstract 7105
Faecal microbiota transplantation alleviates alcohol preference in vulnerable stressed rats
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Sedreh NASSIRNIA
Poster P3565
Abstract 7237
Characterisation of Enterococcus faecalis, platelet interactions: insights into infective endocarditis
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Mustapha Abdeljalil BRAI
Poster P3566
Abstract 7279
Antagonistic interactions among clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa in ex vivo donor cornea model of polymicrobial infections
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Sanchita MITRA
Poster P3567
Abstract 7547
Location and profile of commensal bacteria in human milk
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Ambika SHARMA
Poster P3568
Abstract 7601
A porcine model of pyelonephritis with uropathogenic Escherichia coli
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Kristian STÆRK
Poster P3569
Abstract 7718
Investigating bacterial infections in Galleria mellonella larvae: insights into pathogen dissemination and behavior
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Admella Pedrico JOANA
Poster P3570
Abstract 7749
The taxonomic structure of lung-associated microbiota can modulate tumor microenvironment
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Emerenziana OTTAVIANO
Poster P3571
Abstract 7853
Enriched polyphenol cultures of Lactobacillus helveticus and Lactobacillus rhamnosus inhibit Candida albicans growth and modulate pro-inflammatory signaling
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Silvia RIZZO
Poster P3572
Abstract 8003
Skin microbiome of healthcare workers who utilised individual protective masks during and after the SARS-CoV-2 pandemic
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Joyce Vanessa Da Silva FONSECA
Poster P3573
Abstract 8041
The pro-inflammatory signature of gut microbiota in CDKL5 disorder
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Elisa BORGHI
Poster P3574
Abstract 8100
Strong homology between colonising and bloodstream carbapenem-resistant Acinetobacter spp.: implications for empiric antibiotic therapy in haematological patients
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Jia LI
Poster P3575
Abstract 8479
Evaluation of gastric microbiota and gastric cancer association in patients infected with Helicobacter pylori
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Dogukan OZBEY
Poster P3576
Abstract 8546
Gut microbiota composition and Clostridioides difficile infection: the potential protective role of Faecalibacterium prausnitzii
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Nadim CASSIR
Poster P3577
Abstract 8575
Role of the T4aP pilus of P. aeruginosa in recognition by the innate immune system
30/04 12:00
9b. Host-pathogen interaction (incl basic microbiome studies, animal models)
Youssouf SEREME
Poster P3578
Abstract 61
Oral biofilm engineering: in vitro oral biofilm model for mimicking biofilm development under in vivo conditions on Ti6Al4V and Y-TZP specimens
30/04 12:00
9c. Pre-clinical biofilm studies
Romualdus Nugraha Catur UTOMO
Poster P3579
Abstract 151
Anti-biofilm characterisation of PEEK coated with antiseptics
30/04 12:00
9c. Pre-clinical biofilm studies
Marta DÍAZ-NAVARRO
Poster P3580
Abstract 255
Under the hypercapnic challenge: how macrophages react to pneumonia-causing bacteria
30/04 12:00
9c. Pre-clinical biofilm studies
Elena CAMPAÑA-DUEL
Poster P3581
Abstract 381
Development of inhaled dry powder fluconazole and investigation of the effectiveness in the eradication of Candida albicans biofilms
30/04 12:00
9c. Pre-clinical biofilm studies
Reham ALJALAMDEH
Poster P3582
Abstract 547
Clone-specific effect of ibuprofen, paracetamol and acetylsalicylic acid on growth and biofilm formation of methicillin-resistant Staphylococcus aureus
30/04 12:00
9c. Pre-clinical biofilm studies
Adéla ROZSYPÁLKOVÁ
Poster P3583
Abstract 812
Staphylococcus aureus biofilm attachment strength correlated to zeta-potential charge
30/04 12:00
9c. Pre-clinical biofilm studies
Thomas LAVOIE
Poster P3584
Abstract 981
Determination of multidrug-resistant Proteus mirabilis biofilm formation ability of urinary infection in pregnant women
30/04 12:00
9c. Pre-clinical biofilm studies
Maryna MISHYNA
Poster P3585
Abstract 1070
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model
30/04 12:00
9c. Pre-clinical biofilm studies
Iain ABBOTT
Poster P3586
Abstract 1117
Optimising biofilm management: thymol's synergistic partnership with antibiotics
30/04 12:00
9c. Pre-clinical biofilm studies
María Rosa PINO OTÍN
Poster P3587
Abstract 1155
SdiA regulates biofilm maturation of Klebsiella pneumoniae in response to C6-HSL
30/04 12:00
9c. Pre-clinical biofilm studies
Sergio SILVA BEA
Poster P3588
Abstract 1212
Glucosazone as an inhibitor of quorum sensing in biofilm-forming P. aeruginos, an in silico and in vitro study
30/04 12:00
9c. Pre-clinical biofilm studies
Prasanna Kumar Reddy GAYAM
Poster P3589
Abstract 1409
The antifungal luliconazole is efficient against Aspergillus fumigatus biofilm formation in human-like models
30/04 12:00
9c. Pre-clinical biofilm studies
Dan-Tiberiu FURNICA
Poster P3590
Abstract 1779
Quantification and comparison of different biofilm components from methicillin-susceptible Staphylococcus aureus treated with tranexamic acid using an in vitro model
30/04 12:00
9c. Pre-clinical biofilm studies
Marta DÍAZ-NAVARRO
Poster P3591
Abstract 1904
Tiered approach to predict in vitro antibiofilm activity of plant extracts against cystic fibrosis isolates for drug discovery and development
30/04 12:00
9c. Pre-clinical biofilm studies
Eduarda SILVA
Poster P3592
Abstract 2233
Activity of phage alone and with vancomycin against periprosthetic joint infection-associated Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus lugdunensis on orthopedic Kirschner wires: an in vitro study
30/04 12:00
9c. Pre-clinical biofilm studies
Judith ALVAREZ OTERO
Poster P3593
Abstract 2426
Biofilm formation and antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
30/04 12:00
9c. Pre-clinical biofilm studies
Francesca SIVORI
Poster P3594
Abstract 2460
Antimicrobial and antibiofilm activities of an electrolytic sodium hypochlorite solution against ESKAPE pathogens and Candida albicans from patients with infected pressure ulcers
30/04 12:00
9c. Pre-clinical biofilm studies
Giorgia FABRIZIO
Poster P3595
Abstract 2467
Synergistic activity of amphotericin B with voriconazole against Trichosporon asahii biofilms: is it worth combining?
30/04 12:00
9c. Pre-clinical biofilm studies
Konstantinos ZARRAS
Poster P3596
Abstract 2573
Genotypic and phenotypic characterisation of biofilm-forming Borrelia burgdorferi s.l. strains isolated from patients with erythema migrans
30/04 12:00
9c. Pre-clinical biofilm studies
Giorgia FABRIZIO
Poster P3597
Abstract 2601
Pseudomonas mendocina isolated from Anopheles midguts generates thick biofilms: a potential new malaria transmission blocking tool
30/04 12:00
9c. Pre-clinical biofilm studies
Sofia Santos COSTA
Poster P3598
Abstract 2645
Effectiveness of clindamycin in treatment strategies for staphylococcal mature biofilm-associated infections?
30/04 12:00
9c. Pre-clinical biofilm studies
Sven VAN DUN
Poster P3599
Abstract 2988
Synergistic effect of N-acetyl-L-cysteine and propolis dry extract combination on bacterial biofilms of upper respiratory tract pathogens
30/04 12:00
9c. Pre-clinical biofilm studies
Dragana BOZIC
Poster P3601
Abstract 3618
Biofilm development of enteropathogenic bacteria according to growth temperature
30/04 12:00
9c. Pre-clinical biofilm studies
Marina MEDEL PLAZA
Poster P3602
Abstract 3652
Induction thermal disinfection: in vitro and in vivo control of mature biofilms on prosthetic metal components
30/04 12:00
9c. Pre-clinical biofilm studies
Marina MEDEL PLAZA
Poster P3603
Abstract 3798
Are quaternary ammonium compounds effective against carbapenemase-producing microorganisms?
30/04 12:00
9c. Pre-clinical biofilm studies
Elisabeth PRESTERL
Poster P3604
Abstract 3969
Biofilm formation and multidrug resistance in strains isolated from medical device-associated infection
30/04 12:00
9c. Pre-clinical biofilm studies
Alba SANCHEZ MORILLO
Poster P3605
Abstract 4213
Anti-biofilm activity of virulent Acinetobacter baumannii phages encoding depolymerases
30/04 12:00
9c. Pre-clinical biofilm studies
Sezin UNLU
Poster P3606
Abstract 4253
Characterization of biofilm matrix of Staphylococcus lugdunensis reveals key differences according to strain and iron availability
30/04 12:00
9c. Pre-clinical biofilm studies
Laurie DESTRUEL
Poster P3607
Abstract 5081
Breast Implant Topography Influences S. epidermidis Biofilm: A Comparative In Vivo Study.
30/04 12:00
9c. Pre-clinical biofilm studies
Francisco CARMONA-TORRE
Poster P3609
Abstract 5707
Pharmacodynamic modeling of colistin and imipenem against in vitro P. aeruginosa biofilms
30/04 12:00
9c. Pre-clinical biofilm studies
Yuchen GUO
Poster P3610
Abstract 5807
Activities of CSA-44 and CSA-131 against Staphylococcus aureus and Pseudomonas aeruginosa biofilms in collagen wound biofilm and Caenorhabditis elegans model systems
30/04 12:00
9c. Pre-clinical biofilm studies
Fatima Nur YILMAZ
Poster P3611
Abstract 6300
Antibiofilm activity of a broad-spectrum novel antimicrobial hydrogel in an ex vivo porcine wound infection model
30/04 12:00
9c. Pre-clinical biofilm studies
Hawraa SHAHROUR
Poster P3612
Abstract 6316
Novel compounds with an isocyanide pharmacophore show antimicrobial and antibiofilm activity against multidrug-resistant staphylococci
30/04 12:00
9c. Pre-clinical biofilm studies
Chiara CERESA
Poster P3613
Abstract 6341
Selenocompounds as efflux pump and biofilm inhibitors on Staphylococcus aureus strains
30/04 12:00
9c. Pre-clinical biofilm studies
Gabriella SPENGLER
Poster P3614
Abstract 6354
Evolution of invasive Salmonella typhimurium towards decreased biofilm formation
30/04 12:00
9c. Pre-clinical biofilm studies
Enya ARCONADA NUIN
Poster P3615
Abstract 6358
Psoralen plus UVA (PUVA) treatment as an effective intervention to prevent biofilm formation of Staphylococcus aureus in patients' wounds
30/04 12:00
9c. Pre-clinical biofilm studies
Mohammad POOYA
Poster P3616
Abstract 6558
Evasion of host immune system by Acinetobacter baumannii biofilm
30/04 12:00
9c. Pre-clinical biofilm studies
Deepak KUMAR
Poster P3617
Abstract 6650
3D printed melt electrowritten drug eluting fibre for prevention of device-associated infections: a pilot study
30/04 12:00
9c. Pre-clinical biofilm studies
Joana MARTINS
Poster P3618
Abstract 6907
Evaluation of Direct and Alternating Electrical Current against Staphylococcus aureus Biofilms
30/04 12:00
9c. Pre-clinical biofilm studies
Rima FANAEI PIRLAR
Poster P3619
Abstract 7111
Combination of sonication with dithiothreitol treatment does not improve bacterial dislodging from biofilm in an in vitro model
30/04 12:00
9c. Pre-clinical biofilm studies
Elena DE VECCHI
Poster P3620
Abstract 7135
Biofilm formation and mucosal barrier disruption by mycobacteria on airway epithelial cells
30/04 12:00
9c. Pre-clinical biofilm studies
Amy BARCLAY
Poster P3621
Abstract 7519
Acetylation of xenogenetic silencer H-NS regulates biofilm developmemt through the nitrogen homeostasis regulator in Shewanella
30/04 12:00
9c. Pre-clinical biofilm studies
Xiaoxiao LIU
Poster P3622
Abstract 7525
Iminosugar PDIA as potential novel antibiofilm compound that shows in vivo activity against staphylococcal skin wound infection in mice
30/04 12:00
9c. Pre-clinical biofilm studies
Edyta GOLINSKA
Poster P3623
Abstract 7652
Degradation of preformed Gram-positive and Gram-negative bacteria biofilms using disintegrated and intact phages
30/04 12:00
9c. Pre-clinical biofilm studies
Abdulkerim KARAYNIR
Poster P3624
Abstract 7689
Phage-encoded novel DP21 enzyme, a polysaccharide depolymerase, prevents and destruct biofilms of various species
30/04 12:00
9c. Pre-clinical biofilm studies
Salih Dogan HANIFE
Poster P3625
Abstract 7762
Periprosthetic hip and knee joint infection: biofilm and c-di-GMP production
30/04 12:00
9c. Pre-clinical biofilm studies
Andrea LIBERATORE
Poster P3626
Abstract 8005
Antibacterial and Antibiofilm potential of green synthesised nanoparticles by optimising its reaction parameters against multidrug-resistant clinical isolates of nosocomial infections
30/04 12:00
9c. Pre-clinical biofilm studies
Diksha DIKSHA
Poster P3627
Abstract 8007
Does biofilm forming capacity responsible for antifungal resistance among the Trichophyton mentagrophytes/interdigitale complex isolates without mutation in squalene gene (F397L)?
30/04 12:00
9c. Pre-clinical biofilm studies
Dipika SHAW
Poster P3628
Abstract 8753
Mucin drives fitness trade-offs between phage resistance and biofilm formation in Yersinia enterocolitica serotype O:8
30/04 12:00
9c. Pre-clinical biofilm studies
Sophie GHOLADZE
Poster P3629
Abstract 8919
In vitro biofilm formation by methicillin-resistant S. aureus in skin, blood, and bone/joint infections
30/04 12:00
9c. Pre-clinical biofilm studies
Kevin BOUILLER
Poster P3630
Abstract 47
CRISPRi-seq identifies genes enhancing phage lysin Cpl-1 susceptibility in S. pneumoniae
30/04 12:00
9d. Experimental and cellular microbiology
Hugues DE VILLIERS DE LA NOUE
Poster P3631
Abstract 544
Mutations triggered by antiseptic and antibiotic selective pressure on clinical Pseudomonas aeruginosa isolates
30/04 12:00
9d. Experimental and cellular microbiology
Laurent POIREL
Poster P3632
Abstract 585
Bactericidal effect and the mechanism by the high-speed water nanodroplet generation technology as a new sterilisation method
30/04 12:00
9d. Experimental and cellular microbiology
Yurina TAMURA
Poster P3633
Abstract 659
HemU (Smlt3895) is the inner membrane transporter responsible for hemin acquisition in Stenotrophomonas maltophilia
30/04 12:00
9d. Experimental and cellular microbiology
Tsuey-Ching YANG
Poster P3634
Abstract 711
Comparison between brand-name and generic drugs about meropenem-induced endotoxin release in Pseudomonas aeruginosa
30/04 12:00
9d. Experimental and cellular microbiology
Masato KAWAMURA
Poster P3635
Abstract 736
FepA, FciA, and SbaA are the TonB-dependent transporters responsible for ferri-stenobactin uptake in Stenotrophomonas maltophilia KJ
30/04 12:00
9d. Experimental and cellular microbiology
Li-Hua LI
Poster P3636
Abstract 808
Diversity in infection capacity of epidemic and sporadic vancomycin-variable and resistant Enterococcus faecium isolates studied in an in vitro intestinal flow model
30/04 12:00
9d. Experimental and cellular microbiology
Ditte RASK TORNBY
Poster P3637
Abstract 901
Influencing the paedatric oral resistome: host genetics, environment or mother?
30/04 12:00
9d. Experimental and cellular microbiology
Elena MARTINEZ
Poster P3638
Abstract 947
Induction of antibiotic resistance in Klebsiella pneumoniae: a study on the effects of sub-MIC ciprofloxacin exposure
30/04 12:00
9d. Experimental and cellular microbiology
Zina GESTELS
Poster P3639
Abstract 1573
Development of an antibacterial plus bacteriophage combination assays
30/04 12:00
9d. Experimental and cellular microbiology
Marie ATTWOOD
Poster P3640
Abstract 2358
Staphylococcal occupancy within the human nasal microbiota
30/04 12:00
9d. Experimental and cellular microbiology
Marc STEGGER
Poster P3641
Abstract 2548
Effect of essential oils on microbial cultures tracked by Raman spectroscopy
30/04 12:00
9d. Experimental and cellular microbiology
Katarína REBROSOVÁ
Poster P3642
Abstract 2634
Meropenem or ceftazidime/avibactam first in ESBL-harbouring Enterobacterales?
30/04 12:00
9d. Experimental and cellular microbiology
Doris ZOLLINGER
Poster P3643
Abstract 2992
Graphene quantum dots as promising nanomaterials against Mycobacterium tuberculosis infection
30/04 12:00
9d. Experimental and cellular microbiology
Giulia SANTARELLI
Poster P3644
Abstract 3037
A systematic characterization of the highly conserved Proteus mirabilis urease promoter
30/04 12:00
9d. Experimental and cellular microbiology
Madison FITZGERALD
Poster P3645
Abstract 3098
Structural analysis and chemical mapping of individual bacteriophage using infrared nanospectroscopy
30/04 12:00
9d. Experimental and cellular microbiology
Yue CAO
Poster P3646
Abstract 3117
Microbial growth enhancers and their influence on multi-drug resistance strains
30/04 12:00
9d. Experimental and cellular microbiology
Ilya KLEYN
Poster P3647
Abstract 3153
Assessing mastoparan in eradicating persisters-manifested clinical isolates alone or in-combination with antibiotics and/or immune cells in-vitro
30/04 12:00
9d. Experimental and cellular microbiology
Andrea Lay Hoon KWA
Poster P3648
Abstract 3321
Lactic acid as a factor preventing the development of urinary tract infections caused by Proteus mirabilis
30/04 12:00
9d. Experimental and cellular microbiology
Dominika SZCZERBIEC
Poster P3649
Abstract 3419
Streptococcus pneumoniae serotype 8: to be or not to be mucoid
30/04 12:00
9d. Experimental and cellular microbiology
Joana GOMES-SILVA
Poster P3650
Abstract 3535
A zeta potential study to measure S. aureus adhesion on human bone osteosarcoma cells
30/04 12:00
9d. Experimental and cellular microbiology
Paolo Giuseppe BONACCI
Poster P3651
Abstract 4170
Understanding of quorum sensing profile in Staphylococcus aureus infections
30/04 12:00
9d. Experimental and cellular microbiology
Nerea CASTRO AGIRRE
Poster P3652
Abstract 4936
Biosynthesis of titanium oxide nanoparticles using Olea europaea and evaluation of its antibiofilm potential against Pseudomonas aeruginosa isolates from cystic fibrosis patients
30/04 12:00
9d. Experimental and cellular microbiology
Hafez AL-MONMAI
Poster P3653
Abstract 5244
Exploring the Vaginal Ecosystem in the Rhesus Macaques: A lesson from HIV prevention strategies
30/04 12:00
9d. Experimental and cellular microbiology
Kyla TOZER
Poster P3654
Abstract 5593
Antibacterial, resistance modulation, anti-biofilm, and efflux pump inhibition properties of Loeseneriella africana (Willd.) N. Halle (Celastraceae) stem extract and its constituents
30/04 12:00
9d. Experimental and cellular microbiology
Jonathan ASANTE
Poster P3655
Abstract 5874
Evaluation of the synergy, mutant prevention concentrations and resistance mechanisms to minocycline combinations with a novel cyclic peptide in Pseudomonas aeruginosa
30/04 12:00
9d. Experimental and cellular microbiology
Maria Antonia GOMIS FONT
Poster P3656
Abstract 5888
In vitro activity in urine-mimicking acidic conditions and in vitro selection of resistant mutants for levofloxacin, moxifloxacin and delafloxacin against Enterococcus faecalis isolates responsible for male urinary tract infections
30/04 12:00
9d. Experimental and cellular microbiology
Vincent CATTOIR
Poster P3657
Abstract 6164
Epistasis and antimicrobial resistance in the carbapenemase KPC-2
30/04 12:00
9d. Experimental and cellular microbiology
Zahia Inssaf NEDJARI
Poster P3658
Abstract 6282
Natural loss of LPS biogenesis genes in Serratia spp.: lipid A analysis in bacteraemia isolates
30/04 12:00
9d. Experimental and cellular microbiology
Blanca PÉREZ VISO
Poster P3659
Abstract 6453
Clinical E. coli isolates varies in persistence and antibiotic tolerance when exposed to β-lactams
30/04 12:00
9d. Experimental and cellular microbiology
Nicolai Riff ALEXANDERSEN
Poster P3660
Abstract 6544
Developing a rapid phenotypic assessment of phage susceptibility using a nanomotion technology platform
30/04 12:00
9d. Experimental and cellular microbiology
Amanda LURASCHI-EGGEMANN
Poster P3661
Abstract 6685
Enhanced supply of beneficial microbiota from maternal milk for preterm newborns through a milk personalisation process
30/04 12:00
9d. Experimental and cellular microbiology
Thaís SINCERO
Poster P3662
Abstract 6782
Transmission mechanism of blaCTX-M-1 gene mediated by certain IncI1 plasmids in Salmonella isolates from non-human origin in Germany
30/04 12:00
9d. Experimental and cellular microbiology
Aitor ATXAERANDIO-LANDA
Poster P3663
Abstract 6785
Polyphasic approach to detect, to isolate and to characterise candidate phyla radiation in human saliva
30/04 12:00
9d. Experimental and cellular microbiology
Fatma BENSEDDIK
Poster P3664
Abstract 7013
Anti-toxin B neutralizing mAb AZD5148 provides protection in a Clostridioides difficile gnotobiotic piglet model
30/04 12:00
9d. Experimental and cellular microbiology
Christine TKACZYK
Poster P3665
Abstract 7063
Bypassing proline auxotrophy in Escherichia coli
30/04 12:00
9d. Experimental and cellular microbiology
Diarmaid HUGHES
Poster P3666
Abstract 7467
Role of Burkholderia pseudomallei quorum molecules causes apoposis in A549 cell lines
30/04 12:00
9d. Experimental and cellular microbiology
Vishnu AGARWAL
Poster P3668
Abstract 7946
Classical Klebsiella pneumoniae and hypervirulent Klebsiella pneumoniae have different clinical outcomes and biological characteristics
30/04 12:00
9d. Experimental and cellular microbiology
Xianxia ZHUO
Poster P3670
Abstract 8189
Assessment of Staphylococcus aureus phenotypic heterogeneity mediated by small colony variant formation
30/04 12:00
9d. Experimental and cellular microbiology
Dalida BIVONA
Poster P3671
Abstract 8522
The release of cations from the clinical CoCrMo alloy has a direct impact on staphylococcal adherence
30/04 12:00
9d. Experimental and cellular microbiology
Marta MARTIN GARCIA
Poster P3672
Abstract 150
Determination of the virulence profile of Klebsiella pneumoniae strains by an in vivo model of Galleria mellonella
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Marta DÍAZ-NAVARRO
Poster P3673
Abstract 456
Proteomic investigation of distinct P. aeruginosa strains with reduced motility evolved in the presence of S. aureus and K. pneumoniae supernatants
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Yanrong PAN
Poster P3674
Abstract 469
Specific genes deletion promotes virulence plasmid mobilising into CRKP evolved to CR-HvKP with enhanced antioxidant capacity and survival ability in macrophage
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Xinmiao JIA
Poster P3675
Abstract 534
Construction of a core genome multi-locus sequence typing schemes for population structure analyses of five Nocardia species
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Amos ADLER
Poster P3676
Abstract 811
Unveiling the emergence of hypermucoviscosity during drug adaptive evolution in carbapenem-resistant Klebsiella pneumoniae
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Qi DING
Poster P3677
Abstract 1030
Bacteria and host transcriptome and phenotype revealed the role of a novel plasmid pvirhs1 in hypervirulent carbapenem-resistant Klebsiella pneumoniae
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Yi ZHANG
Poster P3678
Abstract 1390
Mapping co-translation protein aggregation in E coli by inclusion body RNA sequencing and nascent chain profiling
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Khodaparast LADAN
Poster P3679
Abstract 1391
Genomic identification of capsular type and other virulence factors of multi-drug resistant Acinetobacter baumannii clinical isolates recovered from Alexandria, Egypt
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Sandra SÁNCHEZ-URTAZA
Poster P3680
Abstract 1450
Genomic and phenotypic characterization of Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients from two Mexican CF-attention centers
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Luis Ángel NUÑEZ-GARCÍA
Poster P3681
Abstract 1464
Whole genome analysis revels differences in the type VI secretion system among serogroups of neonatal meningitis Escherichia coli
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Julia IENES-LIMA
Poster P3682
Abstract 1567
Gut microbiome characterisation of patients with localised and metastatic colorectal cancer
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Silvia Noemi VAZQUEZ CUESTA
Poster P3683
Abstract 1717
Metabolomic perturbations dictate bacterial growth in the human bloodstream
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Lovnish THAKUR
Poster P3684
Abstract 2416
Insight into Acinetobacter baumannii's phenotypic and genotypic traits in oncological patients
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Ilaria CAVALLO
Poster P3685
Abstract 2658
Bacterial transcriptomics in staphylococcal bone and joint infections: translational experiments from exponential in vitro culture to in vivo infection
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Frederic LAURENT
Poster P3686
Abstract 2693
Presence of microorganisms inside healthy human internal organs, challenging the sterility of human tissues
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Anargyros SKOULAKIS
Poster P3687
Abstract 2709
Anthrax-associated virulence genes in whole genome sequences of archival and contemporary Bacillus cereus group isolates
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Susanna J. SABIN
Poster P3688
Abstract 2892
Staphylococcus epidermidis genome remodelling during adaptation to hospital environment
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Maria MIRAGAIA
Poster P3689
Abstract 3212
The quinone oxidoreductase gene qorA contributes to host adaptation in MRSA ST59 lineage
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Fengning CHEN
Poster P3690
Abstract 3382
Different subtypes of post-stroke pain syndrome: features of the gut microbiota
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Igor STOMA
Poster P3691
Abstract 3645
Whole genome sequences revealed a novel phage-plasmid infecting Klebsiella pneumoniae
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Aylin USKUDAR-GUCLU
Poster P3692
Abstract 4385
Integrative -omic analysis reveals trans-translation pathway small protein B (smpB) as a novel drug target against multi-drug resistant E.coli
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Neelja SINGHAL
Poster P3693
Abstract 4523
Global transcriptomic study of a K.variicola clinical strain mutated in ramR
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Bénédicte LANGLOIS
Poster P3694
Abstract 4660
Comparative genomic analysis of in vitro phenotypically distinct multidrug-resistant Klebsiella pneumoniae recovered from a single patient
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Natalia BURILLO
Poster P3695
Abstract 4799
Accessory genome of difficult to treat K. pneumoniae and P. aeruginosa and its association with inpatient colonization status
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Laura Eva FRANCO FOBE
Poster P3696
Abstract 5818
Alteration of Gut Virome in Primary Antibody Deficiencies
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Lejla IMAMOVIC
Poster P3697
Abstract 5941
Probing Spatial Host-Pathogen Gene Expression: Unveiling Bacterial Pathogenesis and Regulatory Mechanisms of Virulence Factors in Tissues
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Federico DI MARCO
Poster P3698
Abstract 5976
Comparison of direct cDNA and PCR-cDNA Nanopore sequencing to evaluate gene expression in Escherichia coli isolates
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Gillian RODGER
Poster P3699
Abstract 6373
Lipooligosaccharide deficiency does not result in antigen loss in Acinetobacter baumannii membrane vesicles.
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Beatriz CANO CASTAÑO
Poster P3700
Abstract 6419
Unveiling ppGpp's role in Adherent-Invasive Escherichia coli through a transcriptomic analysis
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Llorenç FERNÁNDEZ-COLL
Poster P3702
Abstract 6565
Chromosomal hybrids derived from clinical strains
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Talia BERRUGA FERNANDEZ
Poster P3703
Abstract 6623
High diversity of biosynthetic gene clusters and bacteriocins in staphylococci
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Søren IVERSEN
Poster P3704
Abstract 6700
The Influence of Stress on the Gynecological Health of Minority Women
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Carl YEOMAN
Poster P3705
Abstract 6705
Human milk metabolites association with infant gut microbiome and metabolome development
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Heidi ISOKÄÄNTÄ
Poster P3706
Abstract 6730
Pre-analytic procedures including stabilisation for nucleic acid analysis from stool
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Helena BLOCK
Poster P3707
Abstract 6946
Gardnerella Genomic and Phenotypic Insights into Female Urogenital Health Complexity
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Filipa GROSSO
Poster P3708
Abstract 7602
Comparative transcriptomics disclose differences in gene expression that may be involved in the pathogenicity of adherent-invasive Escherichia coli
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Queralt BONET-ROSSINYOL
Poster P3709
Abstract 7608
Staphylococcus aureus-expressed acetolactate synthase enhances the biosynthesis of branched-chain amino acids and is linked to blood glucose in type 2 diabetes
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Tingting LIANG
Poster P3710
Abstract 7614
Whole genome virulence trait screening of colistin-resistant and colistin-susceptible Acinetobacter baumannii
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Jale BORAL
Poster P3711
Abstract 7769
Genomic profile of Staphylococcus aureus from atopic dermatitis collected worldwide
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Maria MIRAGAIA
Poster P3712
Abstract 7854
Vaginal microbiome and phageome associated with bacterial vaginosis (BV)
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Rumeysa Gulsu OZKAN
Poster P3713
Abstract 8070
Identification and characterisation of coding and non-coding RNAs (cncRNAs) in hepatitis B virus
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Sneha SNEHA
Poster P3714
Abstract 8414
A dual function for the messenger RNA encoding the major pneumococcal virulence factor PspA
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Jens Sivkær PETTERSEN
Poster P3715
Abstract 8679
Whole-transcriptome sequencing identifies key differentially expressed mRNAs, miRNAs, lncRNAs, and circRNAs associated with gastric cancer
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Xiaoli ZHOU
Poster P3716
Abstract 8930
Whole genome sequencing analysis of C. albicans and C. parapsilosis blood-cultured serial isolates collected at different time points: intra-patient analysis of 11 patients with candidaemia
30/04 12:00
9e. Basic science studies using Omics (in vitro and in vivo)
Aina Catalina MESQUIDA MARCOS
Poster P3898
Abstract 2608
Graduate to scientist in UK microbiology: choosing the right path
30/04 12:00
11a. Professional affairs and career development
Ashleigh HALE
Poster P3899
Abstract 4327
Perceptions from pharmacists attending ECCMID conference: a cross-sectional survey of 25 pharmacists from eight countries that attended the 2023 ECCMID conference
30/04 12:00
11a. Professional affairs and career development
Diane ASHIRU-OREDOPE
Poster P3900
Abstract 2187
Sharing and re-use of anonymised individual data for infectious diseases research: challenges and solutions from PrIMAVeRa project
30/04 12:00
11b. Publishing, ethics, other academic affairs
Mariana GUEDES
Poster P3901
Abstract 4462
Full open access in infectious diseases and clinical microbiology is associated with lower article processing charges but lower academic impact
30/04 12:00
11b. Publishing, ethics, other academic affairs
Dafna YAHAV
Poster P3902
Abstract 8691
What do we know about different stakeholders' attitudes towards sharing participant-level biomedical data during and outside of pandemics? A measurement systematic review
30/04 12:00
11b. Publishing, ethics, other academic affairs
Lauren MAXWELL
Poster P3903
Abstract 1154
Lessons learned: vaccination knowledge, opinions and practices of future healthcare providers
30/04 12:00
11c. Medical education for CM/ID
Nelia AFONSO
Poster P3904
Abstract 1730
Identification and evaluation of quality indicators in infectious diseases consultation reports by a Delphi-based online survey: evaluation of first survey responses
30/04 12:00
11c. Medical education for CM/ID
Daniel HORNUSS
Poster P3905
Abstract 1959
A scope of the new OPAT virtual ward service using nurse-filled flucloxacillin elastomeric pumps for orthopaedic infections with respect to cost-effectiveness and its limitation in secondary care
30/04 12:00
11c. Medical education for CM/ID
Alice LIU
Poster P3906
Abstract 2247
Physicians' knowledge, attitude, and practice towards blood culture sampling
30/04 12:00
11c. Medical education for CM/ID
Helmi ERNANDES
Poster P3907
Abstract 2501
Evaluation of multidisciplinary tutorials sessions about antibiotics in the third year of pharmacy studies, school of pharmacy, Angers, France
30/04 12:00
11c. Medical education for CM/ID
Audrey TAISNE
Poster P3908
Abstract 2701
Tricks and treat! Gamification of learning concepts in infectious diseases through escape room case solving
30/04 12:00
11c. Medical education for CM/ID
Romina KARDASHI
Poster P3909
Abstract 2950
Knowledge, attitudes and practices on the climate crisis and the changing burden of infectious diseases among young Italian doctors and medical students: a national survey
30/04 12:00
11c. Medical education for CM/ID
Francesco Vladimiro SEGALA
Poster P3910
Abstract 3194
Challenges in obtaining adequate blood culture volumes: education required
30/04 12:00
11c. Medical education for CM/ID
Lauren HOOKHAM
Poster P3911
Abstract 3907
Medical online independent education significantly improves physician competence regarding the first line management of Clostridioides difficile infection
30/04 12:00
11c. Medical education for CM/ID
Julia DUFFEY
Poster P3912
Abstract 3927
Parasitological and microbiological assessment of contact lens storage cases: a survey on asymptomatic lens student wearers in Monastir, Tunisia
30/04 12:00
11c. Medical education for CM/ID
Sameh BELGACEM
Poster P3913
Abstract 4744
Medical microbiology in Europe: developments in training and scope of practice
30/04 12:00
11c. Medical education for CM/ID
Maeve DOYLE
Poster P3914
Abstract 4826
E-learning and mentoring to fight against antimicrobial resistance: feedback on a unique and impactful experience with Médecins Sans Frontières
30/04 12:00
11c. Medical education for CM/ID
Marie POUPARD
Poster P3915
Abstract 5036
Taking a travel history is not explicitly mapped to undergraduate curricula across the UK
30/04 12:00
11c. Medical education for CM/ID
Francesca LIUZZI
Poster P3916
Abstract 5450
Lessons learned from final year medical students and curriculum analysis on antibiotic stewardship in Africa
30/04 12:00
11c. Medical education for CM/ID
Muhammad Augie BASHAR
Poster P3917
Abstract 5752
Revision of third year medical student microbiology syllabus using serious games: proof of concept
30/04 12:00
11c. Medical education for CM/ID
Sarah DELLIERE
Poster P3918
Abstract 7984
Mini lessons, maximum impact: empowering medical resident's approach to antimicrobial stewardship with microlearning teaching-learning modules
30/04 12:00
11c. Medical education for CM/ID
Raksha KOCHI
Poster P3919
Abstract 8320
Which antimicrobial are you? A personality quiz to create AMR awareness in Belgian healthcare professionals
30/04 12:00
11c. Medical education for CM/ID
Phebe DE NOCKER
Poster P3920
Abstract 8422
Clinicians' confidence in recognising and managing high consequence infectious diseases in the UK: a cross-sectional survey
30/04 12:00
11c. Medical education for CM/ID
Ali ALAM
Poster P3921
Abstract 8427
Educational tool for antimicrobial stewardship (AMS): teaching and learning through self-assessment and feedback
30/04 12:00
11c. Medical education for CM/ID
Susan LAPTHORNE
Poster P3922
Abstract 91
How does ChatGPT respond to questions pertaining to vaccine hesitancy from the general public?
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Matthew Chung Yi KOH
Poster P3923
Abstract 94
ChatGPT as a tool to improve knowledge on sexually transmitted infections
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Matthew Chung Yi KOH
Poster P3924
Abstract 559
High accuracy of convolutional neural network algorithm in Helicobacter pylori detection based on endoscopic imaging: a meta-analysis
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Mochamad AFIFUDIN
Poster P3925
Abstract 560
First steps in establishing EU/EEA level surveillance of bloodstream infections from electronic health records
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Alexis SENTIS
Poster P3926
Abstract 702
Developing an AI-enabled leprosy knowledge base chatbot for healthcare professionals in Malaysia
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Norana ABDUL RAHMAN
Poster P3927
Abstract 841
Clinicians' perceptions of electronic clinical decision support tools to manage patients with lower respiratory tract infections in Sri Lanka
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Warsha DE ZOYSA
Poster P3928
Abstract 848
Co-design of a digital application to remotely monitor long COVID symptoms: results from the UpcomingVoice study
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Aurélie FISCHER
Poster P3929
Abstract 1002
Artificial intelligence in urinary tract infection: can machine learning models accurately predict antimicrobial susceptibility in urine culture bacterial isolates?
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Alfred Lok Hang LEE
Poster P3930
Abstract 1346
Predicting COVID-19 severity level using an attention-based long short-term memory model utilising clinical data
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Inuk JUNG
Poster P3931
Abstract 1361
β-LacFamPred: an online tool for prediction and classi?cation of β-lactamase class, subclass, and family
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Deeksha PANDEY
Poster P3932
Abstract 1397
Health Catch-UP!: process evaluation and co-development of an implementation strategy for a migrant multi-disease screening and vaccination tool
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Jessica CARTER
Poster P3933
Abstract 1692
Machine learning for antibiotic optimisation in multi-morbid patients
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
William BOLTON
Poster P3934
Abstract 1699
Machine learning based individualised intravenous-to-oral antibiotic switch decision support
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
William BOLTON
Poster P3935
Abstract 1969
Optimisation of AI for swift outpatient management of urinary tract infections
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Yannick ROUQUET
Poster P3936
Abstract 2050
Assessing the performance of artificial intelligence vs human experts in answering clinical practice guideline questions related to periprosthetic joint infections
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Thomas SCHMIDT
Poster P3937
Abstract 2310
Evaluation of blood culture outcome prediction machine learning model on prospectively collected emergency department dataset: results, lessons, and opportunities
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Benjamin MCFADDEN
Poster P3938
Abstract 2327
A multicentre federated learning study to identify patients at high risk for 30-day mortality among vaccinated Omicron-infected patients
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Chien-Chang LEE
Poster P3939
Abstract 2513
Insights from artificial intelligence, COVID-19 pandemic impact on vaccination hesitancy in Algerian population
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Baya BOULILA
Poster P3940
Abstract 2567
Epidemiology of the national clinical infectious disease response service in Japan during 2014−2023
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Masahiro ISHIKANE
Poster P3941
Abstract 2733
The use of UZA@home as an online contact tracing tool in the follow up of 12 students after contact with Lassa fever cases
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Yvan SOMERS
Poster P3942
Abstract 3022
Development and validation of an easy-to-use electronic data capture system for HIV-STIs data collection and management to support cohort studies in a pandemic scenario
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Alessia SAVOLDI
Poster P3943
Abstract 3103
Antimicrobial resistance and virulence gene diversity in Escherichia coli and their classification by genomic context
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Takahiro SEKINE
Poster P3944
Abstract 3157
A new approach for establishing multilocus sequence typing scheme: Staphylococcus capitis as an example
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Zhengan WANG
Poster P3945
Abstract 3503
Deep-learning model for discrimination of different pneumonia from chest CT scans
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Wenting JIN
Poster P3946
Abstract 3659
Development and evaluation of an artificial intelligence tool to keep standard operating procedures up to date with guidelines: a test case on hospital infection control
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Thera HABBEN JANSEN
Poster P3947
Abstract 3764
Artificial intelligence for infectious diseases: a systematic review of diagnostics, surveillance, and treatment
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Gijs DANOE
Poster P3948
Abstract 4066
Extracting symptoms from free-text responses using ChatGPT among COVID-19 cases in Hong Kong
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Wan In WEI
Poster P3949
Abstract 4320
Automating routine clinical data extraction to characterise acute infectious presentations in real-time
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Robbie HAMMOND
Poster P3950
Abstract 4463
Daily monitoring of isolation-demanding patients: a programme based on electronic LIMS and automated mails
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Steen Christian RASMUSSEN
Poster P3951
Abstract 4519
Assessing ChatGPT's theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with residents and specialists
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Andrea DE VITO
Poster P3952
Abstract 4661
Performance, efficiency and medical value of artificial intelligence software for MDRO screening
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Olivier DAUWALDER
Poster P3953
Abstract 4875
Public perception of the FDA approval of a long-acting injectable for HIV prevention: natural language processing study
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Tsz Ho KWAN
Poster P3954
Abstract 4917
Evaluation of removal of an electronic health record alert on cephalosporin usage in patients with penicillin allergies
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Scott FERREN
Poster P3955
Abstract 5061
ReferenceSurfer: a bibliometric algorithm to identify underpinning original research in literature review and its application in reviewing beta-lactam pharmacodynamic targets
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Nada REZA
Poster P3956
Abstract 5066
Rapid multiplex antigen testing and self-declared symptom checkers as a tool to detect and manage respiratory disease on a university campus
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Clo O'RIORDAN
Poster P3957
Abstract 5209
Antibiotic dispensing without a prescription among community pharmacies in the post COVID-19 era: a simulated client approach
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Hoa Quoc NGUYEN
Poster P3958
Abstract 5269
Randomised experiment of recruitment letter strategies to maximise clinical trial enrollment: insights from the DANFLU-2 trial
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Niklas Dyrby JOHANSEN
Poster P3959
Abstract 5309
Comparative genome analysis reveals insights into agr gene defects in Staphylococcus aureus
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Furqan AWAN
Poster P3960
Abstract 5436
COVID-19 vaccine introduction amplified negative sentiments on social media
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Guillermo RODRIGUEZ-NAVA
Poster P3961
Abstract 6415
Artificial intelligence/machine-learning tool for post-market surveillance of in vitro diagnostic assays
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Joanna RENIEWICZ
Poster P3962
Abstract 6444
Plasmid annotation confounding not a leading cause for taxonomic misclassification
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Iris GOLD RODAL
Poster P3963
Abstract 6482
Evaluation of travelers surveillance management information system (TSMIS) for points of entry in Pakistan, 2023
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Zeba NASIR
Poster P3964
Abstract 6496
IMMORTOOL: a web based application for quantifying the potential impact of immortal time bias in observational studies seeking to estimate treatment effects
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Tom A. YATES
Poster P3965
Abstract 6774
Impact of intervention using Kaizen method in blood culture workflow and turn around time in Roberto del Rio Children's Hospital microbiology laboratory, experience before and after
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Dona BENADOF
Poster P3966
Abstract 6815
Artificial Intelligence applications in parasitology diagnosis
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Matin SOTOUDEH NEJAD
Poster P3967
Abstract 6895
Imputation of missing antibiotic susceptibility values in Pseudomonas aeruginosa using machine learning
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Elsa DENAKPO
Poster P3968
Abstract 6968
mHealth for point-of-care testing and self-reporting of an infectious disease: a systems developer perspective
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Ciara HEAVIN
Poster P3969
Abstract 7064
GENTRAIN: genome-based infection chain analysis to increase digitalisation level in the public health sector
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Markus TRÖGER
Poster P3970
Abstract 7409
Enhancing cybersecurity resilience in healthcare: a qualitative exploration of ransomware threats and educational interventions
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Jelili MUSTAPHA
Poster P3971
Abstract 7628
Application of the artificial intelligence to identification of the different bacteria in multi-species mixtures from the Gram stained microscopic preparations
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Monika BRZYCHCZY-WLOCH
Poster P3972
Abstract 7656
Clinical decision support of meropenem continuity in PICU using machine learning
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Jaber ABDULLAH
Poster P3973
Abstract 7744
Recent updates on Bakta - a rapid & standardized software tool for the comprehensive annotation of bacterial genomes
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Oliver SCHWENGERS
Poster P3974
Abstract 7864
Off-label indications and outcomes for watch and reserve antibiotics according to the WHO AWaRe classification: a real-time interactive computer-assisted one-year survey in a large tertiary care hospital in northern Italy
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Livia MARLETTA
Poster P3975
Abstract 8582
Impact of electronic auditable pharmaceutical transaction and service (eAPTS) system implementation for supply chain, proper use of medicines, and delivering health services in Ethiopia
30/04 12:00
11d. Digital health and infection (incl AI, data mining, informatics)
Natnael Solomon HASSEN
Poster P3976
Abstract 325
The Colombo dengue study: a successful collaboration between two countries for more inclusive research
30/04 12:00
11e. Diversity and equality
Chathuraka RODRIGO
Poster P3977
Abstract 4319
Evaluating social determinants of health (SDOH) in a diverse cohort initiating long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in NYC
30/04 12:00
11e. Diversity and equality
Patricia PAGÁN PIRALLO
Poster P3978
Abstract 4798
An equitable strategy to recruit underserved populations into LAI-PrEP Care in NYC
30/04 12:00
11e. Diversity and equality
Ofole MGBAKO
Poster P3979
Abstract 8583
Addressing HIV testing gaps amongst migrant communities in Europe
30/04 12:00
11e. Diversity and equality
Denis ONYANGO
Poster P3980
Abstract 8234
Unravelling vaccine hesitancy: insights from an indigenous perspective in Meghalaya, India
30/04 12:00
11f. Advocacy and role of patients
Shanthosh Priyan SUNDARAM
Poster P3981
Abstract 8755
Enhancing World Antimicrobial Resistance Awareness Week: a patient-engaged paediatric hospital initiative to illuminate research questions
30/04 12:00
11f. Advocacy and role of patients
Neha VORALIA
Poster P3982
Abstract 620
Successful use of prolonged oral nirmatrelvir/ritonavir in an immunocompromised host with persistent SARS-CoV-2 viraemia and severe pneumonitis
30/04 12:00
12a. Viral infections
Jessica TAYLOR
Poster P3983
Abstract 1031
Tropical spastic paraparesis or multiple sclerosis? A diagnostic challenge from a non-endemic area
30/04 12:00
12a. Viral infections
Samuele GAGGIOLI
Poster P3984
Abstract 1231
Dumb rabies a close mimicker of Guillain-Barre syndrome
30/04 12:00
12a. Viral infections
Sayan MAHARATNA
Poster P3985
Abstract 1449
Asymptomatic transmission of human mpox
30/04 12:00
12a. Viral infections
Vitor DUQUE
Poster P3986
Abstract 1914
Severe chronic mpox in HIV/AIDS: implications on diagnosis and management
30/04 12:00
12a. Viral infections
Ia Marie Donna CRUZ
Poster P3987
Abstract 2321
Hemophagocytic lymphohistiocytosis in an undiagnosed HIV patient with SARS-CoV-2 co-infection after initiating antiretroviral therapy
30/04 12:00
12a. Viral infections
Szu Yu LIU
Poster P3988
Abstract 2463
Chronic Enterovirus infection following disseminated disease occurred during obinutuzumab treatment
30/04 12:00
12a. Viral infections
Elena STAFFILANO
Poster P3989
Abstract 2726
Hepatitis B virus reactivation in a cancer patient with seronegative occult hepatitis B infection
30/04 12:00
12a. Viral infections
Torres HARRYS
Poster P3990
Abstract 2809
The diagnostic value of HSV antibody index in a post-transplant patient with refractory status epilepticus
30/04 12:00
12a. Viral infections
Asimenia HALIOTI
Poster P3991
Abstract 3076
The utilisation of microbial cell-free DNA next-generation sequencing for the detection of human herpesvirus-8 in a quaternary care centre
30/04 12:00
12a. Viral infections
Rebecca BERGER
Poster P3992
Abstract 3323
Don't trust the appearances: how Epstein-Barr virus infection can mask a diagnosis of lymphoma
30/04 12:00
12a. Viral infections
Silvia RODA
Poster P3993
Abstract 3575
Herpes simplex virus 1 (HSV) pneumonia in post solid organ transplant setting: a case series
30/04 12:00
12a. Viral infections
Polati VISHNU RAO
Poster P3994
Abstract 4230
Emergence of a unique immune evasive SARS-CoV-2 variant during a persistent infection for 613 days in an immunocompromised patient
30/04 12:00
12a. Viral infections
Magda VERGOUWE
Poster P3995
Abstract 4298
Human herpesvirus 6 reactivation in immunocompetent patients with psychiatric disorders
30/04 12:00
12a. Viral infections
Elena STAFFILANO
Poster P3996
Abstract 4360
Early immunoglobulins in disseminated varicella: a worthy thought
30/04 12:00
12a. Viral infections
Netto George MUNDADAN
Poster P3997
Abstract 4555
Dengue-induced haemophagocytic lymphohistiocytosis
30/04 12:00
12a. Viral infections
Irene ODEA
Poster P3998
Abstract 4685
Primary HSV-2 infection complicated by radiculomyelitis in a young immunocompetent female patient with inherited chromosomally integrated HHV-6
30/04 12:00
12a. Viral infections
Marie Therese NGO NSOGA
Poster P3999
Abstract 4778
A clinical case of haemorrhagic fever with renal syndrome in Lviv oblast: difficulties of diagnostics
30/04 12:00
12a. Viral infections
Olena ZUBACH
Poster P4000
Abstract 4829
HTLV-1-associated syndromes: 2 case reports
30/04 12:00
12a. Viral infections
Cristina BAYO
Poster P4001
Abstract 5243
Orthopoxvirus' infection with interpersonal transmission in humans
30/04 12:00
12a. Viral infections
Gabriel RAMALHO DE JESUS
Poster P4002
Abstract 5469
Acquired immunodeficiency syndrome masquerading as anti-neutrophil cytoplasmic antibody-associated vasculitis
30/04 12:00
12a. Viral infections
Ellani Louise HUILAR
Poster P4003
Abstract 5478
A case of leukocytoclastic vasculitis related to acute parvovirus B19 infection
30/04 12:00
12a. Viral infections
Eren ÖZTÜRK
Poster P4004
Abstract 5484
Hemophagocytic lymphohistiocytosis: the hidden sniper unmasked
30/04 12:00
12a. Viral infections
Anupama KURUP
Poster P4005
Abstract 5488
Combination antiviral therapy for persistent SARS-CoV-2 infection in immunocompromised patients: a case series
30/04 12:00
12a. Viral infections
Aikaterini GKOUFA
Poster P4006
Abstract 6450
Dengue or not? A rare case of seronegative dengue haemorrhagic encephalitis in an adult
30/04 12:00
12a. Viral infections
Shekhar ANGIREKULA
Poster P4007
Abstract 6499
Three cases of haemorrhagic fever with renal sydrome
30/04 12:00
12a. Viral infections
Dimitar KOMITOV
Poster P4008
Abstract 6945
Diagnostic dilemma: a case series unraveling disseminated HSV-1 infection in patients with liver disease in a tertiary care liver centre
30/04 12:00
12a. Viral infections
Malika GROVER
Poster P4009
Abstract 7061
Role of early detection of pericholecystic fluid as a predictive marker for dengue fever leaking stage: experience from a low-resource centre
30/04 12:00
12a. Viral infections
Shirom Rajeev SIRIWARDANA
Poster P4010
Abstract 7112
Occupational transmission of measles in the COVID-19 era
30/04 12:00
12a. Viral infections
Gabriella DE CARLI
Poster P4011
Abstract 7121
First documented case of meningoencephalitis by herpes simplex type 2 and human herpesvirus type 6 coinfection in an immunocompetent patient
30/04 12:00
12a. Viral infections
Armando BARRAGÁN-REYES
Poster P4012
Abstract 7238
Herpes simplex virus 2 lymphadenitis in a patient with chronic lymphocytic leukaemia under ibrutinib
30/04 12:00
12a. Viral infections
João Carlos SILVA MATOS
Poster P4013
Abstract 7315
Human rabies and COVID-19 coinfection diagnosed by minimally invasive autopsy: lessons from a development country
30/04 12:00
12a. Viral infections
Luís Arthur Brasil GADELHA FARIAS
Poster P4014
Abstract 7340
Autochthonous dengue outbreak in the Paris region, October 2023
30/04 12:00
12a. Viral infections
Marta ZATTA
Poster P4015
Abstract 7793
Maribavir for resistant CMV disseminated disease in a kidney transplant recipient: what goes around comes around
30/04 12:00
12a. Viral infections
Davide VITA
Poster P4016
Abstract 7918
A case of fatal bocavirus pulmonary infection in an adult autologous haematopoietic stem cell transplant recipient
30/04 12:00
12a. Viral infections
Pantazis-Michael VOUTSINAS
Poster P4017
Abstract 8160
Fever with breathing crisis: a rare case of diffuse alveolar haemorrhage in dengue
30/04 12:00
12a. Viral infections
Naresh Kumar MIDHA
Poster P4018
Abstract 8302
Severe adenovirus pneumonia in immunocompetent patients presenting as typical bacterial pneumonia
30/04 12:00
12a. Viral infections
Matthew KENNEDY
Poster P4019
Abstract 8342
P323L mutation in a case with prolonged SARS-CoV-2 PCR positivity
30/04 12:00
12a. Viral infections
Yücebag EBRU
Poster P4020
Abstract 8347
Cytomegalovirus colitis mimicking ulcerative colitis
30/04 12:00
12a. Viral infections
Monika CHAUDHARY
Poster P4021
Abstract 8490
Progressive multifocal leukoencephalopathy: old acquaintance, new perspective
30/04 12:00
12a. Viral infections
Carmen HIDALGO TENORIO
Poster P4022
Abstract 8538
Unravelling subacute sclerosis panencephalitis in a young patient with seizures and a measles Complexity: a rare encounter
30/04 12:00
12a. Viral infections
Aditya KALE
Poster P4023
Abstract 8662
Persistent replication of the human herpesvirus type 6A in two immunosuppressed patients
30/04 12:00
12a. Viral infections
Virginia RODRÍGUEZ
Poster P4024
Abstract 8682
Varicella pneumonia, in an immunocompetent patient
30/04 12:00
12a. Viral infections
Samet ACAR
Poster P4025
Abstract 8782
Delayed viral clearance during respiratory infections in children with combined immunodeficiency
30/04 12:00
12a. Viral infections
Siwar FRIGUI
Poster P4026
Abstract 24
The devastating triad: a rare case of Austrian syndrome following COVID-19 infection
30/04 12:00
12b. Bacterial infections
Adrian ESTEPA
Poster P4027
Abstract 54
Community-acquired Acinetobacter baumannii meningitis in Guinea: has the threat extended beyond the healthcare facilities?
30/04 12:00
12b. Bacterial infections
Meriam ROMDHANI
Poster P4028
Abstract 115
Dynamic evolution of Achromobacter xylosoxidans during antibiotic treatment in a single patient
30/04 12:00
12b. Bacterial infections
Maria Soledad RAMIREZ
Poster P4029
Abstract 129
Infective endocarditis coexisting with acute bacterial meningitis caused by Streptococcus suis
30/04 12:00
12b. Bacterial infections
Sireethorn NIMITVILAI
Poster P4030
Abstract 170
Old ways won't open new doors
30/04 12:00
12b. Bacterial infections
Teja VASIREDDY
Poster P4031
Abstract 195
Nocardia brain abscesses due to anti-GM-CSF autoantibodies treated with IFN-γ supplementation
30/04 12:00
12b. Bacterial infections
Rob ARTS
Poster P4032
Abstract 229
Clinical characteristics of Desulfovibrio spp. bacteremia in a Japanese tertiary hospital
30/04 12:00
12b. Bacterial infections
Hiroki KITAGAWA
Poster P4033
Abstract 283
Leclercia adecarboxylata necrotising soft tissue infection in an immunocompetent adult
30/04 12:00
12b. Bacterial infections
Lordieliza MELENDREZ
Poster P4034
Abstract 323
Emergence of Neisseria meningitidis isolates with reduced susceptibility to third generation cephalosporins: report of the first two cases in Costa Rica, Latin America
30/04 12:00
12b. Bacterial infections
Manuel Antonio VILLALOBOS ZÚÑIGA
Poster P4035
Abstract 355
Uncommon neonatal pyoderma associated with coagulase-negative Staphylococcus infection
30/04 12:00
12b. Bacterial infections
Meri TER-STEPANYAN
Poster P4036
Abstract 358
Tetanus in a patient with fungating breast cancer
30/04 12:00
12b. Bacterial infections
Lordieliza MELENDREZ
Poster P4037
Abstract 367
Disseminated tuberculosis presenting as Evans syndrome: successful treatment with guideline-directed antituberculosis regimen and eltrombopag
30/04 12:00
12b. Bacterial infections
Vienne PINLAC
Poster P4038
Abstract 460
Bacillary angiomatosis-associated immune reconstitution inflammatory syndrome
30/04 12:00
12b. Bacterial infections
Caryl DURANTE
Poster P4039
Abstract 506
Unmasking multifocal tubercular pyomyositis: a challenging diagnostic journey
30/04 12:00
12b. Bacterial infections
Abhishek G P
Poster P4040
Abstract 637
Primary acute toxogenic Clostridium difficle megaprosthetic joint infection
30/04 12:00
12b. Bacterial infections
Sophie TAN
Poster P4041
Abstract 639
First report of cefiderocol resistance in Croatia
30/04 12:00
12b. Bacterial infections
Branka BEDENIC
Poster P4042
Abstract 648
Hepatobiliary and pancreatic tuberculosis: exceptional association
30/04 12:00
12b. Bacterial infections
Helmi ERNANDES
Poster P4043
Abstract 662
Leptospirosis in Liverpool: another “great imitator”?
30/04 12:00
12b. Bacterial infections
Hugh ADLER
Poster P4044
Abstract 755
Purulent Klebsiella pneumoniae meningitis complicated by thrombosis of the left internal carotid artery, cerebral abscesses and hydrocephalus
30/04 12:00
12b. Bacterial infections
Dady HASSAN
Poster P4045
Abstract 836
Bacteriophage therapy of chronic non-healing wounds: a case series
30/04 12:00
12b. Bacterial infections
Subhash Lal KARN
Poster P4046
Abstract 891
Lyme neuroborreliosis: Tunisian pediatric series
30/04 12:00
12b. Bacterial infections
Nada MISSAOUI
Poster P4047
Abstract 968
A complex case of Brucella endocarditis of cardiac implantable device
30/04 12:00
12b. Bacterial infections
Junais KOLERI
Poster P4048
Abstract 998
Urine brilliance: urine TB LAM's role in challenging AIDS cases from LMIC's perspective
30/04 12:00
12b. Bacterial infections
Ummu Afeera ZAINULABID
Poster P4049
Abstract 1035
A unique case of Listeria monocytogenes superinfection of tuberculous lymphadenitis
30/04 12:00
12b. Bacterial infections
Flavio SANGIORGI
Poster P4050
Abstract 1114
Lactobacillus: an unlikely invader
30/04 12:00
12b. Bacterial infections
Candice DATNOW
Poster P4051
Abstract 1179
Granulicatella adiacens periprosthetic knee joint infection
30/04 12:00
12b. Bacterial infections
Ishani DE SILVA
Poster P4052
Abstract 1250
Unravelling the diagnostic and therapeutic challenges of atypical salmonella infections: insights from three cases
30/04 12:00
12b. Bacterial infections
Harish MANOHARAN
Poster P4053
Abstract 1282
Orthopaedic infections associated with Nocardia species: a case series
30/04 12:00
12b. Bacterial infections
Khodadadi RYAN
Poster P4054
Abstract 1322
Tuberculosis: an enigma for clinicians and an uncertainty in diagnosis
30/04 12:00
12b. Bacterial infections
Akhilesh KUMAR P H
Poster P4055
Abstract 1355
First case of bacterial meningitis caused by Bacteroides pyogenes
30/04 12:00
12b. Bacterial infections
Tomonori TAKANO
Poster P4056
Abstract 1537
A case report of oral condyloma lata with mucous patches mimicking mucosal papilloma
30/04 12:00
12b. Bacterial infections
Kantaphop PATTAMASIRIKUN
Poster P4057
Abstract 1574
Pulmonary actynomicosis following a dog bite
30/04 12:00
12b. Bacterial infections
Sara ARAÚJO
Poster P4058
Abstract 1605
A case series of fatal Streptococcus pyogenes cases in Europe and Turkey: ESGFOR experience
30/04 12:00
12b. Bacterial infections
Amparo FERNÁNDEZ-RODRÍGUEZ
Poster P4059
Abstract 1615
Delamanid use in children aged 0-2 years with MDR/preXDR-TB: case series report
30/04 12:00
12b. Bacterial infections
Vladislav PRIVOLNEV
Poster P4060
Abstract 1725
Unravelling the enigma: a rare case of tuberculosis aortitis in a young adult
30/04 12:00
12b. Bacterial infections
Hamdan ALAWADHI
Poster P4061
Abstract 1799
A case of Listeria rhombencephalitis
30/04 12:00
12b. Bacterial infections
Juan José FERNÁNDEZ DÍAZ
Poster P4062
Abstract 1840
Delayed diagnosis of cutaneous diphtheria within an inpatient setting, leading to a large infection control incident
30/04 12:00
12b. Bacterial infections
Nishchay KAKKAR
Poster P4063
Abstract 1925
Recurrent pulmonary nocardiosis in a patient with underlying idiopathic CD4 lymphocytopenia: a case report
30/04 12:00
12b. Bacterial infections
Durga Shankar MEENA
Poster P4064
Abstract 1951
Mysterious rods: an unusual heart valve infection
30/04 12:00
12b. Bacterial infections
Thivandika JAYASUNDERA
Poster P4065
Abstract 2023
An interesting case of lepra reaction presenting as fever of unknown origin in a tertiary care centre in India
30/04 12:00
12b. Bacterial infections
Jayasree SUBRAMANIAN
Poster P4066
Abstract 2033
A series of leptospirosis cases in industrial city
30/04 12:00
12b. Bacterial infections
Oksana ISHCHENKO
Poster P4067
Abstract 2069
Striking a chord: Fusobacterium nucleatum's symphony in the intricacies of biliary sepsis
30/04 12:00
12b. Bacterial infections
Ummu Afeera ZAINULABID
Poster P4068
Abstract 2070
Pulmonary disease due to Nocardia cyriacigeorgica in an immunomodulated inflammatory bowel disease patient
30/04 12:00
12b. Bacterial infections
Natalí URIBE PULIDO
Poster P4069
Abstract 2108
Conquering the pink invader: a triumph over Roseomonas mucosa bacteraemia in an elderly patient
30/04 12:00
12b. Bacterial infections
Ummu Afeera ZAINULABID
Poster P4070
Abstract 2138
Paws, probes, and PCR: unraveling the clinical jigsaw puzzle of Bartonella henselae infection
30/04 12:00
12b. Bacterial infections
Ummu Afeera ZAINULABID
Poster P4071
Abstract 2269
Difficult-to-treat urethritis and orchiepididymitis due to Mycoplasma hominis in immunocompetent man
30/04 12:00
12b. Bacterial infections
Victor PASSARELLI
Poster P4072
Abstract 2277
The first case of acute cholangitis with bacteremia caused by Weissella viridescens
30/04 12:00
12b. Bacterial infections
Jiwoo LEE
Poster P4073
Abstract 2323
From drowning to stenotrophomonas maltophilia meningitis
30/04 12:00
12b. Bacterial infections
Fatima Halima BOUHALLOUFA
Poster P4074
Abstract 2364
Contamination of an advanced organ support (ADVOS) system with Ralstonia pickettii as potential source of pyrexia in critically ill patients
30/04 12:00
12b. Bacterial infections
Stefanie KAMPMEIER
Poster P4075
Abstract 2474
Cryptic tularaemia infection: a multi-agency investigation of the first case presumed to be acquired in the United Kingdom
30/04 12:00
12b. Bacterial infections
Ameeka THOMPSON
Poster P4076
Abstract 2575
Multiple metastatic primary multidrug-resistant tubercular abscesses in an immunocompetent individual
30/04 12:00
12b. Bacterial infections
Megha PRIYADARSHI
Poster P4077
Abstract 2657
Rapid AST expedites antimicrobial therapy optimisation in BSI patients: clinical cases from the LIFETIMES HEOR study
30/04 12:00
12b. Bacterial infections
Gian Maria ROSSOLINI
Poster P4078
Abstract 2659
Recurrent at intervals of 3 months or more: three cases of recurrent bacteraemic cholangitis caused by Aeromonas caviae
30/04 12:00
12b. Bacterial infections
Yuji HIRAI
Poster P4079
Abstract 2691
Non-typhoidal Salmonella breast implant infection and bacteraemia in an HIV patient: a case report
30/04 12:00
12b. Bacterial infections
Yober Mateo RODRIGUEZ VELASCO
Poster P4080
Abstract 2744
Non-cholera Vibrio spp. invasive infections in the summer following May 2023 flood disaster in Romagna, Italy: a case series
30/04 12:00
12b. Bacterial infections
Irene ZAGHI
Poster P4081
Abstract 2787
Panton-Valentine leukocidin: from diagnostic suspicion to detection in skin and soft tissue pediatric patients infections
30/04 12:00
12b. Bacterial infections
Gabriella PARISI
Poster P4082
Abstract 2790
Community-acquired meningitis due to Pseudomonas aeruginosa (PA) in an immunocompetent patient: case report and literature review
30/04 12:00
12b. Bacterial infections
Alina-Ioana POPA
Poster P4083
Abstract 2956
Bacteriophage therapy plus fecal microbiota transplantation to treat recurrent urinary tract infection (rUTI): a case series
30/04 12:00
12b. Bacterial infections
Shawna MCCALLIN
Poster P4084
Abstract 3008
Navigating the complexity: disseminated Mycobacterium chelonae (M.chelonae) in an immunocompromised host
30/04 12:00
12b. Bacterial infections
Lee Xin TING
Poster P4085
Abstract 3180
A novel bacterium of the family Silvanigrellaceae isolated from blood cultures of a drowned patient
30/04 12:00
12b. Bacterial infections
Xu QINGYE
Poster P4086
Abstract 3296
Shewanella algae: the first reported case of infection in Ireland
30/04 12:00
12b. Bacterial infections
Jane O'CONNOR
Poster P4087
Abstract 3432
Long term prosthetic joint infection caused by an ESBL producing Klebsiella pneumoniae: genomic evolution and clinical microbiology lesson
30/04 12:00
12b. Bacterial infections
Damasie MALANDAIN
Poster P4088
Abstract 3451
My soft kitty: not as innocent as it sounds
30/04 12:00
12b. Bacterial infections
Mar RIVERO RODRÍGUEZ
Poster P4089
Abstract 3484
Campylobacter fetus: a rare cause of cellulitis
30/04 12:00
12b. Bacterial infections
Adrián DOMÍNGUEZ LAGO
Poster P4090
Abstract 3491
Neisseria meningitidis: a cause of anogenital infections in six patients in a tertiary hospital over one-year period
30/04 12:00
12b. Bacterial infections
Llanos SALAR VIDAL
Poster P4091
Abstract 3507
Cefepime/zidebactam as a salvage therapy for lung empyema caused by multidrug-resistant (MDR) Pseudomonas Aeruginosa (PSA) under compassionate use
30/04 12:00
12b. Bacterial infections
Polati VISHNU RAO
Poster P4092
Abstract 3691
A rare encounter of penicillin-resistant Listeria monocytogenes brain abscess
30/04 12:00
12b. Bacterial infections
Santosh GATTU
Poster P4093
Abstract 3696
Dalbavancin paediatric therapeutic drug monitoring: real-life experience of complicated pneumonia treatment in an immunocompromised patient
30/04 12:00
12b. Bacterial infections
Marcello MARIANI
Poster P4094
Abstract 3812
Native valve endocarditis caused by Neisseria gonorrhoeae: a case report
30/04 12:00
12b. Bacterial infections
Manel TUELLS MORALES
Poster P4095
Abstract 3839
Nothing is as it seems in solid organ transplant recipients: the importance of pursuing etiological diagnosis in cutaneous lesions
30/04 12:00
12b. Bacterial infections
Flavia D' ANDREA
Poster P4096
Abstract 4105
Bacteremia due to Weissella confusa in a patient with acute myelogenous leukaemia at the Uganda Cancer Institute
30/04 12:00
12b. Bacterial infections
Margaret LUBWAMA
Poster P4097
Abstract 4110
A case of bacteraemic pneumonia caused by hypervirulent Klebsiella pneumoniae
30/04 12:00
12b. Bacterial infections
Martina Laura COLOMBO
Poster P4098
Abstract 4138
Urogenital infection by Neisseria meningitidis
30/04 12:00
12b. Bacterial infections
Laura ANDRÉS ESLAVA
Poster P4099
Abstract 4353
Beware the rods in Rodney Bay
30/04 12:00
12b. Bacterial infections
Olivia BIRD
Poster P4100
Abstract 4355
Rare case of Lawsonella clevelandensis postoperative infection
30/04 12:00
12b. Bacterial infections
Toni DOSENOVIC
Poster P4101
Abstract 4487
Successful microbiological treatment of extensively drug-resistant Pseudomonas aeruginosa endocarditis with imipenem/cilastatin/relebactam and fosfomycin
30/04 12:00
12b. Bacterial infections
Federica SALVATI
Poster P4102
Abstract 4494
Lung abscess and pleural empyema due to Lawsonella clevelandensis: a first report
30/04 12:00
12b. Bacterial infections
Matthias VON ROTZ
Poster P4103
Abstract 4575
Not a grade B pathogen: two cases of Streptococcus agalactiae meningitis in adults, molecular diagnosis is essential
30/04 12:00
12b. Bacterial infections
Dominic HEINING
Poster P4104
Abstract 4628
Phage therapy in recurrent Pseudomonas septicemia in a patient with an arterial stent
30/04 12:00
12b. Bacterial infections
Ulla OTAVA
Poster P4105
Abstract 4645
Non-O1/non-O139 Vibrio cholerae bacteraemia and cholangitis: an unusual case in an oncological patient in Lecco hospital, Italy
30/04 12:00
12b. Bacterial infections
Nicole GEMIGNANI
Poster P4106
Abstract 4691
A complex case of encephalitis and ventriculitis caused by Bacillus Calmette Guerin (BCG)
30/04 12:00
12b. Bacterial infections
Maddalena ALBERTINI
Poster P4107
Abstract 4761
Roseomonas mucosa an uncommon pathogen responsible for invasive infection with discrepancies among antimicrobial susceptibility testing methods
30/04 12:00
12b. Bacterial infections
Camille COTET
Poster P4108
Abstract 4782
Multivisceral brucellosis: unveiling the great mimicker
30/04 12:00
12b. Bacterial infections
Olfa SMAOUI
Poster P4109
Abstract 4905
Neurobrucellosis: report of 8 cases
30/04 12:00
12b. Bacterial infections
Meryem DJEMA
Poster P4110
Abstract 4944
Tigecycline-based regimens for complicated urinary tract infections caused by carbapenem-resistant Gram-negative bacteria: case series
30/04 12:00
12b. Bacterial infections
Maria-Evelina GOREA
Poster P4111
Abstract 5028
Kingella kingae: a pathogen with profound potential
30/04 12:00
12b. Bacterial infections
Julie-Anne HOULIHAN
Poster P4112
Abstract 5114
Click the right diagnosis of the patient: choose the right sample at the right time
30/04 12:00
12b. Bacterial infections
Bishal GUPTA
Poster P4113
Abstract 5186
Stenotrophomonas maltophilia bloodstream infections successfully treated with ceftazidime/avibactam and aztreonam
30/04 12:00
12b. Bacterial infections
Patricio ROSS
Poster P4114
Abstract 5200
Mycobacterium abscessus complex pneumonia in two immunocompetent patients
30/04 12:00
12b. Bacterial infections
Ana Raquel FERNÁNDEZ
Poster P4115
Abstract 5308
Reason for consult: we need you to evaluate this patient for liver transplantation
30/04 12:00
12b. Bacterial infections
Maria Alejandra MENDOZA
Poster P4116
Abstract 5341
Successful treatment of XDR/ST2 Acinetobacter baumannii ventriculitis with intrathecal tigecycline in 8-month-old infant
30/04 12:00
12b. Bacterial infections
Victor PASSARELLI
Poster P4117
Abstract 5520
Spirochaetastrophe
30/04 12:00
12b. Bacterial infections
Syed Noman ATTA
Poster P4118
Abstract 5553
Unusual syphilis chronicles: unveiling skeletal involvement in two cases at an Italian STI clinic
30/04 12:00
12b. Bacterial infections
Lorenzo Brando LUNDGREN
Poster P4119
Abstract 5595
Fatal necrotising fasciitis caused by hypervirulent Klebsiella pneumoniae serotype K2 ST 380
30/04 12:00
12b. Bacterial infections
Moufida HAMIDI
Poster P4120
Abstract 5654
Bullous chronic type 2 leprosy reaction: a case report
30/04 12:00
12b. Bacterial infections
Deanna Jill BALAGASAY
Poster P4121
Abstract 5762
The first case of bacteremia caused by Chryseobacterium haifensis: identification of C. haifensis with multiple names in 16S rRNA databases
30/04 12:00
12b. Bacterial infections
Woo Jin SHIN
Poster P4122
Abstract 5876
Therapeutic challenges in managing genitourinary infection caused by multidrug-resistant Mycobacterium abscessus strain FLAC013 in a young adult male
30/04 12:00
12b. Bacterial infections
Yash KHATOD
Poster P4123
Abstract 5937
Personalised bacteriophage therapy to treat multidrug-resistant biliary tract Pseudomonas aeruginosa infection
30/04 12:00
12b. Bacterial infections
Na LI
Poster P4124
Abstract 5981
Human infections caused by Shewanella algae producing natural carbapenemase OXA-964: a 4 cases series
30/04 12:00
12b. Bacterial infections
Laurent DORTET
Poster P4125
Abstract 6101
A mysterious chest pain
30/04 12:00
12b. Bacterial infections
Enrico PATRESE
Poster P4126
Abstract 6123
Eggerthella lenta causing bacteraemia in a university hospital of Spain
30/04 12:00
12b. Bacterial infections
Domingo FERNÁNDEZ VECILLA
Poster P4127
Abstract 6161
Mediastinal melioid lymphadenitis: a diagnostic challenge
30/04 12:00
12b. Bacterial infections
Matthew HOWES
Poster P4128
Abstract 6182
The alternative low-cost approach to combating PDR Gram-negative infections of war injuries in Ukraine using a combination of azithromycin-meropenem
30/04 12:00
12b. Bacterial infections
Olena MOSHYNETS
Poster P4129
Abstract 6236
Musculoskeletal involvement in leprosy misdiagnosed as rheumatoid arthritis
30/04 12:00
12b. Bacterial infections
Monika CHAUDHARY
Poster P4130
Abstract 6248
Clinical dilemma: to treat or not to treat the mother in a case of early onset neonatal invasive Neisseria meningitidis serogroup Y infection
30/04 12:00
12b. Bacterial infections
Conor MULROONEY
Poster P4131
Abstract 6314
Surviving a deadly prick: a case of tetanus infection treated successfully in a resource-limited institution
30/04 12:00
12b. Bacterial infections
Ervin ESPINOSA
Poster P4132
Abstract 6503
Escherichia coli plasmidic AmpC production: "I just can't get enough"
30/04 12:00
12b. Bacterial infections
Tosca SEMENZIN
Poster P4133
Abstract 6504
Subcutaneuous antibiotic: "I've got you under my skin"
30/04 12:00
12b. Bacterial infections
Luca MONTANARI
Poster P4134
Abstract 6506
Escherichia coli and plasmidic AmpC production: "I Just Can't Get Enough"
30/04 12:00
12b. Bacterial infections
Tosca SEMENZIN
Poster P4135
Abstract 6728
Neonatal pericardial effusion due to Escherichia coli sepsis
30/04 12:00
12b. Bacterial infections
Nada MISSAOUI
Poster P4136
Abstract 6783
Rifampicin, ciprofloxacin, and carbapenem combination therapy for hypervirulent Klebsiella pneumoniae: induced liver abscess with metastatic infection
30/04 12:00
12b. Bacterial infections
Vishal SHANBHAG
Poster P4137
Abstract 6820
Pulmonary nocardiosis masquerading as a lung mass
30/04 12:00
12b. Bacterial infections
Noor-Mohammad ABDUL-HAQU
Poster P4138
Abstract 6852
Extragenital infection by Neisseria gonorrhoeae
30/04 12:00
12b. Bacterial infections
Lucía TEJEDOR CANTERO
Poster P4139
Abstract 6920
A challenging case of leprosy complicated by severe type 1 immune reaction.
30/04 12:00
12b. Bacterial infections
Ahmed AL MESSABI
Poster P4140
Abstract 6953
The return of forgotten diseases
30/04 12:00
12b. Bacterial infections
Crt LOBODA
Poster P4141
Abstract 6965
Extensively drug-resistant Haemophilus parainfluenzae in a patient from preexposure prophylaxis program
30/04 12:00
12b. Bacterial infections
Marc GARRETA ESTEBAN
Poster P4142
Abstract 6992
Uncommon presentation of cellulitis: a case report of Klebsiella pneumoniae-induced thoracic anterior wall infection
30/04 12:00
12b. Bacterial infections
Ana Patrícia BRITO
Poster P4143
Abstract 7022
Fatal infection caused by cutaneous toxigenic Corynebacterium ulcerans with extensive soft tissue involvement and late-onset toxic myocarditis
30/04 12:00
12b. Bacterial infections
Peter Michael KELLER
Poster P4144
Abstract 7161
Challenges in Pseudomonas aeruginosa infective endocarditis: insights from case series on resistance, clinical manifestations, and treatment outcomes
30/04 12:00
12b. Bacterial infections
Akshatha RAVINDRA
Poster P4145
Abstract 7189
Severe pneumonia caused by Legionella longbeachae: an underdiagnosed infection leading to critical care admission
30/04 12:00
12b. Bacterial infections
Vicki FLEMING
Poster P4146
Abstract 7285
An illustrative case series of complex and challenging left ventricular assist device infections
30/04 12:00
12b. Bacterial infections
Nim WICKRAMASINGHE
Poster P4147
Abstract 7338
Invasive Streptococcus infection: a diagnostic dilemma
30/04 12:00
12b. Bacterial infections
Shahad ABASAEED ELHAG
Poster P4148
Abstract 7346
A rare encounter: Listeria monocytogenes and brain abscess
30/04 12:00
12b. Bacterial infections
Iffat KHANUM
Poster P4149
Abstract 7430
Successful clinical and microbiological resolution of carbapenem-resistant Acinetobacter baumannii in a central nervous system infection in an oncological patient
30/04 12:00
12b. Bacterial infections
Odeli Nicole ENCINAS SEJAS
Poster P4150
Abstract 7552
Tracheobronchitis caused by Mycoplasma hominis in a polytraumatised patient, a finding with clinical repercussions
30/04 12:00
12b. Bacterial infections
Lais SIMONATO ALTOE
Poster P4151
Abstract 7594
Corneal abscess due to Mycobacterium abscessus
30/04 12:00
12b. Bacterial infections
Maria Angeles ASENCIO
Poster P4152
Abstract 7604
Hemophagocytic lymph histiocytosis: a fatal complication of rickettsial infection
30/04 12:00
12b. Bacterial infections
Kamlesh BISHT
Poster P4153
Abstract 7645
Streptococcus equi sp. zooepidemicus meningoencephalitis: an emerging microorganism in northeastern Brazil
30/04 12:00
12b. Bacterial infections
Luís Arthur Brasil GADELHA FARIAS
Poster P4154
Abstract 7668
Whipple disease posing as ear-nose-throat malignancy: a diagnostic challenge
30/04 12:00
12b. Bacterial infections
Andreea STANCIU
Poster P4155
Abstract 7727
Intrigue in the isles: investigating the first presumed indigenous case of tularaemia in the United Kingdom
30/04 12:00
12b. Bacterial infections
Isra HALIM
Poster P4156
Abstract 7837
A case of brain abscess due to Capnocytophaga Sputigena
30/04 12:00
12b. Bacterial infections
Özcan SARBAT
Poster P4157
Abstract 7843
Disseminated Mycobacterium abscessus infection
30/04 12:00
12b. Bacterial infections
Hajir ABID
Poster P4158
Abstract 7910
Disseminated Coccidioidomycosis in a patient with HIV
30/04 12:00
12b. Bacterial infections
Maria Luisa GURRUCHAGA YANES
Poster P4159
Abstract 8043
Primary pyogenic ventriculitis caused by Neisseria meningitidis Serogroup Y
30/04 12:00
12b. Bacterial infections
Gavin Francis KELLY
Poster P4160
Abstract 8054
Precision therapy at its the best: Escherichia coli empyema successfully treated with bacteriophage therapy
30/04 12:00
12b. Bacterial infections
Holly SINCLAIR
Poster P4161
Abstract 8098
From scalp to spine: an interesting case of cutaneous actinomycoses leading to brain invasion
30/04 12:00
12b. Bacterial infections
Naman LODHA
Poster P4162
Abstract 8102
Mycoplasma hominis and two severe clinical presentations
30/04 12:00
12b. Bacterial infections
Laura HUYVENEERS
Poster P4163
Abstract 8121
Acute myocarditis following Campylobacter jejuni enterocolitis: a rare but potentially severe sequelae
30/04 12:00
12b. Bacterial infections
Amrei VON BRAUN
Poster P4164
Abstract 8197
Bacteriophage therapy for extensively drug-resistant Klebsiella aerogenes infection due to necrotising pancreatitis demonstrating in vivo bacterial and phage coevolution and phage resistance.
30/04 12:00
12b. Bacterial infections
Holly A SINCLAIR
Poster P4165
Abstract 8209
Meningococcal pneumonia: diagnosis by blood culture
30/04 12:00
12b. Bacterial infections
Natalia GONZÁLEZ ESPINOSA
Poster P4166
Abstract 8309
Vancomycin variable Enterococci (VVE) responsible for two cases of severe bloodstream infections in immunocompromised patients colonised with vancomycin resistance Enterococcus faecium (VRE)
30/04 12:00
12b. Bacterial infections
Andrea DESSILANI
Poster P4167
Abstract 8349
Native valve endocarditis caused by coagulase negative Staphylococcus kloosii
30/04 12:00
12b. Bacterial infections
Anne-Marie DOLAN
Poster P4168
Abstract 8474
Ceftazidime-related neurotoxicity: what is the ceiling?
30/04 12:00
12b. Bacterial infections
Dorian VANNESTE
Poster P4169
Abstract 8701
Hypervirulent Klebsiella pneumoniae (HvKp) strains in a teaching hospital
30/04 12:00
12b. Bacterial infections
Domingo FERNÁNDEZ VECILLA
Poster P4170
Abstract 8711
A fatal case of septic shock caused by Vibrio cholerae non-O1/O139 in patient with diffuse lymphoma B cells in Italy
30/04 12:00
12b. Bacterial infections
Federica GUIDA MARASCIA
Poster P4171
Abstract 8713
A fatal case of Catabacter hongkongensis
30/04 12:00
12b. Bacterial infections
Nouf ALMAGHLOUTH
Poster P4172
Abstract 8760
An outbreak of Streptococcus equi infection in Italy: clinical features
30/04 12:00
12b. Bacterial infections
Simona COLADONATO
Poster P4173
Abstract 8827
Mom, my knee hurts! Lyme disease arthritis
30/04 12:00
12b. Bacterial infections
Maria Luisa GURRUCHAGA YANES
Poster P4174
Abstract 8858
Melioidosis in northern Luzon, Philippines: a case series
30/04 12:00
12b. Bacterial infections
Keren Joy COMPELIO
Poster P4175
Abstract 8864
Uncommon presentation of cutaneous botryomycosis in an immunocompetent patient
30/04 12:00
12b. Bacterial infections
Sagarika NANDA
Poster P4176
Abstract 8892
The valve was the key: the importance of microbiology techniques
30/04 12:00
12b. Bacterial infections
Maria Del Mar ARENAS MIRAS
Poster P4177
Abstract 8945
Murine typhus triggering haemophagocytic lymphohistiocytosis in an immunocompromised host
30/04 12:00
12b. Bacterial infections
Nicholas POWER
Poster P4178
Abstract 8950
Multifocal actinomycosis in a penicillin-allergic patient
30/04 12:00
12b. Bacterial infections
Rebecca RYAN
Poster P4179
Abstract 8989
Undifferenciated fever: a diagnostic odyssey
30/04 12:00
12b. Bacterial infections
Cristina MARCELO CALVO
Poster P4180
Abstract 8990
Crossing the diagnostic gap
30/04 12:00
12b. Bacterial infections
Abusalem LANA
Poster P4181
Abstract 8998
Ureaplasma spp. peritonitis resulting in hyperammonemia and coma in a heart transplant patient following intrauterine device removal: a case report
30/04 12:00
12b. Bacterial infections
Matthew DRIEDGER
Poster P4182
Abstract 44
Central line-associated Cyberlindnera fabianii fungemia: an emerging fungal pathogen
30/04 12:00
12c. Fungal infections
Gawahir A. ALI
Poster P4183
Abstract 76
Aspergillus endocarditis in an immunocompetent host
30/04 12:00
12c. Fungal infections
Wenjie HUANG
Poster P4184
Abstract 82
Disseminated sporotrichosis in a healthy elderly
30/04 12:00
12c. Fungal infections
Parissada ANUGOOLGARN
Poster P4185
Abstract 187
COVID-19 pneumonitis and reactivation of an endemic mycoses
30/04 12:00
12c. Fungal infections
Catherine JONES
Poster P4186
Abstract 273
Navigating the maze: A 52-year-old man with brain abscess
30/04 12:00
12c. Fungal infections
Sandhya NAGARAKANTI
Poster P4187
Abstract 314
Clinical presentation and management of concurrent infection with Talaromyces marneffei, Cryptococcus neoformans, and nocardiosis in AIDS patient
30/04 12:00
12c. Fungal infections
Laddarat SRIKHAM
Poster P4188
Abstract 384
Diffuse fibrosing mediastinitis with predominant cardiac involvement due to Aspergillus in an immunocompetent patient
30/04 12:00
12c. Fungal infections
Sreethish SASI
Poster P4189
Abstract 444
Lips don't lie: a curious case of facial swelling in a child
30/04 12:00
12c. Fungal infections
Souradeep CHOWDHURY
Poster P4190
Abstract 500
Paracoccidioidomycosis with dramatic skin manifestations
30/04 12:00
12c. Fungal infections
Aliya REHMAN
Poster P4191
Abstract 832
Scedosporium apiospermum peritonitis in patient with continuous ambulatory peritoneal dialysis: a first case report in Thailand
30/04 12:00
12c. Fungal infections
Nattapat NITINAI
Poster P4192
Abstract 881
Successful treatment of severe pulmonary mucormycosis presenting with left lung consolidation and endobronchial obstruction
30/04 12:00
12c. Fungal infections
Cunliang CAI
Poster P4193
Abstract 1197
Cryptococcal myelitis in an immunocompetent patient
30/04 12:00
12c. Fungal infections
Queency Joy BATUCAN
Poster P4194
Abstract 1357
Severe musculoskeletal manifestations of lower extremity coccidioidomycosis: a case series
30/04 12:00
12c. Fungal infections
William ESTES
Poster P4195
Abstract 1429
Candida meningitis and sepsis in an immunocompromised patient with a complication of cerebral sinus venous thrombosis
30/04 12:00
12c. Fungal infections
Marius OGENSKAS
Poster P4196
Abstract 1608
Gastrointestinal basidiobolomycosis, a rare fungal infection: challenging to diagnose yet treatable
30/04 12:00
12c. Fungal infections
Hasti KAMALI SARVESTANI
Poster P4197
Abstract 1709
Human skin infection from Trichophyton verrucosum: a case report presentation
30/04 12:00
12c. Fungal infections
Georgia VRIONI
Poster P4198
Abstract 1895
Uncommon Neosartorya hiratsukae fungus as a causative agent of endophthalmitis
30/04 12:00
12c. Fungal infections
Cristian MATEO LEÓN
Poster P4199
Abstract 1964
Two case reports of disseminated cryptococcosis in patients with anti-granulocyte-macrophage colony-stimulating factor autoantibodies
30/04 12:00
12c. Fungal infections
Sureerat WATCHARASUWANSEREE
Poster P4200
Abstract 2005
Aspergillus endocarditis in a patient with chronic lymphocytic leukemia
30/04 12:00
12c. Fungal infections
Luca MEZZADRI
Poster P4201
Abstract 2007
FDG WBC scan as a diagnostic method in a patient with an equivocal recurrence of pulmonary aspergillosis: a case report
30/04 12:00
12c. Fungal infections
Mohammadreza SALEHI
Poster P4202
Abstract 2166
Enhancing patient care through molecular fungal diagnostics: two clinical cases in the UAE
30/04 12:00
12c. Fungal infections
Akela Ahmed GHAZAWI
Poster P4203
Abstract 2485
Tinea corporis caused by a rare, dysgonic strain of Microsporum canis: a case report
30/04 12:00
12c. Fungal infections
Athanasia SERGOUNIOTI
Poster P4204
Abstract 2599
Meningitis as a complication of progressive disseminated histoplasmosis
30/04 12:00
12c. Fungal infections
Omayra CHINCHA
Poster P4205
Abstract 2868
Safety of prolonged use of rezafungin in two difficult-to-treat azole-resistant Candida tropicalis infections in Lecco hospital, Italy
30/04 12:00
12c. Fungal infections
Valentina MORENA
Poster P4206
Abstract 3106
Mixed sinus and subcutaneous phaeohyphomycosis in a lung transplant recipient
30/04 12:00
12c. Fungal infections
Isabel RAMIREZ
Poster P4207
Abstract 3276
Mixed invasive pulmonary aspergillosis and mucormycosis in prospective format in (non)neutropaenic patients: two cases of early diagnosis with non-invasive sampling
30/04 12:00
12c. Fungal infections
Radim DOBIAS
Poster P4208
Abstract 3896
Chorioamnionitis by Candida spp:a decade of cases in a tertiary hospital
30/04 12:00
12c. Fungal infections
Pedro SUAREZ URQUIZA
Poster P4209
Abstract 3914
Subcutaneous zygomycosis in an immunocompetent child
30/04 12:00
12c. Fungal infections
Divya NANDAKUMAR
Poster P4210
Abstract 4071
Report of the first case of disseminated lomentosporiosis in Singapore
30/04 12:00
12c. Fungal infections
Geraldine GOH
Poster P4211
Abstract 4089
Rapidly progressive fungal infection in a seemingly immunocompetent patient, a diagnostic conundrum
30/04 12:00
12c. Fungal infections
Sagarika NANDA
Poster P4212
Abstract 4112
Treatment of chronic pulmonary aspergillosis with isavuconazole: an indication to perform routine TDM?
30/04 12:00
12c. Fungal infections
Deborah LUSETTI
Poster P4213
Abstract 4205
TDM-guided isavuconazole treatment for cerebro-pulmonary aspergillosis in severe liver impairment
30/04 12:00
12c. Fungal infections
Riccardo UNGARO
Poster P4214
Abstract 4629
Early confirmation of a severe candidaemia caused by Candida albicans in a critical ill patient due to next-generation sequencing results
30/04 12:00
12c. Fungal infections
Sebastian DECKER
Poster P4215
Abstract 4659
Disseminated cryptococcal infection by Cryptococcus gattii in an imunocompetent host presenting with a pulmonary mass and headache
30/04 12:00
12c. Fungal infections
Thiago NETTO
Poster P4216
Abstract 4948
Aspergillus sydowii endocarditis in a patient with a history of drug abuse: a case report
30/04 12:00
12c. Fungal infections
Agnese GIACCONE
Poster P4217
Abstract 5296
Failure of Vitek2 equipment in the identification of Hanseniaspora, a rare yeast of doubtful pathogenicity: report of two cases
30/04 12:00
12c. Fungal infections
Alexander JIMBO ZAPATA
Poster P4218
Abstract 5480
Cryptococcal meningitis in Timor-Leste: a case series
30/04 12:00
12c. Fungal infections
Lucia Florenciana TOTO
Poster P4219
Abstract 5574
Aspergillus endocarditis: a rare presentation of invasive aspergillosis
30/04 12:00
12c. Fungal infections
Faiza MUHAMMAD ILYAS
Poster P4220
Abstract 5722
Interdisciplinary and multimodal seamless cooperation successfully cured one case of hemoptysis pulmonary mucormycosis
30/04 12:00
12c. Fungal infections
Yanfen LIU
Poster P4221
Abstract 5842
Subcutaneous phaeohyphomycosis caused by an emerging fungus Parathyridaria percutanea in an immunocompetent host: a first case from central India
30/04 12:00
12c. Fungal infections
Girish PATIL
Poster P4222
Abstract 6258
Uncommon presentation of cutaneous Basidiobolomycosis: a mimicry of Mucormycosis
30/04 12:00
12c. Fungal infections
Tejasvi KANAGIRI
Poster P4223
Abstract 6377
Aspergillus fumigatus: a rare postoperative peritonitis case report
30/04 12:00
12c. Fungal infections
Marie-Alice BOVY
Poster P4224
Abstract 6642
A case of PUO in immunocompetent person-time to consider commonly missed uncommon agent
30/04 12:00
12c. Fungal infections
Hardik PATEL
Poster P4225
Abstract 6693
Cryptococcal meningoencephalitis in a multiple sclerosis patient receiving fingolimod
30/04 12:00
12c. Fungal infections
Noor-Mohammad ABDUL-HAQU
Poster P4226
Abstract 6770
Clival canal defect causing recurrent meningitis and Aspergillus fumigatus brainstem abscess in an immunocompetent child
30/04 12:00
12c. Fungal infections
James HATCHER
Poster P4227
Abstract 6800
Cryptococcal osteomyelitis manifesting in a leprosy patient: an incidental detection
30/04 12:00
12c. Fungal infections
Sushree SARATHI
Poster P4228
Abstract 7274
Mucorales PCR in blood for early and non-invasive diagnosis of mucormycosis: a confronting case-series
30/04 12:00
12c. Fungal infections
Robina AERTS
Poster P4229
Abstract 7324
Trichophyton rubrum-induced majocchi's granuloma in an immunocompetent individual mimicking fish tank granulomatous disease
30/04 12:00
12c. Fungal infections
Mauricio ARIAS
Poster P4230
Abstract 7451
A difficult diagnosis: concomitant antisynthetase syndrome and coccidioidomycosis infection
30/04 12:00
12c. Fungal infections
Diego ERDMENGER
Poster P4231
Abstract 7942
An atypical case of cutaneous mucormycosis caused by Saksenaea sp. in an immunocompetent patient
30/04 12:00
12c. Fungal infections
David Adolfo SUAREZ SILVA
Poster P4232
Abstract 8052
Successful management of chronic pulmonary mucormycosis with multi-facet diagnosis and non-surgical therapy: a case series
30/04 12:00
12c. Fungal infections
Yiyi QIAN
Poster P4233
Abstract 8391
A cryptic conundrum
30/04 12:00
12c. Fungal infections
Kruthi MALUR
Poster P4234
Abstract 8545
Direct identification of Cladophialophora bantiana by sequencing from a cerebral biopsy specimen
30/04 12:00
12c. Fungal infections
Jacques SEVESTRE
Poster P4235
Abstract 8613
Metagenomic next-generation sequencing promotes the diagnosis of Rhizomucor pusillus infection
30/04 12:00
12c. Fungal infections
Xiaoli ZHOU
Poster P4236
Abstract 8666
Osteomyelitis of the skull caused by Apophysomyces variabilis in an immunocompetent patient after a road-traffic accident in Ghana
30/04 12:00
12c. Fungal infections
Maria Alejandra REHNFELDT
Poster P4237
Abstract 8857
Pneumocystis pneumonia and pulmonary tuberculosis coinfection in an HIV-seronegative older patient
30/04 12:00
12c. Fungal infections
Battikh RIADH
Poster P4238
Abstract 16
Refractory inflammatory bowel disease: Entamoeba histolytica, the forgotten suspect
30/04 12:00
12d. Parasitic infections
Catherine DOMINIC
Poster P4239
Abstract 525
Challenges in screening for Strongyloides: a case of delayed detection
30/04 12:00
12d. Parasitic infections
Caitlin TROTTIER
Poster P4240
Abstract 729
Multiple episodes of Plasmodium malariae despite antimalarial treatment: “quartana te teneat”?
30/04 12:00
12d. Parasitic infections
Federica SALARI
Poster P4241
Abstract 824
Unusual presentation of fever and gastrointestinal symptoms in a traveller returning from Nigeria: A case report
30/04 12:00
12d. Parasitic infections
Anna BOTÉ CASAMITJANA
Poster P4242
Abstract 837
Chronic diarrhoea and failure of oral therapy: treatment of strongyloides hyperinfection with subcutaneous ivermectin in an immunocompromised patient
30/04 12:00
12d. Parasitic infections
Peter CONLON
Poster P4243
Abstract 923
Non-surgical exceptional management of inoperable vertebral hydatidosis with radiotherapy and nitazoxanide
30/04 12:00
12d. Parasitic infections
Maria F RAMIREZ HIDALGO
Poster P4244
Abstract 990
Concomitant parenchymal, subarachnoid, and ventricular neurocysticercosis: a case report with a three-year follow-up
30/04 12:00
12d. Parasitic infections
Maria Letizia GIANCOLA
Poster P4245
Abstract 1217
Swimming with buffaloes: a case of recurrent nasal polyps
30/04 12:00
12d. Parasitic infections
Yuan Yi Constance CHEN
Poster P4246
Abstract 1309
Strongyloides hyperinfection associated with Escherichia coli bacteremia, purulent meningitis and ventriculitis
30/04 12:00
12d. Parasitic infections
Luca CECCARELLI
Poster P4247
Abstract 1802
Leishmania induced hemophagocytic lymphohistiocytosis (HLH) syndrome in a patient with systemic lupus erythematosus (SLE)
30/04 12:00
12d. Parasitic infections
Sunit SIKDAR
Poster P4248
Abstract 1842
Challenging rapid diagnostic test in a rare Plasmodium malariae infection considered as a prozone-like phenomenon
30/04 12:00
12d. Parasitic infections
Frieder FUCHS
Poster P4249
Abstract 1986
Hepatitis C virus (HCV) antibody false positive due to tapeworm infection: a potential new public health concern in HCV diagnosis, a case report
30/04 12:00
12d. Parasitic infections
Yusuke AINODA
Poster P4250
Abstract 2196
An unexpected case: relapsing laryngeal leishmaniasis in an asthmatic woman in Northern Italy
30/04 12:00
12d. Parasitic infections
Serena REATO
Poster P4251
Abstract 3436
Myocardial and mediastinal hydatid cysts
30/04 12:00
12d. Parasitic infections
Raffaella LISSANDRIN
Poster P4252
Abstract 4415
A case of neurocysticercosis thought to be glial tumor
30/04 12:00
12d. Parasitic infections
Elif ATES
Poster P4253
Abstract 4653
The crucial role of early diagnosis in disseminated toxoplasmosis: urging vigilance in the high-risk allogenic-haematologic-stem-cells (allo-HSCT) population
30/04 12:00
12d. Parasitic infections
Fabiana DELLAI
Poster P4254
Abstract 4722
Recurrence of visceral leishmaniasis in immunocompromised patients: experience of long-term treatment with miltefosine at Careggi University Hospital
30/04 12:00
12d. Parasitic infections
Flavia CHECHI
Poster P4256
Abstract 5138
A case of Echinococcus multilocularis acquired in Ontario
30/04 12:00
12d. Parasitic infections
Rahel ZEWUDE
Poster P4257
Abstract 5214
A tale of two lungs, overcoming challenges in managing a complicated pulmonary hydatid cyst with rupture
30/04 12:00
12d. Parasitic infections
Sagarika NANDA
Poster P4258
Abstract 5551
Case series of difficult to treat Giardia intestinalis infections in the immnuocompromised patients seen at the Hospital for Tropical Diseases, London
30/04 12:00
12d. Parasitic infections
Gauri GODBOLE
Poster P4259
Abstract 5805
Primary amoebic meningoencephalitis in a solid-organ transplant recipient
30/04 12:00
12d. Parasitic infections
Adrian Anthony ALEXANDER
Poster P4260
Abstract 5848
Amoebic brain abscess in a tertiary hospital in the Philippines: a case report
30/04 12:00
12d. Parasitic infections
Margie Angelica SIGUE
Poster P4261
Abstract 5891
Is artesunate related to pancreatitis? Description of a case report and review of literature and pharmacovigilance databases
30/04 12:00
12d. Parasitic infections
Alex ALMUEDO-RIERA
Poster P4262
Abstract 6214
A special cause of acute scrotum
30/04 12:00
12d. Parasitic infections
Szofia HAJÓSI-KALCAKOSZ
Poster P4263
Abstract 6247
Mucocutaneous leishmaniasis caused by Leishmania infantum in Europe
30/04 12:00
12d. Parasitic infections
Marie-Therese LEIBENGUTH
Poster P4264
Abstract 6497
Unmasking of visceral leishmaniasis in a patient with a haemophagocytic lymphohistiocytosis (HLH) syndrome in an endemic setting
30/04 12:00
12d. Parasitic infections
Aida MARY VARGHESE
Poster P4265
Abstract 6573
Autochthonous myiasis in infected ulcers: A case report
30/04 12:00
12d. Parasitic infections
Lucía TEJEDOR CANTERO
Poster P4266
Abstract 6617
Hydatidosis in a university hospital in northern Spain over a 5-year period
30/04 12:00
12d. Parasitic infections
Domingo FERNÁNDEZ VECILLA
Poster P4267
Abstract 7045
NGS-characterised infection with Dibothriocephalus latus after consumption of supermarket sushi, France
30/04 12:00
12d. Parasitic infections
Marie Gladys ROBERT
Poster P4268
Abstract 7262
Cutaneous leishmaniasis in Brazil diagnosed by a metagenomic approach
30/04 12:00
12d. Parasitic infections
Andre DOI
Poster P4269
Abstract 7272
Löffler's syndrome due to toxocariasis in male patient
30/04 12:00
12d. Parasitic infections
Giorgio GIANNETTA
Poster P4271
Abstract 8296
Strictures are forever: a case of delayed diagnosis of urogenital schistosomiasis in a patient with obstructive uropathy in a non-endemic setting
30/04 12:00
12d. Parasitic infections
Evdoxia DOUMOULIAKA
Poster P4272
Abstract 8355
Severe non-falciparum malaria with atypical pulmonary involvement
30/04 12:00
12d. Parasitic infections
Ana María GUTIÉRREZ BAENA
Poster P4273
Abstract 8488
An uncommon case of a fleeting rash from Western Rajasthan
30/04 12:00
12d. Parasitic infections
Vibhor TAK
Poster P4274
Abstract 8518
Schistosomiasis unveiled: navigating clinical challenges in non-endemic regions
30/04 12:00
12d. Parasitic infections
Clara CARRERAS-ABAD
Poster P4275
Abstract 8540
One thing is certain on Bamako: everything is uncertain
30/04 12:00
12d. Parasitic infections
Éva Lívia NAGY
Poster P4276
Abstract 8888
Case of Fasciola infection with fever and hepatitis in a chronic lymphocytic leukaemia patient under remission
30/04 12:00
12d. Parasitic infections
Simge SEKIN
Poster P4277
Abstract 57
Disseminated macrolide-resistant Mycobacterium intracellulare infection in a non-HIV paediatric patient: a case report
30/04 12:00
12e. Other unusual clinical situations
Sophida BOONSATHORN
Poster P4278
Abstract 68
Use of next-generation sequencing for assessing and precisely modulating the vaginal microbiome with Lactobacillus crispatus
30/04 12:00
12e. Other unusual clinical situations
Jose ALEXANDER
Poster P4279
Abstract 305
"Silent" infective endocarditis (SIE): a new entity, a poor clinical evaluation or an incidental finding?
30/04 12:00
12e. Other unusual clinical situations
Luis Martin MOLTRASIO
Poster P4280
Abstract 1658
CMV meningitis and Rhodotorula coinfection in a term infant
30/04 12:00
12e. Other unusual clinical situations
Chhavi GUPTA
Poster P4281
Abstract 1987
Delayed diagnosis of chronic necrotising granulomatous skin lesions due to TAP2 deficiency
30/04 12:00
12e. Other unusual clinical situations
Ilad ALAVI DARAZAM
Poster P4282
Abstract 2020
Severe falciparum malaria requiring exchange transfusion in a returned traveler
30/04 12:00
12e. Other unusual clinical situations
Ravi Teja KANDIKUPPA
Poster P4283
Abstract 3060
Rituximab immunosoppression leading to fulminant enteroviruses hepatitis and capsulated bacteria meningitis
30/04 12:00
12e. Other unusual clinical situations
Marcello MAFFEZZONI
Poster P4284
Abstract 3204
An enigmatic case of unmasking nocardiosis immune reconstitution inflammatory syndrome (IRIS) in AIDS, unveiled after anti-retroviral therapy (HAART) initiation
30/04 12:00
12e. Other unusual clinical situations
Rohit KUMAR
Poster P4285
Abstract 3320
Relapsing melioidosis: the hunt for an unusual sanctuary site
30/04 12:00
12e. Other unusual clinical situations
Stephen WOOLLEY
Poster P4286
Abstract 3605
Eosinophilic meningoencephalitis successfully treated with glucocorticoids and intravenous immunoglobulin
30/04 12:00
12e. Other unusual clinical situations
Soo Hyun AHN
Poster P4287
Abstract 4002
Drug-induced aseptic meningitis: unveiling the role of levamisole
30/04 12:00
12e. Other unusual clinical situations
Mikita SALAVEI
Poster P4288
Abstract 4396
Successful treatment of pneumonia due to Mycobacterium goodii in a young, severely underweight 45-year-old woman
30/04 12:00
12e. Other unusual clinical situations
Francesca CATANIA
Poster P4290
Abstract 5648
Tuberculosis immune reconstitution syndrome (TB-IRIS) recurring eight years after the original diagnosis
30/04 12:00
12e. Other unusual clinical situations
Ole SKOUVIG PEDERSEN
Poster P4291
Abstract 6999
A storm of HHV-8: simultaneous multicentric Castleman's disease and visceral Kaposi sarcoma in a HIV-1 infected patient.
30/04 12:00
12e. Other unusual clinical situations
Pedro LEAL
Poster P4292
Abstract 7990
A case of alpha-gal syndrome: focus on the diagnosis and management of an emergent tick-borne disease
30/04 12:00
12e. Other unusual clinical situations
Michelle ABBOTT
Poster P4293
Abstract 8119
Haemophagocytic lymphohistiocytosis driven by hepato-splenic tuberculosis
30/04 12:00
12e. Other unusual clinical situations
Ali ALAM
Poster P4294
Abstract 8199
Acute generalised exanthematous pustulosis caused by meropenem: an uncommon reaction to a common drug
30/04 12:00
12e. Other unusual clinical situations
Sagar CHANDRAKAR
Poster P4295
Abstract 8322
An atypical and rare case of primary facial palsy caused by Mycoplasma pneumoniae and literature review
30/04 12:00
12e. Other unusual clinical situations
Anusha RATHI
Poster P4296
Abstract 8544
Cutaneous tuberculosis presenting as isolated para-articular swellings
30/04 12:00
12e. Other unusual clinical situations
Sudharshan JAGENNATH
Poster P4297
Abstract 8717
Management of a patient with multi-resistant HIV infectionstrain undergoingin allogeneic stem cell transplant
30/04 12:00
12e. Other unusual clinical situations
Zeno PASQUINI
Poster P4299
Abstract 8964
Cerebral toxoplasmosis and persistent Enterovirus encephalitis in a woman with thymoma-associated Good's syndrome
30/04 12:00
12e. Other unusual clinical situations
Frederike WALDECK
Poster P4300
Abstract 8978
Surviving the unseen battle: pulmonary mucormycosis and bacterial Infections in post-renal transplant Patient
30/04 12:00
12e. Other unusual clinical situations
Radhika SARDA